Chiral Separations by Liquid Chromatography Theory and Applications

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.
Chiral Separations by
Liquid Chromatography
and Related Technologies
Hassan Y. Aboul-Enein
King Faisal Specialist Hospital and Research Centre
Riyadh, Saudi Arabia
lmran Ali
National Insitute of Hydrology
Roorkee, India
a%MARCEL
DEKKER
MARCEL
DEKKER,
INC. NEWYORK BASEL

Although great care has been taken to provide accurate and current information, neither the
author(s) nor the publisher, nor anyone else associated with this publication, shall be liable
for any loss, damage, or liability directly or indirectly caused or alleged to be caused by
this book. The material contained herein is not intended to provide specific advice or
recommendations for any specific situation.
Trademark notice: Product or corporate names may be trademarks or registered trademarks

and are used only for identification and explanation without intent to infringe.
Library of Congress Cataloging-in-Publication Data

A catalog record for this book is available from the Library of Congress.
ISBN: 0-8247-4014-9
This book is printed on acid-free paper.
Headquarters
Marcel Dekker, Inc., 270 Madison Avenue, New York, NY 10016, U.S.A.
tel: 212-696-9000; fax: 212-685-4540
Distribution and Customer Service

Marcel Dekker, Inc., Cimarron Road, Monticello, New York 12701, U.S.A.
tel: 800-228-1160; fax: 845-796-1772
Eastern Hemisphere Distribution

Marcel Dekker AG, Hutgasse 4, Postfach 812, CH-4001 Basel, Switzerland
tel: 41-61-260-6300; fax: 41-61-260-6333
World Wide Web

http:==www.dekker.com
The publisher offers discounts on this book when ordered in bulk quantities. For more
information, write to Special Sales=Professional Marketing at the headquarters address
above.
Copyright # 2003 by Marcel Dekker, Inc. All Rights Reserved.
Neither this book nor any part may be reproduced or transmitted in any form or by any
means, electronic or mechanical, including photocopying, microfilming, and recording, or
by any information storage and retrieval system, without permission in writing from the
publisher.
Current printing (last digit):
10 9 8 7 6 5 4 3 2 1
PRINTED IN THE UNITED STATES OF AMERICA

CHROMATOGRAPHIC SCIENCE SERIES
A Series of Textbooks and Reference Books
Editor: JACK CAZES
1. Dynamics of Chromatography: Principles and Theory, J. Calvin Giddings

2. Gas Chromatographic Analysis of Drugs and Pesticides, Benjamin J. Gud-
zinowicz
3. Principles of Adsorption Chromatography: The Separation of Nonionic Or-
ganic Compounds, Lloyd R. Snyder
4. Multicomponent Chromatography: Theory of Interference, Friedrich Helf-
ferich and Gerhard Klein
5 . Quantitative Analysis by Gas Chromatography, Josef Novak
6. High-speed Liquid Chromatography, Peter M. Rajcsanyi and Elisabeth
Rajcsanyi
7. Fundamentals of Integrated GC-MS (in three parts), Benjamin J. Gud-
zinowicz, Michael J. Gudzinowicz, and Horace F. Martin
8. Liquid Chromatography of Polymers and Related Materials, Jack Cazes
9. GLC and HPLC Determination of Therapeutic Agents (in three parts), Part
1 edited by Kiyoshi Tsuji and Walter Morozowich, Parts 2 and 3 edited by
Kiyoshi Tsuji
10. BiologicallBiomedical Applications of Liquid Chromatography, edited by
Gerald L. Hawk
11. Chromatography in Petroleum Analysis, edited by Klaus H. Altgelt and T.
H. Gouw
12. BiologicallBiomedical Applications of Liquid Chromatography II, edited by
Gerald L. Hawk
13. Liquid Chromatography of Polymers and Related Materials I I , edited by
Jack Cazes and Xavier Delamare
14. Introduction to Analytical Gas Chromatography: History, Principles, and
Practice, John A. Perry
15. Applications of Glass Capillary Gas Chromatography, edited by Walter G.
Jennings
16. Steroid Analysis by HPLC: Recent Applications, edited by Mane P. Kautsky
17. Thin-Layer Chromatography: Techniques and Applications, Bernard Fried
and Joseph Sherma
18. BiologicallBiomedicalApplications of Liquid Chromatography Ill, edited by
Gerald L. Hawk
19. Liquid Chromatography of Polymers and Related Materials 111, edited by
Jack Cazes
20. BiologicallBiomedical Applications of Liquid Chromatography, edited by
Gerald L. Hawk
21. Chromatographic Separation and Extraction with Foamed Plastics and
Rubbers, G. J. Moody and J. D. R. Thomas
22. Analytical Pyrolysis: A Comprehensive Guide, William J. Irwin
23. Liquid Chromatography Detectors, edited by Thomas M. Vickrey
24. High-Performance Liquid Chromatography in Forensic Chemistry, edited
by Ira S. Lurie and John D. Wither, Jr.
25. Steric Exclusion Liquid Chromatography of Polymers, editedby Josef Janca
26. HPLC Analysis of Biological Compounds: A Laboratory Guide, Wi/liam S.
Hancock and James T. Sparrow

27. Aftinity Chromatography: Template Chromatography of Nucleic Acids and
Proteins, Herbert Schott
28. HPLC in Nucleic Acid Research: Methods and Applications, edited by
Phyllis R. Brown
29. Pyrolysis and GC in Polymer Analysis, edited by S. A. Liebman and E. J.
Levy
30. Modern Chromatographic Analysis of the Vitamins, edited by Andre P. De
Leenheer, Willy E. Lambert, and Marcel G. M. De Ruyter
31. Ion-Pair Chromatography, edited by Milton T. W. Hearn
32. Therapeutic Drug Monitoring and Toxicology by Liquid Chromatography,
edited by Steven H . Y. Wong
33. Aftinity Chromatography: Practical and Theoretical Aspects, Peter Mohr
and Klaus Pommerening
34. Reaction Detection in Liquid Chromatography, edited by Ira S. Krull
35. Thin-Layer Chromatography: Techniques and Applications. Second Edi-
tion, Revised and Expanded, Bernard Fried and Joseph Sherma
36. Quantitative Thin-Layer Chromatography and Its Industrial Applications,
edited by Laszlo R. Treiber
37. Ion Chromatography, edited by James G. Tarter
38. Chromatographic Theory and Basic Principles, edited by Jan Ake Jonsson
39. Field-Flow Fractionation: Analysis of Macromolecules and Particles, Josef
Janca
40. Chromatographic Chiral Separations, edited by Moms Zief and Laura J. Crane
41. Quantitative Analysis by Gas Chromatography: Second Edition, Revised
and Expanded, Josef Novak
42. Flow Perturbation Gas Chromatography, N. A. Katsanos
43. Ion-Exchange Chromatography of Proteins, Shuichi Yamamoto, Kazuhiro
Nakanishi, and Ryuichi Matsuno
44. Countercurrent Chromatography: Theory and Practice, edited by N. Bhu-
shan Mandava and Yoichiro It0
45. Microbore Column Chromatography: A Unified Approach to Chroma-
tography, edited by Frank J. Yang
46. Preparative-Scale Chromatography, edited by Eli Grushka
47. Packings and Stationary Phases in Chromatographic Techniques, edited
by Klaus K. Unger
48. Detection-Oriented Derivatization Techniques in Liquid Chromatography,
edited by Henk Lingeman and Willy J. M. Underberg
49. Chromatographic Analysis of Pharmaceuticals, edited by John A.
Adamovics
50. Multidimensional Chromatography: Techniques and Applications, edited
by Hernan Cortes
51. HPLC of Biological Macromolecules: Methods and Applications, edited by
Karen M. Gooding and Fred E. Regnier
52. Modern Thin-Layer Chromatography, edited by Nelu Grinberg
53. Chromatographic Analysis of Alkaloids, Milan Popl, Jan Fahnrich, and
Vlastimil Tatar
54. HPLC in Clinical Chemistry, 1. N. Papadoyannis
55. Handbook of Thin-Layer Chromatography, edited by Joseph Sherma and
Bernard Fried
56. Gas-Liquid-Solid Chromatography, V. G. Berezkin
57. Complexation Chromatography, edited by D. Cagniant
58. Liquid Chromatography-Mass Spectrometry, W.M. A. Niessen and Jan
van der Greef
59. Trace Analysis with Microcolumn Liquid Chromatography, Milos Krejcl

60. Modern Chromatographic Analysis of Vitamins: Second Edition, edited b y
Andre P. De Leenheer, Willy E. Lambed, and Hans J. Nelis
61. Preparative and Production Scale Chromatography, edited by G. Ganetsos
and P. E. Barker
62. Diode Array Detection in HPLC, edited by Ludwig Huber and Stephan A.
George
63. Handbook of Affinity Chromatography, edited by Toni Kline
64. Capillary Electrophoresis Technology, edited by Norberfo A. Guzman
65. Lipid Chromatographic Analysis, edited by Takayuki Shibamoto
66. Thin-Layer Chromatography: Techniques and Applications, Third Edition,
Revised and Expanded, Bernard Fried and Joseph Sherma
67. Liquid Chromatography for the Analyst, Raymond P. W. Scoff
68. Centrifugal Partition Chromatography, edited b y Alain P. Foucault
69. Handbook of Size Exclusion Chromatography, edited b y Chi-san Wu
70. Techniques and Practice of Chromatography, Raymond P. W. Scott
71. Handbook of Thin-Layer Chromatography: Second Edition, Revised and
Expanded, edited b y Joseph Sherma and Bernard Fried
72. Liquid Chromatography of Oligomers, Constantin V. Uglea
73. Chromatographic Detectors: Design, Function, and Operation, Raymond
P. w. Scott
74. Chromatographic Analysis of Pharmaceuticals: Second Edition, Revised
and Expanded, edited by John A. Adamovics
75. Supercritical Fluid Chromatography with Packed Columns: Techniques
and Applications, edited by Klaus Anton and Claire Berger
76. Introduction to Analytical Gas Chromatography: Second Edition, Revised
and Expanded, Raymond P. W. Scott
77. Chromatographic Analysis of Environmental and Food Toxicants, edited by
Takayuki Shibamoto
78. Handbook of HPLC, edited by Nena Katz, Roy Eksteen, Peter Schoen-
makers, and Neil Miller
79. Liquid Chromatography-Mass Spectrometry: Second Edition, Revised and
Expanded, W. M. A. Niessen
80. Capillary Electrophoresis of Proteins, Tim Wehr, Roberto Rodriguez-Diaz,
and Mingde Zhu
81. Thin-Layer Chromatography: Fourth Edition, Revised and Expanded, Ber-
nard Fried and Joseph Sherma
82. Countercurrent Chromatography, edited by Jean-Michel Menet and Didier
Thiebaut
83. Micellar Liquid Chromatography, Alain Berfhod and Celia Garcia-Alvarez-
Coque
84. Modern Chromatographic Analysis of Vitamins: Third Edition, Revised and
Expanded, edited b y Andre P. De Leenheer, Willy E. Lambert, and Jan F.
Van Bocxlaer
85. Quantitative Chromatographic Analysis, Thomas E. Beesley, Benjamin
Buglio, and Raymond P. W. Scott
86. Current Practice of Gas Chromatography-Mass Spectrometry, edited b y
W. M. A. Niessen
87. HPLC of Biological Macromolecules: Second Edition, Revised and Ex-
panded, edited by Karen M. Gooding and Fred €. Regnier
88. Scale-Up and Optimization in Preparative Chromatography: Principles and
Biopharmaceutical Applications, edited b y Anurag S. Rathore and Ajoy
Velayudhan
89. Handbook of Thin-Layer Chromatography: Third Edition, Revised and Ex-
panded, edited by Joseph Sherma and Bernard Fried

90. Chiral Separations by Liquid Chromatography and Related Technologies,
Uassan Y. Aboul-Enein and lmran Ali
ADDITIONAL VOLUMES IN PREPARATION
Handbook of Size Exclusion Chromatography and Related Techniques,

Second Edition, Revised and Expanded, Chi-san Wu

Dedicated to the memory of my late parents,
Basheer Ahmed and Mehmudan Begum. Imran Ali
This book is dedicated to the memory of my father, Dr. Youssef Aboul-Enein,

my mother, and my wife, Najla Al-Mojadady, for her patience,
understanding, and never-ending support. Hassan Y. Aboul-Enein

Preface
The development of chiral resolution methods is considered an urgent need in

pharmaceutical, agricultural, and other chemical industries. Perhaps most essen-
tial is the development of new chiral drugs, which are necessary because of the
different physiological properties of enantiomers. Various approaches to chiral
resolution have been developed and used, but the direct resolution by liquid
chromatography on chiral stationary phases has proven to be one of the most
effective, practical, and economical. This volume deals with the art of chiral
resolution by liquid chromatography, focusing on high-performance liquid
chromatography (HPLC), sub- and supercritical fluid chromatography (SFC),
capillary electrochromatography (CEC), and thin-layer chromatography (TLC).
These methods are examined as they are used in analysis and development of
drugs, pharmaceuticals, xenobiotics, and other chiral molecules.
The book provides systematic and detailed descriptions of the numerous
approaches to chiral resolution. The first chapter is an introduction to basic
concepts of molecular chirality and liquid chromatography. Chapters 2 through 9
discuss the chiral resolution of various classes of chiral stationary phases. Chapter
10 deals with chiral resolution using chiral mobile phase additives. These
discussions elaborate the types, structures, and properties of the chiral phases,

as well as their preparations, their applications, and the future scope of chiral
resolution. It is our hope that this volume will be a valuable resource for
scientists, researchers, academics, and graduate students in the chromatographic
sciences.
ACKNOWLEDGMENTS
I express my deep regard and gratitude to my wife, Hajan Seema Imran, who has
helped me and supported me throughout this work. I also thank my dearest son,
Haji al Arsh Basheer Baichain, who has inspired me throughout this difficult job.
I would also like to acknowledge my other family members and relatives who
have helped me directly and indirectly during this period.
I also extend my sincere thanks to Professor Vinod K. Gupta, Chemistry
Department, Indian Institute of Technology, Roorkee, India, for his efforts in
helping me to complete this book. His constant moral support was a great help—
one that I will always remember. Finally, I would like to thank Mr. Russell Dekker
of Marcel Dekker, Inc.
Imran Ali
I would like to express my thanks to the administration of King Faisal Specialist

Hospital and Research Centre for their support of this work. Special thanks to Mr.
Russell Dekker and the editorial staff of Marcel Dekker, Inc., for their assistance
in publishing this book.
Hassan Y. Aboul-Enein

Contents
Preface
1 Introduction
1.1 Chirality and Its Occurrence
1.2 Chemical Evolution of Chirality
1.3 Chirality in Molecules
1.4 Chirality and Its Consequences in Biological Systems
1.5 Chirality and Drug Development
1.6 Chiral Drugs and Their Economic Status
1.7 Chirality and Its Consequence in the Environment
1.8 Resolution of Stereoisomers
1.9 Detection in Liquid Chromatography
1.10 Chiral Recognition Mechanisms
2 Polysaccharide-Based Chiral Stationary Phases

2.1 Polysaccharide Derivatives
2.2 Spectroscopic Studies

2.3 Preparation and Commercialization
2.4 Selectivities
2.5 Applications
2.6 Optimization of HPLC Conditions
2.8 Applications in Sub- and Supercritical Fluid Chromatography
2.9 Applications in Capillary Electrochromatography
2.10 Applications in Thin-Layer Chromatography
2.11 Conclusion
3 Cyclodextrin-Based Chiral Stationary Phases

3.1 Structures and Properties
3.3 Applications
3.5 Chiral Recognition Mechanism
3.6 Applications in Sub- and Supercritical Fluid
Chromatography
3.7 Applications in Capillary Electrochromatography
3.8 Conclusion
4 Macrocyclic Glycopeptide Antibiotics–Based Chiral Stationary

Phases
4.3 Applications
4.6 Miscellaneous Applications
4.7 Conclusion
5 Pirkle-Type and Related Chiral Stationary Phases

5.3 Applications
5.4 Optimization of High-Performance Liquid Chromatographic
Conditions
5.6 Applications in Sub- and Supercritical Fluid
Chromatography

5.8 Conclusion
6 Protein-Based Chiral Stationary Phases

6.3 Applications
6.7 Conclusion
7 Ligand Exchange–Based Chiral Stationary Phases

7.3 Applications
7.4 Optimization of High-Performance Liquid
Chromatographic Conditions
7.7 Conclusion
8 Crown Ether–Based Chiral Stationary Phases

8.3 Applications
8.4 Optimization of High-Performance Liquid
Chromatographic Conditions
8.7 Conclusion
9 Miscellaneous Types of Chiral Stationary Phase

9.1 Alkaloid-Based CSPs
9.2 Amide- and Amine-Based CSPs
9.3 Acid-Based CSPs
9.4 Synthetic Polymer–Based CSPs
9.5 Molecularly Imprinted CSPs

9.6 Miscellaneous CSP in SFC
9.7 Miscellaneous CSP in CEC
9.8 Miscellaneous CSP in TLC
9.10 Conclusion
10 Enantiomeric Separation by the Chiral Mobile Phase Additives

10.1 Cyclodextrin Mobile Phase Additives
10.2 Ligand-Exchanger Mobile Phase Additives
10.3 Protein Mobile Phase Additives
10.4 Macrocyclic Glycopeptide Antibiotic Mobile Phase
Additives
10.5 Miscellaneous Chiral Mobile Phase Additives
10.6 Chiral Mobile Phase Additives in SFC and CEC
10.7 Chiral Mobile Phase Additives in TLC
10.9 Conclusion

1
Introduction
1.1 CHIRALITY AND ITS OCCURRENCE

In 1883 Lord Kelvin used the term ‘‘chirality,’’ derived from the Greek kheir or
chiros for handedness [1]. Any object lacking the three elements of symmetry
(i.e., plane of symmetry, center of symmetry, and axis of symmetry) and existing
in two forms that are nonsuperimposable mirror images of each other is called a
chiral object. From elementary particles to humans, chirality is found in a wide
range of objects [2]. This observation suggests that chirality has very important
and essential roles in the existence of the universe and is still a mystery. Several
examples indicate the presence of chirality in our universe. In the ancient
kingdoms of Upper and Lower Egypt, many mural paintings in burial chambers
depict significant events in ways that emphasize their chirality [1]. Besides, out of
1168 galaxies listed in Carnegie Atlas of Galaxies, 540 are found to be chiral
when coupled with the direction of their recession velocities [3]. The influence of
the chirality is evident in plants and animals, where numerous examples of
asymmetric structures can be observed. For example, helical structures of plants
and animals make them asymmetric. Briefly, chirality exists almost everywhere in
this universe.

1.2 CHEMICAL EVOLUTION OF CHIRALITY
Study of the chemical evolution of chirality started in 1809 with the discovery of
Haüy [4], who postulated from crystal cleavage observations that a crystal and
each of its constituent space-filling molecules are images of each other in overall
shape. Later, in 1848, Pasteur reported the different destruction rates of the
dextro- and levorotatory forms of ammonium tartrate by the mold Penicillium
glaucum [5]. These observations could not be explained properly at that time, but
in 1874 Le Bel [6] and van’t Hoff [7] independently proposed that the four
valences of the carbon atom are directed toward the vertices of an atom-centered
tetrahedron. This finding allowed the development of the theory of the three-
dimensional structure of molecules by which the phenomenon of chirality and
Pasteur’s discovery were explained scientifically.
1.3 CHIRALITY IN MOLECULES

Generally, the phenomenon of chirality exists in organic molecules. However, it is
also found in some inorganic compounds. In some molecules, the carbon atoms
remain attached to four different atoms or groups. This arrangement makes the
whole molecule asymmetric. Molecules of this type differ in their three-dimen-
sional configurations and exist in two forms, which are mirror images of each
other. No matter what symmetry operation is applied to such molecule, it is never
possible to superimpose the two mirror images upon each other. These mirror
images are called optical isomers (having the capacity to rotate the plan polarized
light) or stereoisomers or enantiomers or enantiomorphs or antipodes or chiral
molecules. The existence of these different enantiomers comprises the phenom-
enon of stereoisomerism, or chirality. A 50 : 50 ratio of enantiomers is called a
racemic mixture. In addition to central chirality, axial chirality can occur in
allenes and cumulenes. In the former class, the substituents are not necessarily
different, since the second double bond causes the loss of the C3 rotational
symmetry element. In the latter class, only members with an odd number of
accumulated carbon atoms are potentially chiral, whereas an even number of
carbon atoms results in E=Z isomerism (geometric isomerism) [8].
Another type of axial chirality is represented by atropisomers, which
possess conformational chirality. As long as the ortho substituents in tetrasub-
stituted biaryls are large enough, the rotation around a C—C single bond will be
hindered, preventing the two forms from interconverting. Finally, there exists a
planar chirality that arises from the arrangement of atoms or groups of atoms
relative to a stereogenic plane. However, this form of chirality is rather rare [8].
Helicity is a special form of chirality and often occurs in macromolecules such as
biopolymers, proteins, and polysaccharides [9]. A helix is always chiral owing to
its right-handed (clockwise) or left-handed (counterclockwise) arrangement.

FIGURE 1 The different types of stereoisomerism: I, central chirality; II, axial chirality;
III, atropisomerism; IV, E-=Z-isomerism (geometrical).
When a stereoisomer has more than one stereogenic center (e.g., n), the number
of theoretically possible enantiomers can be derived from the 2n formula. The
four types of stereoisomerism are shown in Figure 1.
1.3.1 Nomenclature of Chiral Molecules

Another point connected to chirality is the nomenclature of enantiomers. In the
beginning, the optical isomers were distinguished with (þ) and () signs or d
(dextro) and l (levo), indicating the direction in which the enantiomers rotate a
plane of polarized light. In this nomenclature, (þ) or d stands for a rotation to the
right (clockwise), whereas () or l indicates a rotation to the left (counter-
clockwise). The main drawback of such an assignment is that one cannot derive
the number of chirality centers from it. Rather, it is necessary to apply the R=S

notation, which describes the absolute configuration (the spatial arrangement of
the substituents) around the asymmetric carbon atom. This assignment, based on
the Cahn–Ingold–Prelog (CIP) convention [10], has mostly replaced the older
D=L notation, which correlates the configuration of a molecule to the configura-
tion of D=L-glyceraldehyde according to the Fischer convention. Today, the latter
designation is restricted mainly to amino acids and carbohydrates [9]. The
assignment of R or S according to CIP follows the sequence rule, that is, the
order of priority of the substituents on the center of chirality. It can be determined
on the basis of the decrease in the atomic number of the atoms directly bonded to
the center of chirality. If two or more of these atoms are identical, the next bonded
atoms are considered, eventually the third bonded atoms and so on. Thus the
branch containing the atoms with the highest atomic numbers has the highest
priority. Atoms connected by double or triple bonds are higher in weight than two
or three singly bonded atoms [9]. Atomic isotopes can be arranged in order of
priority by listing them in a series from highest to lowest mass number. It is very
interesting to observe that in closely related structures the designation of the
absolute configuration may change, whereas the spatial arrangement of the
substituents is maintained. Other consequences of chirality are manifest in the
metabolic processes. Several transformations, such as prochiral to chiral, chiral to
chiral, chiral to diastereoisomer, chiral to nonchiral, and chiral inversion can
occur [11,12].
1.4 CHIRALITY AND ITS CONSEQUENCES IN

BIOLOGICAL SYSTEMS
In a nonchiral environment, the enantiomers of a racemate possess the same
physical and chemical properties. But in the early 1930s, Easson and Stedman
introduced a three-point attachment model that laid the basis for the initial
understanding of stereochemical differences in pharmacological activity [13].
The authors described the differences in the bioaffinity of the enantiomers to a
common site on an enzyme or receptor surface, with the receptor or enzyme
needing to possess three nonequivalent binding sites to discriminate between the
enantiomers. The enantiomer that interacts simultaneously with all three sites is
called the eutomer (active enantiomer), whereas the other, which binds to fewer
than three sites at the same time, is called the distomer (inactive enantiomer)
[14].
Therefore, metabolic and regulatory processes mediated by biological
systems are sensitive to stereochemistry, and different responses often can be
observed upon comparing the activities of a pair of enantiomers. These differ-
ences can be expressed in distribution rates, in metabolism and excretion, in
antagonistic actions relative to each other, or in toxicological properties. It is very

interesting to note that the inactive enantiomer may be not only ballast but also
antagonistic to the action of the eutomer, or sometimes even toxic. The relation of
the potency of the active enantiomer to that of the less active one is called the
eudismic ratio [15,16]. Hence today the main interest in the development of new
drugs is directed toward finding the eutomer. To properly work with chiral drugs
in drug development, in therapeutic drug monitoring, or in clinical and forensic
toxicology, the optically active pure forms of the racemic compound must be
identified. The different biological properties of the enantiomers of some drugs
are given in Table 1.
1.5 CHIRALITY AND DRUG DEVELOPMENT

Although the optical isomers of a racemic drug can exhibit different pharmaco-
logical activities in living systems [12,15,17–23], bioactive synthetic compounds,
which comprise most of the chiral drugs, are administered as racemates [24].
Obviously, the more chiral centers present in a drug molecule, the more complex
the situation. To ensure the optimum therapeutic effect, it would seem to be
convenient to administer the eutomer. However, applying a single enantiomer to
humans does not necessarily prevent side effects or tissue=organ damage, since,
for example, the formation of harmful metabolites, as well as chiral inversion or
racemization, can occur in vivo. An example of chiral inversion without negative
side effects is provided by ibuprofen, where the inactive (R)-()-isomer is
converted by an enzymatic mechanism into the active (S)-(þ) form. The (R)-
isomer can be considered to be a prodrug of its (S)-enantiomer [12]. A negative
example is thalidomide, which was introduced to the market in the late 1960s as a
sedative, in the racemic form. Even when applied in the therapeutic and harmless
(þ)-form, in vivo interconversion into the harmful ()-isomer was shown to be
responsible for disastrous malformations of embryos when thalidomide was
prescribed for women during pregnancy [8,25,26]. In the diuretic indacrinon,
however, the presence of the distomer was useful, since it promoted the efficacy
of the therapeutic eutomer by antagonizing one of its side effects [27]. In addition
to creating a general awareness, the thalidomide tragedy resulted in stricter
controls, and the guidelines for approving new drugs were reconsidered. To
protect patients from unwanted and harmful enantiomers [12] and side effects, the
possibility of a different action of the individual enantiomers with regard to
pharmacology and toxicology had to be taken into account.
In 1993 Witte et al. [28] and in 1994 Rauws and Groen [29] reviewed the
status of the regulation of chiral medicinal products on the pharmaceutical in-
dustries in the United States, Japan, and some European countries where desig-
nated authorities are responsible for the control and approval of newly developed
drugs (both chiral and nonchiral). In the United States, new drug applications are
submitted to the Food and Drug Administration (FDA), which requires appro-

TABLE 1 The Different Physiological Properties of the Enantiomers of Some Drugs
Drugs (þ)-Enantiomer ()-Enantiomer
Barbiturates Excitation Sedation

Dobutamine b1 - and b2 -adrenoceptor a1 -Adrenoceptor agonist
agonist (vasodilatation) (positive inotropic=
vasoconstriction)
Fluoxetine Selective serotonin reuptake Minimal effect
inhibitor
Ketamine Strong anesthetic Weak anesthetic
Fenfluramine Selective serotonin reuptake Norepinephrine=dopamine
inhibitor reuptake inhibitor
(adverse side effect)
Levodopa Antiparkinsonian Agranulocytosis
Methadone Minimal effect Strong analgesic
Methamphetamine Central nervous system Peripheral vasodilator
stimulant
Penicillamine Antirheumatic (Wilson’s Neurotoxic
disease)
Pentazocine Anxiety Analgesia, respiratory
depression
Propoxyphene Analgesia Antitussive
b-Adrenergic antagonist Suppress ventricular Active b-adrenergic blocker
(e.g., propranolol) arrhythmia without
b-adrenergic blockade
Morphine Minimal effect Strong analgesic
Thyroxine Inactive Thyroxemic effect
Verapamil Minimal effect Negative dromotropic;
negative inotropic and
chronotropic effects
Warfarin Weak anticoagulant Anticoagulant
Thalidomide Sedative Sedative, teratogenic
Picenadol m-Receptor agonist Weak m-receptor antagonist
(analgesic)
Tetramisole Minimal effect Anthelmintic
Nonsteroidal anti- Anti-inflammatory Minimal effect
inflammatory
agents (NSAIAs)
priate information on chemistry as well as manufacturing and control data, such

as methods and specifications, results of stability tests, proper labeling, pharma-
cological activity, pharmacokinetic profile, toxicology, and impurity limits [30]. If
the drug contains a racemate, the stereochemistry and all pharmacological and

toxicological data on the individual isomers must be included. For single
enantiomers, a pharmacology and toxicology evaluation must be conducted,
relying on the existing knowledge of the racemate. However, the application
papers should include the longest repeat dose and data on reproductive toxicities
[30]. Additionally, the evaluation should include data regarding the conversion of
the studied eutomer into the distomer.
The FDA now may approve single enantiomers of racemates as new drugs,
which will offer new marketing opportunities for racemic drugs that are about to
go off-patent [31]. In 1995 Stinson [32] predicted that the production and mar-
keting of single enantiomers (i.e., chiral drugs already approved as racemates but
being redeveloped as single enantiomers) might grow by more than 30% by the
end of the year 2000.
In Europe, guidelines on the quality, safety, and efficacy of medicinal
products for human use are also formulated [33]. The European guidelines
generally are similar to the FDA guidelines, since they are based on the same
scientific knowledge [29]. In Japan, no official statements on the regulation of
chiral drugs have been issued [28,34]. However, the Japanese registration
authorities recommend adherence to the guidelines of other countries.
1.6 CHIRAL DRUGS AND THEIR ECONOMIC

STATUS
Many of the pharmaceutical industries have started to market the optically active
pure enantiomeric form of some of their drugs [19–23]. The most important such
drugs are anti-inflammatory agents, analgesics, antiviral drugs, anticancer drugs,
cardiovascular medications, and other pharmaceuticals used for central nervous
system, dermatological, gastrointestinal, and ophthalmic conditions, and respira-
tory diseases [35].
The debate over racemic compounds versus enantiomers resulted in a new
marketing strategy, the so-called racemic switch. A racemic switch results in the
development in single enantiomer form of a drug that was first approved as a
racemate. Economic interests are very important in the development of the drugs,
and since the separation methods (of racemic drugs) are less costly than the
asymmetric synthesis methods, most pharmaceutical companies are preparing
single enantiomers by separation methods. A literature search revealed that about
$300 billion was spent worldwide on drugs in 1997 [35–37]. It has also been
estimated that about 28% of this amount was accounted for by single enantiomers
[35]. Interestingly, sales of enantiomeric pure drugs, which were 26% of the total
in 1996, had increased to 28% by 1997 [35], and the trend was continuing owing
to an increased population and the development of new biological assays of
racemic drugs. Briefly, all the pharmaceutical companies are competing intensely

TABLE 2 Sales (U.S. $, Millions) of Enantiomeric Intermediates and Single
Enantiomer Drugs
Enantiomeric Bulk enantiomeric

intermediates drugs
Drugs 1999 2000 1999 2000
Anti-inflammatory=analgesics 150 156 200 223

Antiviral 794 830 983 1180
Cancer 892 1073 1783 2146
Cardiovascular 1133 2281 1889 3802
Central nervous system 1038 1142 1483 1632
Dermatology 82 85 164 170
Gastrointestinal 251 331 413 567
Ophthalmic 238 284 340 405
Respiratory 516 656 1151 1511
Other 140 170 315 426
Total 5294 7008 8721 12,062
Source: Technology Catalysts International.
with respect to the costs and the marketing of new (optically active pure form)
drugs and also are demanding economical methods for preparing pure enantio-
meric drugs. The sales figures for some enantiomeric intermediates and bulk
enantiomeric drugs in 1999 and 2000 are given in Table 2.
1.7 CHIRALITY AND ITS CONSEQUENCE IN THE

ENVIRONMENT
Many xenobiotics and pollutants are chiral, and the two enantiomers of such
pollutants may have different toxicities [1]. Besides, the degradation of some
achiral pollutants results in chiral toxic metabolites. Moreover, the degradation of
some chiral pollutants is stereospecific in the environment. Therefore, to predict
the exact toxicity of a given pollutant, the concentrations of both enantiomers is
required and essential. For example, the two enantiomers of a-hexachlorocyclo-
hexane pesticide have different toxicities. Moreover, the rates of degradation of
the enantiomers of a-hexachlorocyclohexane also are different. In 1991 Kallen-
born et al. [38] reported the enantioselective metabolism of a-hexachlorocyclo-
hexane in the organs of eider ducks, while in the same year Faller et al. [39]
reported the enantioselective degradation, by marine bacteria, of a-hexachloro-
cyclohexane. Therefore, environmental chemists are also looking for the opti-

mum technique to determine the chiral ratio of xenobiotics in the environment.
Besides, in the field of archaeology, the measurement of racemization of specific
amino acids is used to determine the age of mammalian fossils [40]. Another
interesting application of enantiomer separation in our environment is the
determination of amino acids in meteorites [41]. Because of the different
biological activities present in pairs of enantiomers, diverse groups including
regulators, executives in the material industries, clinicians, nutritional experts,
agriculturalists, and environmentalists are now demanding data on the ratio of
enantiomers rather than total concentration of a racemate (analytical scale).
Moreover, the preparative separation and isolation of pure enantiomers is
especially attractive for medicinal chemists, who can compare the biological
activities of such compounds with those of racemates. Besides, the fate of the
chiral xenobiotics is an important issue in environmental studies. Therefore,
chiral separation (resolution) at the analytical and preparative scales of racemic
compounds is essential and urgently needed in the modern pharmaceutical,
agricultural, and food industries, and for environmental reasons as well. The
resolution of enantiomers having identical physical and chemical properties is
difficult, but various methods have been developed and used for the chiral
separation of different racemic compounds, drugs, and xenobiotics.
1.8 RESOLUTION OF STEREOISOMERS

The separation of a racemic compound into its enantiomers is called resolution.
Various methodologies have been used for the resolution of the enantiomers on
both analytical and preparative scales. The different techniques may be categor-
ized into two classes: the classical approach, using enzymatic degradation of one
of the enantiomers, and preferential crystallization. Modern technologies include
spectroscopic, electrophoretic, and chromatographic methods.
1.8.1 Classical Methods

In the enzymatic method, resolution is effected by means of a biochemical
process that destroys one enantiomeric form. When certain microorganisms such
as yeast, molds, and bacteria are allowed to grow in a solution of racemic
mixtures, they assimilate one form selectively, leaving behind the other one in
solution. For example, if the ordinary mold Penicillium glaucum is added to a
racemic solution of ammonium tartrate, the solution becomes levorotatory owing
to the destruction of the dextrorotatary form [5]. The principle of crystallization is
based on the formation by two enantiomers of the diastereomeric salts of the
optically pure compound, and these diastereoisomeric salts can be separated
easily [2,30]. In this process, the optically active resolving agent must be of high

FIGURE 2 The stereostructures of quartz and sodium ammonium tartrate crystals.
optical purity. In most cases, after the desired enantiomers have been separated
from the diastereomeric salts, the resolving agent is recovered and becomes
available for reuse [30–33]. Mechanical methods of separation (by needle, etc.)
also can be utilized for the separation of crystals of some racemic compounds,
such as sodium ammonium tartrate and quartz, since their crystals are mirror
images of each other (Fig. 2). These classical methods never achieved the status
of routine laboratory practice owing to certain drawbacks, such as the degradation
of one of the enantiomers in the enzymatic method, and the very limited number
of applications of the crystallization method. Moreover, these methods cannot be
used at the analytical scale, especially in natural samples.

1.8.2 Modern Methods
Nowadays, the chromatographic, electrophoretic, spectroscopic, biosensor, and
membrane methods are the ones most commonly applied (Fig. 3) [19–23,42,43].
Among the spectroscopic methods, investigators use optical rotation measure-
ments, nuclear magnetic resonance (NMR) spectroscopy, and infrared (IR)
spectroscopy. The latter, as differential scanning calorimetry (DSC), can
FIGURE 3 The different techniques of chiral resolution: a, analytical; b, analytical and

preparative; c, preparative.

distinguish only racemic mixtures () and individual enantiomers. In NMR
spectroscopy, chiral solvating agents (CSA) can be utilized to promote a change
in the chemical shift of the chiral (carbon) atoms. However, the spectroscopic and
DSC methods are sensitive to interference from chiral or nonchiral impurities in
the sample. Additionally, they can lack sensitivity and accuracy, since the
differences between the isomers and=or isomer mixtures may be very small.
Moreover, these methods fail totally at the preparative scale. Chiral membranes
were used to separate the enantiomers at the preparative scale in 2001 [42], but
the technique is not fully developed.
Among the electrophoretic methods of chiral resolution, various forms of
capillary electrophoresis such as capillary zone electrophoresis (CZE), capillary
isotachophoresis (CIF), capillary gel electrophoresis (CGE), capillary isoelectric
focusing (CIEF), affinity capillary electrophoresis (ACE), and separation on
microchips have been used. However, in contrast to others, the CZE model has
been used frequently for this purpose [44]. On the other hand, drawbacks
associated with the electrophoretic technique due to lack of development of
modern chiral phases have limited the application of these methods. Moreover,
the electrophoretic techniques cannot be used at the preparative scale, which
represents an urgent need of chiral separation science.
1.8.2.1 Chromatographic Methods

In chromatographic methods, two approaches are used: indirect and direct. The
indirect chromatographic separation of racemic mixtures into their enantiomers
can be achieved by derivatization of the racemic compound with a chiral
derivatizing agent (CDA) resulting in the formation of diastereoisomer–salt
complex. Having different physical and chemical properties, the diastereoisomers
can be separated from each other by means of an achiral chromatographic
method. A condition for successful derivatization is the presence of suitable
functional groups in the analyte. Besides, to increase the physicochemical
differentiation, derivatization should occur close to the chiral atom. Although
the indirect chromatographic approach has the advantage of predetermining
elution order, which can be important for the determination of optical purities,
there are some limitations to this technique. The derivatization procedure is
tedious and time-consuming owing to the different reaction rates of the individual
enantiomers. Additionally, suitable chiral derivatizing agents in pure form can
be difficult to obtain. For preparative purposes, the indirect chromatographic
approach includes an additional synthetic step because after the separated
diastereoisomers have been resolved in a nonchiral environment, the derivatizing
agent must be cleaved off.

On the other hand, the direct chromatographic approach involves the use of
the chiral selector either in the mobile phase, a so-called chiral mobile phase
additive (CMPA), or in the stationary phase [i.e., the chiral stationary phase
(CSP)]. In the latter case, the chiral selector is chemically bonded or coated or
allowed to absorb onto a suitable solid support. Of course chiral selectors still can
be used as CMPAs, but the approach is a very expensive one owing to the high
amount of chiral selector required for the preparation of the mobile phase, and the
large amount of costly chiral selector that is wasted (since there is very little
chance of recovering this compound). Moreover, this approach is not successful
in the preparative separation of the enantiomers.
In contrast, CSPs have achieved great repute in the chiral separation of
enantiomers by chromatography and, today, are the tools of the choice of almost
all analytical, biochemical, pharmaceutical, and pharmacological institutions and
industries. The most important and useful CSPs are available in the form of open
and tubular columns. However, some chiral capillaries and thin layer plates are
also available for use in capillary electrophoresis and thin-layer chromatography.
The chiral columns and capillaries are packed with several chiral selectors such as
polysaccharides, cyclodextrins, antibiotics, Pirkle type, ligand exchangers, and
crown ethers.
The chromatographic methods use gas or liquid separately as the mobile
phase, hence the terms gas chromatography (GC) and liquid chromatography
(LC). Gas chromatography could not be accepted as the method of choice for the
chiral resolution of racemic compounds mainly because of its requirement for the
conversion by derivatization of the racemic compound into a volatile species.
Besides, the separated enantiomers cannot be collected for further pharmacolo-
gical and other studies. Moreover, GC cannot be used at the preparative scale.
On the other hand, LC is the only and the best remaining technology for the
chiral resolution of a wide variety of racemates. The main advantage of LC is its
ability to determine enantiomers in both biological and environmental samples.
Besides, the ease of applying LC techniques at the preparative scale contributed
much to the elucidation of the pharmaceutical and toxicological properties of
enantiomers in living systems. Over time, various liquid chromatographic
approaches were developed and used in this work. The most important liquid
chromatographic methods are high performance liquid chromatography (HPLC),
sub- and supercritical fluid chromatography (SFC), capillary electrochromato-
graphy (CEC), and thin-layer chromatography (TLC).
High Performance Liquid Chromatography. Among the various liquid

chromatographic techniques, HPLC remains the best modality owing to several
advantages. High speed, sensitivity, and reproducible results make HPLC the
method of choice in almost all laboratories. Moreover, HPLC can be used
successfully at the preparative scale. There is no serious limitation of this

technique. About 90% of the work in chiral resolution has been achieved by
means of the HPLC mode of chromatography. Almost all the chiral selectors are
available in the form of HPLC columns, owing to the wide range of applications
of HPLC in chiral resolution [19–23]. A variety of mobile phases including
normal, reversed, and new polar organic phases are used in HPLC. The
composition of the mobile phases may be changed by the addition of various
aqueous and nonaqueous solvents. A number of parameters are used in the
optimization of the chiral resolution. Chapters 2 to 10 discuss in detail the
methodology of chiral resolution by HPLC using different CSPs and CMPAs.
Sub- and Supercritical Fluid Chromatography. The use of supercritical
fluids as the mobile phases for chromatographic separation was first reported
more than 30 years ago, but most of the growth in SFC has occurred recently. A
supercritical fluid exists when both temperature and pressure in the system exceed
the critical values: critical temperature (Tc ) and critical pressure (Pc ). Critical
fluids have physical properties between those of liquids and gases. Like gases,
supercritical fluids are highly compressible, and properties of the fluid, including
density and viscosity, can be maintained by changes in the pressure and
temperature conditions. In chromatographic systems, the solute diffusion coeffi-
cients are often of a higher order of magnitude in supercritical fluids than in
traditional liquids. The viscosities, however, are lower than those of liquids [45].
At temperatures below Tc and pressures above Pc , the fluid becomes a liquid. On
the other hand, at temperatures above Tc and pressures below Pc , the fluid
behaves as a gas. Therefore, supercritical fluids can be used as part of a mixture
of liquid and gas [46]. The commonly used supercritical fluids (SFs) are carbon
dioxide, nitrous oxide, and trifluoromethane [45–47]. The SF of choice is carbon
dioxide, owing to its compatibility with most detectors, low critical temperature
and pressure, low toxicity and environmental burden, and low costs. The main
drawback of supercritical carbon dioxide as the mobile phase lies in its inability
to elute more polar compounds. To improve the elution ability of CO2, one can
add organic modifiers to the relatively apolar carbon dioxide. Chiral sub- and
supercritical FC have been carried out in packed and open tubular columns and
capillaries [48]. The first report on chiral resolution by SFC was published in
1985 by Mourier et al. [49]. Later, several other papers and a review appeared
[50–55].
Capillary Electrochromatography. Capillary electrochromatography (CEC)
is a hybrid technique that works on the basic principles of capillary electrophor-
esis and chromatography [41]. This mode of chromatography is used on either
packed or tubular capillaries=columns. The packed column approach was
introduced by Pretorius et al. [60] in 1974, while open tubular CEC was presented
by Tsuda et al. [61] a decade later. In 1984 Terabe et al. [62] introduced
another modification in liquid chromatography, micellar electrokinetic capillary

chromatography (MECC). Of course this mode also depends on the working
principles of capillary electrophoresis and chromatography but adds the forma-
tion of micelles. The recent use of CEC and MECC in the chiral resolution of
racemic compounds resulted in several publications [63–65]. High speed,
sensitivity, lower limit of detection, and reproducible results make CEC and
MECC ideal for chiral resolution. However, these methods are not used
frequently because the techniques are not fully developed. Research is under
way, however.
Thin-Layer Chromatography. The history of thin-layer chromatography

(TLC) is very old, but its use in chiral resolution goes back only about 25 years.
Most TLC enantioseparations are carried out in the indirect mode (i.e., by
preparing diastereoisomers and resolving them on TLC). The derivatization of
racemic mixtures and subsequently separation on silica gel or reversed-phase
(RP) TLC plates represents a method of chiral resolution. There are only a few
reports on direct enantiomeric separation on chiral TLC plates (i.e., using CMPAs
or CSPs). Among the direct approaches, the use of CSPs is very limited. Only
chiral TLC plates based on ligand exchange are commercially available for the
chiral resolution of racemates. However, some reports mention the impregnation
of TLC plates with suitable chiral selectors [66,67]. Several research papers and
review articles on chiral resolution by TLC can be found in the literature [66–72].
Despite the development of more efficient and rapid chromatographic
techniques, TLC remains an important method of chiral resolution. Low running
cost, simplicity, ease of handling, and coelution of the racemate and pure
enantiomers are the main advantages of TLC. The reliable, robust, and efficient
methods for the resolution of enantiomers by thin-layer chromatography comprise
useful additions to the techniques of chiral resolution. Moreover, TLC is the
technique of choice in developing and underdeveloped countries. Its major
weaknesses include relatively low resolving power, with a high limit of detection,
in comparison to other liquid chromatographic approaches. The waste of the
chiral selector or chiral thin-layer material is another serious drawback.
One of the classical approaches of liquid chromatography, paper chroma-
tography, was used for chiral resolution about 50 years ago but is not part of
modern practice. In paper chromatography, the stationary phase is water bonded
to cellulose (paper material), which is of course chiral and hence provides a chiral
surface for the enantiomers. However, some workers used chiral mobile phase
additives also in paper chromatography [73,74]. In 1951 some research groups
independently [73,75–77] resolved the enantiomers of amino acids. Simulta-
neously, numerous interesting publications on chiral resolution by paper chro-
matography appeared [70].

A more recently developed technique, simulated moving-bed chromato-
graphy, has been very successful for chiral separations at the preparative scale.
This technique affords the separation of large amounts of enantiomers by means
of developing suitable chiral selectors and mobile phases [42].
1.9 DETECTION IN LIQUID CHROMATOGRAPHY

In most of chiral resolutions by liquid chromatography, a UV detector is used,
because most racemic drugs and pharmaceuticals are UV sensitive. However,
conductivity, fluorescence, refractive index, and other detectors have also been
used. The choice of detector depends on the properties of the racemic compound
to be resolved [23,78]. Besides, chiroptical detectors, based on the principle of
polarimetry [79,80] or circular dichroism [81,82], are available. In addition,
liquid chromatography–mass spectrometric instruments are now being marketed
for routine use [83,84]. The polarity notation of enantiomers [i.e., (þ)- or (–)-] is
determined by optical detector. Detection on TLC is carried out by a number of
approaches. The UV-sensitive enantiomers are observed in a UV cabinet, while
other non-UV-absorbing chiral molecules such as amino acids and amines are
located by developing the color on the TLC plate with a suitable reagent (e.g.,
ninhydrin, which is used for developing color with amino acids and amines) [85].
Moreover, iodine vapors are used as the universal detection method on TLC
plates. The separated enantiomers adsorb iodine vapors and turn yellow. The
iodine from the spots can be removed by heating the TLC plate, and hence the
pure enantiomers from the plate can be recovered and used for further pharma-
cological studies.
1.10 CHIRAL RECOGNITION MECHANISMS

The chiral recognition mechanisms on all the chiral selectors are quite similar
except on ligand exchangers. All chiral selectors provide a chiral surface to the
enantiomers, which form with the selectors temporary complexes, having
different bonding energies. The enantiomers differ in their binding energies
because they fit differently into the chiral selector structures. Again, the different
stereoconfigurations of the enantiomers are responsible for the differences in fit
on the chiral selectors. These temporary complexes are stabilized by a number of
interactions. The most important interactions are hydrogen, p–p, dipole–induced
dipole, ionic, inclusion complexations, and steric interactions. However, the other
weaker forces such as van der Waals and charge transfer, also play a crucial role
in chiral recognition mechanisms. The chiral recognition mechanism on chiral
ligand exchange selectors is different from that on the other selectors. This is
mainly due to the exchange of ligands through coordinate bonds on a metal ion,
which is not possible on other chiral selectors. Briefly, in general, the chiral

FIGURE 4 Schematic representation of the chiral recognition mechanism.
recognition mechanism on a chiral selector is based on a key-and-lock arrange-

ment (Fig. 4). Details of the chiral recognition mechanism on each type of chiral
selector are given in the chapter covering that particular type.
In view of the importance of chiral resolution and the efficiency of liquid
chromatographic methods, attempts are made to explain the art of chiral
resolution by means of liquid chromatography. This book consists of an
introduction followed by Chapters 2 to 8, which discuss resolution chiral
stationary phases based on polysaccharides, cyclodextrins, macrocyclic glyco-
peptide antibiotics, Pirkle types, proteins, ligand exchangers, and crown ethers.
The applications of other miscellaneous types of CSP are covered in Chapter 9.
However, the use of chiral mobile phase additives in the separation of enantio-
mers is discussed in Chapter 10.
REFERENCES
1. Kelvin L in Kallenborn R, Huhnerfuss H, Chiral Environmental Pollutants: Trace
Analysis and Ecotoxicology, Springer-Verlag, Berlin (2000).
2. Hegstrom R, Kondepudi DK, Sci Am 262: 108 (1990).
3. Kondepudi D, Durand DJ, Chirality 13: 351 (2001).
4. Haüy RJ, Tableaux Comparatif des Resultats de la Crystallographie et de l’Analyse
Chimique Relativement à la Classification des Mineraux, Paris, p. XVII (1809).
5. Pasteur L, C R Acad Sci 26: 535 (1848).
6. Le Bel JA, Bull Soc Chim Fr 22: 337 (1874).
7. Van’t Hoff JH, Arch Neerland Sci Exactes Nat 9: 445 (1874).
8. Aitken RA, Parker D, Taylor RJ, Gopal J, Kilenyi RN, in Asymmetric Synthesis,
Blackie Academic & Professional, New York (1992).
9. Hauptmann S, in Organische Chemie, Hauptmann S (Ed.), VEB Deutscher Verlag
für Grundstoffindustrie (1988).
10. Cahn RS, Ingold CK, Prelog V, Experientia 12: 81 (1956).
11. Caldwell J, J Chromatogr A 694: 48 (1995).
12. Testa B, Trends Pharmacol Sci 60 (1986).
13. Easson EH, Stedman E, Biochem J 27: 1257 (1933).
14. Lehmann PA, Trends Pharmacol Sci 281 (1986).

15. Ariëns EJ, Trends Pharmacol Sci 200 (1986).
16. Waldeck B, Chirality 5: 355 (1993).
17. Simonyi M, Fitos I, Visy J, Trends Pharmacol Sci 112 (1986).
18. Cannon JG, Moe ST, Long JP, Chirality 3: 19 (1991).
19. Krstulovic AM, Chiral Separations by HPLC: Applications to Pharmaceutical
Compounds, Ellis Horwood, New York (1989).
20. Allenmark S, Chromatographic Enantioseparation: Methods and Applications, 2nd
ed., Ellis Horwood, New York (1991).
21. Subramanian G (Ed.), A Practical Approach to Chiral Separations by Liquid
Chromatography, VCH Verlag, Weinheim, Germany (1994).
22. Aboul-Enein HY, Wainer IW (Eds.), The Impact of Stereochemistry on Drugs
Development and Use, Vol. 142, John Wiley & Sons, New York (1997).
23. Beesley TE, Scott RPW, ‘‘Chiral Chromatography,’’ John Wiley & Sons, New York
(1998).
24. Stinson SC, Chem Eng News 72: 38 (1994).
25. Blaschke G, Kraft HP, Fickentscher K, Köhler F, Drug Res 29: 1640 (1979).
26. Knoche B, Blaschke G, J Chromatogr A 666: 235 (1994).
27. Ariëns EJ, Science 259: 68 (1993).
28. Witte DT, Ensing K, Franke JP, de Zeeuw RA, World Sci 15: 10 (1993).
29. Rauws AG, Groen K, Chirality 6: 72 (1994).
30. FDA’s policy statement for the development of new stereoisomeric drugs. Chirality 4:
338 (1992).
33. The Rules Governing Medicinal Products in the European Union. Guidelines on the
Quality, Safety and Efficacy of Medicinal Products for Human Use. Clinical
Investigation of Chiral Active Substances, Pharmaceutical Press, London (1991).
34. Shindo H , Caldwell J, Chirality 3: 91 (1991).
37. Thayer AM, Chem Eng News 76: 25 (1998).
38. Kallenborn R, Hühnerfuss H, Köning WA, Angew Chem 103: 328 (1991).
39. Faller J, Hühnerfuss H, Köning WA, Krebber R, Ludwig P, Environ Sci Technol 25:
676 (1991).
40. Meyer VR, ACS Symp Ser 471: 217 (1991).
41. Cronin JR, Pizarello S, Science 275: 95 (1997).
42. Maier NM, Franco P, Lindner W, J Chromatogr A 906: 3 (2001).
43. Stefan RL, van Staden JF, Aboul-Enein HY, Electrochemical Sensors in Bioanalysis,
Marcel Dekker, New York (2001).
44. Chankvetadze B, Capillary Electrophoresis in Chiral Analysis, John Wiley & Sons,
New York, p. 353 (1997).
45. Weast RC (Ed.), Handbook of Chemistry and Physics, 54th ed., CRC Press,
Cleveland (1973).
46. Berger TA, in Packed Column SFC, Smith RM (Ed.), The Royal Society of
Chemistry, Chromatography Monographs, Cambridge (1995).

Introduction 19
47. Schoenmakers PJ, in Packed Column SFC, Smith RM (Ed.), The Royal Society of
Chemistry, Chromatography Monographs, Cambridge (1988).
48. Terfloth G, J Chromatogr A 906: 301 (2001).
49. Mourier PA, Eliot E, Caude RH, Rosset RH, Tambute AG, Anal Chem 57: 2819
(1985).
50. Macaudiere P, Caude M, Rosset R, Tambute A, J Chromatogr 405: 135 (1987).
51. Lee CR, Porziemsky JP, Aubert MC, Krstulovic AM, J Chromatogr 539: 55 (1991).
52. Biermanns P, Miller C, Lyon V, Wilson W, LC-GC 11: 744 (1993).
53. Pettersson P, Markides KE, J Chromatogr A 666: 381 (1994).
54. Bargmann-Leyder N, Tambute A, Caude M, Chirality 7: 311 (1995).
55. Williams KL, Sander LC, Wise SA, J Chromatogr A 746: 91 (1996).
56. Overbeke AV, Sandra P, Medvedovici A, Baeyens W, Aboul-Enein HY, Chirality 9:
126 (1997).
57. Phinney KW, Sanders LC, Wise SA, Anal Chem 70: 2331 (1998).
58. Duval R, Lévêque H, Prigent Y, Aboul-Enein HY, Biomed Chromatogr 15: 202
(2001).
59. Phinney KW, Sub- and supercritical fluid chromatography for enantiomer separa-
tions, in Chiral Separation Techniques: A Practical Approach, (Subramanian G, Ed.),
p. 299, VCH Verlag, Weinheim, Germany (2001).
60. Pretorius V, Hopkins BJ, Schieke JD, J Chromatogr 99: 23 (1974).
61. Tsuda T, Nomura K, Nagakawa G, J Chromatogr 248: 241 (1982).
62. Terabe S, Otsuka K, Ichikawa K, Tsuchiya A, Ando T, Anal Chem 56: 111 (1984).
63. Schuring V, Wistuba D, Electrophoresis 20: 2313 (1999).
64. Fanali S, Catarcini P, Blaschke G, Chankvetadze, Electrophoresis 22: 3131 (2001).
65. Cohen AS, Paulus A, Karger BL, Chromatographia 24: 15 (1987).
66. Bushan R, Ali I, J Chromatogr 463 (1987).
67. Bushan R, Ali I, Chromatographia, 5, 679 (1993).
68. Günther K, Martens J, Schickedanz M, Angew Chem 96: 514 (1984).
69. Grinberg N, J Chromatogr 333: 69 (1985).
70. Günther K, Enantiomer separations, in Handbook of Thin Layer Chromatography
(Sherma J, Fried B, Eds.), Marcel Dekker, New York, p. 541 (1991).
71. Aboul-Enein HY, El-Awady MI, Heard CM, Nicholls PJ, Biomed Chromatogr 13:
531 (1999).
72. Bhushan R, Martens J, Biomed Chromatogr 15: 155 (2001).
73. Bonino GB, Carassiti V, Nature 167: 569 (1951).
74. Mason M, Berg CP, J Biol Chem 195: 515 (1952).
75. Kotake M, Sakan T, Nakamura N, Senoh S, J Am Chem Soc 73: 2973 (1951).
76. Berlingozzi S, Serchi G, Adembri G, Sper Sez Chim Biol 2: 89 (1951).
77. Fujisawa Y, J Osaka City Med Center 1: 7 (1951).
78. Scott, RP, Chromatography Detectors, Chromatography Science Series, Vol 73,
Marcel Dekker, New York (1996).
79. Mannschreck A, Chirality 4: 163 (1992).
80. Lloyd DK, Goodall DM, Scrivener H, Anal Chem 61: 1238 (1989).
81. Salvadori P, Bertucci C, Rosini C, Chirality 3: 376 (1991).

82. Brandl G, Kastner F, Mannschreck A, Nölting B, Andert K, Wetzel R, J Chromatogr
586: 249 (1991).
83. Bugge CJL, Crun I, Ljungqvist A, Vatankhan M, Garci DB, Warren HB, Gupta S,
American Association of Pharmaceutical Scientists Annual Meeting, Seattle, WA
(1996).
84. Ramos L, Bakhtiar R, Majumdar T, Hayes M, Tse F, Rapid Commun Mass Spectrom
13: 2054 (1999).
85. Stahl E, Thin Layer Chromatography, 2nd ed., Springer-Verlag, Berlin (1969).

2
Polysaccharide-Based Chiral
Stationary Phases
Most of the naturally occurring polymers including polysaccharides are chiral and
optically active because of their asymmetrical structures. These polymers often
possess a specific conformation or higher order structure arising from the chirality
that is essential for the chiral resolution of racemic compounds [1]. Therefore,
polysaccharides are potentially applicable in the chiral separation of racemic
compounds by liquid chromatography [2,3]. Resolution of racemates by using
polysaccharides has been reported since 1951, when Kotake et al. [4], for the first
time, resolved amino acids on paper chromatograms. Later on, several publica-
tions emerged on chiral resolution by means of paper chromatography and
cellulose thin-layer chromatography [5]. Polysaccharide polymers such as cellu-
lose, amylose, chitosan, xylan, curdlan, dextran, and inulin have been used for
chiral resolution in liquid chromatography [6]. However, these derivatives could
not be used as commercial chiral stationary phases (CSPs) because their
resolution capacity was poor and there were handling problems [1]. Therefore,
derivatives of these polymers have been synthesized in the last two decades [1].
Among the various polymers of polysaccharides, cellulose and amylose are the
most readily available naturally occurring polymers and are suitable for chiral
resolution; therefore, most of the reported chiral applications involving liquid
chromatography have used these two polysaccharides [1,6]. The most useful and
successful derivatives of cellulose and amylose are triesters and tricarbamate
[1,6,7]. Figure 1 shows their three-dimensional structures, including the chiral

grooves, of cellulose and amylose. Okamoto et al. [8] prepared several triesters
and tricarbamates of cellulose and amylose derivatives and coated or bonded
them onto macroporous silica gel. These derivatives represent the most univer-
sally applicable kind of chiral stationary phase. Furthermore, a search of the
literature [1,6–11] revealed that polysaccharide-based chiral stationary phases in
liquid chromatography are very effective and have a wide range of applications.
About 80% of the racemic compounds can be resolved on these CSPs. Therefore,
this chapter describes the structure, properties, preparation, applications, and
mechanisms of polysaccharide-based CSPs. Attempts have also been made to
describe the optimization of chiral resolution on these CSPs. Furthermore, the use
of polysaccharide chiral phases in sub- and supercritical fluid chromatography,
capillary electrochromatography, and thin-layer chromatography have also been
discussed.
2.1 POLYSACCHARIDE DERIVATIVES

Cellulose polymer is made of glucose units and polymeric chains of D-(þ)
glucose units containing the b-1,4 linkage. The glucose units have a chair
conformation with 2-OH, 3-OH, and the 5-CH2 OH groups all in equatorial
positions (Fig. 2). These chains lie side by side in a linear fashion in cellulose
(Fig. 1). The degree of polymerization of cellulose is not known exactly, but it
FIGURE 1 Three-dimensional structures of amylose and cellulose polymers.

FIGURE 2 The chemical structures of (a) cellulose and (b) amylose polymers.
ranges from 200 to 14,000 units of glucose. Avicel, the most commonly used type
of microcrystalline cellulose, has a degree of polymerization of about 200 to 300
glucose units [12,13]. Cellulose occurs in different forms, but the two most
commonly used are native cellulose and the material obtained after reprecipita-
tion. Amylose is made of more than 1000 glucose units, and the polymeric chain
of D-(þ)-glucose units contains the a-1,4 linkage. In amylose also, the glucose
units have a chair conformation with 2-OH, 3-OH, and the 5-CH2 OH groups all
in equatorial positions (Fig. 2). To increase their chiral recognition capacity, these
two polysaccharides were converted into their triester and tricarbamate deriva-
tives. Among the prepared derivatives are triacetate, tribenzoate, and triphenyl-
carbamate. The most commonly used derivative, and also the best choice, is
triphenylcarbamate. The structures of these derivatives are discussed next.
2.1.1 Triester and Tricarbamate Derivatives of

Cellulose
The properties of partially acetylated cellulose for the separation of enantiomers
were recognized in 1966 by Luttringhaus and Peters [14]. But the full potential of
cellulose acetate was developed by Hesse and Hagel in 1973 [15]. Since then, this
stationary phase has been frequently used for the resolution of various racemic
compounds. Native cellulose acetylated heterogeneously yields a crystallographic
form of cellulose triacetate (CTA) known as CTA-I, which corresponds to its
source, an indication that the original supramolecular structure of the starting

material is preserved. However, if the process is performed in such a way that the
triacetate dissolves during acetylation, the product obtained after reprecipitation
is defined as CTA-II. This thermodynamically more stable form exists only as a
pure polymer and has properties different from CTA-I. However, CTA-II suffers
from poor chiral resolving power in comparison to CTA-I. Figure 3 shows the
structures of different cellulose tribenzoate derivatives prepared by Okamoto et al.
[16,17].
The effect of substituents on the phenyl groups of cellulose tribenzoate has
been studied [17]. Cellulose triphenylcarbamate derivatives are the most thor-
oughly investigated polysaccharide phases with respect to chiral resolution and its
FIGURE 3 The chemical structures of cellulose benzoate, amylose benzoate, and

carbamate derivatives. (From Ref. 32.)

mechanism. The chiral recognition power of these derivatives can be increased by
adding different substituents to the phenyl rings of the carbamate derivatives [18–
20].
2.1.2 Triester and Tricarbamate Derivatives of

Amylose
The triester and triphenylcarbamate derivatives of amylose were prepared as in
the case of cellulose, but the triester derivatives of amylose are not useful for
chiral resolution. Therefore, the triester derivatives of amylose have not been
studied extensively. The chemical structures of the triphenylcarbamate derivatives
are shown in Fig. 3. Similarly, the chiral resolution power of amylose derivatives
was studied by introducing electron-donating and electron-withdrawing groups
on the phenyl ring of the amylose derivatives [21–24].
2.2 SPECTROSCOPIC STUDIES

Attempts have been made by various workers to explain the structures of these
CSPs by different spectroscopic methods. The exact structures of these phases are
not known owing to problems in NMR studies. Although NMR spectroscopy is
powerful and comprises the main technique for revealing the structures of
polysaccharide-based CSPs, these phases are soluble in solvents such as tetra-
hydrofuran, acetone, and pyridine. However, the presence of many interacting
sites on microcrystalline celluse triacetate (MCTA) derivatives can be determined
by 13 C NMR [25]. Further, the supramolecular structure for MCTA, having
multiple interaction sites with specific surface and grooves, was determined by
NMR techniques [26]. Oguni et al. [27] investigated the structure of tris(4-
methylbenzoate) by 13 C NMR spectroscopy. Later Yashima et al. [28] were able
to use NMR techniques to study the structure of cellulose tris(4-trimethylsilyl-
phenyl) carbamate. The three-dimensional structures of cellulose- and amylase-
based CSPs were determined and compared by using computational chemistry
[29,30]. Vogt and Zugenmaier [31] reported that the possible structures were a
3=2 helical chain conformation for cellulose tris(phenylcarbamate) and a 4=1
helical chain conformation for amylose tris(phenylcarbamate). The amylose CSP
is more helical and has well-defined grooves, making it considerably different
from the corresponding cellulose analogue, which appears to be more linear and
rigid.
The binding of 1,10 -bi-2-naphthol racemate with tris(5-fluoro-2-methyl-
phenylcarbamate) was studied by mass spectroscopy and discussed by Yashima

[32]. The S-enantiomer bound more strongly than the R-enantiomer [33,34]. The
relative peak intensity (RPI) of a complex of a chiral host with deuterated and
nondeuterated guests has been used for detecting chiral discrimination events in
chiral host–guest chemistry since 1997 [35]. A mixture of (RS)-1,10 -bi-2-naphthol
and tris(5-fluoro-2-methylphenylcarbamate) was ionized by electron ionization
(EI) from 25 to 400 C. Reconstructed ion current (RIC) profiles of (R)- and (S)-
enantiomers of 1,10 -bi-2-naphthol showed different shapes, indicating different
patterns of bonding. Direct chiral discrimination in EI-MS was confirmed by
using partially deuterated 1,10 -bi-2-naphthol at the 3 and 30 positions. A mixture
of (S)-1,10 -bi-2-naphthol and (R)-1,10 -bi-2-naphthol-d2 or (S)-1,10 -bi-2-naphthol-
d2 and (R)-1,10 -bi-2-naphthol in CHCl3 containing tris(5-fluoro-2-methylphenyl-
carbamate) was directly inserted into the ion source to measure EI mass spectra.
The mass spectra at scan numbers 30–35, 80–85, and 140–145 in RIC
profiles of (S)-1,10 -bi-2-naphthol-d2 (Mr 288) and (R)-1,10 -bi-2-naphthol-d2 (Mr
286) with tris(5-fluoro-2-methylphenylcarbamate) are shown in Figure 4, where
differences in the ratios of m=z 288 to m=z 286 are clearly detected. A plot of the
ratio of m=z 288 to 286 (the mean value of six scan) versus the scan number is
also shown in Figure 4. Initially, the relative peak intensity of m=z 286 was larger
than that of m=z 288, which increased as the sample temperature was raised.
These results indicate that the molecule of Mr 288 [(S)-1,10 -bi-2-naphthol-d2 ]
vaporizes more slowly at higher temperature than the molecule of Mr 286 [(R)-
1,10 -bi-2-naphthol-d2 ]. When a mixture of (S)-1,10 -bi-2-naphthol-d2 and (R)-1,10 -
bi-2-naphthol-d2 was used instead, the relative intensity of m=z 286 to 288 (the
reciprocal of the ratio in Fig. 4) showed the same tendency.
When optically inactive polystyrene was used as adsorbent, no difference in
the relative peak intensity at m=z 288 to 286 was detected. Moreover, in the
resolution of (RS)-1,10 -bi-2-naphthol and (RS)-1,10 -bi-2-naphthol-d2 on the CSP,
no isotope effect was observed. These findings indicate that the difference in EI-
MS spectra is due to the difference in desorption between the enantiomers from
the chiral adsorbent tris(5-fluoro-2-methylphenylcarbamate). This method can be
used to discriminate the chirality of other enantiomers of small molecules if they
show peaks in their EI-MS spectra in the presence of chiral polymers. Similar
chiral recognition was detected by negative ion fast-atom bombardment mass
spectrometry [34].
It has also been reported from circular dichroism (CD) studies [36] that
polysaccharide-based CSPs can induce chirality in enantiomeric guests such as
(4Z,15Z)-bilirubin-Ixa (BR) (Fig. 5). Although not optically active, BR has two
enantiomeric helical conformations maintained by six intramolecular hydrogen
bonds between two carboxylic acid moieties and two pyrromethenone NH
protons. These (R)- and (S)-helical conformers are in dynamic equilibrium in an
achiral solution [37], but some optically active compounds can enantioselectively
bind to BR to induce CD spectra in solution [38–40]. A significant induced CD

FIGURE 4 Mass spectra of a mixture of (S)-1,10 -bi-2-naphthol-d2 (Mr 288) and (R)-1,10 -bi-2-naphthol (Mr 286) in the
presence of tris(5-fluoro-2-methylphenylcarbamate) at scan numbers (a) 30–55, (b) 80–85, and (c) 140–145 in reconstructed
ion current (RIC) profile. (d) The ratio of peak intensity versus scan number with (open circles) and without (solid circles)
tris(5-fluoro-2-methylphenylcarbamate). (From Ref. 32.)

spectrum was observed in the UV–visible region for BR in the presence of some
cellulose triphenylcarbamate (CTPC) derivatives in chloroform. Figure 5 shows
typical CD spectra of BR (3:0 104 M) in chloroform in the presence of CTPC
derivatives. The nature of the CD spectra is affected by the substituents of CTPC
derivatives. The intramolecular hydrogen bond between phenylcarbamoyl
moieties of the CTPC derivatives and BR is presumed to be the main binding
force for the asymmetric transformation of BR, because addition of small
amounts of 2-propanol to a chloroform solution of BR containing CTPC
derivatives markedly diminishes the CD signal.
2.3 PREPARATION AND COMMERCIALIZATION

Microcrystalline cellulose triacetate (MCTA) is prepared by heterogeneous
acylation of native cellulose in benzene [15,41]. Cellulose and amylose benzoates
were synthesized by the reaction of corresponding benzoyl chloride in N, N-
dimethylacetamide–lithium chloride–pyridine (15 : 1.5 : 7,v=v=v) mixture at about
100 C. These derivatives were isolated as the insoluble fractions in methanol.
Macroporous silica gel was treated with a large excess of 3-aminopropyltriethox-
ysilane in benzene. The prepared benzoate derivatives were dissolved in chloro-
form or tetrahydrofuran and added to the silanized gel separately. This coating
procedure was repeated two or three times and the silica gel obtained was added
to hexane and packed in the desired stainless steel columns [8,17,42,43].
Phenylcarbamate derivatives of cellulose and amylose were prepared by the
reaction of cellulose or amylose with an excess of the corresponding substituted
phenylisocyanate in dry pyridine at 80 to 100 C. The phenylcarbamates obtained
were isolated as a methanol-insoluble fraction (72–90% yield). 1 H-NMR data
showed that hydroxyl groups of cellulose and amylose were almost quantitatively
converted into the carbamate moieties [18,44,45]. The prepared derivatives of
cellulose and amylose again are not useful CSPs and, therefore, these derivatives
are coated or adsorbed on silica gel. In this process, the macroporous silica gel is
treated with 3-aminopropylthriethoxysilane in benzene at 80 C. The polysacchar-
ide derivatives are dissolved in tetrahydrofuran or N, N-dimethylacetamide and
added to the above-mentioned silica gel. After the wetted silica gel has been dried
under vacuum, the resulting dried material is packed in a stainless steel column of
the desired dimension by a slurry method [18]. This column is used for the chiral
resolution in HPLC.
First Rimbock et al. [46] and later Francotte et al. [47–50] developed beads
of benzoyl cellulose, which were found to be very effective for chiral resolution at
the preparative scale. Benzoyl cellulose was dissolved in a mixture of dichloro-
methane and heptanol and added dropwise to an aqueous solution of a surfactant
(sodium lauryl sulfate), which is mechanically stirred at a well-defined speed.
After addition of the benzoyl cellulose solution, stirring is maintained and the

FIGURE 5 The two enantiomeric conformations of bilirubin (top) and (A) UV–visible
and (B) CD spectra of bilirubin (3 104 M) in chloroform–ethanol in the presence of
cellulose triphenylcarbamate derivatives (3 102 M glucose units) with the following
substituents: (a) 4-Br, (b) 3-Cl, (c) 4-CH3 , and (d) 3,5-F2. (From Ref. 32.)
emulsion obtained is heated at 40 C, to remove dichloromethane. This product is

filtered and washed with sufficient amounts of water and ethanol. After washing,
the product is dried at 80 C under vacuum. Recently, Castells and Carr [51]

coated tris(3,5-dimethylphenylcarbamate) on microparticulate porous zirconia.
The CSP that developed was tested for the chiral resolution of amino alcohol
compounds such as b-adrenergic agents.
Since polysaccharide derivatives coat silica gel THF, chloroform and N, N-
dimethylacetamide (in which most polysaccharides are soluble) cannot be used as
the mobile phase, greatly limiting the choice of mobile phase. Therefore, a variety
of approaches have been used to bond the CSPs developed to silica gel [52].
Okamoto el al. [53] developed an approach for stabilizing these CSPs on a silica
surface by immobilization. Later this immobilization technique was improved by
a number of groups [54–56], and it is now used by researchers. However, CSPs
prepared by the immobilization technique show lower chiral recognition ability,
particularly at higher concentrations of the chemical bond, than the corresponding
coated-type CSPs. The introduction of the chemical bond may disturb the
formation of the regular higher order polysaccharide structure.
Okamoto et al. [54] prepared cellulose tris(3,5-dimethylphenylcarbamate
(CDMPC) and amylose tris(3,5-dimethylphenylcarbamate (ADMPC) CSPs by
regioselective bonding to silica gel with 4,40 -diphenylmethane diisocyanate as a
spacer. The ADMPC regioselectively bonded to silica gel when a small amount of
diisocyanate was used, and the CSP that developed showed a higher resolving
power. For CDMPC, the position of glucose in immobilization on silica gel
affects chiral recognition hardly at all. Some racemic compounds were more
efficiently resolved by using chloroform as a component of the mobile phase on
the chemically bonded type of CSP. When CSPs are chemically bonded to silica
gel through plural hydroxy groups of polysaccharides, there is an alteration in the
higher order structure of the polymers, giving rise to a decrease in chiral
recognition ability. Okamoto et al. [57] bonded amylose 3,5-dimethylphenylcar-
bamate to silica gel at the reducing terminal residue of amylose. More recently,
Felix [58] has reviewed the regioselectively modified polysaccharide derivatives
as chiral stationary phases in HPLC, describing methods of preparation of several
regioselectively modified polysaccharide derivatives. The goal was to combine
the effects of the selectivities of the known tris(aryl carbamate) and tris(aryl
esters) of polysaccharides. The use of new substituted derivatives of polysacchar-
ides as the chiral stationary phase in HPLC for chiral resolution was investigated.
Okamoto et al. [56] prepared CSPs of amylose phenylcarbamate bonded to
silica gel by the following enzymatic methods. Amylose that had been prepared
by enzymatic polymerization of a-D-ðþÞ-glucose-1-phosphate dipotassium cata-
lyzed by a phosphorylase, using two kinds of the primer derived from malto-
pentose, was chemically bonded to silica gel. In method I, maltopentose was first
lactonized and allowed to react with (3-aminopropyl)triethoxysilane to form an
amide bond. Amylose chains having the desired chain length and a narrow
molecular weight distribution were then constructed by means of enzymatic
polymerization. The resulting amylose bearing a trialkoxysilyl group at the

terminal was allowed to react with silica gel for immobilization. In method II,
maltopentose was first oxidized to form a potassium gluconate at the residual
terminal. After enzymatic polymerization with the potassium gluconate, the amy-
lose end was lactonized to be immobilized to 3-aminopropyl-silanized silica gel
through amide bond formation.
The two amylose-conjugated silica gels thus obtained were treated with a
large excess of 3,5-dimethylphenyl isocyanate to convert the hydroxyl groups of
amylose to the corresponding carbamate residues. The CSP derived through
method II was found to be superior to the CSP obtained by method I. The scheme
of the preparation of these CSPs are given in Figure 6. In 2001 Okamoto’s group
[59] synthesized cellulose derivatives having vinyl groups and polymerized on
silica gel. Silica gel first was coated with the cellulose phenylcarbamate derivative
and then copolymerized under various conditions with vinyl monomers such as
styrene with a radical initiator. The cellulose phenylcarbamate derivatives were
efficiently immobilized on the silica surface and showed a high capacity for
enantioseparation, similar to that of coated-type CSPs.
In 2001, Franco et al. [52] reviewed an alternative method using a cross-
linking technique to improve the durability of polysaccharide CSPs. Kimata et al.
[60] developed a method for the fixation of cellulose tris(4-vinylbenzoate) on
modified silica by means of a radical copolymerization reaction. In this case there
was no spacer between the matrix and the polysaccharide derivatives, both of
which bore activated double bonds that were capable of being polymerized. On
the other hand, the g-aminopropyl silica gel used as a matrix was treated with
acryloyl chloride. Cellulose was fully derivatized with 4-vinylbenzoyl chloride.
After the cellulose derivative had been coated onto the modified silica, a
suspension of the resulting material in heptane was heated in the presence of a
radical initiator. The CSP obtained from the above-described process was stable
in THF and dichloromethane solvents. For comparison, the coated CSP of the
same material was copolymerized. The bonded CSP showed lower chiral
recognition capacity, but its higher stability in a variety of solvents was proved.
The procedure of this technique is presented in Figure 7.
As noted earlier, not all the prepared derivatives of cellulose and amylose
are useful CSPs. Therefore, some of the useful derivatives of cellulose and
amylose were selected and commercialized. The cellulose and amylose CSPs
were commercialized by Daicel Chemical Industries of Tokyo. About 20
derivatives of cellulose and amylose are commercially available, as shown in
Figure 8, with their chemical and trade names. The trade name of the cellulose
and amylose derivatives are Chiralcel and Chiralpak, respectively. An R added to
the end of a Chiralcel or Chiralpak trade name denotes a reversed-phase nature
CSP. These CSPs are available in stainless steel columns of different dimensions
and with different particle sizes. Generally the CSPs are available in the following
range of column sizes and particle sizes (in parentheses): 25 cm 0.46 cm

FIGURE 6 Preparation of amylose-derived CSPs in which the chiral selector is fixed to
the matrix by the reducing terminal residues. (From Ref. 52.)

FIGURE 7 The polymerization of tris(4-vinylbenzoate) of cellulose onto acrylamido-
propylsilica gel. (From Ref. 52.)
(5 mm), 15 cm 0.46 cm (10 mm), 15 cm 0.46 cm (5 mm), and 25 cm

0.46 cm (10 mm).
2.4 SELECTIVITIES
Although about 20 polysaccharide-based CSPs have been commercialized and
much work on enantioresolution has been carried out on these phases, it remains
very difficult to predict the best CSP for the chiral resolution of a particular
compound. It has been observed that most of the resolved racemic compounds
contain aromatic rings or groups such as carbonyl, sulfinyl, nitro, amino, and
benzoyl. However, some reports have been published on the chiral resolution of
nonaromatic racemates on polysaccharide CSPs [61]. As in the case of other
CSPs, polysaccharide-based CSPs do not require a certain combination of
functional groups. However, only one group can afford a satisfactory separation.
Presumably some chiral space (e.g., a concavity or ravine existing on a
polysaccharide derivative) could enable such a separation [62].
It is not easy to determine the differences in structural selectivity among all
possible derivatives. A rationalization based on an electronic effect [18] and the
length of the acyl substituent on cellulose were attempted [42]. CTA-I (micro-
crystalline cellulose triacetate) is very specific and can be used for resolution of
racemic compounds both having aromatic rings and carbonyl groups. On the
other hand, a CTA-II (cellulose triacetate) CSP has a different selectivity. Both

FIGURE 8 Chemical structures and chemical and trade names of most of the commonly
used polysaccharide-based CSPs.

CSPs (CTA-I and CTA-II) have inverse selectivity for Tröger’s base and trans-
1,2-diphenyloxirane racemates. These characteristics of CTA CSPs are respon-
sible for good chiral resolution of small cyclic carbonyl compounds [42]. In 2001
Aboul-Enein and Ali [63] observed the reversed order of elution of nebivolol on a
Chiralpak AD column when ethanol and 2-propanol were used separately as the
mobile phases. Table 1 presents selectivity data for the polysaccharide-based
CSPs. Okamoto et al. [42] observed that the introduction of a methyl group at the
para position of cellulose tribenzoate results in a dramatic shift of the structural
selectivity toward aromatic compounds with larger skeletons, and its selectivity
was rather similar to that of cellulose tricinnamate.
2.5 APPLICATIONS
2.5.1 Analytical Separations
A single CSP cannot be used for the chiral resolution of all racemic compounds.
Therefore, different CSPs were used for the chiral resolution of different
racemates. To make this part easy and clear, Table 1 includes the names of 20
CSPs and their most frequent applications. However, some other interesting
applications are possible. Upon screening about 510 racemic compounds
described in the literature, we observed that 229 of them resolved completely
and 86 partially on cellulose tris(3,5-dimethylphenylcarbamate), and the rest not
at all. For amylose tris(3,5-dimethylphenylcarbamate) CSP, we screened 384
racemic compounds and observed that 107 resolved completely and 102 partially.
Clearly, cellulose and amylose tris(3,5-diphenylcarbamate) CSPs have the ability
to resolve about 80% of the racemic compounds investigated.
Various aliphatic and aromatic compounds have been resolved on cellulose
triacetate (CTA) CSPs at both the analytical and the preparative scale. Hesse and
Hagel in 1973 reported the complete resolution of Tröger’s base on a 16 cm
column filled with MCTA [15]. Francotte et al. [50] extensively studied the
relationship between the crystallinity of CTA and resolution power; CTA-I
showed the best resolution power, whereas CTA-II exhibited poor resolution.
Moreover, enhancement of the crystallinity of CTA-I by annealing resulted in
lower resolving power for CTA-I, and the chromatographic behavior was rather
similar to that of CTA-II [50]. Further, Francotte et al. [64,65] established that
heterogeneous acetylation may provide a supramolecular structure for CTA-I
having multiple interaction sites with specific surfaces and grooves inside the
matrix that may be responsible for high chiral recognition for a wide range of
enantiomers. The existence of such a supramolecular structure for CTA was also
proposed as a result of NMR studies [26]. When CTA-I is coated on silica gel, the
CSP is called Chiralcel OA, and its properties are different from those of CTA-I.
The new coated CSP offers more advantages, including greater column efficiency,

TABLE 1 Various Polysaccharide-Based Commercial CSPs
Trade namea Chemical name Applications
Cellulose CSPs
Chiralcel OB Cellulose trisbenzoate Small aliphatic and aromatic compounds
Chiralcel OB-Hb Cellulose trisbenzoate Small aliphatic and aromatic compounds
Chiralcel OJ Cellulose tris(4-methyl benzoate) Aryl methyl esters, aryl methoxy esters
Chiralcel OJ-Rb Cellulose tris(4-methyl benzoate) Aryl methyl esters, aryl methoxy esters
Chiralcel CMB Cellulose tris(3-methylbenzoate) Aryl esters and arylalkoxy esters
Chiralcel OC Cellulose trisphenylcarbamate Cyclopentenones
Chiralcel OD Cellulose tris(3,5-dimethylphenylcarbamate) Alkaloids, tropines, amines, b-adrenergic blockers
Chiralcel OD-Hb Cellulose tris(3,5-dimethylphenylcarbamate) Alkaloids, tropines, amines, b-adrenergic blockers
Chiralcel OD-Rc Cellulose tris(3,5-dimethylphenylcarbamate) Alkaloids, tropines, amines, b-adrenergic blockers
Chiralcel OD-RHd Cellulose tris(3,5-dimethylphenylcarbamate) Alkaloids, tropines, amines, b-adrenergic blockers
Chiralcel OF Cellulose tris(4-chlorophenylcarbamate) b-Lactams, dihydroxypryidines, alkaloids
Chiralcel OG Cellulose tris(4-methylphenylcarbamate) b-Lactams, alkaloids
Chiralcel OA Cellulose triacetate on silica gel Small aliphatic compounds
Chiralcel CTA Cellulose triacetate, microcrystalline Amides, biaryl compounds
Chiralcel OK Cellulose triscinnamate Aromatic compounds
Amylose CSPs
Chiralpak AD Amylose tris(3,5-dimethylphenylcarbamate) Alkaloids, tropines, amines, b-adrenergic blockers
Chiralpak AD-Re Amylose tris(3,5-dimethylphenylcarbamate) Alkaloids, tropines, amines, b-adrenergic blockers
Chiralpak AD-RHb Amylose tris(3,5-dimethylphenylcarbamate) Alkaloids, tropines, amines, b-adrenergic blockers
Chiralpak AR Amylose tris(R)-1-phenylethylcarbamate Alkaloids, tropines, amines
Chiralpak AS Amylose tris(S)-1-methylphenylcarbamate Alkaloids, tropines, amines
a
Columns supplied by Daicel Chemical Industries, Tokyo, Japan. Dimensions are column size 25 cm 0:46 cm, particle size 10 mm, except as noted.
b
Column size 25 cm 0:46 cm, particle size 5 mm.
c
Column size 15 cm 0:46 cm, particle size 10 mm.
d
Column size 15 cm 46 cm, particle size 5 mm.

greater durability, and wider choice of mobile phase. X-ray studies indicate that
Chiracel OA is almost amorphous rather than crystal [25], indicating that
microcrystallinity is not essential for chiral resolution. It has also been observed
that the chiral recognition of a CSP greatly depends on the conditions of
preparation of that CSP, such as the type of coating solvent and the molecular
weight of the cellulose [25,66].
Nevertheless, cellulose triacetate derivatives have certain limitations. An
ethanol–water mixture may cause CTA to swell by up to 40% of its volume.
Other solvents (e.g., acetone, acetonitrile, dimethylformamide, chlorinated
alkanes) cannot be used because they dissolve cellulose triacetate more or less
completely. A gel is formed when THF is used as the mobile phase. Furthermore,
in pure 1,4-dioxane, or in a 50 : 50 v=v mixture of dimethoxyethane and toluene-
1,4-dioxane, cellulose triacetate swells strongly. It has been also observed that
CTA swells more in lower alcohols than in ethers or alkanes. Mannschreck et al.
[67] found that in general the capacity factors of the solutes investigated
increased when methanol, ethanol, or propanol, respectively, was used as the
eluent. Similar results were found by Rizzi [68] and also by Isaksson et al. [69].
Thus, since the degree to which CTA will swell depends on the kind of solvent
used, care must be taken when changing from one solvent to another. If shrinkage
of the packing bed occurs, a void volume is created on top of the column,
resulting in decreased column efficiency. Therefore, it is advisable to use a
column equipped with a movable piston to enable compensation for packing bed
volume changes. A few examples of the enantiomeric resolution on CTA are
shown in Figure 9.
The chiral recognition capacities of cellulose tribenzoate (CTB) derivatives
was explored by Okamoto et al. [8,17]. The effect of the substituents on the
phenyl ring of cellulose tribenzoate (Chiralcel OB) has also been systematically
studied [17]. Alkyl, halogen, trifluoromethyl, and methoxy groups were selected
as the substituents. Resolution ability was greatly affected by the inductive effect
of such substituents. Benzoate derivatives having electron-donating substituents
such as methyl groups showed better chiral recognition ability than those having
electron-withdrawing substituents, such as halogens. However, the most heavily
electron-donating methoxy group was not suitable because of the high polarity of
the substituent itself. Among the benzoate celluloses, tris(4-methylbenzoate)
(Chiralcel OJ) exhibited very high chiral recognition for various racemic
compounds, including drugs, and appears to be a practically useful CSP.
Francotte and coworkers resolved large quantities of many drugs on CSPs
derived from CTB [49,50,65,70]. They claimed that the benzoyl cellulose
beads showed complementary chiral recognition to the CTA phase [49]. The
CTB derivative beads show almost the same enantioseparation ability as the
corresponding coated-type CTB derivatives on silica gel. Figure 10 shows the
chromatograms of chiral resolution on cellulose tribenzoate CSPs.

FIGURE 9 Chromatograms of enantiomeric resolution on cellulose triacetate CSPs. (a)
N-Benzoylalanine methyl ester, with hexane–ethanol (80 : 20, v=v) as the mobile phase. (b)
Benzoin with hexane–2-propanol–water (70 : 27 : 3, v=v=v) as the mobile phase. (c)
Mandelic acid with ethanol as the mobile phase. (From Ref. 9.)
The chiral recognition ability of a series of cellulose phenylcarbamate

derivatives has been evaluated extensively [18,43]. The introduction of an
electron-donating methyl group or an electron-withdrawing halogen at the 3-
and=or 4-position improved the resolution ability, but substituents at position 2
showed poor chiral resolution capacity. The derivatives with heteroatom substi-

FIGURE 10 Chromatograms of enantiomeric resolution on cellulose tribenzoate CSPs.
(a) ()-threo-Methylphenidate on Chiralcel OB CSP, with hexane–ethanol–methanol–
trifluoroacetic acid (480 : 9.75 : 9.75 : 0.5, v=v=v=v) as the mobile phase containing 0.2 mM
benzoic acid. (b) ()-threo-methylphenidate on Chiralcel OB CSP, with hexane–ethanol–
methanol–trifluoroacetic acid (480 : 9.75 : 9.75 : 0.5, v=v=v=v) as the mobile phase contain-
ing 0.2 mM phenol. (c) Ic aromatase inhibitor on Chiralcel OJ-R CSP, with acetonitrile–
water (50 : 50, v=v) as the mobile phase. (d) IIc aromatase inhibitor on Chiralcel OJ-R CSP,
with acetonitrile–water (50 : 50, v=v) as the mobile phase. For structures of Ic and IIc
aromatase inhibitors, see later (Fig. 18). (From Refs. 98, 100.)

tuents, such as methoxy and nitro groups, show poor chiral recognition [18].
Racemic compounds can interact with polar substituents far from a chiral glucose
residue. Therefore, bulky alkoxy substituents such as isopropoxy and isobutoxy
improve resolving power [23]. Phenylcarbamate derivatives having both an
electron-donating methyl group and electron-withdrawing substituents (chloro
or fluoro groups), on the phenyl moieties were found to exhibit high enantio-
separation for many racemates. For example, cellulose 3,4- or 3,5-chloromethyl-
phenylcarbamate showed particularly high chiral recognition ability [19–21]. The
chromatograms of the chiral resolution on cellulose tricarbamate are shown in
Figure 11.
Similarly, the chiral resolution power of amylose CSPs was improved by
introducing methyl or chloro groups on the phenyl moieties [21,22]. However, in
contrast to the cellulose derivatives, amylase tris(4-methylphenylcarbamate) [23]
and tris(5-chloro-2-methylphenylcarbamate) [24] showed high chiral recognition.
In general, amylose derivatives were better CSPs than the cellulose derivatives.
Their superiority may be due to the structure of amylose, which is more helical
than that of cellulose [31]. Among many of the amylose derivatives prepared so
far, 3,5-disubstituted derivatives such as 3,5-dimethyl- and 3,5-dichlorophenyl-
carbamate show particularly interesting and effective optical resolving abilities
for a variety of racemic compounds [18,21,71]. For ready reference on the nature
of the resolution, Figure 12 shows chromatograms on amylose triphenylcarba-
mate CSPs.
Tricarbamates are the most important cellulose and amylose derivatives
used for chiral resolution, and derivatives of both types have comparable chiral
recognition capabilities. However, some compounds could not be resolved
completely on amylose carbamate CSPs. For example, both the calcium antago-
nist nicardipine and nitredipine were completely resolved on cellulose tris(4-tert-
butylphenylcarbamate) [72], whereas amylose carbamate could not resolve these
compounds. Thus this is a respect in which the two CSPs (cellulose and amylose
derivatives) differ in their chiral recognition abilities. Some enantiomers that elute
in reversed order on CDMPC may be resolved ADMPC, and vice versa [43]. The
two phases (CDMPC and ADMPC) were compared for performance in the
enantioseparation of a series of amidotetralines [73] and chiral sulfoxide [74], and
complementary chromatographic behavior was observed. Cellulose derivatives
substituted with meta and para (fluoro and methyl) groups showed higher
resolving power than ortho- and meta-substituted derivatives. On the other
hand, amylose derivatives having the substituents at the ortho position also
showed characteristic high chiral recognition, comparable to that afforded by the
meta and para substituents derivatives. The elution order was not influenced by
the change of substituents in either cellulose or amylose derivatives [45].
Similarly, Chankvetadze et al. [24] reported that ortho-substituted phenylcarba-
mate derivatives of amylose showed high chiral recognition abilities, while

FIGURE 11 Chromatograms of enantiomeric resolution on cellulose tricarbamate CSPs.
(a) Econozole. (b) Miconazole. (c) Sulconazole on a Chiralcel OF CSP, with hexane–2-
propanol–diethylamine (425 : 74 : 1, v=v=v) as the mobile phase. (d) ()-threo-Methyl-
phenidate on a Chiralcel OD CSP, with hexane–ethanol–methanol–trifluoroacetic acid
(480 : 9.75 : 9.75 : 0.5, v=v=v=v) as the mobile phase. (From Refs. 100, 101.)

FIGURE 12 Chromatograms of enantiomeric resolution of nebivolol on amylose carba-
mate CSPs. (a)–(c) Chiralpak AD with (a) ethanol, (b) 1-propanol, and (c) 2-propanol.
(d, e) Chiralpak AD-RH with (d) ethanol and (e) 1-propanol, separately, as the mobile
phase. (From Ref. 63.)
cellulose phenylcarbamate derivatives with ortho substituents have poor chiral

resolving power. The superiority of 5-chloro-2-methylphenylcarbamate over the
corresponding dimethyl and dichlorophenylcarbamate derivatives of amylose was
demonstrated. The role of the NH residue of the carbamate moiety and methyl
and chloro groups in chiral recognition was elucidated by IR and 1 H NMR
spectroscopy. In another study Okamoto et al. [44] observed that fluoro, chloro,
bromo, and iodo groups at position 4 on the phenyl ring resulted in higher chiral
recognition than was reported for the corresponding cellulose derivatives. The
applications of chiral resolution on polysaccharide-based CSPs are summarized
in Table 2 [1,6,7,9–116].
2.5.2 Preparative Separations

Analytical methods can be transferred easily to the preparative scale in poly-
saccharide-based CSPs, and these compounds have been used in preparative
chromatography. Cellulose triacetate, which has good loading capacity, has been
used for preparative separation at the industrial scale [70,85]. Moreover, the low
cost of cellulose triacetate synthesis makes CTA ideal for preparative chromato-
graphy.

TABLE 2 The Mobile Phases Most Commonly Used with Polysaccharide-Based CSPs
Solventsa Ratios (v=v) Racemates CSPs
Cellulose CSPs
Hexane–2-PrOH 95 : 5 Tri- and tetrazole aromatase Chiralcel OD
inhibitors
Hexane–2-PrOH–DEA 50 : 50 : 0.4, 20 : 80 : 0.4 b-Adrenergic blockers Chiralcel OD
and 15 : 85 : 0.4
Hexane–EtOH–DEA 80 : 20 : 0.2 Naftopidil Chiralcel OD
Cyclohexane–MeOH–EtOH 2 : 95 : 5 Aminoglutethimide Chiralcel OD
Hexane–EtOH–DEA 90 : 10 : 0.4 b-Adrenergic blockers Chiralcel OD
– – Triacylglycerol Chiralcel OD
Hexane–alcohols Different ratios Tetralin Chiralcel OD-H
Hexane–1-PrOH 95 : 5, 97 : 3 Aromatic amides Chiralcel OB
Hexane–1-PrOH–MeCN 96 : 3 : 1 Aromatic amides Chiralcel OB
Hexane–2-PrOH 90 : 10 Aromatic alcohols Chiralcel OB
– – a-Hydroxy-3-phenoxybenzene- Chiralcel OJ
acetonitrile and its n-butyl ester
Hexane–2-PrOH–DEA 425 : 74 : 1 Imidazole antifungal agents Chiralcel OD, OJ, OB, OK,
OC, and OF
Hexane–2-PrOH Different ratios Organophosphorous pesticides Chiralcel OD, OJ
Perchlorate solution–MeCN 75 : 25 and others b-Adrenergic blockers Chiralcel OD-R
Hexane–2-PrOH–DEA 15 : 85 : 0.4 and others b-Adrenergic blockers Chiralcel OD and OD-R
MeCN–water 50 : 50 o,p-DDT and o,p-DDD Chiralcel OJ-R
MeCN–2-PrOH 50 : 50 o,p-DDT and o,p-DDD Chiralcel OD-R and
Chiralcel OJ-R
MeCN–18 mM NH4 NO3 (pH 7.0) 25 : 75, 55 : 45 Pipiridine derivatives Chiralcel OD-R
(continued )

TABLE 2 Continued.
Solventsa Ratios (v=v) Racemates CSPs
Water–MeCN–TEA 80 : 20 : 0.08 Clenbuterol, cimaterol, Chiralcel OD-R and

and mabuterol Chiralcel OJ-R
Water–MeCN 45 : 55 Tri- and tetrazole aromatase Chiralcel OD-R and OJ-R
inhibitors
Hexane–EtOH–MeOH–TFA 480 : 9.75 : 9.75 : 0.5 Methylphenidate Chiralcel OD and OB
2-PrOH–MeCN 90 : 10, 50 : 50 Tri- and tetrazole aromatase Chiralpak OD-R and OJ-R
inhibitors
MeCN–water 50 : 50, 80 : 20, and 95 : 5 Tri- and tetrazole aromatase Chiralpak OD-R and OJ-R
inhibitors
EtOH Pure Mandelic amide Chiralcel CTA
EtOH Pure or 10% Biaryl compounds Chiralcel CTA
Hexane–EtOH 90 : 10 Biaryl compounds Chiralcel OF and OG
EtOH or MeOH Pure Polycyclic aromatics Chiralcel CA and OB
Hexane–EtOH 90 : 10 Sulfur compounds Chiralcel OB and OC
Hexane–2-PrOH 90 : 10 Phosphorus compounds Chiralcel OB, OK, and OC
Hexane–EtOH 90 : 10 Nitrogen and cyano compounds Chiralcel OA, OB, OC,
and OK
Hexane–EtOH 95 : 5 Amines Chiralcel CA, OA, OC,
OB, and OK
Hexane–2-PrOH 95 : 5-10 Carboxylic acids and derivatives Chiralcel OC, OB, OF,
and OG
EtOH pure Alphatic alcohols Chiralcel CA, OB, OK,
and OK
Hexane–EtOH 95 : 5, 90 : 10 Alphatic alcohols Chiralcel CA, OB, OK,
and OK
– – Triacylglycerol Chiralcel OF

Amylose CSPs
Hexane–EtOH 95 : 5, 90 : 10 and 88 : 12 b-Adrenergic blockers Chiralpak AD
Hexane–2-PrOH 90 : 10 b-Adrenergic blockers Chiralpak AD
Hexane–EtOH–MeOH–TFA 480 : 9.75 : 9.75 : 0.5 Methylphenidate Chiralpak AD
Hexane–2-PrOH, hexane–EtOH Different ratios Vincamine Chiralpak AD
– – 2,4-Dioxo-5-acetamido-6- Chiralpak AD
phenylhexanoic acid
Hexane–2-PrOH–DEA 400 : 99 : 1 Imidazole antifungal agents Chiralpak AD, AS, and AR
Hexane–2-PrOH Different ratios 3-tert-Butylamino-1,2-propanediol Chiralpak AS
MeCN–water 50 : 50 o; p-DDT and o; p-DDD Chiralpak AD-R
MeCN–2-PrOH 50 : 50 o; p-DDT and o; p-DDD Chiralpak AD-R
Water–MeCN–TEA 80 : 20 : 0.08 Clenbuterole, cimaterol, and Chiralpak AD-R
mabuterol
Water–MeCN 60 : 40 Flurbiprofen Chiralpak AD-R
MeCN–water–TEA 50 : 50 : 0.03 Tetralone derivatives Chiralpak AD-R
MeCN–water–AcOH 60 : 40 : 0.03 Tetralone derivatives Chiralpak AD-R
2-PrOH–MeCN 90 : 10, 50 : 50 Tri- and tetrazole aromatase Chiralpak AD-R
inhibitors
MeCN–water 50 : 50, 80 : 20, and 95 : 5 Tri- and tetrazole aromatase Chiralpak AD-R
inhibitors
EtOH, 1-PrOH, and 2-PrOH separately Pure Nebivolol Chiralpak AD and AD-R
a
Abbreviations: AcOH, acetic acid; DEA, diethylamine; MeCN, acetonitrile; MeOH, methanol; MPH, methylphenidate; EtOH, ethanol; 1-PrOH, 1-propanol;
2-PrOH, 2-propanol; TEA, triethylamine; TFA, trifluoroacetic acid.
Source: Refs. 1, 6, 7, 9–116.

In one example of preparative chromatographic separation on a large scale
[9], 20 g of the sample per run was injected onto a column (50 cm 10 cm i.d.)
filled with 20 mm Chiralcel OJ material. The eluent was hexane–ethanol (40 : 60,
v=v). This column has been used for more than 2 years, and the column quality
remains excellent, indicating long-term durability [9]. Recently, Cirrili et al. [117]
described semipreparative-scale chiral resolution of imidazole derivatives by
HPLC. To achieve the resolution of pure enantiomers, recycling [86] and peak
shaving techniques are sometimes very important in preparative chromatography.
The recycling techniques can be performed by two methods: by means of a
closed-circuit system and by the alternating-two-column mode of operation. In
general, the first method is preferred because a closed-circuit system is less
complicated to construct and more economical than the construction of a unit that
functions in the alternating-two-column mode. Moreover, recycling and peak
shaving techniques are advantageous because they can be used for the separation
of pure enantiomers in good yields, are suitable for the separation of partially
resolved enantiomers, offer a higher production rate, consume less solvent, and
can be run on smaller columns with less labor. Preparative enantioseparation by
simulated moving bed (SMB) chromatography has been described by Schulte and
Strube [118]. Their paper details system development, selectivity, saturation
capacity, and mechanical and chemical stability, as well as methods for the
optimization of pure enantiomeric separation.
2.6 OPTIMIZATION OF HPLC CONDITIONS

Chiral resolution on polysaccharide-based CSPs is sensitive, and therefore, the
optimization of HPLC conditions on these phases is very important. The most
important factors that control enantiomeric resolution are the composition, pH,
and flow rate of the mobile phase and parameters, including temperature and
solute structure. The optimization of these parameters on polysaccharide-based
CSPs is discussed next.
2.6.1 Mobile Phase Composition

The selection of the mobile phase is the key aspect in chiral resolution. The
mobile phase is selected according to the solubility and the structure of the drugs
to be resolved. In the normal phase mode, the use of pure ethanol or 2-propanol is
recommended. To decrease the polarity of the mobile phase and increase the
retention times of the enantiomers, investigators use hexane, cyclohexane,
pentane, or heptane as one of the main constituents of the mobile phase. However,
other solvents (e.g., alcohols, acetonitrile) are also used in the mobile phase.
Normally, if pure ethanol or 2-propanol is not well suited for the mobile phase,
pure ethanol and hexane, 2-propanol, or ethanol in the ratio of 80 : 20 is used as

SCHEME 1 Protocol for the development and optimization of mobile phases on
polysaccharide-based CSPs in the normal phase mode. This brief outline gives the
procedure for developing a resolution on polysaccharide-based CSPs in the normal
phase mode. However, other mobile phases may be used.
the mobile phase, and the mobile phase composition is changed on the basis of
ensuing observations. Finally, chiral resolution is optimized by adding small
amounts of amines or acids (0.1–1.0%). In 2001 Ye and Stringham [119,120] used
basic and acidic organic modifiers to optimize the chiral resolution of certain
racemates on amylose CSPs. The protocol of the selection and optimization of
mobile phases for the enantiomeric resolution of drugs on polysaccharide-based
CSPs in normal phase mode is presented in Scheme 1. The presence of small
impurities may change the reproducibility. Moreover, the same solvent from two
different suppliers may give rise to different results for the enantiomeric resolution
of particular racemates under the identical conditions of chromatography.
The effect of the percentage of 2-propanol on the enantiomeric resolution
of benzetimide is shown in Figure 13a. It may be concluded that retention factor
values decreased with an increase in 2-propanol content. According to Wainer et
al. [87], the diminution of retention factor values with increases in the content of
polar modifiers indicates that competition for the binding sites on the CSP is a
saturable process and that a maximum effect on retention factor will be reached at
a certain polar modifier concentration. It is interesting to note that although only a

FIGURE 13 Effects of the concentration of 2-propanol on the enantiomeric resolution
Rs of (a) benzetimide, (b1 ) metomidate, (b2 ) ambucetamide, (b3 ) isoconazole, and (b4 )
parconazole. (From Ref. 9.)
FIGURE 14 (A) Effects of the concentration of 2-propanol in the mobile phase hexane–
2-propanol: n, second eluted isomer solute 1; e, first eluted isomer solute 1; r, second
eluted isomers solute 2; m, first eluted isomer solute 2; s, solute 3; u , second eluted
isomer solute 4; V, first eluted isomer solute 4; d, solute 5; j, solute 6; and ., solute 7.
Solutes: 1, 1-phenylethanol; 2, 1-phenylpropanol; 3, 1-phenyl propanol-2; 4, 2-phenyl-
propanol; 5, benzylalcohol; 6, 3-phenyl propanol-1; 7, 2-phenyl propanol-2. (From Ref.
62.) (B) Effects of chain length of primary alcohol used as polar modifier on k and a for
three different products: (b1 ) Chiralcel OC, (b2 ) Chiralcel OD, and (b3 ) Chiralcel OJ.

small change in retention factor values occurred when the polar modifier content
was varied from 5% to 25%, the effect on resolution can be completely different
(Fig. 13b). The effect of isopropanol on the chiral resolution of certain drugs has
been studied by Wainer et al. [62] and is given in Figure 14a. The effect of mobile
phase composition was also studied by Bonato et al. [88] for the enantiomeric
resolution of propafenone, 5-hydroxypropafenone and N-despropylpropafenone
on Chiralpak AD column. The effect on the length of the carbon chain of the
alcohol (modifier) in the mobile phase was studied and is depicted in Figure 14b.
It may be concluded from this figure that the retention k and separation a factors
usually decrease with an increase in the chain length of the polar modifier,
although at times there are minor changes in or cyclic patterns of the values of k
and a. Based on these observations, it may be concluded that modifier structure
has an effect on stereoselectivity, but the steric fit between solute and CSP
certainly plays an important role, as well. Since no clear trend could be observed
delineating the effect of the polar modifiers on enantioselectivity, it is necessary
to use a specific modifier for each specific application. In CTA, selection of
buffers in the pH range of 5 to 10 is useful. However, eluents with a high water
content or low pH value should be used sparingly because CTA can be
hydrolyzed under these conditions [69].
Gaffney [89] reported the reverse order of elution of 2-phenoxypropanoic
acid on Chiralcel OB CSP when different alcohols were used. In 2001 Aboul-
Enein and Ali [63] observed the reverse order of elution of nebivolol enantiomers
on a Chiralpak AD chiral stationary phase when ethanol and 2-propanol were
used separately as the mobile phases. However, the best resolution was obtained
when ethanol served as the mobile phase. The inversion of the elution may be due
to the different conformation of the polysaccharide CSPs [63]. The pattern of
conversion of order of elution using different ratios of ethanol and 2-propanol is
shown in Figure 15.
The energies of interaction of ethanol and 2-propanol with amylose tris(3,5-
dimethylphenylcarbamate) phases were calculated. The energies of interaction of
ethanol, 2-propanol, and their mixtures in different ratios are calculated and
presented in Table 3. The energy of interaction G and the energy factor (for
ethanol and 2-propanol) F are calculated by the following equations [63].
G ¼ RT ln k ð1Þ
Fet or Fpr ¼ VE ð2Þ
where G; R; T ; Fet ; Fpr ; V , and E are the energy of interaction, the gas
constant, absolute temperature, energy factors for ethanol and 2-propanol,
volume of ethanol or 2-propanol, and energy of interaction of ethanol or 2-
propanol with amylose tris(3,5-dimethylphenylcarbamate), respectively. It has

FIGURE 15 Relationship between the percentage of ethanol and 2-propanol and the
retention times of (þ)- and (–)-enantiomers of nebivolol. (From Ref. 63.)
been concluded that the reversal in elution order was due in part to the chiral
grooves on the amylose CSP, which in turn were responsible for the different
bond magnitudes between the CSP and the enantiomers, and that the type of
alcohol used as the mobile phase influenced the conformation of the 3,5-
dimethylphenylcarbamate moiety on the pyranose ring system of the amylose.
Generally, the order of elution was reversed when the carbamate was changed to
benzoate or the cellulose to amylose types of CSP [121,122]. The possibility of a
change in the elution order may be an interesting tool in analytical and
preparative resolution. In quality control applications, where small amounts of
one enantiomer must be determined in the presence of a large excess of the other
enantiomer, it is far easier to quantify a small peak in front of a large one than to
do the reverse. In preparative chromatography, the first eluting peak is, in general,
easy to isolate with good yields. This is certainly not always the case for the
second elution product.

TABLE 3 Calculated Values of Fet ; Fpr , and Fet þ Fpr on Chiralpak AD CSP
Volume (mL) Valuesa
EtOH 2-PrOH Fet F pr F et þ F pr
00 100 0.00 71.00 71.00

50 50 10:50 35.50 25.00
55 45 11:55 31.95 20.40
60 40 12:60 28.40 15.80
65 35 13:65 24.85 11.20
70 30 14:70 21.30 6.35
75 25 15:75 17.75 2.00
77 23 16:17 16.33 0.16
80 20 16:80 14.20 2:60
85 15 17:85 10.65 7:20
90 10 18:90 7.10 11:80
95 05 19:95 3.55 16:40
100 00 21:00 0.00 21:00
a
F ¼ V E, where F; V and E are factor, volume of alcohols, and E energy of interaction,
respectively. Fet and Fpr are factors for ethanol and 2-propanol, respectively.
Source: Ref. 63.
Chiral resolution on polysaccharide-based CSPs in the reversed-phase

mode is carried out by using aqueous mobile phases. Again the selection of
the mobile phase depends on the solubility and other properties of the drugs to be
analyzed. Choices of a mobile phase in the reversed-phase mode are very limited.
Water is the main constituent of the mobile phases. The modifiers used are
acetonitrile, methanol, and ethanol. Chiral resolution is optimized by adding a
small percentage of amines or acids (0.1–1.0%). Some resolutions are pH
dependent and require a constant pH for the mobile phase. Under such conditions,
generally, the resolution is not reproducible when mobile phases such as water–
acetonitrile or water–methanol are used, and therefore, buffers containing organic
modifiers (acetonitrile, methanol, etc.) have been used as the mobile phase.
Resolution is optimized by adjusting the buffer pH and the amount of
organic modifiers. The most commonly used buffers are perchlorate, acetate, and
phosphate. The protocol of the selection and optimization of the mobile phase for
the enantiomeric resolution of drugs on polysaccharide-based CSPs in reversed-
phase mode is presented in Scheme 2. Table 4 correlates the effects of separation
conditions for neutral, acidic, and basic drugs on polysaccharide-based CSPs.
From Table 4, it may be concluded that a simple mixture of water and an organic
modifier will produce chiral separation of a neutral molecule because there is no

competing ionic interaction. For acidic analytes, it is essential to use an acidic
mobile phase to suppress the dissociation of the analyte and to minimize ionic
interactions. For basic compounds, a mobile phase having a pH greater than 7 is
suitable because hydronium cation is less likely to form at this pH and ionic
interactions do not occur. Recently, Ye et al. [123] reported that sulfonic acid is a
better organic mobile phase modifier than trifluoroacetic acid for the chiral
resolution of amino acids. In another study, the same authors [124] observed a
memory effect of mobile phase additives in the chiral resolution of some amino
acids on a Chiralpak AD column. The authors studied the effects of acidic and
basic mobile phase additives in detail. Similarly, Perrin and coworkers [125]
developed a strategy for rapid screening of the chiral resolution of b-adrenergic
blockers, profens, benzodiazepines, and some other drugs on cellulose- and
amylase-based CSPs. The authors reported a dramatic change in chiral resolution
when diethylamine, triethylamine, ethanol, and 2-propanol were used separately
as organic mobile phase modifiers.

polysaccharide-based CSPs in the reversed-phase mode. This brief outline gives the
procedure for developing a resolution on polysaccharide-based CSPs in the reversed-
phase mode. However, other mobile phases may be used.

TABLE 4 Correlation of Separation Conditions for Neutral, Acidic, and Basic
Compounds
Systemsa
Compounds Normal phase Reversed phaseb
Neutral MP ¼ IPA–hexane MP ¼ water–ACN

pH has no effect on the resolution pH has no effect on the resolution
Acidic MP ¼ IPA–hexane–TFA MP ¼ pH 2.0 perchlorate, acid–ACN
pH near 2.0
Basic MP ¼ IPA–hexane–DEA, MP ¼ pH < 7 buffer–ACN
IPA–hexane–TFA with
pH near 2.0, ion-pair separation Typical buffer is 0.5 M NaClO4
a
Abbreviations: MP, mobile phase; IPA, isopropanol; ACN, acetonitrile; TFA, trifluoroacetic acid;
DEA, diethylamine.
b
Columns normally are not run under basic conditions.
Resolution was effected by changing the polarity of the mobile phases. It is

very interesting to note that the change in resolution with respect to mobile phase
compositions varied from compound to compound. Resolution on polysacchar-
ide-based CSPs in the reversed-phase mode was improved by adding cations and
anions. For propranolol enantiomers on Chiralcel OD-R with sodium perchlorate
salt–acetonitrile (60 : 40, v=v) as the mobile phase, in the presence of cations, the
order of retention was Naþ > Liþ > Kþ > NH4 þ > NðC2 H5 Þ4 þ , while in the
presence of anions this order was ClO4 > SCN > I > NO3 > Br >
Cl > AcO [90].
Another study recorded the effect of the concentration of ammonium
acetate on the chiral resolution of metomidate and etomidate on a Chiralpak
AD-R column.. An increase in k values was observed with an increase in
ammonium acetate concentration. On the other hand, the values of a decreased
with an increase in ammonium acetate concentration [9]. The same trend was also
observed on Chiralcel OD-R CSP for the chiral resolution of propranolol and
trimepramine racemates [9].
Kazusaki et al. [91] studied the effect of acetonitrile concentration on the
resolution of RS-2-(4-bromo-2-fluorobenzyl)-(1,2,3,4-tetrahydropyrrolo[1,2-a]-
pyrazine-4-spiro-30 -pyrrolidine)-1,20 ,3,50 -tetrone, and the results are given in
Figure 16a,b. These authors reported that the resolution factor decreased with
an increase in acetonitrile concentration. Aboul-Enein and Ali [92] have studied
the effect of acetonitrile content on the chiral resolution of flubiprofen on
Chiralpak AD-RH columns at different temperatures. Figure 16c indicates the

FIGURE 16 Effects of acetonitrile percentage on the enantiomic resolution of (a) RS-2-
(4-bromo-2-fluorobenzyl)-(1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-30 -pyrrolidine)-
1,20 ,3,50 -tetrone on Chiralpak AD-RH and (b) Chiralcel OD-RH, and (c) flubiprofen on
Chiralpak AD-RH CSP at different temperatures. (From Refs. 91, 92.)

pattern of flubiprofen resolution with different percentages of acetonitrile. Again,
a high concentration of acetonitrile resulted in poor resolution.
Many researchers have documented the effect of the mobile phase on the
enantioselectivity of different racemates on polysaccharide-based CSPs. But no
comprehensive study aimed at identifying an association between the structural
features of the solute and the appropriate mobile phase conditions has yet been
proposed. Piras et al. [126] have studied the characteristic features of about 2363
racemic molecules separated on a Chiralcel OD CSP. The mobile phases used for
these racemates were compared with their structures available from CHIRBASE
(www.chirbase). The data setup was submitted to data mining programs for
molecular pattern recognition and mobile phase predictions for new cases. Some
substructural solute characteristics were related to the efficient use of some
specific mobile phases. For example, the application of acetonitrile–salt buffer at
pH 6 to 7 was found to be convenient for reversed-phase separation of com-
pounds bearing a tertiary amine functional group. Furthermore, cluster analysis
allowed the arrangement of the mobile phase according to similarities found in
the molecular patterns of the solutes.
2.6.2 pH of the Mobile Phase

Also controlling the chiral resolution of different racemic drugs on polysacchar-
ide-based CSPs is pH value. Aboul-Enein and Ali [93,94] have observed that
chiral resolution on polysaccharide-based CSPs is pH dependent in the normal
phase mode. Only partial resolution of certain antifungal agents was achieved at
lower pH, while resolution was improved by increasing the pH with triethylamine
on amylose and cellulose chiral columns. Aboul-Enein and Ali [94] studied the
chiral resolution of tetralone derivatives over a range of pH values on Chiralpak
AD-RH columns [results shown later (Fig. 18)]. The mobile phase containing
triethylamine was better than the mobile phase having acetic acid for the
resolution of these derivatives. Therefore, the enantiomeric resolution of tetralone
derivatives was pH dependent and was better at higher pH values. The poor
resolution at lower pH might be due to the steric effect exerted by the protonated
nitrogen of the pyridine ring of tetralone derivatives. The effect of pH on the
retention factors of flubiprofen and alprenolol was investigated on polysacchar-
ide-based CSPs in the reversed-phase mode [127] (Fig. 17). It can be observed
that the resolution of flubiprofen and alprenolol was better at about 3.0 pH.
Recently, Aboul-Enein and Ali [92] studied the effect of pH on the chiral
resolution of flubiprofen on Chiralpak AD-RH columns, and results are shown
in Figure 17c, which indicates that 3.5 was the best pH value for the resolution of
flubiprofen. In reversed-phase mode, the chiral resolution on polysaccharide
CSPs are pH dependent; therefore, buffers have been used to achieve the best
resolution.

FIGURE 17 Effects of pH on the retention, separation, and resolution factors of (a)
flubiprofen, (b) alprenolol, and (c) flubiprofen. [Figures (a) and (b) from Ref. 127; Fig. (c)
from Ref. 92.]

2.6.3 Flow Rate
Chiral resolution can be controlled by regulating flow rate on polysaccharide-
based CSPs. However, there are only a few studies dealing with the optimization
of chiral resolution by adjusting flow rates. Aboul-Enein and Ali [93] have
optimized the chiral resolution of some antifungal agents (Fig. 18) on Chiralpak
AD, AS, and AR CSPs by adjusting flow rates. The flow rates were varied
between 0.5 and 2.0 mL=min, but the best resolution was achieved at a flow rate
of 0.5 mL=min. Table 5 shows values for separation factor a and resolution Rs of
the antifungal agents at flow rates of 0.5 and 1.0 mL=min. There was no
resolution for miconazole and sulconazole, while only partial resolution of
econazole was obtained when the flow rate was 1 mL=min. Therefore, a
0.5 mL=min flow rate was found suitable for this study. It is interesting to note
that there was no improvement in resolution when the flow rate was decreased
below 0.5 mL=min. In another study, Aboul-Enein and Ali [94] optimized the
chiral resolution of certain tetralone derivatives (Fig. 18) on a Chiralpak AD-RH
CSP. The results of these findings are given in Table 6, where k1 and k2 are,
respectively, negative and positive retention factors. Similarly, the flow rates were
varied from 0.5 mL=min to 2.0 mL=min. It was observed that the 0.5 mL=min
flow rate was suitable for the chiral resolution of most of the derivatives. All the
tetralone derivatives studied resolved completely at 0.5 mL=min when water–
acetonitrile–triethylamine (50 : 50 : 0.03, v=v=v) served as the mobile phase.
However, partial resolution of tetralone derivative IV was observed at
0.5 mL=min when water–acetonitrile–acetic acid (60 : 40 : 0.03, v=v=v) was the
mobile phase. This study shows that the optimization of chiral resolution can be
achieved by adjusting the flow rate.
2.6.4 Temperature
Temperature also contributes to the chiral resolution of racemic drugs on
polysaccharide-based CSPs. Working at elevated temperatures can often be
beneficial, especially in preparative chromatographic separation on a larger
scale or for analytical purposes, if a good separation of the enantiomers can be
achieved only at very high values of k. Even then only a few studies dealing with
the influence of temperature on chiral resolution are available. The retention and
separation factors may be related to temperature by the following equations:
DH DS
ln k ¼ þ þ ln F ð3Þ
RT R

k dH dS
ln a ¼ ln 2 ¼ þ ð4Þ
k1 RT R

FIGURE 18 Chemical structures of econazole, miconazole, sulconazole, tetralone deri-
vatives, and aromatase inhibitors.
where R is the ideal gas constant, T is the absolute temperature, and F is the phase
ratio [128]; DH and DS represent the enthalpy and entropy terms for each
enantiomer, dH and dS represent their differences, and k2 and k1 are the
retention factors of the two resolved enantiomers. According to these equations,
both retention factors and separation factors are controlled by an enthalpic

TABLE 5 Effects of Flow Rate and Substituents on Chiral
Resolution of Imidazole Antifungal Agents on Amylose CSPs
Using Hexane–2-Propanol–Diethylamine (400 : 99 : 1, v=v=v)
as the Mobile Phase
0.5 mL=min 1.0 mL=min
a Rs a Rs
() (þ) (Þa (þ)
Chiralpak AS
Econazole 1.63 5.32 1.62 2.66
Miconazozle 1.56 4.69 1.54 2.89
Sulconazole 1.48 5.68 1.48 3.08
Chiralpak AD
Econazole 1.05 1.42 1.05 0.37
Miconazole 1.06 1.26 1.06 0.32
Sulconazole 1.16 3.60 1.04 1.36
Chiralpak AR
Econazole 1.07 0.45 1.07 0.40
Miconazole 1.05 0.32 NR —
Sulconazole — — NR —
a
NR, not resolved.
Source: Ref. 93.
contribution, which decreases with elevation of temperature, and a temperature-

dependent entropic contribution. The selectivity is a compromise between
differences in enantiomeric binding enthalpy and disruptive entropic effects
[129].
The effect of temperature on the retention factor of nebivolol enantiomers
on Chiralpak AD, given in Figure 19 [9], indicates poor resolution at higher
temperature. Moreover, 45 C was found to be the best temperature for the
resolution of nebivolol enantiomers, posting the best resolution of all 10
enantiomers, as indicated in Figure 20, which gives their peak shapes and
resolution at 25, 35, and 45 C. Furthermore, when the resolution of benzotriazole
derivatives on Chiralcel OJ is given as a function of temperature (Fig. 21a) [9], we
again see a decrease in resolution at higher temperature. Moreover, the lowest
resolution is observed when methanol was used. For this solvent, the resolution
factor diminishes by a very small extent with increasing temperatures. The
resolution factors are the highest for the hexane–ethanol mixture. The effect of
temperature on the chiral resolution of RS-2-(4-bromo-2-fluorobenzyl)-(1,2,3,4-
tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-30 -pyrrolidine)-1,20 ,3,50 -tetrone on a

TABLE 6 Effects of Flow Rate and Substituents on the Chiral Resolution of Tetralone
Derivatives (Fig. 18)
Conditions, compounds k1 k2 a Rs
MP, water–acetonitrile–triethylamine (50 : 50 : 0.03, v=v=v); flow rate, 0.5 mL=min

I 6.59 8.42 1.28 1.55
II 6.59 9.82 1.42 2.02
III 1.67 4.79 2.84 2.64
IV 1.53 2.98 1.95 1.10
MP, water–acetonitrile–triethylamine (50 : 50 : 0.03, v=v=v); flow rate, 1.0 mL=min
I 6.83 8.71 1.28 1.10
II 6.97 9.87 1.42 1.50
III 1.49 4.04 2.71 1.61
IV 1.30 1.82 1.23 1.00
MP, water–acetonitrile–acetic acid (50 : 50 : 0.03, v=v=v); flow rate, 0.5 mL=min
I 5.45 6.63 1.22 1.50
II 5.82 5.35 1.43 1.60
III 4.12 7.92 1.92 1.80
IV 3.23 3.76 1.16 0.40
MP, water–acetonitrile–acetic acid (50 : 50 : 0.03, v=v=v); flow rate, 0.5 mL=min
I 5.54 6.74 1.22 0.80
II 6.78 8.48 1.26 1.00
III 4.21 7.42 1.76 1.10
IV 3.26 3.80 1.17 0.20
Source: Ref. 94.
Chiralpak AD-RH column was studied by Kazusaki et al. [95], and the results are
shown in Figure 21b. The chiral resolution of flubiprofen on Chiralpak AD-RH
columns was studied by Aboul-Enein and Ali [92]. They observed that the best
resolution occurred at 25 C. Finally, the influence of temperature on enantios-
electivity differs from one analyte to another. Thus researchers have an ideal tool
for optimizing throughput per unit time in preparative chromatography or a
possibility for improving the sensitivity of analytical methods.
Dingenen [9], who studied the effect of the mobile phase velocity on the
height equivalent to a theoretical plate (HETP) at different temperatures for
benzotriazole derivatives, obtained the results shown in Figure 22, which rep-
resents the HETP values found for methanol and the hexane–ethanol mixture.
Both curves of Figure 22 clearly demonstrate that the kinetic circumstances are
less favorable at low temperatures. A slow mass transfer between the two phases
clearly determines the band-broadening process at temperatures below 20 C. This

FIGURE 19 Effects of temperature on the retention factor of nebivolol enantiomers on
Chiralpak AD column, with ethanol as the mobile phase. (From Ref. 9.)
effect is least pronounced when methanol is used as mobile phase. Thus the
favorable effect of a temperature decrease on enantioselectivity will be neutra-
lized, to a great extent, by strongly diminishing column efficiency. Finally, within
the temperature range investigated, some of the racemates posted decreases of
about 45% in retention factor values, while for some other racemates the k values
remained unchanged. Briefly, since the thermodynamic and kinetic parameters
govern the interactions between CSPs and enantiomers, the effect of temperature
on enantiomeric resolution is very important.
2.6.5 Solute Structures

Chiral resolution on polysaccharide-based CSPs is due to the different types of
bonding between racemates and CSP, as discussed later in this chapter. Therefore,
different racemate structures provide bondings of different types, which in turn
means that different patterns of chiral recognition will be observed. The effects of

FIGURE 20 Chromatograms of nebivolol enantiomers on a Chiralpak AD column at
45 ; 35 , and 25 C temperature. (From Ref. 9.)
different groups on the chiral resolution of oxindazac esters were studied by

Francotte et al. [96]. From their results (Table 7), it is clear that the separation and
resolution factors increased when hydrogen was replaced by a phenyl group or a
phenyl group containing an electron-withdrawing group, which indicates, prob-
ably, the major role of p–p interactions and hydrogen bonding between the CSP

FIGURE 21 (a) Effects of temperature on the resolution of benzotriazole derivatives on a
Chiralcel OJ column with methanol, ethanol, and hexane–ethanol (40 : 60, v=v) as the
mobile phases separately and respectively. (b) Effects of temperature (van’t Hoff plot) on
the resolution of RS-2-(4-bromo-2-fluorobenzyl)-(1,2,3,4-tetrahydropyrrolo[1,2-a]pyra-
zine-4-spiro-30 -pyrrolidine)-1,20 ,3,50 -tetrone on a Chiralpak AD-RH column; mobile
phase was 0.01 M acetate buffer (pH 4.7)–acetonitrile (50 : 50, v=v). (From Ref. 95.)

FIGURE 22 Dependence of height equivalent theoretical plate (HETP) on flow velocity
at different temperatures on a Chiralcel OJ CSP. (From Ref. 9.)
and the enantiomers. Further, Francottte and Wolf [50] studied the effects of alkyl
groups on the chiral resolution of some aromatic alcohols. They found that
resolution decreased when the alkyl chain was increased in length. These authors

TABLE 7 Chromatographic Resolution of Esters of Oxindazac (Fig. 18) on a Triacetyl
Column (60 1:3 cm) Using 95% Ethanol as the Mobile Phase
Retention factors
Separation factor Resolution
Compounds, R k1 ðÞ k2 ðþÞ a Rs
Methyl 2.67 4.16 1.56 2.10

Isopropyl 1.10 1.72 1.55 1.50
Phenyl 4.13 8.27 2.00 3.00
Benzoyl 4.15 7.94 1.91 2.90
4-Bromobenzoyl 3.68 15.23 4.14 2.10
Source: Ref. 96.
concluded that the decrease in chiral resolution may be due to the steric effect. In
the same study [50], they also investigated the effect of electron-donating (alkyl)
and electron-withdrawing (halogen) groups on the chiral resolution of phenyl-
cycloalkane and lactone derivatives. The substitution of halogens for hydrogen in
phenylcycloalkane improved the resolution, while the resolution decreased when
hydrogen was replaced by alkyl groups. The resolution in lactone derivatives was
decreased by increasing the size of the alkyl chain. Francotte and Wolfe explained
their results on the basis of different magnitudes of bonding.
Later, Wainer et al. [62,97] observed that the increase in the p basicity of
the solute (substituting a phenyl group for hydrogen) resulted in improved chiral
resolution of amides on cellulose tribenzoate (OB CSP) [97], while for certain
aromatic alcohols resolution was decreased when the p basicity on a Chiralcel OB
column was increased [62].
More recently, Aboul-Enein and Ali [94,98,99] studied the effects of
substituents of certain molecules on their chiral resolution on polysaccharide-
based CSPs. The racemates used for this purpose were aromatase inhibitors,
tetralone derivatives, and antifungal agents (Fig. 18); for the results, refer again to
Tables 5 and 6. The effects of substituents on the chiral resolution of aromatase
inhibitors (triazole and tetrazole derivatives) on Chiralpak AD-RH, Chiralcel OD-
RH and Chiralcel OJ-R columns are presented in Tables 8 to 10. It is interesting
to note that more sulconazole is retained than econazole and miconazole. This
may be because the strong coordination bonding between sulconazole and the
stationary phases of sulfur allows stronger coordination bonding than is possible
with oxygen. Miconazole is less well retained than econazole owing to the steric
effect exerted on miconazole by the extra chlorine atom. Furthermore, micona-
zole is less well retained than sulconazole owing to steric effects (due to the
presence of the extra chlorine atom in miconazole) and the lack of coordination

TABLE 8 Effects of Substituents on the Chiral Resolution of Aromatase Inhibitors
(Triazole and Tetrazole Derivatives, Fig. 18) on a Chiralpak AD-RH CSP
Retention factors
Compounds k1 (–) k2 ðþÞ Separation factor a Resolution Rs
MP, 2-PrOH–MeCN (90 : 10, v=v)

Ia 1.03 2.04 1.98 0.90
Ib 1.16 2.42 2.08 1.12
Id 0.93 1.71 1.84 0.71
IIa 0.40 0.55 1.26 0.11
IIb 0.42 0.75 1.79 1.50
Ia 5.91 13.29 2.29 4.92
Ib 6.89 16.72 2.43 3.86
Ic 5.75 6.79 1.18 1.39
Id 6.18 12.61 2.04 3.65
IIa 3.09 3.72 1.20 1.28
MP, MeCN–H2 O (50 : 50, v=v)
Ia 4.81 5.51 1.16 1.52
Ib 8.32 12.45 1.50 6.72
Ic 14.89 17.08 1.15 1.64
Id 6.98 8.05 1.15 2.64
IIa 8.82 9.84 1.12 1.24
MP, MeCN–H2 O (80 : 20, v=v)
IIa 0.47 1.12 2.39 1.77
IIb 0.66 2.05 3.11 3.86
IIc 0.57 1.55 2.72 2.72
MP, MeCN–H2 O (95 : 5, v=v)
IIb 0.12 0.68 5.63 1.98
Source: Ref. 98.
bonding in miconazole. In the case of tetralone derivatives, the order of elution,

which was III > II > I > IV, may be attributable to the type of substitution on the
aromatic ring of these compounds, which resulted in hydrogen bonds of different
magnitudes. Additionally, substitution on the aromatic ring of tetralone deriva-
tives also exerted steric effects of different magnitude. The chiral resolution
behavior of aromatase inhibitors differed on Chiralpak AD-RH, Chiralcel OD-
RH, and Chiralcel OJ-R columns because of the different groups attached to the
aromatic rings of these derivatives. Therefore, different racemates exhibit

(Triazole and Tetrazole Derivatives, Fig. 18) on a Chiracel OD-RH CSP
Retention factors

IIb 1.04 2.12 2.03 0.67
IIc 1.06 2.26 2.13 1.95
MP, MeCN–H2 O (50 : 50, v=v)
Ia 9.78 9.98 1.02 0.38
Ib 9.95 10.35 1.04 0.43
Ic 12.05 12.90 1.07 0.51
IIc 7.58 9.45 1.25 0.48
MP, MeCN–H2 O (80 : 20, v=v)
Ia 0.57 0.63 1.11 0.26
Ib 0.59 0.70 1.19 0.31
Ic 0.82 1.48 1.80 2.73
Id 0.94 0.99 1.05 0.80
IIb 0.32 0.41 1.28 0.25
IIc 0.75 1.12 1.49 1.55
Source: Ref. 98.

(Triazole and Tetrazole Derivatives, Fig. 18) on Chiracel OJ-R CSP
Retention factors
MP, MeCN–H2 O (50 : 50, v=v)

Ib 4.04 4.52 1.12 0.49
Ic 6.03 6.56 1.09 1.60
Id 4.76 5.00 1.05 0.31
IIb 3.22 3.69 1.15 0.52
IIc 9.65 10.40 1.08 1.55
MP, MeCH–H2 O (80 : 20, v=v)
Ia 0.48 0.73 1.52 0.33
Ib 0.34 0.57 1.68 0.30
Ic 0.68 0.89 1.31 0.29
Id 0.55 0.80 1.46 0.33
Source: Ref. 98.

different chiral recognition on the same CSP because of various bondings
between the racemates and the CSP. Therefore, a single CSP cannot be used
for the chiral resolution of all racemic compounds. Ding et al. [130] studied the
effects of various groups on the chiral resolution of indanediol and related
racemates. They observed that the inclusion mechanism is the major contributor
to enantioselectivity, with the size and shape of the racemates rather than
electrostatic interactions involving the functional groups of the solute.
2.6.6 Other Parameters

In addition to the optimization of HPLC factors as just discussed, chiral resolution
may be improved by adjusting other parameters. In 1996 Okamoto et al. [66]
studied the effects of silica gel pore size, coating amount, and coating solvent on
the chiral discrimination of some aromatic racemates. They found that CSPs with
a silica gel having a large pore size and small surface area showed higher chiral
recognition. CSPs coated with acetone solvent showed good chiral resolution
capacity. Resolution was improved by preparing new derivatives of cellulose and
amylase, which contain groups capable of good capacities for bonding with
racemates [71]. Recently we observed very interesting results during the resolu-
tion of a methylphenidate racemate. The partial resolution of methylphenidate on
Chiralcel OB was improved to complete resolution when phenol and benzoic acid
were used separately as mobile phase additives [100]. In addition to the foregoing
parameters, the optimization of chiral resolution on these CSPs can be achieved
by varying other HPLC conditions such as particle size of CSP, column dimen-
sions, racemic compound concentration, and choice of detector.

For applications and development of chiral resolution methods, it is essential to
have knowledge of the chiral resolution mechanism on polysaccharide-based
CSPs. At the molecular level, this mechanism is still unclear because of diffi-
culties associated with spectroscopic studies, as discussed earlier. Nevertheless,
some experimental efforts have been made, and chiral resolution reportedly has
been achieved through different types of bonding on the chiral grooves of
polysaccharide-based CSPs.
Hesse and Hagel [41] and later Francotte et al. [64] proposed an inclusion
mechanism by which enantiomers may be adsorbed in the chiral grooves of the
CTA-I matrix. Other theoretical [110] and X-ray studies of the model compound,
a fully acetylated D-glucopyronose-(R)-phenylethylamine inclusion complex
[111], also support an inclusion mechanism. It has been established that the
main chiral sites of bonding are polar carbonyl groups of esters, which can
interact with racemic compounds through hydrogen bonding and dipole–dipole
interactions for chiral discrimination [17].

Wainer and Alembic [97] proposed a similar mechanism based on the
separation properties of a series of aromatic amides [17] and alcohols [62] on
CTB phases; the mechanism of retention is an attractive binding–steric fit
formulation involving hydrogen bonding and dipole–dipole interactions rather
than inclusion. Wainer et al. [62] explained the mechanism by citing (1) the
formation of a CSP complex through hydrogen-bonding interaction between the
solute and the CSP, (2) the stabilization of this complex through insertion of the
aromatic portion of the solute into a chiral groove of the CSP, and (3) chiral
discrimination between enantiomeric solutes due to differences in their steric fit in
the chiral groove.
The most important adsorbing sites on the phenylcarbamate derivatives are
probably the polar carbamate groups as shown in Figure 23. These groups are
capable of interacting with a racemic compound via hydrogen bonding with
NH and >CO groups and dipole–dipole interaction on >C¼O [43]. There-
fore, the nature of the substituents on the phenyl ring affects the polarity of the
phenyl group, which in turn leads to different chiral recognition capacities.
Molecular dynamics calculations were carried out, and the structure of cellulose
phenylcarbamate was predicted. Figure 24 shows the stable structure obtained by
means of molecular mechanics calculations based on the structure of cellulose
tris(phenylcarbamate) (CTPC) proposed on the basis of X-ray analysis (Fig. 25)
[30,31]. CTPC has a left-handed threefold (3=2) helix, with glucose units
regularly arranged along the helical axis. A chiral helical groove with polar
carbamate residues exists along the main chain. The polar carbamate groups are
favorably located inside, permitting the insertion of polar enantiomers into the
grooves, where they can interact with the carbamate residues via hydrogen
FIGURE 23 Schematic interactions between phenylcarbamate residue and racemates.

(From Ref. 1.)

FIGURE 24 Optimized structure (left) and possible interaction sites (right) of a cellulose
triphenylcarbamate derivative. (From Ref. 32.)
FIGURE 25 The structure of cellulose tris(phenylcarbamate). (From Ref. 1.)

bonding. This interaction results in efficient chiral discrimination. Besides these
polar interactions, p–p interactions between the phenyl group of a CSP and
aromatic group of a solute may play a role in chiral resolution because several
nonpolar aromatic compounds have also been resolved (Table 2).
Lipkowitz [131,132] has extensively studied the mechanism of chiral
recognition from a theoretical viewpoint, carrying out computational studies on
a chiral discrimination mechanism in cellulose triphenylcarbamate. Yashima et al.
[114] concluded that NH and >C¼O groups are the most important bonding
sites. More recently, the same group extended their work [29] and compared
chiral recognition between cellulose tris(phenylcarbamate) (CTPC) and cellulose
tris(3,5-dimethylphenylcarbamate) (CDMPC), with trans-stilbene oxide and
benzoin as the racemates. The calculations of interaction energies between
CTPC or CDMPC and trans-stilbene oxide or benzoin were performed by
various force-field methods. Before the interaction energy was calculated, one
of two methods was applied: (1) enantiomers were generated and tumbled around
the NH proton and the >C¼O oxygen of the carbamoyl group of CTPC and
CDMPC, which are considered to be the most important adsorption sites, or (2)
enantiomers were randomly generated by the Monte Carlo method on the surface
of CTPC and CDMPC defined by the particular van der Waals radius, using the
technique of ‘‘blowing up’’ the atomic radii [133].
For the chiral resolution of trans-stilbene oxide or benzoin, the results
obtained from both methods were in agreement with the results obtained by
chromatographic studies for both CTPC and CDMPC CSPs. However, significant
differences of interaction energies between enantiomers appeared only when
enantiomers were generated inside CTPC or CDMPC. The results indicate that
the polar carbamate residues of cellulose derivatives may be the most important
adsorbing sites for polar racemates and may play a crucial role in chiral
recognition. The method of energy calculation is shown in Figure 26. These
methods are useful for a qualitative understanding of the chiral recognition
mechanism of cellulose phenylcarbamate, although the use of molecular
dynamics calculations will be needed to simulate the dynamic behavior of the
interactions occurring in chromatography.
Recently, Aboul-Enein and Ali [100] carried out certain studies on the
chiral resolution of methylphenidate on derivatives of cellulose and amylose.
They observed that p–p interactions are also the important binding forces for the
chiral resolution of aromatic racemates. The best resolution of methylphenidate
(MPH) on a Chiralcel OB column was achieved when phenol or benzoic acid,
separately, was used as the mobile phase additive. Phenol (benzoic acid) forms
the MPH–phenol (MPH–benzoic acid) pair in which the possibility of p–p
interaction between one of these pairs and CSP is greater than the possibility of
p–p interactions between MPH and CSP. Therefore, the resolution of MPH
enantiomers was improved when phenol or benzoic acid served as the mobile

FIGURE 26 Method for calculating the interaction between cellulose tris(phenylcarba-
mate) derivatives or cellulose tris(3,5-dimethylphenylcarbamate) derivatives and enantio-
mers of trans-stilbene or benzoin. (From Ref. 29.)
phase additive, as evidenced by an enhancement of p–p interactions. In another

study, Aboul-Enein and Ali [101] observed that coordination bonding also plays
an important role in the chiral resolution of the racemates having a sulfur atom.
Therefore, the chiral resolution of sulcanozole was better than the chiral resolu-
tion of econazole and miconazole on cellulose and amylose CSPs.
Finally, a look at the structures of polysaccharide-based derivatives
(cellulose and amylose) (Fig. 1) clearly shows the presence of one or more
chiral grooves on these CSPs. Electronegative atoms such as oxygen, nitrogen,
and halogens of racemates form hydrogen bonds and there are dipole–dipole
induced interactions with polysaccharide-based CSP. Besides, p–p interactions
also occur between the phenyl rings of aromatic racemates and the CSP. During
chiral resolution, the enantiomers fit stereogenically in different ways into the

FIGURE 27 Graphical representation of the mechanism of chiral resolution on a
polysaccharide-based CSP.

chiral grooves of the CSP, which is stabilized by bonds of various types (as
discussed earlier) and magnitudes, and hence the enantiomers were resolved. In
addition to these bonds, steric effects govern chiral resolution on polysaccharide-
based CSPs. Besides, some other achiral weak bonds like van der Waal forces and
ionic bonds may also contribute to the chiral resolution. To clarify the picture of
chiral resolution, the graphical representation of chiral resolution on a poly-
saccharide-based CSP shown in Figure 27 indicates the different interactions of
the two enantiomers.
2.8 APPLICATIONS IN SUB- AND SUPERCRITICAL

FLUID CHROMATOGRAPHY
Polysaccharide-based CSPs have been used for chiral separations in subcritical
fluid chromatography (subcritical-SFC) and supercritical fluid chromatography
(SFC) since 1988 [134]. Two groups have reported the separation on cellulose
tris(3,5-dimethylphenylcarbamate) of enantiomers of b-adrenergic blockers CSPs
[135,136]. Bargmann-Leyder et al. [137] achieved the chiral resolution of
enantiomers of b-adrenergic blockers and other drugs on Chiralcel OD and
Chiralpak AD CSPs. Wang et al. [138] utilized Chiralcel OD for the chiral
resolution of camazepam and its metabolites. Phinney et al. [139] demonstrated
the separation of a series of benzodiazepines. An amino column was coupled in
series with the Chiralcel OD to achieve the desired separation. Overbeke et al.
[140] resolved racemic drugs such as benzoxaprofen, temazepam, and mepho-
barbital on Chiralcel OJ. The four optical isomers of calcium channel blockers
were resolved on Chiralcel OJ by Siret et al. [141]. Amylose CSPs have been
used for the resolution of nonsteroidal anti-inflammatory drugs (ibuprofen,
flurbiprofen, and related drugs) [142,143].
Attempts have also been made to compile the results of chiral resolutions
by SFC using polysaccharide-based CSPs, as summarized in Table 11. To show
the nature of the SFC chromatograms, Figure 28 represents the SFC chiral
resolution of ibuprofen on a Chiralpak AD CSP. Stringham et al. [144] resolved
the enantiomers of four intermediates encountered in the process of developing
synthetic antiviral drugs on a Chiralcel OD CSP. In another report, Blackwell
[145] used various mobile phase additives to resolve the enantiomers of isoxazo-
line-based IIb=IIIb receptor antagonists on Chiralcel OD-H columns. Besides,
polysaccharide-based CSPs have also been used for preparative SFC. Saito et al.
[146] separated the enantiomers of DL-flavanone on a preparative scale using a
Chiralcel OD column. Oka and coworkers resolved four optical isomers of the
antidiabetic drug troglitazone on cellulose CSPs by means of preparative SFC
[147]. Blum et al. [148] published a comparison of chiral resolution of a variety

TABLE 11 Chiral Resolution by Means of SFC Using Polysaccharide-Based CSPs
Racemates SFC mode CSPs Ref.
Alkyl alkanols Packed column Chiralcel OB, 158

Chiralcel OD
Benzodiazepines Packed column Chiralcel OD, 139
Chiralcel OD-H, 155,
Chiralpak AD 152
Benzothiazepines Packed column Chiralcel OC, 156
Chiralcel OJ
Calcium channel blockers Packed column Chiralcel OD 158
b-Adrenergic blockers Packed column, Chiralcel OD, 137,139,
packed capillary Chiralpak AD 155
column
Imidazole derivatives Packed column Chiralcel OD, 145,
Chiralcel OJ, 158
Chiralpak AD,
Chiralpak AS
N-protected amino acids Packed column Chiralpak AD 158
and esters
Nonsteroidal anti- Packed column Chiralpak AD 143
inflammatory drugs
Camazepam and Packed column Chiralcel OD 138
metabolites
Fluoxetine Packed column Chiralpak AD 152
Barbiturates Packed column Chiralcel OJ 158
b-Adrenergic blockers Packed column Chiralcel OD 158
of drugs on Chiralcel CSPs in preparative SFC and HPLC, and better results were
obtained on SFC.
The effect of various SFC parameters on chiral resolution were also studied.
Modifiers can provide control over both retention and selectivity and, therefore,
certain modifiers were used to optimize the separation in sub-FC and SFC. The
effect of the enantioselectivity of carbon dioxide on acidic drugs (benzoxaprofen,
temazepam, and mephobarbital), profen, and barbiturate derivatives was carried
out on Chiralcel OJ, with acetonitrile or methanol as organic modifier [140].
Acetonitrile proved to be a good alternative to methanol, especially for the profen
compounds that were not well resolved when methanol was used. Wilson [143]
studied the effects of methanol, ethanol, and 2-propanol as organic modifiers on
the chiral resolution of ibuprofen on Chiralpak AD CSPs. Methanol was found to
be the best organic modifier.

FIGURE 28 Chromatograms of the chiral resolution of ibuprofen by SFC on Chiralpak
AD column, with (a) methanol, (b) ethanol, and (c) 2-propanol as the organic modifiers.
(From Ref. 143.)
Temperature and pressure are rarely optimized in HPLC, but these para-
meters are very important in SFC, hence can alter retention, selectivity, and
resolution. Toribio et al. [149] presented the chiral separation of ketoconazole and
its precursors on Chiralpak AD and Chiralcel OD CSPs. The authors also
reported that alcohol modifiers provided better separation than acetonitrile.
Further, Wilson [143] studied the effects of composition, pressure, temperature,
and flow rate of the mobile phase on the chiral resolution of ibuprofen on a
Chiralpak AD CSP. It was observed that temperature affords the greatest change
in resolution, followed by pressure and composition. An increase in methanol
concentration, pressure, and temperature has resulted in poor chiral resolution. At
first chiral resolution increased with an increase of flow rate (up to 1.5 mL=min)
but then started to decrease. Contrary to this, Biermann et al. [135] described the

rapid chiral resolution of b-adrenergic blockers at a flow rate of 4 mL=min.
Therefore, chiral resolution in SFC can be optimized by controlling the flow rate.
The resolution of certain calcium channel blockers was optimized by
temperature variations on cellulose tris(4-chlorophenylcarbamate) CSP coated
on silica gel [150]. The van’t Hoff plots for retention were curved, while those for
selectivity were linear.
The chiral separation of cis enantiomers was improved with a decrease in
temperature, whereas that of trans enantiomers was improved with an increase in
temperature. The temperature dependence of enantioselectivities was studied to
determine the thermodynamic parameters H ; S , and Tiso . The thermodynamic
parameters revealed that the separation of trans enantiomers was controlled by
entropy in the range of temperatures examined, whereas enthalpy-controlled
separation was observed for cis enantiomers. The separations of both cis and
trans enantiomers, however, were controlled by enthalpy in normal phase HPLC
[150].
In sub-FC, a detailed study of the influence of mobile phase additives on
the chiral resolution of isoxazoline-based IIb=IIIb receptor antagonists was
carried out by Blackwell [145] on Chiralcel OD-H CSPs. The different mobile
phase additives used were acetic acid, trifluoroacetic acid, formic acid, water,
triethylamine, triethanolamine, n-hexylamine, trimethyl phosphate, and tri-n-
butyl phosphate. In general, n-hexylamine and tri-n-butyl phosphate mobile
phase additives resulted in better resolution. The chiral separation of four 1,3-
dioxolane derivatives on an amylose-based column has been described [151]. The
effects of mobile phase composition, temperature, and pressure have been
investigated. The nature of the modifier is the main parameter: it has the highest
impact on chiral resolution and is more important than the polarity of the mobile
phase. Therefore, the organic modifier that gave the best enantiomeric separation
was different for each compound.
The pressure-related effects on chiral resolution were studied by Bargmann-
Leyder et al. [137] on Chiralpak AD columns, while no pressure effect was
observed on Chiralcel OD. These investigators also studied and compared the
chiral resolution of b-adrenergic blockers on HPLC and SFC [137]. Although
resolution was generally higher in SFC than in HPLC, differences in selectivity
between the two techniques were observed, and these discrepancies seemed to be
compound specific. Examination of a series of propanolol analogues provided
additional insight into differences in the chiral recognition mechanisms operative
in HPLC and SFC [137].
Packed column SFC is now rapidly replacing many HPLC methods for
chiral resolution [152]. These CSPs are coated on the silica gel, like the CSPs for
HPLC [150,153]. Besides, chiral resolutions on capillary chiral CSPs (Table 11)
have also been reported. Finding the best combination of chiral stationary
and mobile phases can be time-consuming. CHIRBASE (www.chirbase.u-

3mrs.fr=chirbase) [154], a database specializing in chiral chromatographic
separation including sub-FC and SFC, can often aid in reducing the work
associated with method development [155–158].
2.9 APPLICATIONS IN CAPILLARY

ELECTROCHROMATOGRAPHY
In 2000 Wistuba and Schuring [159] reviewed the chiral resolution of pharma-
ceuticals by capillary electrochromatography (CEC) and discussed the different
aspects of chiral resolution by this technique. Polysaccharide-based CSPs have
been packed in capillaries, and the chiral resolution of various racemates was
obtained [160–163]. The packed capillaries were prepared by means of the slurry
packing method [161,162]. Chankvetadze et al. [161,163] has carried out the
chiral separation of different racemates by means of capillary electrochromato-
graphy. Further, Chankvetadze et al. [163] observed that Chiralpak AD packed
with 25% amylose tris(3,5-dimethylphenylcarbamate) coated on macroporous
aminopropylsilanized silica gel exhibited higher resolving ability for thalidomide
than the similar cellulose tris(3,5-dimethylphenylcarbamate) (Chiralcel OD), as
well as cellulose tris(4-methylbenzoate) (Chiralcel OJ) CSPs. Enantioseparations
of b-adrenergic blockers, benzodiazepines, and diuretics were performed in fused
silica capillaries packed with silica gel that was modified by coating with
cellulose tris(3,5-dimethylphenylcarbamate) [160].
In addition to other modes of liquid chromatography, chiral resolution by
capillary electrochromatography was also optimized by adjusting the different
chromatographic parameters. Francotte et al. [164] chirally resolved certain
enantiomers by applying packed capillary electrochromatography. Fused-silica
capillaries of different lengths with an inner diameter of 100 mm were packed with
a cellulose derivative immobilized on macroporous silica gel. Parameters such as
content of modifier in the mobile phase, concentration, and buffer pH were varied
for a set of tests. In packed CEC the highest influence on resolution of the test
racemates was found when the acetonitrile content was changed, while variation
of the buffer concentration mostly affected the electroosmotic velocity. The
performance of packed CEC and nano-LC was also compared. Packed CEC
showed much better column efficiency and enantioselectivity under similar
conditions of flow and electroosmotic velocity. Chankvetadze et al. [161] studied
the effect of the amount of cellulose tris(3,5-dimethylphenylcarbamate) loaded on
silica gel. The reduced coating of the chiral selector allowed more effective
exploitation of the advantages of electrokinetically driven flow over pressure-
driven propulsion of the analyte. Plate numbers were in the range of 180,000 to
215,000 m1 , which are among the highest efficiencies observed in CEC. The
effect of the amount of cellulose tris(3,5-dimethylphenylcarbamate) loaded on

FIGURE 29 Chromatograms of the chiral resolution of 2-(benzylsulfinyl) benzamide in
capillaries packed with tris(3,5-dichlorophenylcarbamate) at three different loadings: (a)
4.8 (w=w), (b) 1.0 (w=w), and (c) 0.5 percent (w=w). (From Ref. 161.)

silica gel on the chiral resolution of 2-(benzylsulfinyl) benzamide is shown in
Figure 29 [161]. It was observed that 4.8% (w=w) resulted in the best resolution.
Chankvetadze et al. [162] also investigated the effects of silica gel pore size and
concentration of buffer on the chiral resolution of piprozolin. It was observed that
the ionic strength of a buffer solution dramatically affected electroosmotic flow
generation and intraparticle perfusive flow, especially for silica gel pore sizes
below 12 nm. Optimization of packing material and separation conditions led to
plate numbers above 400,000 m1 and very good resolutions.
2.10 APPLICATIONS IN THIN-LAYER

CHROMATOGRAPHY
In 1973 Hesse and Hagel [15] first described the chiral thin-layer chromato-
graphic (TLC) separation of Tröger’s base on cellulose acetate. Later, Faupel’s
systematic investigation of the chiral resolution capacities of this technique [165]
resulted in the commercialization of the cellulose triacetate plates pioneered by
Hesse and Hagel. These plates are stable and can be used in aqueous media (acid
or base) and in nonaqueous mobile phases with the exception of glacial acetic
acid and ketonic solvents. Other resolutions on cellulose plates include oxindanac
benzylester and 2-phenylcyclohexanone [5]. Xuan and Lederer [166] reported the
enantiomeric resolution of substituted tryptophans on microcrystalline cellulose.
They observed that aqueous solvents and liquid–liquid systems yielded essen-
tially the same separations, suggesting that adsorption can play a role in liquid–
liquid (partition) systems in some instances. Yuasa et al. [167–171] used
crystalline cellulose as the chiral stationary phase for TLC and investigated the
separation of DL-tryptophan, DL-amino acids, and other derivatives of amino
acids. Separation was performed in a variety of aqueous and nonaqueous
solvents. In trying to explain the chiral recognition mechanism, the authors
concluded that chiral resolution is attributable to the helical forms of the
polysaccharide chains, which differ in aqueous and nonaqueous media. Suedee
and Heard [172] reported the use of cellulose phenylcarbamate derivatives as the
stationary phase for the resolution of enantiomers of b-adrenergic blockers. Lepri
et al. [173] described the resolution of 21 racemates on microcrystalline cellulose
triacetate plates eluted with aqueous=organic mixtures containing methanol or
ethanol or 2-propanol. In 2000 Okamoto et al. [174] prepared TLC plates of
cellulose derivatives, using the usual method as described in 1969 [175]. For the
preparation of fluorescent chiral TLC plates, a fluorescent indicator is mixed with
the cellulose derivatives in methanol and the resulting slurry is spread over the
plate in a uniform layer. The plate is oven-dried for 30 min at 110 C [174]. TLC
plates with cellulose (0.5%) coated with silica gel, immersed in Cu(II) acetate
followed by L-arginine were used for the chiral resolution of amino acids and

their derivatives [176]. Malinowska and Rozylo used chitin and chitosan as TLC
plate material for the enantiomeric resolution of amino acids [177].
The cellulose derivatives used for chiral TLC are trisphenylcarbamate, 2,3-
dichlorophenylcarbamate, 2,4-dichlorophenylcarbamate, 2,6-dichlorophenylcar-
bamate, 3,4-dichlorophenylcarbamate, 3,5-dichlorophenylcarbamate, 2,3-dimethyl-
phenylcarbamate, and 3,5-dimethylphenylcarbamate. Aboul-Enein et al. [178]
have reviewed the chiral resolution of racemates on polysaccharide chiral TLC
plates. They discussed the role of the substituents of polysaccharide derivatives
on chiral resolution. The effects of the substituents of cellulose derivatives and the
mechanisms of chiral resolution on these plates are similar to what is found for
HPLC CSPs.
2.11 CONCLUSION
Today polysaccharide-based derivatives are considered to be one of the best and
most widely used chiral stationary phases because of their greater efficiencies and
wide range of applications. Although many racemic compounds can be resolved
on these CSPs, these CSPs are not yet fully developed because they are not
capable of resolving all, or almost all, racemic compounds. A disadvantage of
polysaccharide-based CSPs remains, however, the limited choice of solvents for
the coated form. On the other hand, the bonded forms generally have poor chiral
resolution power. The polysaccharide-based CSPs that are most widely used and
usually achieve 80% successful resolution are Chiralcel OD, Chiralcel OD-R,
Chiralcel OJ, Chiralcel OJ-R, Chiralpak AD, and Chiralpak AD-R CSPs, while
the use of the other polysaccharide-based CSPs is limited. Research is still under
way to improve the chiral resolution capacities of these phases in preparing new
derivatives of cellulose and amylose. We expect that these CSPs will gain more
and more interest in the field of chiral resolution in the near future. HPLC with
polysaccharide-based CSPs has been used very frequently for chiral resolution,
but there are few applications of chiral resolution by sub- and supercritical fluid
chromatography modes, which are emerging as important modes of liquid
chromatography for chiral resolution because of their versatility, sensitivity, and
high speed of resolution. The further development of these two modalities of
liquid chromatography certainly will lead to their use as routine methods of chiral
resolution in the near future.
REFERENCES
1. Okamoto, Y, Yashima, E, Chiral recognition by optically active polymers, in
‘‘Molecular Design of Polymeric Materials’’ (Hatada K, Kitayama T, Vogl O,
Eds.), Marcel Dekker, New York, pp. 731–746 (1997).
2. Okamoto Y, CHEMTECH 176 (1987).

3. Okamoto Y, Aburatani R, Polym News 14: 295 (1989).
4. Kotake M, Sakan T, Nakamura N, Senoh S, J Am Chem Soc 73: 2973 (1951).
5. Günther K, Enantiomer separations, in ‘‘Handbook of Thin Layer Chromatogra-
phy’’ (Sherma J, Fried B, Eds.), Marcel Dekker, New York, p. 541 (1991).
6. Yashima E, Okamoto Y, Chiral recognition mechanism of polysaccharides chiral
stationary phase in ‘‘The Impact of Stereochemistry on Drugs Development and
Use’’ (Aboul-Enein, HY, Wainer IW, Eds.), John Wiley & Sons, New York, p. 345
(1997).
7. Shibata T, Mori K, Okamoto Y, Polysaccharide phases, in ‘‘Chiral Separations by
HPLC’’ (Krstulovic AM, Ed.) Ellis Horwood, New York, p. 336 (1989).
8. Okamoto Y, Kawashima M, Yamamoto K, Hatada, K, Chem Lett 739 (1984).
9. Dingenen J, Polysaccharide phases in enantioseparations, in ‘‘A Practical Approach
to Chiral Separations by Liquid Chromatography’’ (Subramanian G, Ed.), VCH
Verlag, Weinheim, Germany, p. 115 (1994).
10. Allenmark, S. (Ed.), ‘‘Chromatographic Enantioseparation: Methods and Applica-
tions,’’ 2nd ed., Ellis Horwood, New York (1991).
11. Beesley TE, Scott RPW (Eds.), ‘‘Chiral Chromatography,’’ John Wiley & Sons,
New York (1998).
12. Stivala SS, Crescenti V, Dea ICM (Eds.), ‘‘Industrial Polysaccharides: The Impact of
Biotechnology and Advanced Methodologies: Proceedings,’’ Ellis Horwood, New
York (1987).
13. Harding SE, Tombs MP, Harding S, ‘‘Introduction to Polysaccharide Biotechnol-
ogy,’’ Ellis Horwood, New York (1997).
14. Luttringhaus A, Peters K, Angew Chem 78: 603 (1966).
15. Hesse G, Hagel R, Chromatographia 6: 277 (1973).
16. Ichida A, Shibata T, Okamoto I, Yuki Y, Namikoshi H, Toda Y, Chromatographia
19: 280 (1984).
17. Okamoto Y, Aburatani R, Hatada K, J Chromatogr 389: 95 (1987).
18. Okamoto Y, Kawashima M, Hatada K, J Chromatogr 363: 173 (1986).
19. Chankvetadze B, Yashima E, Okamoto Y, Chem Lett 671 (1992).
20. Chankvetadze B, Yashima E, Okamoto Y, J Chromatogr A 670: 39 (1994).
21. Okamoto Y, Aburatani R, Fukumoto T, Hatada K, Chem Lett 1857, (1987).
22. Okamoto Y, Aburatani R, Hatada K, Bull Chem Soc Jpn 63: 955 (1990).
23. Okamoto Y, Oshashi T, Kaida Y, Yashima E, Chirality 5: 616 (1993).
24. Chankvetadze B, Yashima E, Okamoto Y, J Chromatogr A 694: 101 (1995).
25. Shibata T, Sei T, Nishimura H, Deguchi K, Chromatographia 24: 552 (1987).
26. Buchanan CM, Hyatt JA, Lowman DW, J Am Chem Soc 111: 7312 (1989).
27. Oguni K, Matsumoto A, Isokawa A, Polym 11: 1257 (1994).
28. Yashima E, Yamamoto C, Okamoto Y, J Am Chem Soc 118: 4036 (1996).
29. Yamamoto C, Yashima E, Okamoto Y, Bull Chem Soc Jpn 72: 1815 (1999).
30. Steinmeir H, Zugenmaier P, Carbohydr Res 164: 97 (1987).
31. Vogt U, Zugenmaier P, Ber Bunsenges Phys Chem 89: 1217 (1985).
32. Yashima E, J Chromatogr A 906: 105 (2001).
33. Matsumoto K, Yamamoto C, Yashima E, Okamoto Y, Anal Commun 35: 63 (1998).

34. Matsumoto K, Yamamoto C, Yashima E, Okamoto Y, Rapid Commun Mass
Spectrom 13: 2011 (1999).
35. Sawada M, Mass Spectrom Rev 16: 73 (1997).
36. Yashima E, Fukaya H, Sahavattanapong P, Okamoto Y, Enantiomer 1: 193 (1996).
37. Lightner DA, Reisinger M, Landen GL, J Biol Chem 261: 6034 (1986).
38. Lightner DA, Gawronski JK, Gawronska K, J Am Chem Soc 107: 2456 (1985).
39. Kano K, Yoshiyasu K, Hashimoto S, J Chem Soc Chem Commun 801 (1988).
40. Murakami Y, Hayashida O, Nagai Y, J Am Chem Soc 116: 2611 (1994).
41. Hesse G, Hagel R, Liebigs Ann Chem 966 (1976).
42. Shibata T, Okamoto Y, Ishii K, J Liq Chromatogr 9: 313 (1986).
43. Okamoto Y, Kaida Y, J Chromatogr A 666: 403 (1994).
44. Yashima E, Kasashima E, Okamoto Y, Chirality 9: 63 (1997).
45. Yashima E, Yamamoto C, Okamoto Y, Polym J 27: 856 (1995).
46. Rimbock K-H, Kastner F, Mannschreck A, J Chromatogr 351: 346 (1986).
47. Francotte E, Wolf RM, Chirality 3: 43 (1990).
48. Francotte E, Baisch G, European Patent EP 0316270A2 (1988).
49. Juvancz Z, Grolimund K, Francotte E, Chirality 4: 459 (1992).
50. Francotte E, Wolf RM, J Chromatogr 595: 63 (1992).
51. Castells CB, Carr PW, J Chromatogr A 904: 17 (2000).
52. Franco P, Senso A, Oliveros L, Minguillon C, J Chromatogr A 906: 155 (2001).
53. Okamoto Y, Aburatani R, Miura S, Hatada K, J Liq Chromatogr 10: 1613 (1987).
54. Yashima E, Fukuya H, Okamoto Y, J Chromatogr A 677: 11 (1994).
55. Minguillon C, Franco P, Oliveros L, Lopez P, J Chromatogr A 728: 407 (1996).
56. Enomoto N, Furukawa S, Ogasawara Y, Akano H, Kuwamura E, Yashima E,
Okamoto Y, Anal Chem 68: 2789 (1996).
57. Enomot N, Furukawa S, Ogasawara, Y, Yashima E, Okamoto Y, 66th Annual
Meeting of the Chemical Society of Japan, 2B233: 140 (1994).
58. Felix G, J Chromatogr A 906: 171 (2001).
59. Kubota T, Kusano T, Yamamoto C, Yashima E, Okamoto Y, 13th International
Symposium on Chirality 118: 35 (2001).
60. Kimata K, Tsuboi R, Hosoya K, Tanaka N, Anal Methods Instrum 1: 23 (1993).
61. Hampe TRE, Schluter J, Brandt KH, Nagel J, Lamparter E, Blaschke G, J
Chromatogr 634: 205 (1993).
62. Wainer IW, Stiffin RM, Shibata T, J Chromatogr 411: 139 (1987).
63. Aboul-Enein HY, Ali I, J Biochem Biophys Methods 48: 175 (2001).
64. Francotte E, Wolf RM, Lohmann D, Mueller R, J Chromatogr 347: 25 (1985).
65. Francotte E, Wolf RM, Chirality 2: 16 (1990).
66. Yashima E, Sahavattanapong P, Okamoto Y, Chirality 8: 446 (1996).
67. Mannschreck A, Koller H, Wernick R, Kontake 1: 40 (1995).
68. Rizzi A, J Chromatogr 478: 87 (1989).
69. Isaksson R, Erlandsson P, Hansson L, Holmberg A, Berner S, J Chromatogr 498:
257 (1990).
70. Francotte E, J Chromatogr A 666: 565 (1994).
71. Chankvetadze B, Yamamoto C, Okamoto Y, Comb Chem High Throughput Screen
3: 497 (2000).

72. Okamoto Y, Aburatani R, Hatano K, Hatada K, J Liq Chromatogr 11: 2147 (1988).
73. Witte DT, Bruggeman FJ, Franke JP, Copinga S, Jansen JM, de Zeeuw RA,
Chirality 5: 545 (1993).
74. Matlin SA, Tiritan ME, Crawford AJ, Cass QB, Boyd DR, Chirality 6: 135 (1994).
75. Toussaint B, Duchateau ALL, ven der Waal S, Albert A, Hubert P, Crommen J, J
Chromatogr A 890: 239 (2000).
76. Caccamese S, Principato G, J Chromatogr A 893:47 (2000).
77. Fadnavis NW, Babu RL, Sheelu G, Deshpande A, J Chromatogr A 890: 189 (2000).
78. Belloli E, Foulon C, Yous S, Vaccher MP, Bonte JP, Vaccher C, J Chromatogr A
907: 101 (2001).
79. Feng J, May SW, J Chromatogr A 905: 103 (2001).
80. Iwasaki Y, Yasui M, Ishikawa T, Irimescu R, Hata K, Yamane T, J Chromatogr A
905: 111 (2001).
81. Cirilli R, Costi R, Santo RD, Ferretti R, Torre FL, Angiolella L, Micocci M, J
Chromatogr A 942: 107 (2002).
82. Aboul-Enein HY, Biomed Chromatogr 12: 116 (1998).
83. Aboul-Enein HY, J Chromatogr A 906: 185 (2001).
84. Maier NM, Franco P, Linder W, J Chromatogr A 906: 3 (2001).
85. Blaschke G, J Liq Chromatogr 9: 341 (1986).
86. Schlogl K, Widhalm M, Monatsh Chem 115: 1113 (1984).
87. Wainer IW, Alembic MC, Smith E, J Chromatogr 388: 65 (1987).
88. Bonato PS, Pires de Abreu LR, de Gaitani CM, Lanchote VL, Bertucci C, Biomed
Chromatogr 14: 227 (2000).
89. Gaffney MH, Chromatographia 27: 15 (1989).
90. Ishikawa A, Shibata T, J Liq Chromatogr 16: 859 (1993).
91. Kazusaki M, Kawabata H, Matsukura H, J Liq Chromatogr Relat Technol 23: 2819
(2000).
92. Aboul-Enein HY, Ali I, Seventh International Symposium on Hyphenated Tech-
niques in Chromatography and Hyphenated Chromatographic Analyzers (7-HTC),
Feb. 6–8, 2002, Brugge, Belgium, p. 193 (2002).
93. Aboul-Enein HY, Ali I, Fresenius J Anal Chem 370: 951 (2001).
94. Aboul-Enein HY, Ali I, J Sep Sci 24: 831 (2001).
95. Kazusaki M, Kawabata H, Matsukura H, J Liq Chromatogr Relat Technol 23: 2937
(2000).
96. Francotte E, Stierlin H, Faigle JW, J Chromatogr 346: 321 (1985).
97. Wainer IW, Alembic M, J Chromatogr 358: 85 (1986).
98. Aboul-Enein HY, Ali I, Gubitz G, Simons C, Nicholls PJ, Chirality 12: 727 (2000).
99. Aboul-Enein HY, Ali I, Schmid MG, Jetcheva V, Gecse O, Gubitz G, Anal Lett 34:
1107 (2001).
100. Aboul-Enein HY, Ali I, Chirality 14: 47 (2002).
101. Aboul-Enein HY, Ali I, J Pharm Biomed Anal 27: 441 (2002).
102. Chimonczyk Z, Ksycinska H, Mazgajska M, Aboul-Enein HY, Chirality 11: 790
(1999).
103. Aboul-Enein HY, Bakr SA, J Liq Chromatogr Relat Technol 21: 1137 (1998).

104. Van Overbeke A, Sandra P, Medvedovici A, Baeyens W, Aboul-Enein HY, Chirality
9: 126 (1997).
105. Aboul-Enein HY, Ali I, Pharmazie, 56: 214 (2001).
106. Aboul-Enein HY, Ali I, Arch Pharm 334: 258 (2001).
107. Aboul-Enein HY, Ali I, Chromatographia 54: 200 (2001).
108. Schmid MG, Gecse O, Szabo Z, Kilár F, Gübitz G, Ali I, Aboul-Enein HY, J Liq
Chromatogr Relat Technol 24: 2493 (2001).
109. Huhnerfuss H, Chemosphere 40: 913 (2000).
110. Ellington JJ, Evans JJ, Prickett KB, Champion WL Jr, J Chromatogr A 928: 145
(2001).
111. Wolf RM, Francotte E, Lohmann D, J Chem Soc Perkin Trans II 893 (1988).
112. Francotte E, Rihs G, Chirality 1: 80 (1989).
113. Ronden NG, Nyquist RA, Gillie JK, Nicholson LW, Goralski CT, Fourth Interna-
tional Symposium, Montreal, Canada, Abstract 162, p. 90 (1993).
114. Yashima E, Yamada M, Kaida Y, Okamoto Y, J Chromatogr A 694: 347 (1995).
115. Tachibana K, 13th International Symposium on Chirality, Abstract 138, p. 41
(2001).
116. Geiser F, Champion WL Jr., Pickett KB, 13th International Symposium on
Chirality, abstract 157, p. 48 (2001).
117. Cirrili R, Costi R, Di Santo R, Ferretti R, L Torre F, Angiolella L, Micocci M, J
Chromatogr A, 942: 107 (2002).
118. Schulte M, Strube J, J Chromatogr A 906: 399 (2001).
119. Ye YK, Stringham R, J Chromatogr A 927: 47 (2001).
120. Ye YK, Stringham R, J Chromatogr A 927: 53 (2001).
121. Wang T, Chen YW, Vailaya A, J Chromatogr A 902: 345 (2000).
122. Yamamoto C, Okamoto Y, J Chromatogr A 922: 127 (2001).
123. Ye YK, Lord B, Yin L, Stringham RW, J Chromatogr A, 945: 147 (2002).
124. Ye YK, Lord B, Stringham RW, J Chromatogr A, 945: 139 (2002).
125. Perrin C, Vu VA, Matthijs N, Maftouh M, Massart DL, Heyden YV, J Chromatogr
A, 947: 69 (2002).
126. Piras P, Roussel C, Pierrot-Sanders J, J Chromatogr A 906: 443 (2001).
127. Tachibana K, Ohnishi A, J Chromatogr A 906: 127 (2001).
128. O’Brien T, Crocker L, Thompson R, Thompson K, Toma PH, Conlon DA, Moeder
C, Bicker GR, Grinberg N, Anal Chem 69: 1999 (1997).
129. Stringham RW, Blackwell JA, Anal Chem 69: 1414 (1997).
130. Ding H, Grinberg N, Thompson R, Ellison D, J Liq Chromatogr Relat Technol 23:
2641 (2000).
131. Lipkowitz KB, Modeling enantioseparation in chiral chromatography, in ‘‘A
Practical Approach to Chiral Separations by Liquid Chromatography,’’ (Subrama-
nian G, Ed.), VCH Verlag, Weinheim, Germany, p. 19 (1994).
132. Lipkowitz KB, J Chromatogr A 694: 15 (1995).
133. Theodorou DN, Suter UW, Macromolecules 18: 1467 (1985).
134. Macaudiere C, Rosset M, Tambute R, J Chromatogr 450: 255 (1988).
135. Biermanns P, Miller C, Lyon V, Wilson W, LC-GC 11: 744 (1993).
136. Lee CR, Porziemsky JP, Aubert MC, Krstulovic AM, J Chromatogr 539: 55 (1991).

137. Bargmann-Leyder N, Tambute A, Caude M, Chirality 7: 311 (1995).
138. Wang MZ, Klee MS, Yang KS, J Chromatogr B 665: 139 (1995).
139. Phinney KW, Sanders LC, Wise SA, Anal Chem 70: 2331 (1998).
140. Overbeke AV, Sandra P, Medvedovici A, Baeyens W, Aboul-Enein HY, Chirality 9:
126 (1997).
141. Siret L, Macaudiere P, Bargmann-Leyder N, Tambute A, Caude M, Guogeon E,
Chirality 6: 440 (1994).
142. Kot A, Sandra P, Venema A, J Chromatogr Sci 32: 439 (1994).
143. Wilson WH, Chirality 6: 216 (1994).
144. Stringham RW, Lynam KG, Grasso CC, Anal Chem 66: 1949 (1994).
145. Blackwell JA, Chirality 10: 338 (1998).
146. Saito M, Yamauchi Y, Higashidate S, Okamoto I, in ‘‘35th Anniversary Research
Group on Liquid Chromatography’’ (Hatano H, Hanai T, Eds.), World Scientific,
Singapore, p. 863 (1995).
147. Oka K, Shoda S, Kato K, Watanabe T, Nakazawa H, Hiroyki T, Kawasaki T, Ikeda
M, Jpn Chromatogr 20: 310 (1999).
148. Blum AM, Lynam KG, Nicolas EC, Chirality 6: 302 (1994).
149. Toribio L, Bernal JL, Nozal MJ, Jimenze JJ, Nieto EM, J Chromatogr A 921: 305
(2001).
150. Yaku K, Aoe K, Nishimura N, Morishita F, J Chromatogr A 848: 337 (1999).
151. Bernal JL, Toribio L, Nozal MJ, Nieto EM, Jimneze JJ, J Chromatogr A 87: 127
(2000).
152. Phinney KW, Anal Chem 72: 204A (2000).
153. Nitta T, Yakushijin Y, Kametani T, Katayama T, Bull Chem Soc Jpn 63: 1365
(1990).
154. Koppenhoefer B, Graf R, Holzschuh H, Nothdurf A, Trittin U, Piras P, J
Chromatogr A 826: 217 (1998).
155. Medvedovici A, Sandra P, Toribio L, David F, J Chromatogr A 785: 159 (1997).
156. Yaku K, Aoe K, Nishimura N, Sato T, Morishita F, J Chromatogr 785: 185 (1997).
157. Villeneu MS, Anderegg RJ, J Chromatogr A 826: 217 (1998).
159. Wistuba D, Schuring V, J Chromatogr A 875: 255 (2000).
160. Krause K, Girod M, Chankvetadze B, Blaschke G, J Chromatogr A, 837: 51 (1999).
161. Girod M, Chankvetadze B, Okamoto Y, Blaschke G, J Sep Sci 24: 27 (2001).
162. Chankvetadze B, Kartozia I, Okamoto Y, Blaschke G, J Sep Sci 24: 635 (2001).
163. Meyring M, Chankvetadze B, Blaschke J Chromatogr A 876: 157 (2000).
164. Mayer S, Briend X, Francotte E, J Chromatogr A 875: 331 (2000).
165. Faupel M, Fourth International Symposium on Instrumental TLC, Selvino=
Bergamo, Italy (1987).
166. Kieu Xuan HT, Lederer M, J Chromatogr 635: 346 (1993).
167. Yuasa S, Itoh M, Shimada AK, J Chromatogr Sci 22: 228 (1984).
168. Yuasa S, Shimada A, Isoyama M, Fukuhara T, Itoh M, Chromatographia 21: 79
(1986).
169. Yuasa S, Shimada A, Kameyama K, Yasui M, Adzuma K, J Chromatogr Sci 18: 311
(1990).

170. Yuasa S, J Biol Phys 20: 229 (1994).
171. Yuasa S, Fukuhara T, Isoyama M, Tanaka M, Shimada A, Biomed Chromatogr 11:
276 (1997).
172. Suedee R, Heard CM, Chirality 9: 139 (1996).
173. Lepri L, Bubba MD, Masi F, J Planar Chromatogr Mod TLC 10: 108 (1997).
174. Kubota T, Yamamoto C, Okamoto Y, J Am Chem Soc 122: 4056 (2000).
175. Stahl E, ‘‘Thin Layer Chromatography,’’ 2nd ed., Springer-Verlag, Berlin (1969).
176. Deng QY, Zhang Z, Zhy YF, Su JY, Fenxi Huaxue 25: 197 (1997).
177. Malinowska I, Rozylo JK, Biomed Chromatogr 11: 272 (1997).
178. Aboul-Enein HY, El-Awady MI, Heard CM, Nicholls PJ, Biomed Chromatogr
13: 531 (1999).

3
Cyclodextrin-Based Chiral
Stationary Phases
Cyclodextrins (CDs) are cyclic, nonreducing oligosaccharides obtained from

starch. Villiers [1] described CDs in 1891 and called them cellulosine. Later
Schardinger [2] identified three different naturally occurring forms and referred
them as Schardinger’s sugars, a-, b-, and g-CDs. These are also called
cyclohexamylose(a-CD), cycloheptamylose(b-CD), cycloctamylose(g-CD), cyclo-
glucans, glucopyranose, and Schardinger dextrins. From 1911 to 1935,
Pringsheim, in Germany, carried out an extensive research and reported that
these sugars form stable aqueous complexes with many compounds [3]. By the
mid-1970s, all three naturally occurring CDs had been structurally and chemi-
cally characterized, and many more complexes had been studied [4]. Therefore,
the ability of CDs to form complexes with a wide variety of molecules has been
documented [5–10]. The details of CD complex formation and their binding
constants were determined and found to be controlled by several different factors:
hydrophobic interactions, hydrogen bondings, and van der Waals interactions.
Therefore, CDs and their derivatives have been widely used in separation science
since the early 1980s [4,11].
The evolution of CDs as chiral selectors in the liquid chromatographic
separation of enantiomers has been a subject of interest for the last two decades.
The presence of the chiral hollow basket, or cavity, makes these molecules
suitable for the chiral resolution of a wide range of racemic compounds. At
present, the use of CDs as chiral selectors for enantiomeric resolution by liquid

chromatography is very common. Indeed, CDs have been used in the form of
both chiral stationary phases (CSPs) and chiral mobile phase additives (CMPs).
This chapter describes the techniques of chiral resolution by liquid chromato-
graphy using cyclodextrins as the stationary phases. The use of CDs as chiral
selectors in the form of mobile phase additives is covered in Chapter 10.
3.1 STRUCTURES AND PROPERTIES

Cyclodextrins are cyclic oligosaccharides comprising six to twelve D-(þ)-
glucopyranose units in a-(1,4) linkage with the chair conformation. The three
types of CD have different numbers of glucopyranose units: a-, b-, and g-CDs
contain six, seven, and eight glucopyranose units, respectively. Secondary 2- and
3-hydroxyl groups line the mouth of the CD cavity, while primary 6-hydroxyl
groups are found on the opposite end of the molecule. This arrangement makes
the CD cavity hydrophilic, which results in the formation of inclusion complexes
with a variety of molecules. However, the interior of the cavity is slightly
hydrophobic.
Many derivatives of CDs have been synthesized with various derivatizing
groups, including acetyl, hydroxypropyl, naphthyl, ethylcarbamoyl, 3,5-dimethyl-
phenyl carbamoyl, tosyl, trimethyl, dimethyl, phenyl carbamoyl, propyl carba-
moyl, and aminomethylbenzyl. These derivatives modify the CD hydroxyl groups
without destroying the CD cavity. Derivatized CDs exhibit behavior significantly
different from native CDs. The derivatization results in partial blocking of the
mouth of the CD cavity and eliminates some or all of the hydrogen bonds, leading
to significant differences in enantioselectivity. The internal diameter of these CDs
varies because of the different numbers of glucopyranose units present on the a,
b, and g forms. The most stable three-dimensional molecular configuration for
these nonreducing cyclic oligosaccharides is a toroid, its upper (larger) and lower
(smaller) openings having secondary and primary hydroxyl groups, respectively.
The interior of the toroid is hydrophobic as a result of the electron-rich
environment provided in large part by the glycosidic oxygen atoms. CDs are
highly stable in acidic and basic conditions. The chemical structures of CDs and
their derivatives are shown in Figure 1.
As noted earlier, CDs are capable of forming inclusion complexes with a
variety of molecules. The stoichiometry (guest : CD) is 1 : 1, 1 : 2, or 2 : 1
depending on the structure of the molecule [12]. Complexation in CDs is
molecule specific, and generally ternary complexes, stable in water solutions
and containing lower alcohols, amines, and nitriles, are favored. However, a-CD
includes single phenyl and naphthyl groups (small molecules), b-CD accepts
naphthyl and heavily substituted phenyl groups, and g-CD attracts bulky steroid-
type molecules. The stability constants of complex formation vary from 102 to
105 M1 with the complex formation speed T1=2 0:001–1.0 ms. These

FIGURE 1 The chemical structures of cyclodextrins and their derivatives.

TABLE 1 The Properties of CDs
Properties a-CD b-CD g-CD
Number of glucopyranose units 6 7 8

Molecular weight 972 1135 1297
pKa 12.33 12.20 12.08
Inner diameter, nm 0.45–0.57 0.62–0.78 0.79–0.95
Outer diameter, nm 1.37 1.53 1.69
Height, nm 79 79 79
Cavity volume, nm3 0.174 0.262 0.472
Cavity volume
per milliliter 104 157 256
per gram 0.10 0.14 0.20
Solubility in water, g=mL 14.5 1.85 23.2
Chiral centers 30 35 40
½aD 25 þ150:5 þ162:0 þ177:4
complex formation properties are advantageous in the chiral resolution of

enantiomers because two enantiomers form inclusion diastereoisomeric
complexes. The other properties of CDs are given in Table 1.

CDs are produced from starch by the action of Bacillus macerans amylase or the
enzyme cyclodextrin transglycosylate (CTG) [13–16]. The latter enzyme can be
used to produce CDs of specific sizes by controlling the reaction conditions.
Initially, CDs were linked to solid supports. In 1978, Harada et al. [17]
polymerized and cross-linked a cyclodextrin with a gel support and the CSP
that developed was tested for chiral resolution of mandelic acid and its
derivatives. Later, various workers bonded all the three CDs with different
solid supports [18–21]. Of course, the CDs bonded to gel supports were used
for the chiral resolution of different racemates, but their poor mechanical strength
and low efficiency were distinct drawbacks. An improvement in these CSPs was
introduced through covalent bonds between CDs and silica gel via propylamine,
ethylenediamine, and other related linkages [22–27]. Again inherent problems
prevented these developed phases from achieving the status of the best CSPs. The
drawbacks related to these CD CSPs were tedious synthesis, involving the
formation of nitroxide in the reaction mixture, as well as poor loading capacities,
hydrolytic instability, and the effect of amines on enantioseparation. These
drawbacks were overcome, however, by preparing CSPs that were more hydro-

lytically stable [28–43]. These CSPs were utilized in the reversed-phase mode, as
well, and commercialized. Most of the chiral resolution work was carried out on
these CSPs. The development of derivatized CD-based CSPs constituted a major
development in the field [44–52]. The biggest advantage of these CSPs was
versatility, for they could be used in normal, reversed, and new polar organically
modified phases.
The three CDs and their derivatives can be bonded to silica gel by using
silane reagents. The most commonly used silane reagents are 3-glycidoxypropyl
trimethoxysilane, 3-glycidoxypropyldimethylchlorosilane, and 3-glycidoxypro-
pyltriethoxysilane. The preparation of CD-based CSPs is a two-step process.
The silane reagent is attached to silica gel (spherical; 5 mm particle diameter) by
refluxing in dry toluene at 95 C for 3 h. The mixture is then cooled, filtered,
FIGURE 2 Chemical immobilization pathways for cyclodextrins on silica gel (see text).

washed several times with toluene and methanol, and then dried at 60 C over
phosphorus pentoxide under vacuum. In the second step, the treated silica gel is
allowed to react with CD in pyridine at 80 C [29,53]. The chemical pathways for
these reactions are shown in Figure 2. The synthetic procedure varies slightly
depending on the use of silane reagent and the CD type. From the theoretical
point of view, linkage can occur through either the primary or the secondary
hydroxyl groups, but in practice primary hydroxyl groups are more reactive, since
they are less sterically hindered. If more than one chloro or methoxy groups are
present on the silane reagent, more than one bonding link may occur between the
silane reagent and the silica gel. CD has many free hydroxyl groups and,
therefore, bonding with silica gel may occur through more than one silane
bond. The high stability of CD bonded phases supports the binding of CDs
through more than one bond, but no experimental evidence of this has been
presented till today. The structures of some bonded CD chiral stationary phases
are shown in Figure 3. In general, CD columns are only moderately robust but
easily regenerated. At present, CD-based CSPs are among the most inexpensive
tools for chiral resolution purposes. Table 2 lists the commercialized CD-based
columns offered by different companies.
TABLE 2 Various Cyclodextrin-Based Commercial CSPs
Commercialized CSPs Companies
Cyclobond I, II, and III (CDs) Advanced Separation Technologies,

Whippany, NJ, U.S.A.
Cyclobond AC, RN, SN
(derivatives of CDs)
ApHpera ACD and BCD
(polymer-bonded CD derivatives)
Nucleodex b-OH and Nucleodex b-PM Macherey-Nagel, Duren, Germany
ORpak CD-HQ
(CDs bonded to polymer gel)
ORpak CDB-453 HQ Showa Denko, Kanagawa, Japan
ORpak CDBS-453,
ORpak CDA-453 HQ, and
ORpak CDC-453 HQ
(CDs bonded to polymer-based gel)
Keystone b-OH and Keystone b-PM Thermo Hypersil, Bellefonte, PA, U.S.A.
YMC Chiral cyclodextrin BR, YMC, Kyoto, Japan
YMC Chiral NEA (R), and
YMC Chiral NEA (S)
b-Cyclose-6-OH Chiral Separations, La Frenge, France

FIGURE 3 The chemical structures of some cyclodextrin-based CSPs.

3.3 APPLICATIONS
Cyclodextrin-based CSPs are among the most popular materials used for the
chiral resolution of racemic compounds. These CSPs have a wide range of
applications because they can be used successfully in all three mobile phase
modes: normal, reversed, and polar organic. There are numerous examples of
chiral separations on CDs and CSPs based on their derivatives. Some of the
important chiral separations are discussed herein.

In 1978, Harada et al. [17] used polymerized CD with gel support for the chiral
resolution of mandelic acid and its derivatives. Later Zsadon et al. [18–21] used
cyclodextrin-based CSPs for the chiral resolution of indole alkaloids, with
aqueous buffers as the mobile phases. Today CD-based CSPs have a good
reputation. In separate studies, Fujimura [22] and Kawaguchi [23] and their
colleagues resolved the enantiomers of aromatic compounds in the reversed-
phase mode. Armstrong et al. [29,30,33,34,41,44–46,48,54–63] carried out
extensive and remarkable work on the chiral resolution of various racemic
compounds using CD-based CSPs.
Armstrong et al. [54] resolved the enantiomers of some amino acids and
their derivatives on a-CD-based CSPs using 1% aqueous triethylammonium
acetate (pH 5.1). The same authors also tested a b-CD CSP for the chiral
resolution of amino acids [55]. In addition, they evaluated a g-CD phase for the
enantiomeric resolution of some dansyl amino acids and other drugs. The mobile
phase was 38% methanol with 1% triethylammonium acetate [58]. In another
study, the same authors reported the chiral resolution of 25 pairs of amino acids in
less than 30 min [63]. The enantiomers of some b-adrenergic blockers were
resolved on a b-CD stationary phase, with 1% aqueous triethylammonium
acetate, containing methanol, as the mobile phase [9,48].
The enantiomers of baclofen, mandelic acid, tropic acid, chlorhexylphenyl-
acetic acid, and chlorhexylphenylglyconic acid were resolved on b-CD phases,
with a complex of potassium phosphate buffer (0.1 M) and acetonitrile (65 : 35,
v=v) as the mobile phase [26]. The chiral resolution of rotenoids and their
hydroxy analogues was carried out on b-CD, with different mixtures of water–
acetonitrile and water–methanol, separately, as the mobile phases [64]. The
enantiomers of epinephrine and norepinephrine were resolved on a b-CD phase
by using a variety of mobile phases [65]. The chiral resolution of tetrahydroiso-
quinoline alkaloids was achieved on a b-CD phase by using mobile phases
comprising citric acid monohydrate and phosphoric acid [66]. Furthermore,
Seeman and Secor [57] resolved the enantiomers of nicotine analogues on a
b-CD-bonded phase using 1% aqueous triethylammonium acetate (pH 7.1)

containing acetone as the mobile phase modifier. A column bonded with b-CD
carbamate was used for the chiral resolution of chlorpheniramine, with sodium
phosphate and phosphoric acid containing acetonitrile as the mobile phase [67].
Chromatograms of the chiral resolution of amino acids and nicotine alkaloids and
derivatives are shown in Figure 4.
Major advances have been made in recent years in the development and
optimization of chiral resolutions of derivatized CD-based CSPs [68]. It has been
reported that CSPs based on CD derivatives were more enantioselective than
CSPs obtained from native CDs [68]. An acetyl b-CD column exhibited
enhanced separation for scopolamine in comparison to the native b-CD CSP in
the reversed-phase mode [69]. The enantiomeric resolution of some drugs was
compared on the native b-CD and on CSPs based on (S)- and (R)-2-hydroxy-
propyl b-CD, and the best resolution was reported on the derivatized CSPs [44].
Five types of natural and chemically modified b- or g-CD stationary phases were
developed and used for the chiral resolution of dansyl amino acids. The best
resolution of dansyl amino acids was provided by g-CD CSPs [70].
In another study [71], native and chemically modified b-CD-bonded
stationary phases of six types were evaluated for the chiral resolution of some
FIGURE 4 Chromatograms of (a) tyrosine (A), phenylalanine (B), tryptophan (C),

6-fluorotryptophan (D), and o-methyltyrosine (E) on an a-CD phase; and (b) N 0 -(2,2,2-
trifluoroethyl)nornicotine (A), N 0 -benzylnornicotine (B), and N 0 -(2-naphthylmethyl)nor-
nicotine (C) on a b-CD column. (From Refs. 54,57.)

derivatized amino acids in the reversed-phase mode. The chiral separations of
derivatized amino acids were compared on (R)- and (S)-naphthylethylcarbamate
derivatives of b- and g-CD-based CSPs. The best separations were reported on b-
CD-based CSPs. Han and Armstrong [4] used (R)- and (S)-naphthylethylcarba-
mate b-CD-based phases for the chiral resolution of pesticides (dyfonate, ruelene,
ancylmidol, and coumachlor) and some pharmaceuticals, including trocanide,
indapamide, and tolperisone. These CSPs were highly effective multimodal
phases, (i.e., suitable for use in the normal, reversed, and organic mobile phases).
A novel heptasubstituted b-cyclodextrin bearing the methoxyethylamine
group linked to the upper cyclodextrin rim was successfully used as the chiral
selector for the enantiomeric separation of nonsteroidal anti-inflammatory drugs
(NSAIDs) and phenoxypropionic acid herbicides (PPAHs) [72]. Results indicated
that heptakis(6-methoxyethylamine-6-deoxy)-b-cyclodextrin (b-CD-OMe)
performed exceptionally well in the enantiomeric resolution of two NSAIDs,
indoprofen and fenoprofen. In addition, baseline enantiomeric separation of a
mixture of six pairs of PPAHs was achieved within 30 min. Compared with other
cationic b-cyclodextrins reported in the literature, the b-CD-OMe showed
improved selectivity for both classes of the aforementioned anionic racemates
[72]. Further, Ryu et al. [73] carried out the chiral separation of 2,4-dinitrophenyl
(DNP) amino acids (Phe and Trp) on native b-CD and heptakis(3-O-methyl)-b-
CD; the use of various substituents at different positions allowed the investigators
to compare the enantioselectivity of these CSPs. Both native b-CD and hepta-
kis(3-O-methyl)-b-CD showed good enantioselectivity for the DNP amino acids
investigated. Heptakis(3-O-methyl)-b-CD, the cavity of which is more electron
rich than that of native b-CD, showed in general much better enantioselectivity
for the amino acid derivatives studied.
Generally, CD-based chiral stationary phases have been used in the
reversed-phase mode. Earlier, it was assumed that in the normal phase mode,
the more nonpolar component of the mobile phase would occupy the CD cavity,
thereby blocking inclusion complexation between the chiral analyte and CD
[4,11]. But with the development of CD derivatives, it has become possible to use
the normal phase mode too [45,74]. Among the various CSPs based on CD
derivatives, one based on a naphthylethyl carbamoylated derivative has shown
excellent enantioselectivity in the normal phase mode [46,59]. Armstrong et al.
[45] synthesized several b-CD derivatives and had them tested in the normal
phase mode to resolve the enantiomers of a variety of drugs; hexane–2-propanol
(90 : 10, v=v) served as the mobile phase. The authors discussed the similarities
and differences of the enantioselectivities on the native and derivatized CD
phases.
In another study, Armstrong et al. [59] resolved the enantiomers of profens
on (R)- and (S)-naphthylethylcarbamate b-CD phases in the normal phase mode.
Dichloro-, dimethyl-, and chloromethylphenylcarbamate derivatives of CDs were

prepared and used for the chiral resolution of Tröger’s base, flavanone, benzoin,
and other drugs [49]. The mobile phase used was hexane–2-propanol (90 : 10,
v=v). A phenylated b-CD CSP was developed and evaluated for the chiral
resolution of b-adrenergic blockers, benzodiazepine anxiolytics, arylpropionic
acid, and some herbicides. The column showed good chiral recognition capability
when heptane, with 2-propanol or chloroform, was used as the mobile phase [75].
Chromatograms of the normal phase mode chiral separation of trans-2,3-
cyclopropanedicarboxylic acid anilide, benzoin, fluoxetine, and norfluoxetine
are shown in Figure 5.
The mobile phase conditions traditionally used for the chiral resolution on
CD phases containing high concentrations of buffers adversely affected column
stability and enantioselectivity. Therefore, in 1992, Armstrong et al. [60]
developed a new mobile phase, comprising 90 to 99% polar organic solvent
(i.e., methanol) for the chiral resolution of b-adrenergic blocking agents on b-CD
based CSPs. The authors also used acetic acid and triethylamine as mobile phase
additives. The same group [76] evaluated new polar organic mobile phases for the
chiral resolution on CD-based CSPs.
Furthermore, Armstrong et al. [48] used the polar organic phase mode to
resolve the enantiomers of b-adrenergic blockers on CSPs based on b-CD and its
2,3-methylated derivatives. The mobile phase used had methanol as the major
component, with acetic acid and triethylamine (1%). In 1996, two reports were
published on the polar organic phase mode chiral resolution of some drugs by
means of CD-based CSPs [62,77]. The racemic compounds resolved were amino
acids [62] and propranolol [75]. Zukowski [78] later resolved the enantiomers of
Jacobson’s catalyst on a hydroxypropyl b-CD phase with methanol–triethylamine
(99.95 : 0.05, v=v) as the mobile phase. Even more recently, Péter et al. [79]
separated the enantiomers of diendo- and diexo-3-aminobicyclo[2.2.1]heptane-2-
methanol and diendo- and diexo-3-aminobicyclo[2.2.1]heptane-2-methanol deri-
vatives on a naphthylethylcarbamate-derivatized b-CD cyclodextrin (Cyclobond I
SN) stationary phase, which was used in the polar organic mode. This approach
allowed the simultaneous separation of stereoisomers of alcohol and ester
analogues of the bicyclic 1,3-amino alcohols. The chromatograms of the chiral
resolution of b-adrenergic blockers on CSPs based on b- and g-CDs are shown in
Figure 6.
Direct analysis of the enantiomers in biological fluids is very important
because it reduces both analysis time and sample preparation time. Indeed, when
there is risk of the quick racemization of the enantiomer, direct analysis is
essential. It has been observed that CD-based CSPs employ mobile phases that
are generally compatible with biological samples, hence can be used for the direct
analysis of the enantiomers in biological fluids [67,80]. Stalcup et al. [58]
employed coupled column chromatography to isolate scopolamine from a plant
extract and found that the extent of racemization depends on the isolation

FIGURE 5 Chromatograms of (a) trans-2,3-cyclopropanedicarboxylic anilide, (b)
benzoin, and (c) norfluoxetine (A) and fluoxetine (B) on b-CD phases using the normal
mobile phase mode. (From Refs. 49,108.)

FIGURE 6 Chromatograms of (a) propranolol, (b) metoprolol, (c) timolol, (d) atenolol,
(e) cateolol, and (f) alprenolol on b-CD columns, using the organic polar phase mode.
(From Ref. 60.)
protocol. Furthermore, Stalcup and Williams [80] developed a special CD-based

CSP with suitable spacer and used it successfully in the chiral resolution of
hexabarbital in blood samples. Armstrong et al. [81] analyzed unnatural (D-)
isomers of various amino acids in human urine samples. The chiral separation of
lorazepam was achieved on a b-cyclodextrin derivative immobilized with silica
gel under reversed-phase conditions. The method described allows the quantita-
tion of the stereoisomers of lorazepam in human plasma following the admin-
istration of a therapeutic dose of the racemic drug [82]. The chiral resolution of
various racemic compounds on native and derivatives of cyclodextrin-based CSPs
is summarized in Table 3 [4,9,26,27,48,54–60,62–66,70–73,75,85–108].

CD-based CSPs can be used for chiral resolution at the preparative scale because
their loading capacities are quite good. West and Cardellina [83] reported a
semipreparative chiral separation of polyhydroxylated sterols on a b-CD phase.
Later, Shaw et al. [84] presented a preparative chiral resolution of a substituted
thienopyran on a b-CD phase. Advanced Separation Technologies, Inc., of
Whippany, New Jersey, offers CD-based columns having diameters of 10, 20,
and 50 mm on which 20 mg, 200 mg, and 5 g samples, respectively, can be loaded,
in a single run [85]. The highest sample-loading capacity is in the polar organic
mode, followed by the normal phase mode. A wide variation appears with the

TABLE 3 Enantiomeric Resolution of Some Racemic Compounds on Cyclodextrin-
Based CSPs
Racemic Compounds CSPsa Refs.
Reversed-phase mode
Alkaloids b-CD and derivatives 9,56,57,66,87,88
Hydantoins b-CD and derivatives 56,65,89–91
Antihistamines b-CD 90
b-Adrenergic blockers b-CD 9,48,75
Amino acids and derivatives b-CD and derivatives 55,58,62,63,70,71,73,89,92
a-CD 54
Peptides b-CD 92
Crown ethers and analogues b-CD and derivatives 93
Metallocenes b-CD 94
Rotenoids b-CD 64
Carboxylic acids and esters b-CD and derivatives 9,25,26,27,56,89
Profens b-CD 9,59,72,95
Propranolol b-CD 96
Aminoalkyl phosphonic acid b-CD 97
Dimethylaminobutyrophenone b-CD 98
Antifungal agents b-CD 99
Tetracyclic eudistomins b-CD 100
Deltahedral carbonate b-CD 101
9-Fluorenylmethyl chloroformate g-CD 102
NDP–amino acids b-CD 103
Nomifensine hydrogen maleate b-CD 104
Alkaloids and metabolites b-CD 105
Warfarin b-CD derivative 106
Terfenamide b-CD 107
Pesticides b-CD 4
Normal phase mode
Tetracyclic eudistomins b-CD 100
Ciprofibrate Cyclobond I SN 85
Amino acids and derivatives Cyclobond I SN 85
Cyclobond I RN
Terfenamide b-CD 107
Fluoxetine and its metabolites b-CD 108
Carotenes b-CD 57
Herbicides b-CD 75
New polar organic phase
Amino acids and derivatives b-CD 62,85
Ciprofibrate Cyclobond I 85
Warfarin Cyclobond I SN 85
b-Adrenergic blockers b-CD 48,60,75,85
Profens Cyclobond I RN 85
Methadone Cyclobond I 85
a
Cyclobond I, b-CD; Cyclobond I SN, S-naphthylethylcarbamated b-CD; Cyclobond I RN, R-
naphthylethylcarbamated b-CD.

reversed-phase mode, which depends on the structures of the racemic compounds
to be resolved. To reduce solvent consumption and improve purity and yield,
recycling is the best technique. The enantiomeric resolution of warfarin was
carried out on the preparative scale by separating enantiomers of about 500 mg on
a Cyclobond 1 2000 column (25 cm 2:5 cm), with methanol–acetic acid–
triethylamine (100 : 0.3 : 0.2, v=v=v) as the mobile phase, at a flow rate of
12 mL=min [86]. AmeriChrom Global Technologies, of Beltsville, Maryland,
markets VersaPrep CSP, which is also good for the preparative chiral separation of
different racemic compounds. This CSP gave excellent results when used with
recyclic technology in peak-shaving chromatography [85].

The formation of CD inclusion complexes is favored in aqueous media, and
hence most of the early chiral resolutions were carried out in the reversed-phase
mode. However with the development of various derivatives of CDs, normal and
polar organic mobile phases could also be used. The selectivities of these modes
increase in the following order: normal > polar organic > reversed phase. This is
due to certain advantages associated with the normal and polar organic phase
modes. Now that all three mobile phase modes can be used, optimization on these
phases can be achieved by varying a number of parameters such as composition
of the mobile phase, use of organic modifiers, mobile phase pH, flow rate, and
temperature. The details of the optimization of the chiral resolution on these CSPs
are presented next.
3.4.1 Composition of the Mobile Phase

Most of the initial chiral resolutions on CD-based CSPs were carried out with
aqueous mobile phases. Buffers of different concentrations and pH values were
developed and used for this purpose. Triethylammonium acetate (TEAA),
phosphate, citrate, and acetate are among the most commonly used buffers
[4,11,26,68]. Also phosphate buffers such as sodium, potassium, and ammonium
phosphate buffers are commonly used. The stability constant of the complexes
decreases as organic solvents are added, hence organic modifiers are used to
optimize the chiral resolution. The most commonly used organic solvents are
methanol and acetonitrile. Acetonitrile is a stronger organic modifier than
methanol. Some other organic modifiers, such as ethanol, 2-propanol, 1-propanol,
n-butanol, tetrahydrofuran, triethylamine, and dimethylformamide were also used
for the optimization of chiral resolution on CD-based CSPs [4,11,109,110]. Since
the effect of the type and concentration of these organic modifiers varies from one
analyte to another, it is very difficult to predict a successful strategy for their use
as organic modifiers.

In 1987 Abidi [64] used an aqueous solution of methanol for the chiral
resolution of rotenoids. The author reported that the best resolution occurred with
50% methanol as the mobile phase. The chiral resolution of hydantoin racemates
was optimized by using 10 and 20% methanol as the mobile phase [88].
Armstrong et al. [54] achieved the chiral resolution of amino acids by using
60% methanol as the mobile phase. Similarly, the chiral resolution of nicotine
analogues was achieved by using 40% methanol as the mobile phase [55]. Aboul-
Enein et al. [104] optimized the chiral resolution of nomifensine hydrogen
maleate by adding methanol in the mobile phase. The authors reported 15% as
the optimum concentration of methanol for chiral resolution. According to
Fujimura et al. [70], concentrations of 10 to 30% were better for the chiral
resolution of dansyl amino acids. In another study, Stammel et al. [66] reported a
decrease in the retention factors of the enantiomers of tetrahydroquinoline upon
increasing the concentration of methanol. A very interesting study on the effects
of organic modifiers on the chiral resolution of some drugs was presented by
Piperaki et al. [109]. Of the organic modifiers tested (acetonitrile, methanol,
ethanol, tetrahydrofuran, 1-propanol, and 2-propanol), methanol proved to be the
best. Furthermore, Armstrong et al. [48] used a variety of solvent systems for the
chiral resolution of different drugs. The effects of these organic modifiers on the
chiral resolution of zopiclone are shown in Figure 7.
Armstrong et al. compared the chiral resolution of N-benzylnornicotine
with two different organic modifiers: methanol and acetonitrile [57]. The
maximum retention factor value (k ¼ 6:0) was obtained with methanol as the
organic modifier. On the other hand, the maximum retention factor value was 5.0
with acetonitrile as the mobile phase organic solvent. These findings indicate that
methanol is a more suitable organic modifier than acetonitrile under the
chromatographic conditions reported. When Abidi [64] compared the chiral
resolution of rotenoids using methanol and acetonitrile as the organic modifiers,
better resolution was achieved with methanol. Therefore, the role of organic
modifiers in chiral resolution is not fixed and varies from one analyte to another.
Figure 8 shows the effects of methanol and acetonitrile concentrations on the
chiral resolution of N-benzylnornicotine [57] and nomifensine hydrogen maleate
[104] racemates. The protocol for the development and use of the mobile phase in
the reversed-phase mode is presented in Scheme 1.
Sometimes, the use of high-concentration buffers in the reversed-phase
mode decreases column life and efficiency. Therefore, the use of an alternative
mobile phase (i.e., normal phase) is an advantage in chiral resolution with these
buffers. The most commonly used solvents in the normal phase mode are hexane,
cyclohexane, and heptane. However, dichloromethane, acetone, propanol, ethyl-
acetate, ethanol, and chloroform also have been used as mobile phase solvents.
Hargitai and Okamoto [110] used hexane–2-propanol (in different ratios) as the
mobile phase in the chiral resolution of several drugs. These authors also studied

FIGURE 7 The effects of selected organic solvents on the enantioselectivity of zopiclone
on a b-CD-based CSP. (From Ref. 109.)
chiral resolution in the reversed-phase mode. The highest selectivities were

usually observed under normal phase chromatographic conditions. Hilton et al.
[111] compared the chiral resolution of profens and amino acids, using methanol
and acetonitrile as the major component of the mobile phase. The authors
reported that the CSPs acted like cellulosic phases when used with 100%
methanol or acetonitrile, which resulted in an improved chiral resolution.
Chankvetadze et al. [49] resolved the enantiomers of benzoin using hexane–2-
propanol (90 : 10, v=v) as the mobile phase. The chiral resolution of herbicides
and b-adrenergic blockers [75] was achieved in the normal phase mode. The
columns showed good chiral recognition ability for most of the solutes tested
when heptane containing either 2-propanol or chloroform was one of the
components. The protocol for the development and use of the normal phase
mobile mode on these CSPs is presented in Scheme 2.

FIGURE 8 The effects of (a) methanol on the chiral resolution of N 0 -benzylnornicotine,
(b) acetonitrile on the chiral resolution of N 0 -benzylnornicotine, and (c) methanol on the
chiral resolution of nomifensine hydrogen maleate on b-CD-based CSPs. (From Refs.
57,104.)

CD-based CSPs in the reversed-phase mode.

CD-based CSPs in the normal phase mode.

In 1996 it was reported [85] that it is possible to override inclusion
complexation in favor of interacting directly with the secondary hydroxyl
groups across the larger opening of the cyclodextrin toroid or the pendant
carbamate, acetate, or hydroxypropyl functional groups. To accomplish this,
the polar organic mode, comprising a polar organic solvent such as methanol or
acetonitrile, was developed, and it produced very efficient separations not
previously reported on these phases. Warfarin, b-adrenergic blockers, and other
analytes have been separated by using the polar organic phase mode. This mode
is also suitable for molecules that do not contain an aromatic group. Moreover,
chiral separations achieved by using the polar organic phase mode are more
efficient, more reproducible, and more effective at the preparative scale.
The ratio of acid to base is crucial, and the separation is optimized by
monitoring the acid and base concentrations: if the analyte is eluting too fast, the
concentration of acid or base is reduced; if the analyte is too well retained, the
acid or base concentration is increased. The parameters for concentration are
between 1 and 0.001%. In 1992 Armstrong et al. [60] used the polar organic
phase mode to resolve the enantiomers of b-adrenergic blockers. The authors
urged that other molecules could be resolved successfully under this mobile
phase mode. A few years later, Matchett et al. [77] utilized this approach for the
chiral resolution of propranolol and some of its analogues. Ekborg-Ott and
Armstrong [62] used acetonitrile as the major component in the CSP resolution of
amino acids. The separation was optimized by adjusting the concentrations of
triethylamine and acetic acid. In another study, Zukowski [78] adopted the same
polar organic mobile phase for the chiral resolution of Jacobson’s catalyst. The
author used 1000 mL of acetonitrile with 0.5 mL of triethylamine and 2.5 mL of
acetic acid as the mobile phase; as recommended earlier [111], DNB and dansyl
amino acids were resolved by using methanol or acetonitrile as the major
component of the mobile phase. Optimization was achieved by adjusting the
concentrations of triethylamine, acetic acid, and ethanol [111]. The effect of the
concentration of methanol on the chiral resolution of some b-adrenergic blockers
is shown in Figure 9 [77]. It may be concluded from Figure 9 that the retention
factors decreased as a function of the increase in methanol concentration. Yet Han
[68] has reported that in general, retention increases, without significantly
affecting the enantioselectivity, when methanol concentration is increased. The
protocol for the development and use of the polar organic mobile phase is given
in Scheme 3.

Many of the early chiral resolutions were carried out in the reversed-phase mode.
Therefore, the pH of the mobile phase, which affects the degree of complexation
of analytes with CD, is very important. In 1985 Feitsma et al. [26] studied the

SCHEME 3 Protocol for the development and optimization of mobile phases on CD-
based CSPs in the polar organic phase mode. TEA, triethylamine; AcOH, acetic acid.
FIGURE 9 The effects of methanol on the chiral resolution of some b-adrenergic

blockers on b-CD column, in the polar organic mobile phase mode. (From Ref. 77.)

chiral resolution of aromatic acids. They reported that mandelic acid could be
separated at pH 4.2 but not at pH 6.5. Furthermore, it was observed that
cyclohexylphenylglycolic acid and cyclohexylphenylacetic acid were highly
retained at pH 4.2 and 6.5, respectively. Aboul-Enein et al. [104], who optimized
the chiral resolution of nomifensine hydrogen maleate at pH 3.5, reported that an
increase in pH resulted in an increase in retention factor. Armstrong et al. [105]
observed three types of pH effect on the chiral resolution of rotenoids: (1) an
increase in retention with pH, (2) an increase in retention followed by a decrease,
and (3) an increase in retention that becomes constant. Therefore, chiral
resolution varied from one rotenoid to another.
In another study, Piperaki and Parissi-Poulou [108] carried out the chiral
resolution of fluoxetine and norfluoxetine at pH 3.5 to 7.0. The best resolution of
both racemates was reported at pH 5.0 to 5.5. Lemer et al. [112] studied the chiral
resolution of ephedrine, methamphetamine, and selegiline at pH 3.5 to 5.5, and
their results are given in Table 4. The lower retention factor values at lower pH
may be due to drug protonation, since the compounds studied were basic. It is
interesting to observe from Table 4 that the separation factor values decreased
when pH increased, while the reverse was true for the resolution factor values.
Haynes et al. [72] reported a major effect of pH on the chiral resolution of anti-
inflammatory drugs and phenoxypropionic acid herbicides. Recently, Chen et al.
[113] studied the effect of pH on the chiral resolution of b-adrenergic blockers
and amines. The authors reported the best resolution of these compounds between
4.65 and 6.30 pH range. The effects of pH on the chiral resolution of nomifensine
hydrogen maleate, fluoxetine, and norfluxetine are shown in Figure 10. Optimiza-
tion in the normal and polar organic phase modes was also achieved when acids
and bases were used. Therefore, pH also controls optimization in the normal and
polar organic phases. To the best of our knowledge, however, no report has been
published on this issue.
TABLE 4 Effects of pH on the Chiral Resolution of Ephedrine, Methamphetamine,

and Selegiline
Ephedrine Methamphetamine Selegiline
pH k a Rs k a Rs k a Rs
3.5 0.59 0.73 0.53 0.80 1.00 1.00 0.87 0.83 0.69
4.5 0.65 0.71 0.58 0.84 0.90 0.95 0.92 0.79 0.91
5.5 0.77 0.69 0.66 0.92 0.78 0.90 1.00 0.67 0.84
Source: Ref. 112.

FIGURE 10 The effects of pH on the chiral resolution of (a) nomifensine hydrogen
maleate and (b) fluoxetine and norfluoxetine on b-CD columns. (From Refs. 104 and 108.)

3.4.3 Ionic Strength of the Mobile Phase
Buffer concentration is a very important aspect of chiral resolution on CD-based
phases in the reversed-phase mode. Addition of salts to the reversed mobile phase
has improved chiral resolution [68]. In some cases, as the buffer concentration
increased, the retention times decreased and the peaks sharpened. These results
prompted some studies to evaluate the effect of buffer concentration on chiral
resolution in these phases. Fujimura et al. [70], who studied the effects of
phosphate buffer concentration on the chiral resolution of dansyl amino acids,
reported that the best separations were obtained at 0.2 M buffer concentration.
The retention factors were increased when the ionic strength of the buffer was
raised. Lemer et al. [112] varied from 50 nmol=L to 750 nmol=L the concentra-
tion of triethylamine in a triethylamine–aqueous sulfuric acid mobile phase for
the chiral resolution of ephedrine, selegiline, and methamphetamine racemates.
The authors reported that the highest concentration was the best. In another study,
Fukushima et al. [65] investigated the effects of ammonium phosphate concen-
tration on the chiral resolution of ephedrine and norephedrine. It was observed
that retention factors increased when the concentration of the buffer was
increased. Haynes et al. [72] optimized the chiral resolution of anti-inflammatory
drugs and phenoxypropionic acid herbicides by adjusting the concentration of the
buffer. The effect of buffer concentration on the chiral resolution of ephedrine,
norephedrine, and some amino acids is presented in Figure 11.
The effects of certain ions on the chiral resolution on CD-based CSPs also
were evaluated. Fukushima et al. [65] used sodium, ammonium, and triethyl-
amine cations in the mobile phase and assessed the effects of their presence on
the chiral resolution of some drugs. The enantioselectivity was in the following
order: triethylamine > ammonium > sodium. Lemer et al. [112] also studied the
effects of acetate, bicarbonate, sulfate, chlorate, nitrate, and phosphate anions on
the chiral resolution of ephedrine, methamphetamine, and selegiline racemates.
The authors reported that the retention of all the three drugs increased in the
following order: chlorate < acetate < nitrate < bicarbonate < phosphate < sulfate.
They attributed the increase in retention factor values to the increasing hydration
of the anions studied. However, the authors reported the best resolution in the
presence of sulfate anion. Similarly, Aboul-Enein et al. [104] tried to improve the
chiral resolution of nomifensine hydrogen maleate by adding ammonium chloride
to a mobile phase consisting of TEAA (at 3.5 pH) and methanol (80 : 20, v=v).
But the authors reported no effect on chiral resolution due to the presence of
ammonium chloride in the mobile phase. The effects of the presence of anions on
the chiral resolution of ephedrine, methamphetamine, and selegiline are shown in
Figure 12.

FIGURE 11 The effects of phosphate buffer concentration (ionic strength) on the chiral
resolution of (a) d-ephedrine (j), l-ephedrine (u), d-norephedrine (d), and l-norephedrine
(s) and (b) the dansyl amino acids aspartic acid (n), glutamic acid (s), serine (u), and
phenylalanine (,) on b-CD columns. (From Refs. 65,70.)

FIGURE 12 The effects of anions on the chiral resolution of ephedrine (n), meth-
amphetamine (u), and selegiline (s) on ChiraDex columns. (From Ref. 112.)

3.4.4 Flow Rate of the Mobile Phase
Enantiomeric separations on mobile phases depend on the placement of the
enantiomers in the cavities of the CDs. Therefore, upon displacing the enantio-
mers from the CD cavities, flow rate may be used as one of the optimizing
parameters. This allows investigators to optimize chiral resolution in all the three
mobile phase modes by means of flow rate. Piperaki and Parissi-Poulou [108]
varied the flow rate from 0.2 mL=min to 1.0 mL=min and observed the chiral
resolution of fluoxetine and norfluoxetine. The effects of flow rate on the chiral
resolution of ephedrine, methamphetamine, selegiline, fluoxetine, and norfluox-
etine are shown in Figure 13, which indicates that retention times are affected
tremendously by decreases in flow rate. The authors suggest that by decreasing
the flow rate, one affords the molecules a greater opportunity to interact with
CDs, thus increasing the chiral discrimination ability of the cyclodextrins.
Similarly, Lemer et al. [112], who varied flow rate from 0.2 mL=min to
1 mL=min in the chiral resolution of ephedrine, methamphetamine, and selegiline,
reported that chiral resolution was decreased at higher flow rates for all three
drugs. The best resolution was reported at a flow rate of 0.2 mL=min. Thus, 0.2 to
1.0 mL=min seems to be the best range of working flow rates on these CSPs. The
effects of flow rate on the chiral resolution of ephedrine, methamphetamine,
selegiline, fluoxetine, and norfluoxetine are shown in Figure 13.
3.4.5 Temperature
The kinetics of the formation of inclusion complexes between enantiomers and
CDs is affected by changes in temperature and, therefore, temperature may be
used to optimize chiral resolution on these phases. The degree to which
temperature affects resolution is dependent on analyte and CD phase, respec-
tively. Generally, lower temperatures enhance the weaker bonding forces between
enantiomers and CD phase, and the net result is an improvement in chiral
resolution. In one study, Feitsma et al. [26] were plagued by the tailing of peaks in
the chiral resolution of mandelic acid, tropic acid, cyclohexylphenylglycolic acid,
and cyclohexylphenylacetic acid racemates at room temperature. This problem
was removed by increasing the experimental temperature. However, higher
temperature resulted in shorter retention times owing to decreased stability of
the inclusion complexes at higher temperature. Aboul-Enein et al. [104], who
studied the effects of temperature by resolving the enantiomers of nomifensine
hydrogen maleate found that temperature did not exert a prominent effect. The
best resolution of nomifensine hydrogen maleate, however, was achieved at 8 C.
Lipkowitz and Stoehr [114] studied the binding of the enantiomers of
methyl mandelate under buffered and unbuffered conditions at different tempera-
tures. The authors reported that the stereodifferentiating binding energies for the

FIGURE 13 The effects of flow rate (mL=min) on the chiral resolution of (a) ephedrine
(n), methamphetamine (u), and selegiline (s) on a ChiraDex column and (b) fluoxetine
and norfluoxetine on b-CD based CSPs. (From Refs. 108,112.)

enantiomers were higher at lower temperatures. Lemer et al. [112], who studied
the effects of temperature, in the range 5 to 30 C, on the chiral resolution of
ephedrine, methamphetamine, and selegiline drugs, reported an increase in the
retention, separation, and resolution factors at lower temperatures. This behavior
was explained on the basis of more stable inclusion complexes at lower
temperatures. The effects of temperature on the chiral resolution of ephedrine,
methamphetamine, selegiline, and nomifensine hydrogen maleate are shown in
Figure 14.
3.4.6 Solute Structures

The chiral resolution on CD-based CSPs depends on the formation of inclusion
complexes in the cavities and, therefore, the structures and sizes of analytes are
very important for the chiral resolution of racemates on these phases. Amino
acids often are considered to be the best class of racemic compounds to use in
structural studies. In 1987, Han and Armstrong [55] studied the chiral resolution
of amino acids on b-CD-based CSPs. It was observed that different retention,
separation, and resolution factor values were obtained for different amino acids
under identical chromatographic conditions, which indicated that the structures
and sizes of amino acids govern their chiral resolution. The same observations
may be found in the work of Fujimura et al. [70].
Maguire [89] carried out an interesting study of the chiral resolution of
hydantoins on a b-CD phase. The results (Table 5) indicate that retention,
separation, and resolution factor values increased when bulky alkyl groups
were introduced into the molecules. Similarly, Han et al. [56] studied the effects
of hydantoin structures on their chiral resolution. The authors reported good
chiral resolution when these compounds had two or more rings. Recently,
Tazerouti et al. [75] used the normal phase mode (two mobile phases) to achieve
chiral resolution of some related herbicides on the b-CD-based phase (Table 6).
In general, retention, separation, and resolution factor values increased when
bulky alkyl groups were introduced into the molecules. Furthermore, the reten-
tion, separation, and resolution factor values dramatically increased upon addition
of a phenyl group. Thus selection of the structures and sizes of analytes is very
important for successful chiral resolution on a specific CD-based CSP. It may be
concluded that structures and sizes exert their effects on chiral resolution as a
result of certain interactions and forces between the CSP and the analytes, which
will be discussed later (Sec. 3.5).
3.4.7 Structures of the CDs and Their Derivatives

All three natural cyclodextrins have different selectivities and enantiorecognition
capacities owing to differences in cavity diameter and length. Generally, a-, b-,
and g-CDs are suitable for the chiral resolution of small, medium, and large

FIGURE 14 The effects of temperature ( C) on the chiral resolution of (a) ephedrine (n),
methamphetamine (u), and selegiline (s) on a ChiraDex column and (b) nomifensine
hydrogen maleate on b-CD-based CSP. [From Refs. 112 (a), 104 (b).]
molecules respectively. Moreover, the chiral recognition capacities of the different

CD derivatives vary greatly. Thus published results of studies of chiral resolution
on different CD-based CSPs have been compared and discussed.

TABLE 5 Effects of the Substituents on the Chiral Resolution
of 5-Alkyl-5-phenylhydantoin Enantiomers on a b-CD Phase
Substituents k a Rs
H 0.67 1.09 0.20

CH3 1.17 1.11 0.50
C2 H5 2.30 1.21 2.00
n-C3 H7 3.30 1.26 2.20
iso-C3 H7 4.96 1.27 2.50
n-C4 H9 4.40 1.14 1.10
Source: Ref. 88.
Fujimura et al. [70] prepared five types of natural and chemically modified
b- and g-CD-based CSPs and evaluated their performance in the chiral resolution
of amino acids. Chiral resolution data for some amino acids on b-CD, 6-O-
phenylcarbamoylated b-CD, and 6-O-propylcarbamoylated b-CD are presented in
Table 7. A perusal of Table 7 indicates that b-CD is the best CSP. In an interesting
study, Hargitai and Okamoto [110] compared the chiral recognition capacities of
3,5-dimethylphenylcarbamoylated b-CD with those of Cyclobond I SN and
Cyclobond I DMP (carbamoylated b-CD) in the chiral resolution of a variety
of drugs. The authors reported the best resolution on 3,5-dimethylphenylcarba-
moylated b-CD. Chankvetadze et al. [49] prepared dichloro-, dimethyl-, and
chloromethylphenylcarbamate CD derivatives (Fig. 15) and tested them in the
chiral resolution of drugs including flavanone and cyclopropanedicarboxylic acid
dianilide in the normal phase mode (Fig. 16). Furthermore, the authors studied
the effects of substitution at the narrow and wide ends of the CDs. The results of
this work are given in Tables 8 to 10.
TABLE 6 Effects of the Substituents on the Chiral Resolution of

N-(3,5-Dinitrobenzoyl)-2-aminoalkyl Propanoate Enantiomers on a b-CD Phase
Heptane– Heptane–
2-propanol chloroform
Substituents (v=v) k a Rs (v=v) k a Rs
CH3 80 : 20 1.89 1.09 0.99 25 : 75 2.38 1.00 —

CH(CH3 )2 80 : 20 1.40 1.11 1.04 75 : 25 15.02 1.07 1.13
CH2 C6 H5 90 : 10 4.02 1.62 5.65 50 : 50 2.93 1.10 1.15
Source: Ref. 75.

TABLE 7 Effects of the Structures of b-CD Phasesa on the Chiral Resolution of
Dansyl Amino Acids
CSP I CSP II CSP III
Dansyl amino acids k Rs k Rs k Rs
Glutamic acid 2.79 1.19 1.55 0.99 0.82 0.63

Aspartic acid 3.03 2.18 1.68 1.58 0.84 0.89
Serine 4.24 1.05 2.42 1.14 1.40 0.80
Threonine 4.49 2.17 2.72 1.78 1.53 1.21
Norvaline 7.26 0.62 3.51 0.67 2.04 0.00
Valine 7.56 1.07 3.73 1.00 2.17 0.85
Norleucine 10.90 0.55 4.70 0.00 2.59 0.00
Leucine 17.10 0.88 4.95 0.00 2.89 0.00
Phenylalanine 22.90 0.85 7.46 0.85 4.33 0.70
Tryptophan 13.30 0.00 8.09 0.00 4.28 0.00
a
CSP I, CSP II, and CSP III are b-CD, (6-O-phenylcarbamoylated)-b-CD, and (6-O-propylcarba-
moylated)-b-CD, respectively.
Source: Ref. 70.
TABLE 8 Chiral Resolutions of Some Drugs on 4-Chloro-3-methylphenylcarbamate

Derivatives of a-, b-, and g-CDsa
CSP 1 CSP 2 CSP 3
Solutes k a k a k a
Tröger’s base (I) 1.30 1.00 1.80 1.07 1.80 1.00

trans-2,3-Diphenyloxirane (II) 1.20 1.06 0.87 1.10 0.73 1.00
1-(9-Anthryl)-2,2,2-trifluoroethanol (III) 1.23 1.00 1.33 1.00 1.80 1.10
1,2,2,2-Tetraphenylethanol (IV) 0.97 1.34 1.18 1.00 1.40 1.06
2,20 -Dihydroxy-6,60 -dimethylbiphenyl (V) 2.10 1.00 2.00 1.00 2.50 1.00
2-Phenylcyclohexanone (VI) 1.23 1.00 1.83 1.00 1.70 1.06
Flavanone (VII) 1.10 1.00 3.20 1.60 1.83 1.56
Benzoin (VIII) 2.70 1.00 3.75 1.03 1.53 1.00
trans-Cyclopropanedicarboxylic acid 1.30 1.15 2.17 1.65 1.93 1.41
anilide (IX)
a
The structures of the CSPs and the solutes are given in Figures 15 and 16, respectively.
Source: Ref. 49.

TABLE 9 Chiral Resolutions of Some Drugs on Phenylcarbamate Derivatives of b-CDs with Variations in
the Nature and Position of the Substituents on the Phenyl Ring
Solutesb
I II III IV V VI VII VIII IX
CSPsa k a k a k a k a k a k a k a k a k a
2 1.80 1.07 0.87 1.10 1.33 1.00 1.18 1.00 2.00 1.00 1.83 1.00 3.20 1.60 3.75 1.03 2.17 1.65
4 1.32 1.06 0.48 1.10 2.37 1.00 1.17 1.00 3.00 1.00 1.07 1.00 1.70 1.00 3.75 1.03 2.17 1.65
5 1.40 1.00 0.63 1.00 0.90 1.00 0.60 1.00 1.73 1.00 1.13 1.00 0.90 1.00 2.10 1.00 1.07 1.00
6 0.90 1.00 0.60 1.00 2.10 1.00 1.17 1.00 2.13 1.03 1.36 1.00 1.03 1.03 1.05 2.23 1.07 2.23
7 1.67 1.00 0.68 1.00 1.20 1.00 1.10 1.00 1.80 1.00 1.50 1.00 1.30 1.04 2.20 1.00 0.95 1.00
8 1.18 1.11 0.67 1.00 1.50 1.00 0.95 1.00 1.87 1.00 1.40 1.00 1.84 1.84 2.50 1.05 1.33 1.35
9 1.07 1.00 0.67 1.00 1.83 1.00 6.67 1.00 1.27 1.00 1.18 1.00 1.28 1.05 2.07 1.11 0.67 1.00
10 1.23 1.00 1.53 1.00 2.77 1.00 1.20 1.00 2.58 1.05 1.58 1.00 1.70 1.09 2.70 1.00 1.90 1.00
11 1.40 1.00 0.67 1.00 1.66 1.00 1.10 1.20 2.23 1.00 2.03 1.05 1.80 1.11 2.83 1.00 1.87 1.07
12 1.17 1.00 0.67 1.00 2.53 1.00 1.00 1.00 2.67 1.00 1.23 1.00 0.98 1.15 2.20 1.00 1.70 1.00
13 1.23 1.00 0.55 1.00 1.17 1.00 0.77 1.00 1.17 1.00 1.30 1.00 0.90 1.11 2.05 1.14 1.58 1.09
14 1.10 1.00 0.60 1.00 3.00 1.00 1.37 1.00 2.57 1.00 1.07 1.00 1.20 1.00 2.70 1.00 2.50 1.08
a
All CSPs are b-CD derivatives, the structures are given in Figure 15.
b
Solute structures are given in Figure 16.
Source: Ref. 49.

TABLE 10 Chiral Resolutions of Some Drugs on 3-Chloro-4-methyl (CSPs 8 and 15,
Bonded to Silica via the Narrow Opening of CD) and 3-Chloro-2-methyl (CSPs 13 and
16, Bonded to Silica via the Wider Opening of CD) Phenylcarbamate Derivatives of
b-CD
CSPsb
8 15 13 16
Solutesa k a k a k a k a
I 1.18 1.11 1.45 1.05 1.23 1.00 1.90 1.00

II 0.67 1.00 0.80 1.00 0.55 1.00 0.90 1.00
III 1.50 1.00 1.07 1.00 1.17 1.00 1.45 1.00
IV 0.95 1.00 1.70 1.00 1.17 1.00 2.10 1.00
V 1.87 1.00 1.70 1.00 1.17 1.00 2.10 1.00
VI 1.40 1.00 1.57 1.00 1.30 1.00 1.77 1.00
VII 2.07 1.84 2.20 2.04 0.90 1.11 1.80 1.11
VIII 2.50 1.05 2.96 1.06 2.05 1.04 3.70 1.02
IX 12.33 1.35 1.26.02 1.50 1.58 1.09 2.13 1.13
a
Solute structures are given in Figure 15.
b
CSP structures are given in Figure 16.
Source: Ref. 49.
In another study, the effects on chiral recognition of CD type, the nature

and position of the substituents on the phenyl ring, and the binding mode were
investigated in detail [49]. No marked change of the chiral recognition abilities
was established when the CD binding side was reversed, that is, it made no
difference whether the opening of the cone-shaped CD to silica gel was the
narrower (primary) one or the wider (secondary) side. Furthermore, the authors
concluded that chiral recognition of some compounds by these CSPs critically
depends on the type of CD used [49]. Lévêque et al. [115], who synthesized
mono-2-O-pentenyl- and mono-6-O-pentenyl b-CD-based CSPs, concluded that
these CD derivatives, linked to silica gel, were not equivalent in chiral discrimi-
nation and that the orientation of CDs grafted onto silica gel played an important
role in the chiral resolution.

In addition to the parameters already discussed, other factors contribute the chiral
resolution on these cyclodextrin phases. These include injection amount, silica
gel particle size, spacers between the CD and the silica gel, and column dimen-
sions. In 1985 Feitsma et al. [26] studied variations in chiral resolution by varying

FIGURE 15 The chemical structures of some CSP-based a- and b-cyclodextrin deriva-
tives. (From Ref. 49.)
the amount of cyclohexylphenylglycolic acid injected. The authors reported a

decrease in the retention times of the two enantiomers when the injection amount
was increased. Similarly, Lemer et al. [112] studied the effects of the amount of
b-CD-based CSP loaded on the chiral resolution of ephedrine, methamphetamine,
and selegiline. The resolution factor values decreased drastically when the
amount injected was increased. The findings of these two research groups are
shown in Figure 17.
Stalcup et al. [44] reported an interesting effect of spacers on the chiral
resolution of some drugs, namely, there was no chiral resolution without a spacer
between the CD and the silica gel. Chankvetadze et al. [49] studied the effects of
such spacers on the chiral resolution of certain drugs. Two types of spacer, 4,40 -
diphenylmethane diisocyanate and hexamethylene diisocyanate, were used to

FIGURE 16 The chemical structures of some drugs resolved on different CSPs based on
a- and b-cyclodextrin derivatives (Fig. 15): Tröger’s base (I), trans-2,3-diphenyloxirane
(II), 1-(9-anthryl)-2,2,2-trifluoroethanol (III), 1,2,2,2-tetraphenylethanol (IV), 2,20 -dihy-
droxy-6,6-dimethylbiphenyl (V), 2-phenylcyclohexanone (VI), flavanone (VII), benzoin
(VIII), and trans-cyclopropanedicarboxylic acid anilide (IX). (From Ref. 49.)

FIGURE 17 The effects of amount injected on the chiral resolution of (a) cyclohexyl-
phenylglyconic acid and (b) ephedrine (n), methamphetamine (u), and selegiline (s) on
b-CD-based CSPs. (From Refs. 26,112.)
bind the same chiral selector onto a silica surface. CSPs having the first
diisocyanate showed better chiral recognition than CSPs containing the second.
The most interesting spacer effect was the reversal of the elution order for
flavanone. Similar results were observed with benzoin when the spacer was

changed [116]. Hargitai and Okamoto [110] studied the influence of pore
diameter of silica gel on the chiral resolution of some drugs. Pore diameters of
60, 100, and 300 Å were used for this purpose. The enantioselectivities of these
silica-based CSPs varied from one drug to another. In addition, enantiorecogni-
tion on these CSPs may be optimized by using columns of different dimensions.
3.5 CHIRAL RECOGNITION MECHANISM

The primary C-6 hydroxyl groups, free to rotate, can partially block the CD cavity
from one end. The mouth of the opposite end of the CD cavity is enriched owing
to the presence of C-2 and C-3 secondary hydroxyl groups. This arrangement
favors complex formation with a variety of compounds. The presence of
stereospecific glucopyronose units, as well as the restricted conformational
freedom and orientation of the secondary hydroxyl groups, are assumed to be
responsible for the chiral recognition capacities of CDs [117]. Therefore, different
diastereoisomeric inclusion complexes are formed by the two enantiomers
(Fig. 18). This is known from data obtained from crystallography, NMR, and
mass spectrometric studies [10,42,114,118–122]. Basically, in the chiral recogni-
tion process, enantiomers enter the cavities of CD molecules and diastereoiso-
meric complexes are formed; hence these units are called inclusion complexes.
Therefore, even a slight variation in the chromatographic conditions, such as a
FIGURE 18 Computer-projected structures of the diastereoisomeric inclusion complexes

of (a) d-propranolol and (b) l-propranolol in b-CD; dashed lines, hydrogen bondings.
(From Ref. 9.)

change in the mobile phase or the derivatization of the CDs, affects the chiral
resolution greatly. Because of this, many research groups have synthesized
different derivatives for use in the chiral resolution of different molecules.
Therefore, the selection of the CD phase is an important factor in the formation
of a stable complex with a specific racemic compound. This aspect has been
discussed (Sects. 3.4.6 and 3.4.7).
Lipkowitz and Stoehr [114] carried out an NMR study of methyl mandelate
on b-CD. The authors conducted molecular dynamics simulations and predicted
the guest–host (i.e., the interactions between the methyl mandelate molecule and
the CD). It was observed that short-range dispersion forces rather than long-range
Coulombic forces were responsible for both complexation and enantiodiscrimi-
nation. To explain the chiral resolution on CDs, several models of and approaches
to guest–host formation were proposed and discussed [59,120,123,124]. Inclu-
sion complex stability is controlled by a number of interactions between the
enantiomers and the CSPs. The most important interactions are hydrogen
bonding, interactions between dipoles and induced dipoles, and those of p–p
forces [4,11,114,125]. Steric effect also plays a crucial role in the chiral
resolution, since complexation is governed by the type of groups on the
enantiomers [48,57]. However, other forces, such as van der Waals, ionic
interactions, and solvation effect, also have roles in chiral resolution. These
different types of interaction, which occur between the CD hydroxyl groups and
various groups of enantiomers, may be enhanced by introducing electronegative
or phenyl groups into CDs (derivatization). This is why the CSPs of CD
derivatives are better than those obtained from native CDs.
In summary, the enantiomers fit in stereogenically different ways into the
chiral cavity of CD, and these arrangements are stabilized at different magnitudes
by different interactions as discussed earlier. Manipulation of these differences, in
turn, results in the chiral separation of enantiomers. It has also been reported that
the magnitudes of these interactions vary in the normal, polar organic, and
reversed-phase modes, and hence the chiral recognition mechanism differs
slightly in all the three mobile phase modes. However, the exact mechanism of
chiral resolution on these phases is still obscure. A schematic representation of
chiral resolution on these phases is shown in Figure 19.
FIGURE 19 Schematic representation of solute inclusion in a cyclodextrin cavity.

Because of the wide range of applications of CD-based CSPs, these phases have
been evaluated for the chiral resolution of enantiomers in sub- and supercritical
FC modes. In 1987 Macaudiere et al. [126] reported the first chiral resolution of
phosphine oxides and amides on native cyclodextrins-based CSPs under sub-
critical conditions. Later, several reports were published on the chiral resolution
of various compounds using CD-based CSPs in sub- and supercritical FC models
[127–131]. Work on the chiral separation by sub-FC and SFC was reviewed
recently [130,132]. Shen and coworkers [128] carried out a detailed comparison
of the SFC performance of packed and open tubular columns containing the same
cyclodextrins-modified polymers. They observed that the retention factors could
differ drastically within a certain range of pressure, with no significant change in
chiral selectivity. Enantiomeric separation of a variety of drugs and related
compounds was achieved on an (S)-naphthylethylcarbamoylated-b-cyclodextrin
(S-NEC-CD) chiral stationary phase (CSP) using sub-FC and SFC. The mobile
phase was a simple carbon dioxide–methanol mixture. Resolution of cromakalim,
which is not possible on an S-NEC-CD column in LC, was readily accomplished
in SFC. The importance of modifier, temperature, and pressure was also assessed
in relation to retention, selectivity, and resolution. The nature of the modifier and
the modifier concentration were found to be crucial parameters [133].
Schurig et al. [134] bonded permethylated b-CD via an octamethylene
bridge to polydimethylsiloxane, resulting in the chiral polymer Chiralsil-Dex.
This polymer was immobilized onto the inner surface of a capillary or onto a
silica particle by cross-linking or bonding, and the resulting CSPs were inves-
tigated in SFC. Duval et al. [135] linked covalently mono-2- and mono-6-O-
pentenyl-b-cyclodextrins (mono-2-pent-b-CD and mono-6-pent-b-CD), to
mercaptopropyl silica gel (thiol-Si) through thioether or sulfone linkage, and
the CSPs developed revealed different enantioselectivities in the separation of
piperidine-2,6-dione-related drugs, namely, aminoglutethimide and thalidomide,
under supercritical fluid conditions. The authors discussed the impact on chiral
discrimination of the position of the pentenyl moiety on one of the glucopyr-
anosidics of the CD cage [135]. Additionally, the role of the heteroatom present
in the spacer arm between the CD and the silica gel, in this case a thioether or
sulfone functionality, was also addressed in terms of enantioselectivities [135].
Verillon and Boutant [136] presented a method of separating the enantio-
mers of some b-adrenergic blockers at the preparative scale. SFC modified with
carbon dioxide and standard HPLC columns having bores of 4 to 20 mm could
produce from 10 to 500 mg of purified enantiomers per hour. The authors
described the practical rules of their method and its performance. In another
study, Lévêque and Duval [137] described the fast and easy transportation of

FIGURE 20 Chromatograms of the chiral resolution of tropicamide on Cyclobond I SN
CSP using SFC. (From Ref. 130.)
chiral separation conditions of racemates from HPLC to SFC. The HPLC and
SFC modes of liquid chromatography were used to compare chiral resolution on
naphthylethylcarbamoylated b-CDs phases [130]. Williams et al. [138] reported
that the separations obtained in HPLC (using all three mobile phase modes) could
be replicated with a simple carbon dioxide–methanol eluent in SFC. Armstrong et
al. [139] resolved the enantiomers of 1-aminoindanone on a b-CD-based phase.
Figure 20, which shows chromatograms of the chiral resolution of tropicamide on
Cyclobond I SN CSP, illustrates the kind of chiral resolution on CD-based CSPs
that can be obtained by using SFC. Some of the applications of CD-based CSPs
using sub- and supercritical fluid chromatography are given in Table 11.
TABLE 11 The Enantiomeric Resolution of Racemic Compounds on

Cyclodextrin-Based CSPs by Means of Subcritical and Supercritical
Fluid Chromatography
Racemic compounds CSPs Refs.
Alkanes b-CD 130,134

Amide b-CD 126,130
Ketone b-CD 130,134
Lactones b-CD 130,134
Cromakalim b-CD derivatives 133
Aminoglutethimide and thalidomide b-CD derivatives 135
b-Adrenergic blockers b-CD derivatives 136
1-Aminoindane b-CD derivatives 139
Phosphine oxides b-CD 126

3.7 APPLICATIONS IN CAPILLARY
ELECTROCHROMATOGRAPHY
Native CDs and their derivatives have been packed into capillaries columns of
different dimensions and the CSPs developed used for the chiral resolution of
different compounds by capillary electrochromatography (CEC) [140,141]. The
CD-based chiral selectors were used in open tubular [142–151], packed
[152,153], and monolithic columns [153–157]. Schurig et al. [134] linked
permethylated b-CD via an octamethylene bridge to polydimethylsiloxane,
resulting in the chiral polymer Chiralsil-Dex. The polymer was immobilized
onto the inner surface of a capillary by cross-linking or bonding, and the CSP was
used in CEC chiral resolution. Pesek et al. [149] etched the capillary wall and
bonded it with b-CD as an achiral selector. The authors observed that the bonded
organic moieties on the etched inner wall of the capillary provided the solutes
sufficient interactions to influence retention through a capillary by electroosmosis
or a combination of electroosmotic and electrophoretic forces. Koide and Ueno
[156] achieved the enantiomeric resolution of cationic compounds by CEC on
b-CD-bonded, negatively charged polyacrylamide gels. The columns used were
capillaries filled with a negatively charged polyacrylamide gel, a so-called
monolithic stationary phase, covalently bonded to an allyl-carbamoylated b-CD
derivative. High efficiencies (150,000 plates=m) were obtained. The applica-
tions of CEC using CD-based CSPs are summarized in Table 12 [140,142–
147,150,154–158]. The chiral recognition mechanism in sub- and supercritical
fluid chromatography and in capillary electrochromatography is similar to that in
HPLC separations.
TABLE 12 The Enantiomeric Resolution of Racemic Compounds on

Cyclodextrin-Based CSPs by Means of Capillary Electrochromatography
Profens and barbiturates Native and derivatized CDs 140,142–147

in open tubular columns
Ephedrine Native and derivatized CDs 150
in open tubular columns
Benzoin, mandelates, praline derivatives, Native and derivatized CDs 152
barbiturates, and glutethimide in packed capillary columns
Dansyl amino acids, hydroxy acids, Organic monoliths of CD 154–157
and warfarin
Cationic and neutral compounds b-CD 158

3.8 CONCLUSION
The applications of CD-based CSPs for chiral resolution in liquid chromatogra-
phy has increased exponentially in the last decade owing to the high potential of
these phases as chiral selectors in all three mobile phase modes. Moreover, the
synthesis of CD derivatives has increased the demand of these phases because
they have unique selectivities for a larger number of racemic compounds.
Besides, the chiral resolution strategies on these phases may be predicted
theoretically because of their well-known structures and sizes. This facility
makes experiments inexpensive and less laborious. Thus, liquid chromatographic
approaches using CD-based chiral stationary phases are the method of choice for
the chiral resolution of a wide range of racemic compounds. Although these
phases present no serious limitation, the evaluation of the exact chiral recognition
mechanism is demanding. Therefore, the chiral recognition mechanism should be
established in detail, to permit the use of these CSPs in a more scientific way in
all modes of chromatography.
REFERENCES
1. Villiers A, C R 112: 536 (1891).
2. Schardinger F, Zentr Bacteriol Parasitenk Abt II 29: 188 (1911).
3. Gröger M, Katharina E, Woyke A, Cyclodextrins, in ‘‘Science Forum an der
Universität Siegen,’’ Siegen, Germany (2001).
4. Han SM, Armstrong DW, HPLC separation of enantiomers and other isomers with
cyclodextrin bonded phases: rule for chiral recognition, in Chiral Separations by
HPLC (Krstulovic AM, Ed.), Ellis Horwood, Chichester, p. 208 (1989).
5. Michon J, Rassat A, J Am Chem Soc 101: 4337 (1979).
6. Han SM, Atkinson WM, Purdie N, Anal Chem 56: 2827 (1984).
7. Lightner DA, Gawronski JK, Gawronska J, J Am Chem Soc 107: 2456 (1985).
8. Ihara Y, Nakashini E, Mamuro K, Koga J, Bull Chem Soc Jpn 59: 1901 (1986).
9. Armstrong DW, Ward TJ, Armstrong RD, Beesley TE, Science 222: 1132 (1986).
10. Hamilton JA, Chen L, J Am Chem Soc 110: 5833 (1988).
11. Stalcup AM, Cyclodextrin bonded chiral stationary phases in enantiomer separa-
tions, in A Practical Approach to Chiral Separations by Liquid Chromatography
(Subramanian G, Ed.), VCH Verlag, Weinheim, Germany, p. 95 (1994).
12. Armstrong DW, Nome F, Spino LA, Golden TD, J Am Chem Soc 108: 1418
(1986).
13. Bender ML, Komiyama M, ‘‘Cyclodextrin,’’ Springer-Verlag, Berlin (1978).
14. Szejtli J, Cyclodextrins and Their Inclusion Complexes, Akademia Kiado, Budapest
(1982).
15. Hinze WL, Applications of cyclodextrins in chromatographic separations and
purification methods, in Separations and Purification Methods (Van Oss C, Ed.),
Vol. 10, p. 159, Marcel Dekker, New York (1981).
16. Jones D, Am Lab 72 (1987).

17. Harada A, Furue M, Nozakura S, J Polym Sci 16: 187 (1978).
18. Zsadon B, Szilasi M, Otta KH, Tudos F, Fenyvesi E, Szejtli J, Acta Chim Acad Sci
Hung 100: 265 (1979).
19. Zsadon B, Szilasi M, Tudos F, Fenyvesi E, Szejtli J, Stark 31: 11 (1979).
20. Zsadon B, Szilasi F, Tudos F, Szejtli J, J Chromatogr 208: 109 (1981).
21. Zsadon B, Decsei L, Szilasi M, Tudos F, J Chromatogr 270: 127 (1983).
22. Fujimura K, Ueda T, Ando T, Anal Chem 55: 446 (1983).
23. Kawaguchi Y, Tanaka M, Nakae M, Funazo K, Shono T, Anal Chem 55: 1852
(1983).
24. Tanaka M, Kawaguchi Y, Shono T, Uebori M, Kuge Y, J Chromatogr 301: 345
(1984).
25. Feitsma KG, Drenth BFH, De Zeeuw RA, J High Resolut Chromatogr 7: 147
(1984).
26. Feitsma KG, Bosmann J, Drenth BFH, De Zeeuw RA, J Chromatogr 333: 59
(1985).
27. Fujimura K, Kitagawa M, Takayanagi H, Ando T, J Liq Chromatogr 9: 607 (1986).
28. Fisher CM, Chromatogr Int 5: 10 (1984).
29. Armstrong DW, US Patent 4,539,399 (1985).
30. Armstrong DW, Alak A, DeMond W, Hinze WL, Riehl TE, J Liq Chromatogr 8:
261 (1985).
31. Fisher CM, Chromatogr Int 8: 38 (1985).
32. Beesley TE, Am Lab 78 (1985).
33. Chang CA, Abdel H, Melchoir N, Wu K, Pennell KH, Armstrong DW,
J Chromatogr 347: 51 (1985).
34. Ward TJ, Armstrong DW, J Liq Chromatogr 9: 407 (1986).
35. Isasaq HJ, J Liq Chromatogr 9: 229 (1986).
36. Weaver DE, van Lier RBL, Anal Biochem 154: 590 (1986).
37. Issaq HJ, Weiss D, Ridlon C, Fox SD, Muschik GM, J Liq Chromatogr 9: 1791
(1986).
38. Issaq HJ, McConnell JH, Weiss DE, Williams DG, Saavedra JE, J Liq Chromatogr
9: 1783 (1986).
39. Issaq HJ, Glennon M, Weiss DE, Chmurny GN, Saavedra JE, J Liq Chromatogr 9:
2763 (1986).
40. Abidi SL, J Chromatogr 362: 33 (1986).
41. Armstrong DW, Li W, Chromatography 2: 43 (1987).
42. Street Jr KW, J Liq Chromatogr 10: 655 (1987).
43. Connelly JA, Siehl DL, Methods Enzymol 142: 422 (1987).
44. Stalcup AM, Chang S, Armstrong DW, J Chromatogr 513: 181 (1990).
45. Armstrong DW, Stalcup AM, Hilton ML, Duncan JD, Faulkner JH, Chang SC, Anal
Chem 62: 1610 (1990).
46. Stalcup AM, Chang SC, Armstrong DW, J Chromatogr 540: 113 (1991).
47. Stalcup AM, Gahm KH, Anal Chem 68: 1369 (1996).
48. Armstrong DW, Chang SC, Wang Y, Ibrahim H, Reid III GR, Beesley TE, J Liq
Chromatogr Relat Technol 20: 3279 (1997).
49. Chankvetadze B, Yashima E, Okamoto Y, Chirality 8: 402 (1996).

50. Blondel F, Peulon V, Prigent Y, Duval R, Combret Y, Eighth International
Symposium on Chiral Discrimination, Edinburgh, Scotland, June 30–July 3,
1996, p. 1.5 (1996).
51. Elfakir CC, Dreux M, Bourgeaux E, Lévêque H, Duval R, 214th ACS National
Meeting, Las Vegas, Sept. 7–11, 1997 (1997).
52. Caron I, Elfakir C, Dreux M, Ninth International Symposium on Cyclodextrins,
Santiago de Compostela, May 31–June 3, 1998 (1998).
53. Beesley TE, Scott RPW, Chiral Chromatography, John Wiley & Sons, New York,
p. 265 (1998).
54. Armstrong DW, Yang X, Han SM, Menges RA, Anal Chem 59: 2594 (1987).
55. Han SM, Armstrong DW, J Chromatogr 389: 256 (1987).
56. Han SM, Han YI, Armstrong DW, J Chromatogr 441: 376 (1988).
57. Seeman JI, Secor HV, Armstrong DW, Timmons KD, Ward TJ, Anal Chem 60: 2120
(1988).
58. Stalcup AM, Jin HL, Armstrong DW, J Liq Chromatogr 13: 473 (1990).
59. Armstrong DW, Chang CD, Lee SH, J Chromatogr 539: 83 (1991).
60. Armstrong DW, Chen S, Chang C, Chang S, J Liq Chromatogr 15: 545 (1992).
61. Chen S, Li Y, Armstrong DW, Borrell JI, Martinez-Teipel B, Matallana JL, J Liq
Chromatogr 18: 1495 (1995).
62. Ekborg-Ott KH, Armstrong DW, Chirality 8: 49 (1996).
63. Chang SC, Wang CR, Armstrong DW, J Liq Chromatogr 15: 1411 (1992).
65. Fukushima Y, Murayama K, Santa T, Hana H, Imai K, Biomed Chromatogr 12: 1
(1998).
66. Stammel W, Woesle B, Thomas H, Chirality 7: 10 (1995).
67. Haginaka J, Wakai J, Anal Chem 62: 997 (1990).
68. Han SM, Biomed Chromatogr 11: 259 (1997).
69. Lee SH, Berthod A, Armstrong DW, J Chromatogr 603: 83 (1992).
70. Fujimura K, Suzuki S, Hayashi K, Masuda S, Anal Chem 62: 2198 (1990).
71. Stalcup AM, Faulkner JR Jr, Tang Y, Armstrong DW, Levy LW, Regalado E,
Biomed Chromatogr 5: 3 (1991).
72. Haynes JL III, Shamsi SA, O’Keefe F, Darcey R, Warner IM, J Chromatogr A 803:
261 (1998).
73. Ryu JW, Kim DW, Lee KP, Pyo D, Park JH, J Chromatogr A 814: 247 (1998).
74. Armstrong DW, Hilton DW, Coffin L, LC-GC 9: 647 (1992).
75. Tazerouti F, Badjah-Hadj-Ahmed AY, Meklati BY, Franco P, Minguillon C,
Chirality 14: 59 (2002).
76. Chang SC, Reid III GL, Chen S, Chang CD, Armstrong DW, Trends Anal Chem 12:
144 (1993).
77. Matchett MW, Branch SK, Jefferies TM, Chirality 8: 126 (1996).
78. Zukowski J, Chirality 10: 362 (1998).
79. Péter A, Kámán J, Fülöp F, van der Eycken J, Armstrong DW, J Chromatogr A 919:
79 (2001).
80. Stalcup AM, Williams KL, J Liq Chromatogr 15: 29 (1992).
81. Armstrong DW, Duncan JD, Lee SH, Amino Acids 1: 97 (1991).

82. Kanazawa H, Matsushima Y, Okubo S, Mashige F, J Chromatogr A 871: 181
(2000).
83. West RR, Cardellina JH, J Chromatogr 539 15 (1991).
84. Shaw CJ, Sanfilippo PJ, McNally JJ, Park SA, Press JB J Chromatogr A 631: 173
(1993).
85. A Guide to Using Cyclodextrin Bonded Phases for Liquid Chromatography,
Advanced Separation Technologies, Inc., Whippany, NJ (1996).
86. Beesley TE, Scott RPW, ‘‘Chiral Chromatography,’’ John Wiley & Sons, New York,
p. 375 (1998).
87. Armstrong DW, Han SM, Han YI, Anal Biochem 167: 261 (1987).
88. Armstrong DW, Han YI, Han SM, Anal Chim Acta 208: 275 (1988).
89. Maguire JH, J Chromatogr 387: 453 (1987).
90. Armstrong DW, Alak A, Bui K, DeMond W, Ward TJ, Reihl TE, Hinze WL, J Incl
Phenom 2: 533 (1984).
91. McClanahan JS, Maguire JH, J Chromatogr 381: 438 (1986).
92. Florance J, Galdes A, Konteatis Z, Kosaryeh Z, Langer K, Martucci C,
J Chromatogr 414: 313 (1987).
93. Armstrong DW, Ward TJ, Czech A, Czech BP, Bartsch RA, J Org Chem 50: 5556
(1985).
94. Armstrong DW, Demond DW, Czech BP, Anal Chem 57: 481 (1985).
95. Krstulovic AM, Gianviti JM, Burke JT, Mompon B, J Chromatogr 426: 417 (1988).
96. Pham-Huy, C, Radenen B, Sahui-Gnassi A, Claude J, J Chromatogr B 665: 125
(1995).
97. Camilleri P, Reid CA, Manallack DT, Chromatographia 11=12: 771 (1994).
98. Barderas AV, Duprate F, J Liq Chromatogr 17: 1709 (1994).
99. Furuta R, Nakazawa H, J Chromatogr 625: 231 (1992).
100. Kuijpers PH, Gerding TK, de Jong GJ, J Chromatogr 625: 223 (1992).
101. Plesek J, Bruner B, J Chromatogr 626: 197 (1992).
102. Lim TY, Kim HJ, J Chromatogr A 933: 99 (2001).
103. Li S, Purdy WC, J Chromatogr 543: 105 (1991).
104. Aboul-Enein HY, Islam MR, Bakr SA, J Liq Chromatogr 11: 1485 (1988).
105. Armstrong DW, Bertrand GL, Ward KD, Ward TJ, Anal Chem 62: 332 (1990).
106. Thuaud N, Sebille B, Deratani A, G. Lelievre G, J Chromatogr 555: 53 (1991).
107. Weems H, Zamani K, Chirality 4: 268 (1992).
108. Piperaki S, Parissi-Poulou M, Chirality 5: 258 (1993).
109. Piperaki S, Kakoulidou-Tsantili A, Parissi-Poulou M, Chirality 7: 257 (1995).
110. Hargitai T, Okamoto Y, J Liq Chromatogr 16: 843 (1993).
111. Hilton ML, Chang SC, Gasper MP, Pawlowska M, Armstrong DW, Stalcup AM,
J Liq Chromatogr 16: 127 (1993).
112. Lemer K, Jirovsky D, Seveik J, J Liq Chromatogr Relat Technol 19: 3173 (1996).
113. Chen L, Zhang LF, Ching CB, Ng SC, J Chromatogr A 950: 65 (2002).
114. Lipkowitz KB, Stoehr CM, Chirality 8: 341 (1996).
115. Lévêque H, Adam N, Duval R, Seventh International Symposium on Preparative
and Industrial Chromatography and Allied Techniques, Sept. 23–25, 1998, Stras-
bourg, France (1998).

116. Hargitai T, Kaida Y, Okamoto Y, J Chromatogr A 628: 11 (1993).
117. Lipkowitz KB, Green K, Yang JA, Chirality 4: 205 (1992).
118. Boeham RE, Martire DE, Anal Chem 60: 522 (1988).
119. Linnemayr K, Rizzi A, Günther A, J Chromatogr A 791: 299 (1997).
120. Morin N, Guillaumine YC, Rouland JC, Chromatographia 48: 388 (1998).
121. Redondo J, Blazquez MA, Torrens A, Chirality 11: 694 (1999).
122. Lipkowitz KB, J Chromatogr A 906: 417 (2001).
123. Armstrong DW, Yang X, Han SM, Menges RA, Anal Chem 59: 316 (1987).
124. Berthod A, Chang SC, Armstrong DW, Anal Chem 64: 395 (1992).
125. Torr MA, Nelson G, Patonay G, Warner IM, Anal Lett 21: 843 (1988).
127. Jung M, Mayer S, Schurig V, LC-GC 12: 458 (1994).
128. Shen Y, Chen Z, Owen NL, Li W, Bradshaw JS, Lee ML, J Microcol Sep 8: 249
(1996).
129. Williams KL, Sander LC, Wise SA, J Chromatogr A 746: 91 (1996).
tions, in Chiral Separation Techniques: A Practical Approach (Subramanian G, Ed.),
VCH Verlag, Weinheim, Germany, p. 299 (2001).
131. Röder W, Ruffing FJ, Schomburg G, Pirkle WH, J High Resolut Chromatogr 10:
665 (1987).
133. Salvador A, Herbreteau B, Lafosse M, Dreux M, Analusis 25: 263 (1997).
134. Schurig V, Mayer S, Jung M, Fluck M, Jakubetz H, Glausch A, Negura S, Chem
Anal 142: 401 (1997).
135. Duval R, Lévêque H, Prigent Y, Aboul-Enein HY, Biomed Chromatogr 15: 202
(2001).
136. Verillon F, Boutant R, Proceedings of the Fifth Meeting on Supercritical Fluids,
Materials, and Natural Products Processing, March 23–25, 1998, Nice, France
(1998).
137. Lévêque H, Duval R, Proceedings of the Fifth Meeting on Supercritical Fluids,
Materials, and Natural Products Processing, March 23–25, 1998, Nice, France
(1998).
138. Williams KL, Sander LC, Wise SA, Chirality 8: 325 (1996).
139. Armstrong DW, Tang Y, Ward T, Nichols M, Anal Chem 65: 1114 (1993).
140. Schurig V, Wistuba D, Electrophoresis 20: 2313 (1999).
141. Fanali S, Catarcini P, Blaschke G, Chankvetadze B, Electrophoresis 22: 3131
(2001).
142. Mayer S, Schurig V, J High Resolut Chromatogr 15: 129 (1992).
143. Mayer S, Schurig V, J Liq Chromatogr 16: 915 (1993).
144. Schurig V, Jung M, Mayer S, Fluck M, Negura S, Jakubetz H, J Chromatogr A 694:
119 (1994).
145. Schurig V, Jung M, Mayer S, Negura S, Fluck M, Jakubetz H, Angew Chem 106:
2265 (1994).
146. Jakubetz H, Czesla H, Schurig V, J Microcol Sep 9: 421 (1997).
147. Mayer S, Schleimer M, Schurig V, J Microcol Sep 6: 43 (1994).

148. Armstrong DW, Tang Y, Ward T, Nichols M, Anal Chem 65: 2265 (1993).
149. Pesek JJ, Matyska MT, Menezes S, J Chromatogr A, 853: 151 (1999).
150. Szeman J, Ganzler K, J Chromatogr A 668: 509 (1994).
151. Schurig V, Wistuba D, Electrophoresis 20: 50 (1999).
152. Wistuba D, Czesla H, Roeder M, Schurig V, J Chromatogr A 815: 183 (1998).
153. Wistuba D, Schurig V, Electrophoresis 21: 3152 (2000).
154. Koide T, Ueno K, Anal Sci 14: 1021 (1998).
156. Koide T, Ueno K, J Chromatogr A 893: 177 (2000).
157. Koide T, Ueno K, J High Resolut Chromatogr 23: 59 (2000).

4
Macrocyclic Glycopeptide
Antibiotics^Based Chiral
Stationary Phases
Macrocyclic antibiotics are one of the newest and perhaps the most varied class of
chiral selectors [1]. The concept of utilizing macrocyclic glycopeptide as the
chiral stationary phase (CSP) for high-performance liquid chromotography
(HPLC) was introduced by Armstrong in 1994 [2]. Since then, their use for
chiral resolution by liquid chromatography is increasing exponentially [3,4]. The
antibiotics have been found to have a very good potential for chiral resolution. It
may be due to their specific structures and the possibility of their use in a wide
range of mobile phases. In addition, their relatively small size and the fact that
their structures are known allows basic studies on chiral recognition to be done
easily and exactly. They are often complimentary in the type of compounds they
can separate. For example, rifamycin B, an ansamycin, is enantioselective for
many positively charged analytes, whereas vancomycin can resolve a variety of
chiral compounds containing free carboxylic acid functional groups. The anti-
biotics used for chiral resolution are vancomycin, vancomycin aglycon, teico-
planin, teicoplanin aglycon, ristocetin A, thiostrepton, rifamycin, fradiomycin,
streptomycin, kanamycin, and avoparcin. However, the most commonly used
antibiotics are vancomycin, teicoplanin, teicoplanin aglycon, and ristocetin A.
This chapter describes the structures, properties, applications, effect of various
chromatographic factors on chiral resolution, and the chiral recognition mechan-
ism. The use of these antibiotic-based chiral selectors in subcritical and super-

critical fluid chromatography, capillary electrochromatography, and thin-layer
chromatography is also discussed.

Only 11 antibiotics have been used as chiral selectors for the enatiomeric
resolution of a variety of racemic compounds. It is very interesting to note that
all of them contain ionizable groups at different pHs in their structures. The
FIGURE 1 The chemical structures of antibiotics.

FIGURE 1 Continued.
chemical structures of these antibiotics are shown in Figure 1. The physical and
chemical properties of these antibiotics are discussed in the following subsec-
tions.
4.1.1 Vancomycin
Vancomycin has been used widely for enantiomeric resolution as it is very
effective for the enantiorecognition of anionic compounds, particularly those
containing carboxylic groups in their structure. The selectivity toward these

compounds is due to the presence of amine groups. It is synthesized by
Streptomyces orientalis bacterium and is very soluble in water and polar aprotic
solvents and less soluble or insoluble in higher alcohols and less polar organic
solvents [5]. In an aqueous solution, vancomycin dimerizes depending on the
solvent type and its concentration. The solution of vancomycin is stable if stored
at low temperature and in a buffer of pH value 3–6 [5,6]. The pK values are 2.9,
7.2, 8.6, 9.6, 10.4, and 11.7. The isoelectric point is 7.2. There are 18 chiral
centers in this molecule with 3 cavities (viz. A, B, and C in Fig. 1). Five aromatic
ring structures and hydrogen donor and acceptor sites are readily available close
to the ring structures. Several functional groups such as carboxylic, hydroxyl,
amino, and amido are mainly responsible for the ionization of these antibiotics in
buffer with various pHs and compositions and, therefore, it is enantioselective in
nature. The relative stability of the aqueous solution of vancomycin is about 1–2
weeks. Without the sugar component of vancomycin, the antibiotic is called a
vancomycin aglycon (Fig. 1). The physical and chemical properties of vancomy-
cin aglycon are similar to vancomycin.
4.1.2 Teicoplanin and Teicoplanin Aglycon

Teicoplanin is a macrocyclic glycopeptide antibiotic that is structurally related to
vancomycin and ristocetin A. Its solubility in water is poor in comparison to
vancomycin. Teicoplanin shows a different behavior, exhibiting a very slight
anionic character even at an acidic pH (pI 3.8). It is obtained from fermentation
of Actinoplanes teichomyceticus bacterium. There are 23 chiral centers in this
molecule with four cavities (viz. A, B, C, and D in Fig. 1). Three sugar moieties
are also present. The hydrogen donor and acceptor sites are readily available close
to the ring structures. It also contains a hydrophobic acyl side chain attached to a
2-amino-2-deoxy-b D-glucopyranosyl moiety, which activates its surface and
enables [7] the formation of micellar aggregates [critical micellar concentration
(CMC) about 0.18 mM in unbuffered aqueous solutions]. The relative stability of
the aqueous solution of teicoplanin is about 2–3 weeks. The above-mentioned
characteristics render teicoplanin highly stereo-specific in nature. Teicoplanin
without a sugar part is called a teicoplanin aglycon antibiotic (Fig. 1). This
antibiotic contains almost all of the groups and cavities as in teicoplanin and,
therefore, has similar chemical and physical properties.
4.1.3 Ristocetin A
Ristocetin A has a structure very similar to teicoplanin and vancomycin. It is
produced as the fermentation product of Nocardia lurida bacterium and it is
characterized by an aglycon portion with 4 fused macrocyclic rings, 1 tetra-
saccharide moiety and 6 monosaccharides, together with 38 stereogenic centers.
It has also 21 hydroxyl groups, 2 amine groups, 6 amido groups, and 1 methyl

ester. This antibiotic also contains three cavities (viz. A, B, and C in Fig. 1). The
pI of the antibiotic is 7.5. The relative stability of the aqueous solution of
ristocetin A is about 3–4 weeks. It has been used to resolve anionic compounds
and those enantiomers not separated by vancomycin [7].
4.1.4 Thiostrepton
Thiostrepton is a macrocyclic polypeptide antibiotic that is structurally different
from vancomycin and teicoplanin. It is soluble in water and acetic acid. It is
obtained from Streptomyces azureus bacterium. There are 17 chiral centers in this
antibiotic, with 2 large cavities (A and B in Fig. 1). Five thiazole rings, 1
quinoline ring, 5 hydroxyl groups, 10 amide linkages, and 1 secondary amine
make the molecule stereo-specific in nature.
4.1.5 Rifamycin
Different members of the rifamycin family are used for enantiomeric resolution.
They are very soluble in water and in low-molecular-weight alcohols and acetone.
The members of this class can be used either in the positive, negative, or neutral
mode. Among these members, rifamycin B was used commonly for enantio-
resolution of a variety of compounds. It is obtained from Nocardia mediterranei
bacterium. The pK values are 2.8 and 6.7, respectively. There are nine chiral
centers in this molecule with one large cavity (A in Fig. 1). A napthohydro-
quinone chromophore with a long aliphatic bridge, four hydroxyl groups, one
carboxylic moiety, and one amide bond make the molecule stereo-specific in
nature.
4.1.6 Kanamycin
Kanamycin is an aminoglycoside antibiotic. It is obtained from Streptomyces
kanamyceticus bacterium and is soluble in water. There are 16 chiral centers in
this molecule and no cavity. It contains two pyranose rings, six hydroxyl groups,
and three amine groups. This characteristic makes the molecule capable of
enantiorecognition of different antipodes.
4.1.7 Streptomycin
Streptomycin is also an aminoglycoside antibiotic that is soluble in water. It is
obtained from Streptomyces griseus bacterium. There are 15 chiral centers in this
molecule and no cavity. It has one pyranose and one furanose ring, six hydroxyl
groups, two primary amine groups, and four secondary amine groups. This
arrangement makes the molecule stereo-specific in nature.

The fradiomycin is structurally similar to kanamycin. It contains one pyranose,
two furanose, and one cyclohexane ring. There are five primary amine and seven
hydroxyl groups. Various alkyl groups are also present. The presence of these
different types of group makes the antibiotics enantioselective at different pHs.
Fradiomycin does not have a cavity.
4.1.9 Avoparcin
Avoparcin [8] is an antibiotic produced by Streptomyces candidus bacterium and
is commonly used in animal feedstuffs. Commercially, it is available as a product
called Avotan that contains 10% avoparcin, which is used to promote animal
growth. Unfortunately, the large-scale use of avoparcin appears to give rise to a
vancomycin-resistant enterococci in the feces of chickens and pigs. There are two
forms of avoparcin: the unsubstituted a-avoparcin and the chlorinated b-avopar-
cin. The structures of these two forms are shown in Fig. 1. The molecular weights
of these forms are 1909 and 1944, respectively. The ratio of a- to b-avoparcin is
1 : 4. The mixture is a white, amorphous solid and is hygroscopic, with no clearly
defined melting point. These two forms are soluble in methanol, water, di-
methylformamide, and dimethyl sulfoxide. The aglycon portion of avoparcin
contains three connected semirigid macrocyclic rings (one 12 membered and two
16 membered). These two forms of avoparcin contain 32 stereogenic centers with
4 carbohydrate chains, 16 hydroxy groups, 1 carboxylic group, 2 primary amines,
1 secondary amine, 6 amide linkages and chlorine atoms (two for b-avoparcin
and one for a-avoparcin). There are three cavities (A, B and C in Fig. 1) in this
molecule.

Almost all of the antibiotics used for chiral resolution are produced by different
bacteria and are commercially available. The preparation of antibiotic CSPs only
involves the bonding of these antibiotics on a suitable support. Although the
antibiotics can be bonded to a number of different substrates, the material used
most commonly in liquid chromatography is silica gel. The reagents may be
organosilanes that are terminated by carboxylic groups, amine groups, epoxy
groups, and isocyanate groups. Examples of such reagents are 2-(carboxy-
methoxy)-ethyltrichlorosilane, 3-aminopropyldimethylethoxysilane, (3-glycid-
oxypropyl)-trimethoxysilane and 3-isocyanatopropyltriethoxysilane. Thus, the
linkage attaching these peptide antibiotics to silica gel could be ether, thioether,
amine, amide, carbamate, or urea [9].

To make the procedure clear, an example of a reaction sequence that could
be used to attach a peptide to silica employing 3-isocyanatopropyltriethoxysilane
as the bonding agent is presented in Figure 2. The silica gel (spherical silica 5 mm
in particle diameter and mean pore size of 100 Å) is added to the toluene
containing a silyl reagent. The mixture is refluxed, and the ethanol produced in
the reaction with silanol groups is distilled off periodically. The silica gel is then
FIGURE 2 The chemical pathway for covalent bonding of antibiotic with silica gel.
(From Ref. 8.)

filtered, washed with hot toluene, and dried. In the next step, the peptide antibiotic
is allowed to react with an isocyanate group on the silica gel. The particular bond
used to attach the peptide antibiotic to the carbamate group will depend largely on
the nature of the peptide antibiotic used. Prior to the reaction, the peptide
antibiotic may be derivatized and such groups as 3,5-dimethylphenyl may be
added to the macromolecule to improve or change the interactive nature of the
material with regard to chromatographic retention and selectivity. The reaction is
carried out by adding the peptide (dried in vacuum at 100 C over phosphorus
pentoxide) dropwise to a dispersion of silica particles, in anhydrous N ; N -
dimethylformamide. The reaction is carried out at 90–95 C under nitrogen
atmosphere. If the isocyanate reacts with a hydroxyl group on the peptide
antibiotic, then a carbamate bond is formed. Alternatively, if the isocyanate
reacts with an amino group present on the peptide antibiotic structure, then the
bond formed is a urea bond [9]. Very recently, Gasparrini et al. [10–13]
developed a novel and effective ‘‘one pot’’ synthetic strategy to covalently link
teicoplanin and teicoplanin aglycon antibiotics to aminopropyl functionalized
silica gel via a bifunctional aliphatic isocyanates. It has been observed that all the
above-mentioned antibiotics are not suitable and economic enough to be used as
chiral selectors and, therefore, only some of them were commercialized. The
commercial antibiotic CSPs are available from Advanced Separation Technolo-
gies Inc. (Whippaney, NJ, USA). The most commonly used antibiotics are
vancomycin, teicoplanin, teicoplanin aglycon, and ristocetin A. These antibiotics-
based CSPs are sold under the names Chirobiotic V, Chirobiotic R, Chirobiotic T,
Chirobiotic TAG, which contain vancomycin, ristocetin A, teicoplanin, and
teicoplanin aglycon antibiotics, respectively. These CSPs are available in the
form of columns of different sizes and dimensions.
4.3 APPLICATIONS
The application of antibiotics as chiral selectors has resulted in the successful
resolution of almost all types of neutral, acidic, and basic racemic molecule.
These antibiotics have been used for the enantiomeric resolution of amino acids,
their derivatives, peptides, alcohols, and other pharmaceuticals. The selectivities
of the most commonly used antibiotic-based (vancomycin, teicoplanin, and risto-
cetin A) CSPs varied from one racemate to another and are given in Table 1.
Vancomycin was used for the chiral resolution of amino acids, amines, amides,
imides, cyclic amines, amino alcohols, hydantoins, barbiturates, oxazolidinones,
acids, profens, and other pharmaceuticals. Teicoplanin was found to be excellent
chiral selector for the enantiomeric resolution of amino acids, amino alcohols,
imides, peptides, hydantoins, a-hydroxy and halo acids, and oxazolidinones,
whereas ristocetin A is capable of chiral resolution of amino acids, imides, amino

TABLE 1 The Selectivities of Antibiotic CSPs in the Three Mobile Phase Modes
Mobile phase Vancomycin Teicoplanin Ristocetin A
Normal phase Hydantoins, barbiturates Hydantoins, Imides, hydantoins,

imides, imides amino acids
oxazolidinones
Reversed phase Amines, amides, a-Hydroxy acids, a-Hydroxy acids,
imides, acids, oxazolidinones, acids, profens,
profens amino acids, amino acids,
peptides amino esters,
hydantoins,
peptides
New polar Cyclic amines, Amino alcohols, a-Hydroxy and halo
organic phase amino alcohols amino acids acids, organic acids,
profen, amino acids
esters, peptides, a-hydroxy acids, hydantoins, acids, and profens. The different
racemates resolved on the antibiotic CSPs are summarized in Table 2. These
antibiotics behave as excellent chiral selectors for a variety of molecules in
normal, reversed, and new modified organic polar mobile phases. The properties
of these antibiotics make them superb chiral selectors in liquid chromatography.
Because of their particular characteristics as chiral selectors, these macrocyclic
antibiotics can be used for the resolution of the racemates, which have not been
reported as separated on any other chiral stationary phase [2].
Chen et al. [20] demonstrated the complementary use of the two macro-
cyclic CSPs (i.e., vancomycin and teicoplanin) for the chiral resolution of
substituted pyridones. The chromatograms are shown in Figure 3. It was observed
that although one type of CSP failed to achieve the separation, the other can often
succeed. It can be seen from Figure 3 that all three of the enantiomeric pairs could
be resolved either on the vancomycin or on teicoplanin-based CSPs. However, the
resolution times of the different solutes varied widely from about 5 to 16 min.
Armstrong et al. [28] resolved the enantiomers of alkoxysubstituted esters of
phenylcarbamic acids using vancomycin and teicoplanin CSPs. Lehotay and co-
workers [29] compared the chiral resolution of amino acids on vancomycin and
teicoplanin antibiotics. The macrocyclic antibiotics, vancomycin and teicoplanin,
were used for the enantioselective separation of semisynthetic ergot alkaloids in
reversed-phase modes [30]. Aboul-Enein and Serignese [17] resolved several
cyclic imides on vancomycin under normal phase and reversed-phase modes.
Recently, the reversal order of elution of oxazolidiones and dansyl amino acids on
Chirobiotic V, Chirobiotic T, and Chirobiotic R has been reported by Armstrong
et al. [31]. A mechanistic study on the chiral resolution of 26 sulfoxides was
carried out using vancomycin, vancomycin aglycon, teicoplanin, teicoplanin

TABLE 2 Enantiomeric Resolution of Different Racemates on Antibiotics as CSPs
Compounds resolved Antibiotics (CSP) Ref.
Bendroflumethiazide, benoxaprofen, benzoin methyl ether, Vancomycin 5

4-benzyl-2-oxazolidinone, biotin, bromacil, bupivacaine,
chloroquine, citalopram, clenbuterol, coumachlor,
coumafuryl, devrinol, fenoprofen, fenoterol, fluoxetine,
flurbiprofen, folinic acid, hydrochloroquine, ibuprofen,
isopromethazine, labetalol, luciferin, mephobarbital,
a-methylbenzyl amine 3,5-DNB derivative,
methylphenidate (ritalin), 5-methyl-5-phenylhydantoin,
metoprolol, naproxen, phensuximide, pindolol,
proglumide, promethazine, promethazine sulfoxides,
propanolol, pyridoglutethimide, sotalol, terbutaline,
3a,4,5,6-tetrahydrosuccinimido (3,4-b) acenaphthen-
10-one, and warfarin
Amino acids, amino alcohols, bendroflumethiazide, bezoin Vancomycin 1
methyl ester, N -benzoylleucine, bromacil, 3-methyl-5-
cyano-6-methoxy-3,4-dihydro-2-pyridone,3-
benzylphthalide, 1-1-binapthyl-2,20 -diylhydrogen
phosphate, coumafuryl, devrinol, bupivacaine,
coumachlor, 5-(-4-hydroxyphenyl)-5-phenylhydantoin,
indapamide, indoprofen, methsuximide, 5-methyl-5-
phenylhydantoin, norverapamil, proglumide,
pyridoglutethimide, temazepam, verapamil, and warfarin
Amino acids, AQC-3aminopiperidine dihydrochloride, Vancomycin 7
bendrolumethiazide, coumachlor, indoprofen, warfarin,
AQC (6-aminoquinoline-N-hydroxysuccinimidyl
carbamate)
Tetralone derivatives Vancomycin 14
4- or 5-Substituted 2-methoxy-6-oxa-1,4,5,6- Vancomycin 15
tetrahydropyridine-3 carbonitriles
Aryloxypropanols Vancomycin 16
Cyclic imides Vancomycin 17
Sulfoxides Vancomycin and 18
vancomycin
aglycon
4-Aryldihydropyrimidine-5-carboxylates, aza analogs of Vancomycin 19
nifedipine-type dihydropyridine calcium channel
modulators
4- or 5-Substituted pyridones Vancomycin 20
(continued )

TABLE 2 Continued
Amino acids, albuterol, arotinolol, atenolol, Teicoplanin 5

bendroflumethiazide, biotin, bromacil, clenbuterol,
cyclophosphamide, folinic acid, ifosfamide,
isoproterenolol, a-methyl-, a-phenyl-succinimde,
metoprolol, oxazepam, oxprenolol, pindolol, propanolol,
sotalol, and terbutaline
Amino acids, dipeptides, organic acids, althiazide, Teicoplanin 6
bendoroflumethiazide, 4-benzyl-2-methoxy-6-oxo-
1,4,5,6-tetrahydropyridine-3-carbonitrile, 4-benzyl-2-
oxalidinone, 1-benzoyl-2-tert-buytl-3-methyl-4-
imidazolidinone, bromacil, bupivacaine, carprofen,
coumachlor, coumafuryl, 4-cyclohexyl-2-methoxy-6-
oxo-1,4,5,6-tetrahydropyridine-3-carbonitrile, devrinol,
flurbiprofen, buprofen, indoprofen, ketoprofen,
methsuximide, 4-methyl-2-methoxy-6-oxo-1,4,5,6-
tetrahydropyridine-3-carbonitrile, 5-methyl-5-
phenylhydantoin, 5-(4-methylphenyl)-5-phenylhydantoin,
a-methyl-a-phenyl-succinamide, phesuxamide, 3-
phenylphthalide, 4-phenyl-2-methoxy-6-oxo-1,4,5,6-
tetrahydropyridine-3-carbonitrile, proglumide, suprofen,
tropicamide, and warfarin
Native amino acids, peptides, a-hydroxyl carboxylic acids, Teicoplanin 21
cyclic amines, and amides
Amino acids, carboxylic acids, organometalic complexes, Teicoplanin and 10
b-blockers, nonsteroidal anti-inflamatory drugs, and teicoplanin
carnitines aglycon
Sulfoxides Teicoplanin and 18
teicoplanin
aglycon
Amino acids containing 1,2,3,4-tetrahydroisoquinoline, Teicoplanin 22
tetraline, 1,2,3,4-tetrahydro-2-carboline, cyclopentane,
cyclohexane, heptane and bicyclo [2.2.1] heptane
skeleton
Amino acids and imino acids Teicoplanin and 23
teicoplanin
aglycon
Phenyl glycine Teicoplanin 24
Amino acids and carboxylic acids Teicoplanin 25
Aryloxypropanols Teicoplanin 16
Native amino acids and peptides Teicoplanin 26
Usual amino acids and their derivatives Teicoplanin 27
(continued )

TABLE 2 Continued
4- or 5-Substituted 2-methoxy-6-oxa-1,4,5,6- Teicoplanin 15

tetrahydropyridine-3-carbonitriles
4-Aryldihydropyrimidine-5-carboxylates, aza analogs of Teicoplanin 19
nifedipine-type dihydropyridine calcium channel
modulators
4- or 5-Substituted pyridones Teicoplanin 20
Tetralone derivatives Ristocetin A 21
Thioridazine and 2,2,2-trifluoro-1(9-anthyryl)ethanol Thiostrepton 1
Idazoxam Rifamycin B 1
aglycon, and ristocetin A antibiotic CSPs using a wide range of mobile phases
[18]. It has also been observed that the sugar moieties of vancomycin and
teicoplanin antibiotics did not participate in the chiral resolution of these
sulfoxides. Recently, Armstrong et al. [32] compared the chiral resolution of
plant growth regulators on vancomycin, teicoplanin, and ristocetin A CSPs using
the reversed-phase mode.
Wainer et al. [24] resolved the enantiomers of albuterol in plasma on
teicoplanin CSP. Jandera et al. [33] studied the retention behavior of underi-
vatized phenylglycine on the Chirobiotic T column packed with amphoteric
glycopeptide teicoplanin covalently bonded to the silica surface. A teicoplanin-
based CSP was tested for enantioseparation of underivatized amino acids and
their N-tert-butyloxycarbonyl (t-Boc) derivatives [34]. Peter et al. [35] studied the
resolution of amino acids on teicoplanin CSP. Aboul-Enein and Serignese [36,27]
have resolved clenbuterol enantiomers qualitatively and quantitatively in blood on
teicoplanin CSP. Berthod et al. [38] studied 26 racemates (amino acids, carnitine,
and bromacil) on teicoplanin and teicoplanin aglycon CSPs using seven reversed
phases and two polar organic mobile phases. They observed a difference in the
enantioselective free energy ranging from 0.3 to 1 k cal=mol for amino acid
enantiomers. The chromatograms of 3,4-dihydroxyphenyl alanine (DOPA) and
4-hydroxymandelic acid on teicoplanin and teicoplanin aglycon CSPs are shown
in Figure 4. Enantiomeric resolution of cyclic b-substituted quaternary a-amino
acids was carried out on teicoplanin CSP [39]. Tesova et al. [40] used teicoplanin
for the chiral resolution of N-tert-butyloxycarbonyl amino acids. Peyrin and co-
workers [41] described a wide range of mobile phases for the chiral resolution of
dansyl amino acids on teicoplanin CSP. An approach based on the development
of various equilibria was carried out in order to describe the retention behavior
of the solute in the chromatographic system. The equilibrium constants were
used to explain the retention and separation factors observed. Gasparrini et al.
[10] developed a novel linkage between teicoplanin and teicoplanin aglycon

FIGURE 3 Chromatograms of substituted pyridones on vancomycin (a, c, e) and teico-
planin (b, d, f) CSPs using methanol–1% triethylammonium acetate buffer, pH 4.1 (10 : 90,
v=v). (From Ref. 20.)
antibiotics with amino silica gel, and the developed CSPs were tested for the
resolution of carboxylic acids, organometalic complexes, amino acids, b-block-
ers, anti-inflammatory drugs, and carnitines.
In addition to the common use of vancomycin and teicoplanin, the use of
other antibiotics as chiral selectors in HPLC were limited. Only a few reports are
available in the literature dealing with these antibiotics as HPLC CSPs.
Armstrong et al. [42] resolved about 230 racemates on the ristocetin A antibiotic
covalently bonded to silica gel. The resolution was carried out using the three
modes of mobile phases. The results were complimentary to those obtained on
vancomycin and teicoplanin CSPs. In another study, the effect of selector
coverage and mobile phase composition on enantiomeric resolution with risto-
cetin A CSP was carried out by Armstrong et al. [43]. Thiostrepton-based CSP
was also used to resolve the enantiomers of thioridazine, 2,2,2-trifluoro-1-

FIGURE 4 Chromatograms of DL-DOPA and 4-hydroxymandelic acid on teicoplanin
(a, c) and teicoplanin aglycon (b, d) CSPs using methanol–water (60 : 40, v=v, pH 4.1) for
DL-DOPA and methanol-water (85 : 15, v=v, pH 4.1) for 4-hydroxymandelic acid. (From
Ref. 38.)

(9-anthryl)ethanolalthiazide, and 4-benzyl-2-oxazolidinone [1]. In addition, the
enantiomers of idazoxan, coumafuryl, laudanosine, and 1-[5-chloro-2-(methyl-
amino)phenyl]-1,2,3,4-tetrahydrosoquinoline have been resolved on rifamycin B
antibiotic [1]. Ristocetin A [44] has been used for the chiral resolution of 28
amino acids. Excellent resolution was achieved by using the reversed phase and
the polar organic mobile phase [44]. Recently, Aboul-Enein and Ali [14] used
ristocetin A CSP for the chiral resolution of tetralone derivatives. Avoparcin, a
costly antibiotic, has been tested for the chiral resolution of a variety of racemates
such as verapamil, thyroxine, mephenytoin, and 2-imidazolidone-4-carboxylic
acid [8]. Figure 5 presents the resolution of tetralone derivatives 3-amino-3-
phenyl propionic acid, midodrine, N-g-fluorenylmethyl oxycarbonyl (N -FMOC)-
glycyl-arginine, thyroxine, trihexyphenidyl and verapamil on ristocetin A- and
avoparcin-based CSPs.
FIGURE 4.5 Chromatograms of (a–e) tetralone derivatives on ristocetin A CSP using

hexane-ethanol-TEA (12 : 8 : 02, v=v=v), (f) 3-amino-3-phenyl propionic acid [methanol–
water (60 : 40, v=v)], (g) midodrine [methanol–1% triethyl ammonium acetate buffer, pH 7
(20 : 80, v=v)], (h) N -FMOC-glycyl-arginine [methanol–water (60 : 40, v=v)], (i) thyroxine
[methanol–1% triethyl ammonium acetate buffer, pH 7 (20 : 80, v=v)], ( j) trihexyphenidyl
[methanol–1% triethyl ammonium acetate buffer, pH 7 (20 : 80, v=v)] and (k) verapamil
[methanol–1% triethyl ammonium acetate buffer, pH 7 (20 : 80, v=v)] on avoparcin CSP
(From Refs. 8 and 14.)

Armstrong et al. [1,21] and Beesley and co-workers [8,45] reported the chiral
preparative separation at the milligram scale on antibiotic CSPs. Columns up to
2 in. in diameter are available and can effectively operate up to 500 mL=min. It
has been reported that the high flow rates are suitable for the increasing sample
throughput. The preparative chiral separations on antibiotic CSPs have been
reported using reversed-phase and normal phase modes [2]. Although resolution
is better in the reversed-phase mode for the analyte (e.g., 5-methyl-5-phenyl-
hydantoin on Chirobiotic V), the solubility is much greater in the normal phase
solvent, allowing for greater column loads. The most efficient processing of this
sample has been described by the AmeriChrom recycle and shave systems [2]. It
was observed that the retention times with the vancomycin column are signifi-
cantly shorter than those reported with many other CSPs. Therefore, throughput
reported as grams per hour is more illustrative than grams per injection. The
Chirobiotic T column was used for the preparative chiral separation of chloro-
kynurenine using the reversed-phase mode [2]. Recently, Francotte [46] has
reviewed the chiral preparative separation on antibiotics CSPs. The author
described the limitations of these CSPs in the preparative scale.

Recently, Aboul-Enein and Ali reviewed the chiral resolution on antibiotic CSPs
by HPLC [3,47]. It was observed that chiral resolution on antibiotic CSPs is
governed by various HPLC parameters. The antibiotic CSPs may be used in
normal, reversed, and new modified polar organic phase modes. The most
important parameters which control the chiral resolution on antibiotic CSPs by
HPLC are mobile phase composition, pH of the mobile phase, flow rate,
temperature, structures of solutes, structures of antibiotics, and other parameters.
These parameters are discussed herein.
4.4.1 Mobile Phase Compositions

Because of the complex structure of the antibiotics, most of the antibiotics
function equally well in reversed, normal, and modified polar organic phases. All
of the three solvent modes generally show different selectivity with different
analytes. Sometimes equivalent separations were obtained in both normal and
reversed phases. This ability to operate in two different solvent modes is an
advantage in determining the best preparative methodology where sample
solubility is a key issue. In normal phase chromatography, the most common
solvents used are hexane, ethanol, methanol, and so on. The optimization of
chiral resolution is achieved by adding some other organic solvents such as acetic

acid, tetrahydrofuran (THF), diethylamine (DEA) and triethylamine (TEA) [42].
The protocols for the development and optimization of mobile phases on
vancomycin, teicoplanin, and ristocetin A CSPs are shown in Schemes 1 to 3,
respectively. The effect of the composition of mobile phases on the enantiomeric
resolution of different racemates on a normal phase column is shown in Figure 6.
It can be concluded from this figure that lower concentrations of alcohols favor
the chiral resolution.

vancomycin-based CSP.

teicoplanin-based CSP.
In the reversed phase system, buffers are used most often as the mobile
phases with small amount of organic modifiers. The use of buffers as the mobile
phases has increased the efficiency of the resolution. Ammonium nitrate,
triethylammonium acetate (TEAA), and sodium citrate buffers have been used
very successfully. A variety of organic modifiers have been used to alter
selectivity [2,5,22]. Acetonitrile, methanol, ethanol, 2-propanol, and THF have
shown good selectivities for various analytes. In the reversed-phase mode, the
amount of organic modifiers is typically low, usually of the order of 10–20%. The
typical starting composition of the mobile phase is an organic modifier–buffer

SCHEME 3 Protocol for the development and optimization of mobile phases ristocetin-
based CSP.
(pH 4.0–7.0) (10 : 90). Using alcohols as organic modifiers generally requires
higher starting concentrations (i.e., 20% for comparable retention when using
acetonitrile or tetrahydrofuran in starting concentration of 10%). The effect of
organic solvents on the enantioselectivities also depends on the type of antibiotic.
In fact, better recognition is obtained at acidic buffer pH values below or close to

FIGURE 6 Effect of mobile phase composition on the resolution of enantiomers of
different racemates in normal phase HPLC on antibiotic CSPs. (a) First (j) and second
(u) eluted enantiomers of g-phenyl-g-butyrolactone and first (d) and second (s) eluted
enantiomers of 4-phenyl-2-methoxy-6-oxo-2,4,5,6-tetrahydropyridine-3-carbonitrile on
Chirobiotic T column and (b) first (u) and second (s) eluted enantiomers of mephenytoin
on Chirobiotic V column. (From Refs. 1 and 21.)
the isoelectric point of the antibiotics, especially for vancomycin. For vancomy-
cin, a low concentration of organic solvents did not significantly influence the
separation; however, enantioresolution is improved for some compounds with
ristocetin A and teicoplanin [45], even at low concentrations of organic modifiers.
Figure 7 shows the effect of the organic modifiers on the enantioselectivities of
different enantiomers in reversed-phase liquid chromatography. The effect of
organic modifiers on chiral resolution varies from racemate to racemate [34,42].

FIGURE 7 Effect of mobile phase composition on the resolution of enantiomers of
different racemates in reversed-phase HPLC on antibiotic CSPs. (a) First (u , s) and
second (r, d) enantiomers of 5-methyl-5-phenylhydantoin on a Chirobiotic T column
using an acetonitrile–triethylammonium acetate buffer (—) and a methanol–triethylammo-
nium acetate buffer (- - - -) as mobile phases; (b) first (u) and second (d) enantiomers of
5-methyl-5-phenylhydantoin on a Chirobiotic V column, (c, d): first (þ) and second (d)
eluted enantiomers, and the resolution (u) and selectivity () for methionine (c) and
phenylalanine (d) on a Chirobiotic T column; (e) dependence of the resolution of the
enantiomers of fluoxetine (Prozac) on the amount of methanol (u), 2-propanol (),
acetonitrile (s), and THF (n) as organic modifiers. (From Refs. 1 and 2.)

The presence of triethylamine in the aqueous portion of the mobile phase was
shown to be important for the separation of enantiomers of t-Boc-amino acids,
whereasa native amino acids were almost not affected by the addition of TEAA
[34]. Lee and Beesley [48] observed that a change in the ionic interactions
occurred when changing the acid=base ratio in reversed and polar organic mobile
phases or changing the buffer pH in the reversed-phase mode. Consequently, the
retention, selectivity, and peak shape is affected.
A simplified approach has proven very effective for the resolution of a
broad spectrum of racemate analytes. The first consideration in this direction is
the structure of the analytes. If the compound has more than one functional group
capable of interacting with the stationary phase and at least one of those groups is
on or near the stereogenic center, then the first mobile phase choice would be the
new polar organic phase. Because of the strong polar groups present in the
macrocyclic peptides, it was possible to convert the original mobile phase concept
to 100% methanol with the acid=base added to effect selectivity. The key factor in
obtaining complete resolution is still the ratio of acid to base. The actual
concentration of the acid and base only affects the retention. Therefore, starting
with a 1 : 1 ratio, some selectivity is typically observed, then different ratios of
1 : 2 and 2 : 1 are applied to note the change in resolution indicating the trend. If
the analyte is eluting too fast, the concentration of acid=base is reduced.
Conversely, if the analyte is retained too well, the acid=base concentration is
increased. The parameters for concentration are between 1% and 0.001%. Above
1%, the analyte is too polar and indicates a typical reversed-phase system,
whereas below 0.001% indicates a normal phase system. Both trifluoroacetic acid
(TFA) and acetic acid have been used as the acid component, with ammonium
hydroxide as the base. For an analyte that has only one functional group or for
reasons of solubility, typical normal phase solvents (hexane=ethanol) or reversed-
phase solvents (THF=buffer) are employed. The typical chromatograms, using the
new polar organic modified phases, of the chiral resolution of trimipramine,
chlorthalidone, and naproxen on vancomycin, teicoplanin, and ristocetin A CSPs,
respectively, are shown in Figure 8.

The pH is an important controlling factor of enantiomeric resolution in normal,
reversed, and new organic phases. Generally, buffers are used in the mobile
phases to control the pH in HPLC. The pH of the buffers ranges from 4.0 to 7.0 in
the reversed-phase system. In general, the analytes interact more favorably at a
pH at which they are not ionized. Therefore, retention and selectivity of the
molecules that possess ionizable acidic or basic functional groups can be effected
by altering the pH. A strategy is to take advantage of a difference in pKa values,
(i.e., keeping the analyte of interest neutral and strongly interacting while keeping
other components ionized and poorly retained). Because of the complexities of

FIGURE 8 Chromatograms of (a) trimipramine on vancomycin CSP using methanol–
acetic acid–TEA (100 : 0.3 : 0.2, v=v=v), (b) chlorthalidone on teicoplanin CSP using
methanol–TEAA, pH 4.1 (10 : 90, v=v) and (c) naproxen on ristocetin A CSP using
methanol–EAA (30 : 70, v=v) mobile phases. (From Ref. 2.)
these interactions, it is necessary to observe the retention and resolution as the

function of pH, usually testing at pH 4.0 and pH 7.0 or 0.50 pH units above and
below the pKa value. It has been observed that with increasing the pH values, the
values of Rs (resolution factor), k (retention factor), and a (separation factor)
decrease in most of the cases. Therefore, the safest and suitable values of pH in
reversed-phase systems vary from 4.0 to 7.0 [1,2]. The enantiomeric resolution by
normal phase and new modified polar organic phases has been achieved below
pH 7.0. To show the effect of pH on the chiral resolution of some racemates on
teicoplanin and vancomycin CSPs, the values of k, a, and Rs are given in Tables 3
and 4, respectively. It can be observed from these tables that pH 4.0 and 7.0 are

TABLE 3 Effect of pH on the Chiral Resolution of Several Racemates on Chirobiotic
T CSP Using Methanol–1% Triethylammonium Acetate Buffer (20 : 80, v=v) as the
Mobile Phase
pH k1 a Rs
5-(4-Hydroxyphenyl)-5-phenylhydantoin
7.0 4.29 1.30 1.12
6.0 3.78 1.35 1.25
5.0 3.38 1.38 1.36
4.1 3.10 1.40 1.70
3.6 1.82 1.31 1.10
5-Methyl-5-phenylhydantoin
7.0 0.97 2.34 2.58
6.0 0.95 2.30 2.64
5.0 0.92 2.28 2.72
4.1 0.87 2.11 2.87
3.6 0.70 1.87 2.18
3-Phenylphthalide
7.0 2.66 2.06 2.93
6.0 2.88 2.01 3.04
5.0 2.94 1.96 3.26
4.1 2.98 1.78 3.69
3.6 2.20 1.47 2.24
1-Benzoyl-2-tert-butyl-3-methyl-4-imidazolidone
7.0 1.41 2.28 2.80
6.0 1.83 2.20 3.05
5.0 1.97 2.11 3.22
4.1 2.09 1.85 3.40
3.6 1.69 1.64 1.97
N -Formylphenylalanine
7.0 0.89 2.52 2.28
6.0 1.45 2.36 2.32
5.0 1.56 2.27 2.43
4.1 1.61 2.16 2.53
3.6 1.10 2.05 2.33
Mandelic acid
7.0 0.14 6.57 2.75
6.0 0.28 4.96 2.89
5.0 0.36 4.34 2.98
4.1 0.46 3.28 3.17
3.6 0.40 2.35 2.43
Source: Ref. 45.

TABLE 4 Effect of pH on Chiral Resolution of Several Racemates
on Chirobiotic V CSP Using Acetonitrile-1% Triethylammonium
Acetate Buffer (10 : 90, v=v) as the Mobile Phase
pH k1 a Rs
Coumachlor
7.6 1.00 1.69 1.60
6.2 1.21 1.64 2.00
5.5 2.00 1.60 2.70
4.5 3.00 1.64 4.10
3.6 1.65 1.42 3.90
Devrinol
7.6 1.15 1.80 3.20
6.2 1.16 1.77 3.30
5.5 1.36 1.76 3.50
4.5 1.46 1.70 3.60
3.6 1.19 1.41 3.70
Source: Ref. 1.
suitable for chiral resolution. Recently, Schlauch et al. [39] studied the effect of
pH on the chiral resolution of cyclic substituted amino acids. They observed two
different enantiomeric and diastereomeric discrimination mechanisms based on
different interactions with the stationary phase. The effect of the pH on the chiral
resolution of mandelic acid on teicoplanin is studied by Jandera et al. [25]. These
FIGURE 9 Effect of mobile phase pH on the chiral resolution of mandelic acid on

Chirobiotic T CSP using ethanol–water–TEA (17.5 : 70.2 : 12.3, v=v=v) as the mobile

findings are shown in Figure 9, which indicates that pH 7 is the optimum pH.
Briefly, the interactions of enantiomers with CSP are effected by the pH of the
mobile phase and, hence, the enantioselectivity is pH dependent.
4.4.3 Flow Rate

Armstrong et al. [21] studied the effect of flow rate on the resolution of 4-
hydroxy-5-cyano-6-methoxy-3,4-dihydro-2-pyridone and a-methyl-a-phenyl suc-
cinamide on the teicoplanin column. It has been observed that the flow rate does
not affect the enantioselectivity (a) but does affect the separation efficiency. This
is reflected by the inverse relationship between Rs and the flow rate. Decreasing
the flow rate from 2.0 to 1.0 mL=min enhanced the resolution by 20–30%.
Further, the decrease in the flow rate did not produce any increase in the
resolution. No increase in resolution was obtained below the flow rate of
0.5 mL=min in any separation mode. The loss of efficiency at higher flow rates
has also been observed with most of the chiral antibiotics. The enantioselec-
tivities of some of the derivatives of amino acids on the teicoplanin phase have
been enhanced by simply lowering the flow rates [1]. The effect of the flow rate
on the normal phase enantiomeric resolution of 3a,4,5,6-tetrahydrosuccina-
mido[3,4-b]acenapthen-10-one on vancomycin has been studied by Armstrong
and co-workers [1]. They have varied the flow rates from 0.5 to 2.0 mL=min and
observed that the values of a decreased from 1.31 to 1.29 and the values of Rs
decreased from 1.28 to 1.11. The effect of flow rate on the enantioselectivity of
various racemates is given in Table 5. Recently, Peter et al. [44] optimized the
chiral resolution of synthetic amino acids on ristocetin A CSP by controlling the
flow rate. The flow rate up to 500 mL=min has been used for preparative chiral
resolution [2].
4.4.4 Temperature
Temperature is also an important parameter for controlling the resolution of
enantiomers in HPLC. The enthalpy and entropy control of chiral resolution on
antibiotic CSPs is similar to the case of polysaccharide-based CSPs (Chapter 2).
Armstrong et al. [1] have studied the effect of temperature on the resolution
behavior of proglumide, 5-methyl-5-phenylhydantoin and N -carbamyl-D-pheny-
lalanine on the vancomycin column. The experiments were carried out from 0 C
to 45 C. These results are given in Table 6 for three chiral compounds. It has been
observed that the values of k, a, and Rs for the three studied molecules have
decreased with the increase in temperature, indicating the enhancement of chiral
resolution at low temperature. In another work, the same workers [22] have also
studied the effect of temperature on the resolution of certain amino acid
derivatives on the teicoplanin chiral stationary phase. They further observed
poor resolution at ambient temperature, whereas the resolution increased at low

TABLE 5 Effect of Flow Rate on Enantiomeric Resolution on Chirobiotic V and
Chirobiotic T CSPs
Flow Rate (mL=min) a Rs

a
3a,4,5,6-Tetrahydrosuccinimido [3,4-b] acenaphthen-10-one
0.50 1.31 1.28
0.75 1.31 1.19
1.00 1.27 1.14
1.50 1.30 1.13
2.00 1.29 1.11
4-Hexyl-5-cyano-6-methoxy-3,4-dihydro-2-pyridoneb
0.50 1.4 2.4
1.0 1.4 2.3
1.5 1.4 2.0
2.0 1.4 1.6
a-Methyl-a-phenylsuccinamideb
0.5 1.3 1.9
1.0 1.3 1.8
1.5 1.3 1.6
2.0 1.3 1.4
a
Chirobiotic V using 2-propanol-hexane (50 : 50, v=v) as the mobile phase. (Source: Ref. 1.)
b
Chirobiotic T using ethanol–hexane (30 : 70, v=v) as the mobile phase. (Source: Ref. 21.).
and high temperatures. The increase in the resolution at lower temperature may be
the result of the increase in efficiency of the column. It has also been observed
that the change in temperature has a greater effect on the retention of solutes in
the normal phase in comparison to the reversed phase. It might be due to the fact
that the binding constant of a solute to the macrolide involves several interactive
mechanisms that dramatically change with temperature. Inclusion complex
formation is effectively prevented for most solutes in the temperature range of
60–80 C. The lower temperature enhances the weaker bonding forces and the net
result is that the chromatographers have an additional powerful means to control
selectivity and retention. The effect of temperature in HPLC on enantioselectivity
of a variety of racemates is given in Figure 10 [22]. This figure indicates that the
effect of temperature on enantioselectivity varies from antipode to antipode. Peter
et al. [44] optimized the chiral resolution of synthetic amino acids on ristocetin A
CSP by controlling the experimental temperature. Peyrin and co-workers [41]
calculated the thermodynamic parameters for the chiral resolution of dansyl
amino acids on the teicoplanin stationary phase. The authors observed that the
driving forces of the solutes on CSP varied with temperature, indicating the
control of chiral recognition by the interactions of solutes with teicoplanin CSP.
Peter et al. [49] studied the effect of temperature on the chiral separation of amino

TABLE 6 Effect of the Temperature on Chiral Resolution of Some Racemates on
Vancomycin CSP Using Acetonitrile–1% Triethylammonium Acetate, pH 4.1 (10 : 90,
v=v) as the Mobile Phase
Temp. ( C) k a Rs
Proglumide
0 1.33 2.27 3.60
5 1.33 2.11 3.30
15 1.31 1.87 2.40
22 1.18 1.75 2.10
35 0.93 1.57 1.80
45 0.76 1.44 1.60
5-Methyl-5-phenylhydantoin
0 0.35 1.38 1.50
5 0.27 1.36 1.00
22 0.24 1.34 1.00
35 0.24 1.30 0.90
45 0.19 1.32 0.70
N -Carbamyl-D,L-phenylalanine
0 0.51 1.39 1.50
5 0.39 1.34 1.30
15 0.38 1.23 1.00
22 0.31 1.20 0.80
35 0.27 1.11 0.70
45 0.22 1.00 0.00
acids on teicoplanin CSP using the reversed-phase mode. The retention and
selectivity factors of all amino acids decreased with the increase in temperature.
The natural logarithms of the retention factors (ln k) of the investigated compound
depended linearly on the inverse of the temperature (1=T ). van’t Hoff plots
afforded thermodynamic parameters such as enthalpy (H ), entropy (S ), and
Gibbs free energy (G ) changes for the transfer from the mobile to the stationary
phase. The thermodynamic constants (H , S , and G ) were calculated in order to
promote an understanding of the thermodynamic driving forces, for the retention
in the chromatographic system.
4.4.5 Structures of Solutes

Figure 1 shows a variety of groups on antibiotic CSP that can take part in the
bonding with the different groups of the racemates. Therefore, different structures
of the racemates provide different types of bondings and, therefore, the different
patterns of chiral resolution observed. Amino acids is the best class of com-

FIGURE 10 Effect of temperature on enantiomeric resolution on antibiotic CSPs. (a): k,
a, and Rs for proglumide (s), 5-methyl-5-phenylhydantoin (d) and N -corbyl-DL-pheny-
lalanine () on Chirobiotic V column using acetonitrile–1% triethylammonium acetate
buffer (10 : 90, v=v) as the mobile phase and (b) separation of enantiomers of b-methyl
phenylalanine on the Chirobiotic T column using water–methanol (10 : 90, v=v) as the
mobile phase at (A) 1 C, (B) 20 C, (C) 50 C. 1 ¼ erythro-L; 2 ¼ erythro-D; 3 ¼ threo-L;
4 ¼ threo-D. (From Refs. 1 and 22.)

pounds by which effect of the substituents on chiral resolution can be studied. A
number of reports are available for the chiral resolution of amino acids on
antibiotics CSPs [1–7,22,23,25–27]. The survey of these reports indicated the
different enantioselectivities of all the amino acids on a particular CSP reflecting
the effect of substituents on chiral resolution. Aboul-Enein and Ali [14] have
observed different chiral recognition patterns of certain tetralone derivatives on
vancomycin, teicoplanin, and ristocetin CSPs. Generally, the resolution of these
tetralone derivatives was in the order of I > II > IV > V > III (for structures of
tetralone derivatives, see Fig. 18 of Chap. 2). This could be the result of the
different types of bonding of different magnitudes between these derivatives and
the chiral stationary phases. The resolution of II and IV derivatives was better
than III and V analytes, which could be due to the different steric effects among
these (II–IV) analytes. The different steric effects among these compounds might
be due to the different positions of the substituent groups on the phenyl ring.
Lee et al. [48] achieved the chiral resolution of a variety of ionizable
racemates on vancomycin, teicoplanin, and ristocetin A CSPs. The authors
discussed the results of the chiral resolution due to the structures of the solutes
and the CSPs. Ananieva and co-workers [50] resolved several substituted amino
acids on teicoplanin and teicoplanin aglycon CSPs. The authors observed
different patterns of retention and selectivity of these amino acids on the reported
CSPs. Retention factors for the amino acids on teicoplanin were in the order of
bezoyl- < o-phthaldialdehyde- < phthalyl- < carbobenzyloxy < 2,4-dinitrophenyl-
< dansyl < 9-fluorenylmethyloxycarbonyl- and those on teicoplanin aglycon
were o-phthaldialdehyde- < benzoyl- < phtalyl- < carbobenzyloxy- < 2,4-dinitro-
phenyl- < dansyl- < 9-fluorenylmethyloxycarbonyl-. This type of chiral recogni-
tion behavior might be the result of the different structures of the solutes.
Armstrong et al. [16] studied the chiral resolution of alkylamino derivatives of
aryloxypropanols on vancomycin and teicoplanin CSPs. The authors observed
that steric effect interactions were contributing to enantioselectivity. The substi-
tuents in the 2-position of the aromatic ring influence the asymmetric carbon
atom environment and have a negative effect on the resolution of the enantiomers.
The substituents in the 3-position of the aromatic ring have no significant effect
on the enantioseparation. It seems that the type of nitrogen substituent in the
hydrophilic part of molecule has the dominant influence on the resolution of the
enantiomers. Further, Armstrong et al. [32] studied the chiral resolution of
substituted tryptophan compounds on vancomycin, teicoplanin, and ristocetin
A CSPs. The authors noted the effect of electron-donating (methyl) and electron-
withdrawing (fluoro) groups (on the indole moiety of the tryptophan molecule) on
enantioselectivity. The fluoro substituents (relative to the methyl group in the
same position) decrease retention and increase enantioselectivity. However, the
resolution of the fluorotryptophan enantiomers was somewhat less than those of
the corresponding methyl tryptophan.

4.4.6 Structures of Antibiotics
It is clear from Figure 1 that all of the reported antibiotics have different struc-
tures with various groups and, hence, all of the antibiotics cannot be used for the
chiral resolution of any racemic compound. Therefore, the optimization of chiral
resolution on these CSPs may be achieved by selecting the appropriate antibiotic
for a particular racemate. There are a number of reports indicating that all of the
antibiotics cannot be used for the chiral resolution of all the antipodes [2,9–
13,14,17,18,20,28–31]. For example, Aboul-Enein and Ali [14] studied the chiral
resolution of tetralone derivatives on vancomycin, teicoplanin, and ristocetin A
CSPs. It was observed that the best resolution of these tetralone derivatives was
achieved on vancomycin CSP. The retention of reported tetralone derivatives was
in the order vancomycin > ristocetin A > teicoplanin columns. It may be due to
the different steric effects among the studied tetralone derivatives and CSPs. From
these findings, it may be concluded that the strength of the steric effect was in the
order teicoplanin > ristocetin A >vancomycin. Therefore, vancomycin and risto-
cetin A provide a stronger bonding with enantiomers than the bonding provided
by teicoplanin. The role of the carbohydrate moieties of teicoplanin on chiral
resolution was studied extensively by Armstrong et al. [38]. They have observed
that carbohydrate units on teicoplanin are not needed for the chiral resolution of
common amino acids. Furthermore, Armstrong et al. [18] observed that the
aglycon portion of vancomycin and teicoplanin has a negative effect on the chiral
resolution of a number of racemic compounds. On the other hand, sometimes the
carbohydrate units were found suitable for the chiral resolution of certain
racemates. Briefly, the suitability of the antibiotics CSPs varies from analyte to
analyte.
4.4.7 Other HPLC Parameters

Apart from the above-discussed parameters for HPLC optimization of chiral
resolution on antibiotic CSPs, some other HPLC conditions may be controlled to
improve chiral resolution on these CSPs. The effect of the concentrations of
antibiotics (on stationary phase) on enantioresolution varied depending on the
type of racemates. The effect of the concentrations of teicoplanin has been
studied on the retention (k), enantioselectivity (a), resolution (Rs ), and theoretical
plate number (N ) for five racemates [21]. An increase in the concentration of
teicoplanin resulted in an increase of a and Rs values. The most surprising fact is
that the theoretical plate number (N ) increases with the increase in the concen-
tration of teicoplanin. It may be the result of the resistance of mass transfer
resulting from analyte interaction with free silanol and=or the linkage chains
(antibiotics linked with silica gel). This would tend to trap an analyte between the
silica surface and the bulky chiral selector adhered to it. This is somewhat

analogous to the effect of stationary phase adsorption on the efficiency of achiral
separation in micellar chromatography [27]. A denser surface coverage of the
selector could prevent this deep penetration by steric means. This would tend to
limit the analyte interactions to surface interaction with the chiral selector alone,
thereby enhancing efficiency and possibly affecting selectivity in some cases. It is
apparent that the surface coverage and the orientation of the stationary phase are
important for these separations. However, there are few reports in the literature
indicating the effect of surface coverage for any chiral stationary phase [45]. The
effect of the concentrations of antibiotics on the retention (k), enan-tioselectivity
(a), resolution (Rs ), and theoretical plate number (N ) is given in Table 7. A
perusal of Table 7 indicates that 1.5 g was found suitable for good chiral
resolution of the reported racemates. In addition, Berthod et al. [51] used the
entirely new approach for the chiral resolution of underivatized amino acids. They
used copper metal ions as the mobile phase additives. Furthermore, the authors
observed a complex formation between copper ions and teicoplanin that resulted
in an improved resolution. Wang et al. [52] introduced a new approach to
optimize the chiral resolution on these CSPs. They immobilized vancomycin and
teicoplanin antibiotics on the same silica gel (mixed CSP) and it was tested for the
chiral resolution of profens and b-blockers. The results were compared with those
obtained by individual antibiotic CSPs or antibiotic CSPs coupled in series. The
authors reported that the mixed CSP was not suitable. However, the coupling of
these CSPs in series resulted in an improved resolution in comparison to the
results obtained with individual CSPs.
TABLE 7 The Effect of the Teicoplanin Concentration (X ), on the Column, on

Enantioselectivity in HPLC Using Acetonitrile–Triethylammonium Acetate Buffer of pH
4.1 (10 : 90, v=v) as the Mobile Phase
Racemates X ðgÞ k1 a Rs N ðm1 Þ
Bromacil 1.5 1.72 1.3 1.7 32,300

1.0 0.94 1.2 1.5 26,900
Dansyl methionine 1.5 3.6 1.4 2.4 40,680
1.0 2.10 1.3 1.7 29,300
Mandelic acid 1.5 0.40 2.3 2.3 31,100
1.0 0.37 1.6 2.0 21,500
5-Methyl-5-phenylhydantoin 1.5 0.78 1.7 2.3 34,500
1.0 0.46 1.4 1.9 28,600
3-Phenylphthalide 1.5 2.87 1.3 2.3 25,100
1.0 1.57 1.2 1.8 20,900
Source: Ref. 45.

The macrocylic antibiotics are stable in a 0–100% organic modifier and exhibit
high sample capacity. The selectivities of antibiotics in normal, reversed, and new
polar organic mobile phase modes make them ideally suitable chiral selectors.
The macrocyclic antibiotics stationary phases have similarities and differences
with both the cyclodextrin and protein phases from the mechanism point of view.
All of the antibiotics contain ionizable groups and their charge and, possibly, their
conformation can vary with the pH of the mobile phase. The three-dimensional
complex structures and different spatial stereochemical arrangements of the
functional groups of the antibiotics containing different chiral centers, inclusion
cavities, phenyl rings, pyranose, furanose, quinoline and thiazole rings, several
hydrogen donor and acceptor sites, sugar moieties, and other groups are
responsible for their surprising chiral selectivities in different modes. This
allows for an excellent potential to resolve a greater variety of racemates. The
possible interactions involved with the use of antibiotics as chiral selectors for
chiral recognition are as follows:
1. p p Complexation
2. Hydrogen-bonding
3. Inclusion complexation
4. Dipole interactions
5. Steric interactions
6. Anionic and cationic bindings
The functions of these interactions are well known [2,53,54] and a detailed
discussion of them is beyond the scope of this book. However, these interactions
take place individually or in combinations that can result in the very high chiral
recognition capacities for these antibiotics. The strength of these interactions
depends on the type of mobile phase used. The reversed-phase condition favors
ionic interactions, hydrophobic inclusion, hydrogen-bonding, and steric inter-
action. The normal phase favors p p complexation, hydrogen bonding, dipole
stacking, and steric interaction. On the other hand, the new polar organic phase
mode enhances hydrogen-bonding, dipole stacking, p p interaction, and steric
interaction. Vancomycin, teicoplanin, and ristocetin A are supposed to be the best
chiral selectors because of the presence of an aglycon (fused macrocyclic rings)
portion which can exhibit different morphological characteristics such as the
openness of the aglycon cavity and the degree of helical twist. The twist degree
does not seem to depend on the molecular size; in fact, vancomycin, which
possesses the smallest macrocyclic ring, has the highest twist degree.
The importance of the amino group of amino acids in the interaction
mechanism was evaluated. Native amino acids have better possibility for
interaction with teicoplanin; they are more retained on the CSP and better

enantioresolved than the blocked amino acids [34]. Recently, Lee and Beesley
[48] presented the different interactions, such as p p, hydrogen-bonding, dipole–
dipole, and steric repulsion, between the racemates and the glycopeptide anti-
biotics CSPs (vancomycin, teicoplanin, and ristocetin A) under aqueous versus
organic mobile phases. Finally, the electronegative atoms such as oxygen,
nitrogen and halogens of racemates form hydrogen-bondings and dipole–
dipole-induced interactions with certain groups in the antibiotics. In addition,
p p interactions also occur between the phenyl ring of aromatic racemates and
the CSP. During the chiral resolution, the enantiomers fit stereogenically in
different ways into the chiral cavities of the CSP, which is stabilized by various
types of bonding (as discussed earlier) of different magnitudes and, hence, the
resolution of enantiomers occur. In addition to these bondings, the steric effect
also governs the chiral resolution on antibiotic CSPs. In addition, some other
achiral weak bondings like van der Waal forces and ionic bondings may also
contribute in the chiral resolution. A graphical representation of chiral recognition
mechanism of phenylalanine amino acid on teicoplanin CSP is presented in
Figure 11. It may be observed from this figure that the D-enantiomer of
phenylalanine is more strongly bonded to CSP (because of lower steric hindrance)
than the L-enantiomer and, hence, the L-enantiomer is eluted first, followed by the
D-enantiomer.
4.6 MISCELLANEOUS APPLICATIONS

The use of antibiotic-based CSPs in supercritical fluid chromatography (SFC) is
under development stage and are not extensively used in sub-SFC and SFC
modes of chromatography. Only a few reports are available on chiral resolution
on these CSPs by SFC and only vancomycin and teicoplanin were used for this
purpose. Medvedovici et al. [55] resolved some racemates on vancomycin and
teicoplanin CSPs, covalently bonded to silca gel. A high concentration of organic
modifiers was essential in SFC. However, a complex mixture of methanol, water
and glycerol was used for chiral separation on teicoplanin CSP. The separation of
coumachlor enantiomers on vancomycin CSP was achieved by Phinney [56]. The
chromatograms are shown in Figure 12. Donneck et al. [57] used vancomycin,
immobilized on aldehyde functionalized silica support and packed capillary, for
the chiral resolution of basic racemates (b-blockers) [57]. Various modifiers were
tested, but methanol as the modifier resulted in successful results. The effect of
temperature on the chiral resolution was also studied and resulted in nonlinear
van’t Hoff plots. Large differences in enantioselectivity in a homologous series of
local anesthetic compounds indicated that the fit of a host–guest interaction
between analyte and vancomycin could be very precise. Recently, vancomycin
was used to resolve the enantiomers of anticoagulants, aryloxypropionic acid and
arylpropionic acid, using SFC [58]. Duret et al. [59] used vancomycin as the

FIGURE 11 Graphical representation of chiral recognition mechanism of phenylalanine
on teicoplanin CSP.
chiral selector for the enantiomeric resolution of dansyl norleucine by centrifugal

partition chromatography. The authors reported exceptionally high values of
selectivity factors (a > 30).
The use of antibiotic-based CSPs has been reported in capillary electro-
chromatography (CEC) for chiral resolution [60]. Teicoplanin CSP covalently
bonded to silica gel was used to resolve the enantiomers of tryptophan and
dinitrobenzoyl leucine by CEC [61]. Good levels of enantioselectivity were
obtained with optimized separations. Vancomycin covalently bonded to silica gel
was also evaluated in CEC for the chiral resolution of thalidomide and b-
adrenergic blocking agents under all the three mobile phase modes. The

FIGURE 12 Chromatograms of the chiral resolution of coumachlor on vancomycin CSP
using 15% methanol in carbon dioxide under the SFC mode. (From Ref. 56.)
selectivities of the CSP were found to be very good. Different ratios of methanol
and acetonitrile played a significant role in controlling both the resolution and
efficiency [62]. Enantiomeric resolution of alprenolol, metoprolol, and couma-
chlor was reported on teicoplanin CSP under reversed and new polar organic
modified phases [63]. A statical experimental design was used to investigate the
effects of nonaqueous polar organic mobile phase parameters on the CEC electro-
osmotic flow, resolution, and peak efficiency. Results indicated that higher
efficiency and resolution values could be attained at higher methanol contents,
which is similar to findings obtained on this CSP in HPLC. Recently, the
enantiomers of venlafaxine and its main active metabolite O-desmethylvenlafax-
ine were resolved by CEC on vancomycin CSP [64]. The mobile phase used was
100 mM ammonium acetate buffer (pH 6)–water–acetonitrile (5 : 5 : 90, v=v=v).
The acetonitrile concentration was found to modulate the elution time, efficiency,
and selectivity.
Bhushan and Parsad [65] resolved dansyl amino acids on erythromycin
impregnated thin-layer chromatographic (TLC) silica plates. The mobile phase
used was different ratios of 0.5 M aqueous NaCl–acetonitrile–methanol. Further,
Bhushan and Thiong’o [66] achieved the chiral resolution of dansyl amino acids
on silica TLC plates impregnated with vancomycin chiral selector. The mobile
phase used for this study was acetonitrile–0.5 M aqueous NaCl (10 : 4 and 14 : 3,
v=v). The chiral recognition mechanisms of antibiotic CSPs in sub-SFC, SFC,
CEC, and TLC modes of chromatography were found to be similar to HPLC.
4.7 CONCLUSION
The development of the macrocyclic antibiotics as chiral selectors has resulted in
an inexpensive, easy, reproducible and fast enantiomeric resolution method for a
wide variety of racemates both for analytical and preparative scales. There is a

good potential to use these antibiotics for a large-scale preparative resolution of
drug racemates that can be resolved to provide the desired active single
enantiomer in a pure form. In addition, these CSPs are multimodal in nature
and can be switched from one mobile phase to another without any deleterious
effect, which makes column coupling an efficient and economical methodology.
By using the method development procedures and optimizing chromatographic
parameters, these CSPs can be used to simulate further investigations and
understanding of the chiral recognition for a large number of racemates. Research
work carried out on these CSPs and discussed herein indicated no serious
limitation of these antibiotics. However, the high ultraviolet background of
these macrocyclic antibiotics could prevent operation at low wavelengths and
generally reduces sensitivity compared to other chiral selectors. We believe that in
the near future, antibiotic-based CSPs will become the method of choice for the
chiral resolution of a wide variety of racemic compounds.
REFERENCES
1. Armstrong DW, Tang Y, Chen S, Zhou Y, Bagwill C, Chen R, Anal Chem 66: 1473
(1994).
2. Chirobiotic Handbook, Guide to Using Macrocyclic Glycopeptide Bonded Phases
for Chiral LC Separations, 2nd ed., Advance Separation Tech. Inc., Whippany, NJ,
(1999).
3. Aboul-Enein HY, Ali I, Chromatographia 52: 679 (2000).
4. Maier NM, Franco P, Linder W, J Chromatogr A 906: 3 (2001).
5. Armstrong DW, Rundlett KL, Chen JR, Chirality 6: 496 (1994).
6. Ward TJ, LC-GC Int 14: 428 (1996).
7. Gasper MP, Berthod A, Nair UB, Armstrong DW, Anal Chem 68: 2501 (1996).
8. Ekborg-Ott KH, Kullman JP, Wang X, Gahm K, He L, Armstrong DW, Chirality 10:
627 (1998).
9. Beesley TE, Scott RPW (Eds.), Chiral Chromatography, John Wiley & Sons, New
York (1998).
10. Gasparrini F, D’Acquarica I, Villani, C, Misiti D, Pierini M, 13th International
Symposium on Chirality 2001, Orlando, FL, Abstract P-234: 65 (2001).
11. D’Acquarica I, Gaspirrini F, Misiti D, Villani C, Carotti A, Cellamare S, Muck S, J
Chromatogr A 857: 145 (1999).
12. Berthod A, Yu T, Kullman JP, Armstrong DW, Gasparrini F, D’Acquarica I, Misiti D,
Carotti A, J Chromatogr A 897: 113 (2000).
13. D’Acquarica I, Gasparrini F, Misiti D, Zappia G, Cimarelli C, Palmieri G, Carotti A,
Cellamare S, Villani C, Tetrahedron: Asymm 11: 2375 (2000).
14. Aboul-Enein HY, Ali I, Arch Pharm 334: 258 (2001).
15. Vespalec R, Billiet HAH, Frank J, Bocek P, Electrophoresis 17: 1214 (1996).
16. Hrobonova K, Lehotay J, Cizmarikova R, Armstrong DW, J Liq Chromatogr Relat
Technol 24: 2225 (2001).
17. Aboul-Enein HY, Serinese V, Chirality 10: 358 (1998).

18. Xiao TL, Jenks W, Armstrong DW, 13th International Symposium on Chirality 2001,
Orlando, FL, Abstract P-243, p. 68 (2001).
19. Kleidernigg OP, Kappe CO, Tetrahedron: Asymmetry 8: 2057 (1997).
20. Chen S, Liu Y, Armstrong DW, Borrell JI, Martinez-Teipel B, Matallana JL, J Liq
Chromatogr 18: 1495 (1995).
21. Armstrong DW, Liu Y, Ekborg-Ott K, Chirality 7: 474 (1995).
22. Peter A, Torok G, Armstrong DW, J Chromatogr A 793: 283 (1998).
23. Berthod A, Liu Y, Bagwill C, Armstrong DW, J Chromatogr A 731: 123 (1996).
24. Fried KM, Koch P, Wainer IW, Chirality 10:484 (1998).
25. Jndera P, Skavrada M, Klemmova K, Backovska V, Guiochon G, J Chromatogr A
917: 123 (2001).
26. Desiderio D, Fanali S, J Chromatogr A 807: 37 (1998).
27. Armstrong DW, Ward TJ, Berthord A, Anal Chem 58: 579 (1986).
28. Hroboova K, Lehotay J, Iungelova J, Eimarik J, Armstrong DW, 13th International
Symposium on Chirality 2001, Orlando, FL, Abstract P-128, p. 38 (2001).
29. Lehotay J, Hrobonova K, Krupcik J, Cizmarik J, Pharmazie 53: 863 (1998).
30. Tesaova E, Zaruba K, Flieger M, J Chromatogr A 844: 137 (1999).
31. Zhang B, Xiao L, Lee JT, Hui F, Armstrong DW, 13th International Symposium on
Chirality 2001, Orlando, FL, Abstract P-147, p. 44 (2001).
32. Hui F, Ekborg-Ott KH, Armstrong DW, J Chromatogr A 906: 91 (2001).
33. Jndera P, Backovska V, Felinger A, J Chromatogr A 919: 67 (2001).
34. Tesaova E, Bosakova Z, Pacakova V, J Chromatogr A 839: 121 (1999).
35. Peter A, Olajos E, Casimir R, Tourwe D, Broxterman QB, Armstrong DW, J
Chromatogr A 871: 105 (2000).
36. Aboul-Enein HY, Serinese V, J Liq Chromatogr Relat Technol 22: 2177 (1999).
37. Aboul-Enein HY, Serinese V, Biomed Chromatogr 13: 520 (1999).
38. Berthod A, Chen X, Kullman JP, Armstrong DW, Gasparrini F, DiAcquarica, Villani
C, Anal Chem 72: 1767 (2000).
39. Schlauch M, Frahm AW, J Chromatogr A 868: 197 (2000).
40. Tesova E, Bosakova Z, Zuskova I, J Chromatogr A 879: 147 (2000).
41. Peyrin E, Ravelet C, Nicolle E, Villet A, Grosset C, Ravel A, Alary J, J Chromatogr
A 923: 37 (2001).
42. Ekborg-Ott, KH, Liu Y, Armstrong DW, Chirality 10: 434 (1998).
43. Ekborg-Ott KH, Wang, X, Armstrong DW, Microchemical J 62: 26 (1999).
44. Peter A, Torok G, Armstrong DW, Toth G, Tourwe D, J Chromatogr A 904: 1 (2000).
45. Wu, DR, Lohse K, Beesley TE, 23rd International Symposium on HPLC (HPLC 99),
Canada (1999).
46. Francotte ER, J Chromatogr A 906: 379 (2001).
47. Aboul-Enein HY, Ali I, IL Farmaco 57: 513 (2002).
48. Lee JT, Beesley TE, 13th International Symposium on Chirality 2001, Orlando, FL,
Abstract P-225, p. 62 (2001).
49. Peter A, Torok G, Armstrong DW, Toth G, Tourwe D, J Chromatogr A 828: 177
(1998).
50. Ananieva IA, Davankov VA, Armstrong DW, 13th International Symposium on
Chirality 2001, Orlando, FL, Abstract P-257, p. 72 (2001).

51. Berthod A, Tizon, V, Leonce E, Caussignac C, Valleix A, Armstrong DW, 13th
International Symposium on Chirality 2001, Orlando, FL, Abstract P-203, p. 53
(2001).
52. Wang AX, Lee JT, Beesley TE, LC-GC 18: 629 (2000).
53. Allenmark S., Chromatographic Enantioseparation: Methods and Applications, 2nd
Ed., Ellis Horwood, New York (1991).
54. Yashima, E, Okamoto Y, Chiral recognition mechanisms of polysaccharides chiral
stationary phases, in The Impact of Stereochemistry on Drug development and Use,
Aboul-Enein HY, Wainer IW (Eds.), John Wiley & Sons, New York (1997).
55. Medvedovici A, Sandra P, Toribio L, David F, J Chromatogr A 785: 159 (1997).
tions, in Chiral Separation Techniques: A Practical Approach, Subramanian G (Ed.),
Wiley–VCH, Weinheim, Germany, p. 299 (2001).
57. Donneck J, Svensson LA, Gyllenhaal O, Karlsson KE, Karlsson A, Vessman J, J
Microcolumn Sep 11: 521 (1999).
58. Selditz U, Copinga S, Grol CJ, Frank JP, De Zeeuw RA, Wikstroem H, Gyllenhall O,
Pharmazie 54: 183 (1999).
59. Duret P, Foucault A, Margraff R, J Liq Chromatogr & Relat Technol 23: 295 (2000).
60. Dermaux A, Lyen F, Sandra P, J High Resolut Chromatogr 21: 575 (1998).
61. Caster-Finch AS, Smith NW, J Chromatogr A 848: 375 (1999).
62. Wikstrom H, Svensson LA, Torstensson A, Owens PK, J Chromatogr A 869: 395
(2000).
63. Karlsson C, Wikstrom H, Armstrong DW, Owens PK, J Chromatogr A 897: 349
(2000).
64. Fanali S, Rudaz S, Veuthey JL, Desiderio C, J Chromatogr A 919: 195 (2001).
65. Bhushan R, Parshad V, J Chromatogr A 736: 235 (1996).
66. Bhushan R, Thiong’o GT, J Planar Chromatogr Mod TLC 13: 33 (2000).

5
Pirkle-Type and Related Chiral
Stationary Phases
Generally, all of the chiral stationary phases (CSPs) have some specific structures
such as polysaccharides, proteins are polymeric, cyclodextrins and crown ethers
have cyclic features, antibiotic-based CSPs contain chiral cavities, and ligand-
exchange phases comprise metal ions coordinated with suitable ligand exchan-
gers. However, in 1976, Mikeš et al. [1] introduced a new concept by attaching a
small chiral molecule to silica gel. In this CSP, the organic groups of the chiral
molecule remain directed away from the silica gel, appearing in the form of a
brush; hence, it is called a brush-type phase. Later, Pirkle and co-workers
developed these types of CSP extensively and now these CSPs are popularly
called Pirkle-type CSPs [2–12]. Normally, the chiral molecule attached to the
silica gel contains a p-electron donor or a p-electron receptor or both types of
group. Therefore, these CSPs are classified into three groups [i.e., p-acidic (with
p-electron-acceptor groups), p-basic (with p-electron-donor groups), and p-
acidic–basic (with p-electron-acceptor and -donor groups)]. The reciprocality
concept put forth by Pirkle allowed several generations of these types of CSP
[4,7]. The main advantage of these types of phase is having the chiral molecule
attached to the silica gel. A specific and required chiral molecule (to attach onto
silica gel) can be selected by the reciprocality concept and bonded to the silica
gel; hence, the chiral resolution of a wide variety of racemic compounds can be
obtained easily and successfully. Recently, some chiral molecules having specific
groups, other than p donor or p acceptors, such as polar and polarizable groups

have been grafted onto the silica gel surface. These types of CSP were found to
have great potential for the chiral resolution of different racemic compounds. The
high stability of these phases at high pressure in normal phase or reversed-phase
modes make them ideally suitable for the chiral resolution of large number of
racemic compounds. It is also very interesting to note that these phases have been
used successfully for the chiral resolution at analytical and preparative scales. In
view of this, the present chapter describes the art of the chiral resolution by liquid
chromatography using Pirkle-type CSPs.

Basically, these CSPs contain two parts (i.e., silica gel and the chiral molecule
attached to silica gel). A general structure outlining these CSPs is shown in
Figure 1. Normally, the chiral molecules are bonded to silica gel through ionic or
covalent bonds. The phenyl groups of the chiral molecules are supposed to have
the tendency to donate the p-electrons, whereas the phenyl groups containing
electronegative groups=atoms are p-electron deficient and have the tendency to
accept p-electrons.
The first ionically bonded phase was presented by Pirkle; it contained (R)-
3,5-dinitrobenzoyl phenylglycine [13]. The most commonly used p-acid moiety is
the 3,5-dinitrophenyl group introduced by the reaction of 3,5-dinitrobenzoyl
chloride (DNB-Cl) on chiral selectors such as amino acids, amino alcohols, and
amines. In addition, pentafluorobenzoyl derivatives have also been reported
[14,15]. The p-basic phases are complimentary to the p-acidic phases. These
CSPs include the presence of phenyl- or alkyl-substituted phenyl groups.
Macaudiere et al. [9] designed a CSP containing both p-acidic and p-basic
FIGURE 1 Graphical representation of a Pirkle-type CSP.

groups on the same chiral molecule. The main precursors of these CSPs are
amino acids, amino alcohols, and amines. However, other chiral molecules have
also been used as the precursors for these CSPs.
Normally, these CSPs bear p-electron-donating or p-electron-accepting
groups closer to the chiral center and, therefore, p p interactions with the
complimentary groups of the racemic molecules resulted into the charge-transfer
complexes, which is an essential feature of the chiral resolution on these CSPs.
These CSPs are very effective for the chiral resolution of racemic compounds
containing both p-electron-donating and p-electron-accepting groups. The struc-
tures of some of these phases are shown in Figure 2.
FIGURE 2 The chemical structures of some Pirkle-type CSPs.

Pirkle phases contain small chiral molecules and, hence, are easy to prepare in
comparison to other phases. These CSPs are prepared either by ionic or covalent
bondings of the chiral molecule to the silica gel (normally of 5 mm particle size).
The preparation of these CSPs containing ionic bonding involves a three-step
procedure. The silica gel is allowed to react with some suitable silyl reagent such
as 3-aminopropyldimethoxyethoxysilane and the product obtained is 3-amino-
propyl silica gel. In the next step (step II), the chiral molecule [e.g., (R)-
phenylglycine] is treated with 3,5-dinitrobenzoyl chloride to produce the benzoyl
derivative, which was then allowed to react with the 3-aminopropyl group that
was linked to silica gel via one or more siloxyl bonds. A solution of (R)-3,5-
dinitrobenzyol phenylglycine in tetrahydrofuran (THF) is allowed to react with a
suspension of the 3-aminopropyl silica gel and the mixture is stirred well (step
III), simply producing the ionically bonded stationary phase. These types of
phases are quite effective in the normal phase mode, but they can be somewhat
labile in the aqueous phase; therefore, attempts were made to bind the chiral
molecule to silica gel by covalent bonds.
In covalent bonding, silica gel is derivatized with a suitable silyl reagent.
There are numerous silyl reagents available that contain aminopropyl, hydroxy-
propyl, and isocyanatopropyl groups which can be bonded to silica gel. The
chiral molecule is also derivatized with some suitable derivatizing reagent.
Finally, the derivatized chiral molecule is allowed to bind onto the surface of
derivatized silica gel. For example, the synthetic steps of the (R)-3,5-dinitroben-
zoyl phenylglycine CSP are shown in Figure 3. It is a three-step process including
the derivatization of silica gel with 3-aminopropyltriethoxysilane to produce 3-
aminopropyl silica gel (step I). In step II, (R)-phenylglycine is derivatized with
3,5-dinitrobenzoyl chloride. In the third step, the derivatized phenylglycine is
covalently bonded to the surface of 3-aminopropyl silica gel. Contrary to the
preparation of ionic bonding phases, the mixture of (R)-3,5-dinitrobenzoyl
phenylglycine and 3-aminopropyl silica gel is refluxed for 2–3 hr in toluene.
These types of CSP are quite stable in the reversed-phase mode even at extreme
values of pH and, hence, have been used successfully for the chiral resolution of a
wide variety of racemic compounds using different types of mobile phase. With
the development of the research in this area, different types of chiral molecule
have been grafted onto silica gel, and the new CSPs were developed and
commercialized by different trade names such as Whelk-O1, Ulmo, Kromasil
Chiral TBB, Kromasil Chiral DMB, Chiris, and so forth. The commercialized
CSPs are summarized in Table 1.

FIGURE 3 The chemical pathway for the preparation of 3,5-dinitrobenzoyl phenylglycine
CSP (Pirkle type).

TABLE 1 Various Commercial Pirkle-Type CSPs
Commercialized CSPs Companies
Opticrown Chiralhyun-Leu-1 and Opticrown Usmac Corp., Glenview, IL, USA

Chiralhyun-PG-1
Whelk-O1, Whelk-O2, Leucine, Phenylglycine, Regis Technologies, Austin, TX, USA
b-Gem 1, a-Burke 1, a-Burke 2,
Pirkle 1-J, Naphthylleucine, Ulmo, and Dach
Nucleosil Chiral-2 Macherey-Nagel, Duren, Germany
Sumichiral OA Sumika Chemical Analysis Service,
Konohana-ku Osaka, Japan
Kromasil Chiral TBB and Kromasil Chiral Eka Chemicals Separation Products,
DMB Bohus, Sweden
Chirex Type I Phenomenex, Torrance, CA, USA
Chiris series IRIS Technologies, Lawrence, KS, USA
5.3 APPLICATIONS
The Pirkle-type chiral stationary phases are quite stable and exhibit good chiral
selectivities to a wide range of solute types. These CSPs are also popular for the
separation of many drug enantiomers and for amino acid analysis. Primarily,
direct chiral resolution of racemic compounds were achieved on these CSPs.
However, in some cases, prederivatization of racemic compounds with achiral
reagents is required. The applications of these phases are discussed considering
p-acidic, p-basic, and p-acidic–basic types of CSP. These CSPs have also been
found effective for the chiral resolution on a preparative scale. Generally, the
normal phase mode was used for the chiral resolution on these phases. However,
with the development of new and more stable phases, the reversed phase mode
became popular.

The applications of p-acidic chiral stationary phases include the resolution of a-
blockers and b-blockers, amines, arylacetamine, alkylcarbinols, hydantoins,
barbiturates, naphthols, benzodiazapines, carboxylic acids, lactams, lactones,
phthaldehydes selenoids, and phosphorus compounds. Hyun et al. [16] achieved
a chiral resolution of a homologous series of N -acyl-a-(1-naphthyl)ethylamine on
N -(3,5-dinitrobenzoyl-(R)-phenylglycine and N -(3,5-dinitrobenzoyl)-(S)-leucine
CSPs. The authors used hexane-2-propanol (80 : 20, v=v) as the mobile phase.
Similarly, the scope of p-basic CSPs comprises the chiral resolution of b-
blockers, amino acids, amines, diamines, amino phosphonates, naphthols, benza-
diazapines, carboxylic acids, hydroxy acids, dipeptides, tripeptides, diols,

glycerols, lactones, lactams, sulfoxides, and thiols. Uray et al. [17] studied the
chiral recognition behavior of 3,5-dinitrobenzoylated (DNB) diphenylalkane-
amine-derived CSPs and their four racemic precursors using the normal phase
mode. In 13 cases, successful enantioseparation of these p-electron-acceptor
analytes was achieved on the p-acceptor CSPs. The authors reported that the
stereochemistries of the DNB-modified stereogenic centers of the chiral selector
and the higher retained enantiomer of the corresponding precursor were identical.
Currently, p-acidic–basic-type CSPs are very effective and common in use,
as they have a wide applicability. The most common applications of these CSPs
include the resolution of a-blockers, b-blockers, amino acids, amines, amino
phosphonates, arylacetamine, alkylcarbinols, hydantoins, barbiturates, naphthols,
benzodiazapines, carboxylic acids, hydroxy acids, dipeptides, tripeptides,
lactams, lactones, phthaldehydes, phosphorus compounds, diols, glycerols, sulf-
oxides, thiols, and selenoids. Imai et al. [18] derivatized phenylalanine and
leucine amino acids with 4-fluoro-7-nitro-2,1,3,-benzoxadiazole (afluorogenic
reagent) and separated them on a Sumichiral OA 2500 (S) column using
20 mM ammonium acetate in methanol as the mobile phase. In other studies,
the same authors [19–21] derivatized amino acids with different fluorogenic
reagents and, again, achieved the chiral resolution of these derivatives on a series
of Sumichiral OA CSPs using different mobile phases. Siddiqui et al. [22] used
the phenylglycine-type CSP to access the enantiomeric purity of different
intermediates in the synthetic route of (10 R; 20 S; 50 RÞ-menthyl-(5R)-acetoxy-1,3-
oxathiolan-(2R)-carboxylates [22]. Caccamese et al. [23] studied the chiral
resolution of 17 a-hydroxybenzoylphosphonate diethylesters on Whelk-O1 CSP
using hexane-2-propanol (70 : 30, v=v) as the mobile phase. Quaglia et al. [24]
obtained the enantioseparation of 3-benzoylchroman-4-ones, the potent antiviral
agents, on Whelk-O1 CSP with different ratios of hexane and 2-propanol as the
mobile phases. In another study, the same group [25] used (R,R)-Whelk-O1 CSP
for the chiral resolution of 2-cyclopentylthio-6-[1-(2,6-difluorophenyl)ethyl]-3,4-
dihydro-5-methylpyrimidin-4(3H)-one, a potent inhibitor of human immuno-
deficiency virus (HIV)-1. The mobile phase used was hexane-2-propanol
(90 : 10, v=v). Baeyens et al. [26] compared the chiral resolution of 2-arylpro-
pionic acids on the Whelk-O1 column using a variety of normal mobile phases.
Uray and Kosjek [27] obtained the chiral resolution of 4-(20 ; 40 -difluorobiphenyl-
4-yl)-4-oxo-2-methylbutanoic acid (flobufen) on Whelk-O1 and Ulmo CSPs
using different ratios of hexane, 2-propanol, and trifluoroacetic acid. The authors
reported the best resolution on Whelk-O1 CSP. Again, the same authors [28]
prepared and evaluated the several brush-type CSPs based on undecanoyl- or
butanoyl-bound (R,R)-1,2-diphenylethane-1,2-diamine as chiral selectors. A
benzoylated analog of the commercially available Ulmo CSP was shown to be
very effective in separating the enantiomers of N-acyl amino acids. In this way,
the CSPs containing both p-acidic and p-basic moieties proved very effective and

successful for the chiral resolution of different groups of racemic compounds.
The chromatograms of the chiral resolution on some of the commonly used CSPs
are shown in Figure 4. The chiral resolution on these CSPs is summarized in
Table 2.

The Pirkle-type CSPs are also effective for the chiral resolution of racemic
compounds at the preparative scale. Some reports have been published on the
chiral resolution using these phases at the preparative scale [53,70,94,131,132].
The Whelk-O1 CSP has been found quite good for preparative purposes. Even
using a conventional analytical column (4.6-mm inner diameter25-cm length),
small samples of a racemate can often be resolved. In one study, 12.6 mg of
naproxen was resolved within 20 min on the Whelk-O1 analytical column [131].
In 1994, Möller et al. [133] developed new chiral stationary phases for
preparative purposes. The chiral selectors were N ,N 0 -diallyltartardiamide deriva-
tives and a multifunctional hydrosilanes. The authors reported the separation of
various racemic compounds at milligram levels. Jageland et al. [134] presented
the methodology to improve the chiral resolution at the preparative scale using
Kromasil chiral columns. Pirkle-1J has been reported as a useful CSP for the
chiral resolution at the semipreparative scale [127]. The production of large
quantities of the enantiomers has been claimed for Chirex columns [125]. Eka
Chemical (Marietta, GA, USA) has also commercialized Kromasil columns for
preparative chiral separations [126]. a-Burke 1 CSP was reported to be useful for
the chiral resolution of various racemic compounds at the preparative level [127].
Sumichiral columns were claimed as useful CSPs for preparative purposes [135].
Recently, Pirkle and Koscho [136] reported the preparative chiral separation of
various N -acetyl proline anilides on Pirkle-1J and Burke 2 CSPs.
5.4 OPTIMIZATION OF HIGH-PERFORMANCE

LIQUID CHROMATOGRAPHIC CONDITIONS
The chiral resolutions on p-acidic and p-basic CSPs were carried out under the
normal phase mode. However, some reports are also available dealing with the
use of reversed-phase eluents, but the prolonged use of the reversed-phase mobile
phase is not recommended. With the development of the more stable and new
CSPs, the use of the reversed-phase mode came into existence on these CSPs.
Currently, both modes of mobile phases (i.e., normal and reversed) are in use.
Therefore, the optimization of the chiral resolution on these phases can be
achieved by varying the concentration of the mobile phases, including the use of
organic modifiers. In addition, the temperature, structures of solutes, and CSPs
are also important parameters that control the chiral resolution on these CSPs.

FIGURE 4 Chromatograms of (a) naphthyl derivatives of 1-phenyl-2-aminopropane on
3,5-dinitrobenzoyl phenylglycine CSP [29], (b) 4-fluoro-7-nitro-2,1,3-benzoxadiazole
derivatives of leucine (I) and penylalanine (II) on Sumichiral OA-2500(S) [18], (c) 3-(4-
chlorobenzyl)-chroman-4-one on Whelk-O1 [24], (d) 6-chloro-3-(4-chlorobenzyl)chro-
man-4-one on Whelk-O1 [24], and (e) benzylleucine on Ulmo column [28].

TABLE 2 Enantiomeric Resolution of Some Racemic Compounds on Pirkle-Type
CSPs
p-Acidic CSPs
a- and b-Blockers DNBGP 13, 30–35
Amines DNBGP 5–7, 29, 32,
36–51
DNBLeu 7, 29, 48–51
Arylacetamide DNBGP 13, 30
Alcohols DNBGP 4, 13, 14, 30,
32, 52–66
DNBLeu 51–66
Hydantoins DNBGP, DNBLeu 13, 30, 50, 52,
53, 67, 68
2-Carboalkoxyindolines DNBGP 50
Barbiturates DNBGP, DNBLeu 68
Naphthols DNBGP 13, 30, 32, 37,
52, 68, 69
Benzodiazepinones DNBLeu 32, 37, 70, 71
Carboxylic acids DNBGP 43, 44, 52, 72–85
Imides DNBGP, DNBLeu 13, 30, 52, 67
Lactams DNBGP 13, 30, 52, 86
DNBLeu 87
Aryllactones DNBGP, DNBLeu 88, 89
Phthalides DNBGP, DNBLeu 13, 52, 53, 71, 88
Phosphorus compounds DNBGP 13, 30, 90–95
DNBLeu 91–95
Selenoxides DNBGP 96, 97
Sulfoxides DNBGP, DNBLeu 13, 30, 53, 88, 98
Dipeptides DNBGP 99
Rotenoids DNBGP 100, 101
p-Basic CSPs
Alcohols 1R,3R-trans Chrysanthemic 4
4 acid chloride
N-Hydroxysuccinamide esters of 102
N -(1R,3R)-trans-Chrysanthemoyl-
D-phenylglycine
1-(a-Naphthyl)ethylamine and 103
2-(4-chlorophenyl)-isovaleric acid
(R)-N-(2-Naphthyl)alanine and 104
(R)-N -acylated a-aryl-
a-aminoalkane
N -(S)-2-(4-Chlorophenyl) 105, 106
isovaleroyl-D-phenylglycine
(continued )

TABLE 2 Continued
N -3,5-Dinitrobenzamide of 107
(S)-leucine and (R)-phenylglycine
Amino acids Amino acids, amines, phosphine, 108–118
oxide, alkaloids based
Phenylthiohydantoin Supelcosil LC(R)–urea 119
amino acids
Amines Dinitrobenzoic acid based 108
Amino acids and amines based 47, 107, 109–111
Aminophosphonates Amino acid based 107, 111
Naphthols Alkaloid based 120
Carboxylic acids Amino acids and amine based 87, 102, 111
Hydroxy acids 1R,3R,-trans-Chrysanthemic 4
acid chloride
Lactones and lactams 1R,3R,-trans-Chrysanthemic 4
acid chloride
Amino acid based 87
Sulfoxides 1R,3R,-trans-Chrysanthemic 4
acid chloride
Thiols 1R,3R,-trans-Chrysanthemic 4
acid chloride
p-Acidic–Basic CSPs
Alcohols Sumipax 121
Pirkle urea 122
Chiris series 123
Chirex 124
Chirex 125
Kromasil phases 126
Pirkle-1J 127
a-Burke 1 127
Sumipax 119
Amino acids Naphthyl urea 128
Whelkosil-II 3C18 RS 129
Chirex 126
Kromasil phases 127
Sumipax 119
Amines, amides, and imides Amino acids based 22
Chirex 124, 126
Kromasil phases 127
Pirkle-1J 128
a-Burke 1 128
Sumipax 18–22, 119
(continued )

TABLE 2 Continued
Naphthols Kromasil phases 127

Carboxylic acids and esters Whelk-O1 26
Ulmo 27
Chirex 124, 126
Kromasil phases 127
Sumipax 119
Ketones Whelk-O1 24, 25
Chiris series 123
Chirex 126
Kromasil phases 127
a-Burke 1 128
Lactones and lactams Kromasil phases 127
Sulfoxides Kromasil phases 127
Phosphorus compounds Whelk-O1 23
Chirex 126
Uridine analogs Whelk-O1 130
Note: DNBGP=3,5-dinitrobenzoyl phenylglycine; DNBLeu=3,5-dinitrobenzoyl leucine.
Because of the development of the new types of CSP (p-acidic–basic types), the
use of p-acidic and p-basic types of CSP are not common. In view of this,
attempts are made to describe the art of the optimization of the chiral resolution
using only p-acidic–basic-type CSPs. The optimization of the chiral resolution on
Pirkle-type CSPs are presented in Scheme 1.

Generally, the normal phase mode has been used frequently for the chiral
resolution of racemic compounds on Pirkle-type CSPs. Hexane, heptane, and
cyclohexane are the nonpolar solvents of choice on these phases. Aliphatic
alcohols may be considered as hydrogen donors and acceptors and may thus
interact at many points with the aromatic amide groups of CSPs generating the
hydrogen bonds. Therefore, the addition of aliphatic alcohols improve the chiral
resolution; hence, the alcohols are considered as organic modifiers. The most
commonly used alcohol is 2-propanol. However, methanol, ethanol, 1-propanol,
and n-butanol were also used. Some reports also indicated the use of dichloro-
methane and chloroform as the organic modifiers with hexane. In addition to this,
acidic and basic additives improve the chromatographic resolution. A small
amount of acetic acid, formic acid, or trifluoroacetic acid improve the peak shape

SCHEME 1 Protocol for the development and optimization of mobile phases on Pirkle-
type CSPs under the normal phase mode. AcOH, acetic acid; TEA, triethylamine.
and enantioselectivity for acidic and basic solutes. Sometimes, there is a need to
combine an acid and organic amine (e.g., triethylamine) for strong basic racemic
compounds. We have carried out an extensive search of literature on these phases
and proposed a protocol for the development and use of the mobile phases; it is
presented in Scheme 1.
Fell and Days [137] studied the effect of the chain length of the alcohols on
the chiral resolution of propranolol on 3,5-dinitrobenzoyl-a-phenylglycine CSP.
In one study, the separation of the phenylurea derivatives of the enantiomers of
propranolol using n-dodecane and n-pentane as the mobile phase was carried out
and is shown in Figure 5 [11]. This figure indicates the greater resolution using n-
pentane in comparison to using n-dodecane. The authors also reported an
improved selectivity and column efficiency when using n-pentane as the
mobile phase.
Uray and Kosjek [27] used different ratios of the hexane and 2-propanol for
the chiral resolution of flobufen and its metabolites. The CSPs used were Whelk-
O1 and Ulmo. In another study, the same authors [28] utilized the mixtures of
heptane, 2-propanol, and trifluoroacetic acid for the chiral resolution of a variety
of racemic compounds using Ulmo and related CSPs. Caccamese et al. [23]
studied the effect of the concentration of 2-propanol on the chiral resolution of

FIGURE 5 Chromatograms of the chiral resolution of propranolol enantiomers on 3,5-
dinitrobenzoyl-a-phenylglycine CSP using (a) n-dodecane and (b) n-pentane as the major
component of the mobile phases. (From Ref. 11.)
some a-hydroxybenzoyl phosphonate diethyl esters. The authors reported a

different pattern of chiral resolution for different esters. Baeyens et al. [26]
reported the best resolution of several nonsteroidal anti-inflammatory drugs and
benzoin using hexane-2-propanol-acetic acid (70 : 30 : 0.5, v=v=v) as the mobile
phase on Whelk-O1 CSP. Imai et al. [19] carried out the chiral resolution of
derivatized amino acids on a series of Sumipax CSPs using methanol containing
citric acid as the mobile phase. The authors studied the effect of the concentration
of citric acid on the chiral resolution of amino acid derivatives. They found the
10 mM concentration of citric acid to be the best one (Fig. 6). Stringham and
Blackwell [138] studied the effect of organic modifiers (i.e., methanol, ethanol, 1-
propanol, 2-propanol, n-butanol, trifluoroethanol and tetrahydrofuran) on the
chiral resolution of aromatic alcohols using the Whelk-O1 column at different
temperatures. These findings are given in Figure 7, which shows different types of
chiral resolution pattern. Magora and Abu-Lafi [130] used a variety of mobile
phases for the chiral resolution of uridine analogs on the Whelk-O1 column.
Macaudiere et al. [139] observed the reversal order of elution of some amino acid
derivatives just by changing ethanol as an organic modifier to chloroform or
dichloromethane in hexane as a mobile phase.
A few reports are available on the use of reversed-phase eluents on the
ionically bonded CSPs. However, with the development of new and more stable
CSPs, the use of reversed-phase eluents could be possible. The reversed-phase
mode is usually chosen to minimize nonstereoselective polar adsorption of the
enantiomers on the stationary phase. The reversed-phase mode is preferred when
solubility problems occur in the mobile phase or when injection without analyte

FIGURE 6 Effect of the concentration of citric acid in methanol on the chiral resolution
of phenylalanine and its derivatives on Sumichiral OA-2500(S) CSP: (d) D-phenylalanine,
(s) L-phenylalanine, (j): D- and L-phenylalanine amide and (n) D- and L-phenylalanine
ester. (From Ref. 20.)
prederivatization is needed. Iwaki et al. [140] used acetonitrile–0.15 M sodium

acetate (pH 5.0) (70 : 30, v=v) as the mobile phase for the chiral resolution of p-
bromophenylcarbamyl threonine and p-bromophenylcarbamyl phenylalanine on
the naphthyl urea Pirkle phase. The same CSP was used for the chiral resolution
of other amino acids derivatives using different ratios of acetonitrile and
phosphate buffer (pH 6.0) [140].
5.4.2 Temperature
The effect of the temperature is also important for the chiral resolution on these
CSPs. Pirkle and Murray [141] reported the inversion of the elution order of
3,5-dinitrobenzoyl-a-phenylethylamine when the temperature was successively
changed. The observed effect of temperature was dependent on the content and
polarity of the organic modifier in the mobile phase. Stringham and Blackwell
[138] studied the effect of the temperature on the chiral resolution of aromatic
alcohol on the Whelk-O1 column. The results are given in Figure 7 and it is clear
from this figure that the resolution decreased by increasing the temperature.
Recently, Magora et al. [130] studied the effect of temperature on the chiral

FIGURE 7 Effect of the organic modifiers on the chiral resolution of aromatic alcohol
using Whelk-O1 CSP at different temperatures with negative values of ln k indicating the
reversal order of elution: (j) ethanol, (d) 1-butanol, (m) 2-propanol, (r) 1-propanol, ( þ )
trifluoroethanol, and () tetrahydrofuran. (From Ref. 138.)
resolution of uridine analogs on the Whelk-O1 column. Generally, the increase in

temperature results into a decrease in the differences of the binding energies of
the two enantiomers and, hence, a decrease in the enantioselectivity occurs.
5.4.3 Structures of the Solutes

As in the case of other CSPs, the chiral resolution is effected by the structure of
the solute. The chiral resolution of amino acids may be considered as the best
example for this study. The work of Fukushima et al. [20] (i.e., the chiral
resolution of amino acids) indicated the different behavior of the chiral resolution
on (S)-N -3,5-dinitrobenzoyl-1-naphthylglycine CSP. Altomare et al. [142] studied
the chiral resolution of a series of 3-phenyl-4-(1-adamantyl)-5-X -phenyl-D2 -
1,2,4-oxadiazolines on N ,N 0 -(3,5-dinitrobenzoyl)-1(R),2(R)-diaminocyclohexane
CSP. The effect of the influence of aromatic ring substituents on enantioselectivity
was studied by traditional linear free-energy-related equations and comparative
molecular field analysis methods. The authors reported that an increase in
retention was favored by the p-basicity and the hydrophilicity of the solutes. In

one of the studies, Pirkle and Spence [143] developed a relationship between the
structures of aryl-substituted heterocycles, focusing on lactones and analogs. The
authors obtained the enantioselectivity and elution order of heterocycles practi-
cally via a mechanistic hypothesis developed by them.
5.4.4 Structures of the CSPs

The chiral resolution on these CSPs varied from one CSP to another; therefore, it
can be optimized by selecting the suitable chiral stationary phases. In one of the
studies, the effect of the structures of the CSPs on the chiral resolution of certain
nonsteroidal anti-inflammatory drugs was carried out by Pirkle and Welch [144].
The studied CSP 1 had the long aliphatic chain; this chain was removed in CSP 2
(Fig. 8a). The results of this study are given in Table 3. The CSP 2 was found to
have significantly greater chiral selectivity than the long-chain CSP 1. For a better
selectivity of CSP 2, the authors claimed the stronger and different interactions
between CSP 2 and the enantiomers. However, the elimination of the long
aliphatic chain would also greatly reduce the dispersive interactions of the solute
with the stationary phase and thus relatively augment the polar interactions. Imai
et al. [19] carried out an interesting study of the chiral resolution of 4-fluoro-7-
nitro-2,1,3-benzoxadiazole (DNB) derivatives of amino acids on several Sumi-
chiral OA series CSPs. The various studied CSPs are Sumichiral OA 2000(S),
OA-2500(S), OA-2500(R), OA-3000(S), and OA-3200(S) and their structures are
given in Figure 8b. The chiral centers of these CSPs are derived from N -
acylamino-(S)-amino acid amides. The results of the chiral resolution of amino
TABLE 3 Effect of the Structures of Pirkle-Type CSPs on the Chiral Resolution of

Profens
CSP 1 CSP 2
Profens k a k a
Naproxen 3.96 2.26 1.71 2.93

Ibuprofen 0.94 1.12 0.19 1.47
Ketoprofen 4.53 1.11 1.39 1.29
Flurbiprofen 1.63 1.19 0.37 1.59
Pirprofen 2.53 1.38 0.85 1.81
Fenoprofen 1.48 1.22 0.38 1.61
Cicloprofen 3.03 1.71 1.16 2.15
Tioprofenic acid 6.15 1.09 2.02 1.23
Note: CSP 1 contains larger aliphatic alkyl chain than CSP 2.

Source: Ref. 144.

FIGURE 8 The chemical structures of (a) Pirkle-type CSPs with small and large alkyl
chains (from Ref. 144) and (b) different Sumichiral OA CSPs. (From Ref. 20.)

TABLE 4 Effect of the Structures of Sumichiral OA CSPs on the Chiral Resolution
of DNB Amino Acids
OA- OA- OA-

2000(S) OA-2500(S) OA-2500(R) 3000(S) 3100(S)
DNB-amino acids k a k a k a k a k a
Leu 0.91 1.10 2.73 1.12 2.19 1.17 1.48 1.08 1.01 1.52
Ile 1.09 1.07 3.28 1.15 2.72 1.19 1.58 1.00 1.18 1.25
Val 1.31 1.00 3.53 1.14 2.93 1.20 1.71 1.00 1.29 1.22
Ala 2.58 1.06 4.66 1.14 4.29 1.19 2.34 1.00 2.05 1.31
Pro 5.47 1.00 7.31 1.09 7.87 1.44 3.30 1.00 5.48 1.06
Thr 2.36 1.06 5.43 1.12 4.62 1.16 2.77 1.00 2.13 1.35
Ser 4.68 1.00 7.54 1.11 6.96 1.15 3.96 1.00 3.10 1.33
Phe 2.62 1.10 6.37 1.21 6.18 1.28 2.65 1.04 2.16 1.36
Met 2.55 1.10 4.91 1.17 5.18 1.24 2.55 1.06 2.08 1.40
Gln 3.90 1.00 6.76 1.10 6.55 1.12 2.97 1.00 3.00 1.27
Lys 8.16 1.12 12.04 1.18 15.04 1.24 2.65 1.00 4.96 1.57
Mobile phase: 5 mM citric acid in methanol; DNB=4-fluoro-7-nitro-2,1,3-benzoxadiazole.

Source: Ref. 20.
acids derivatives on these CSPs are given in Table 4. It is clear from this table that
the chiral resolution varies from one CSP to another. The larger values of
separation factors were obtained on OA-3100(S), which bears the 3,5-dinitro-
phenyl group instead of the tert-butyl group in OA-3000(S). The extent of the
separation factors of DNB-amino acids on OA-2000(S), bearing a phenyl group,
were lower than OA-3100(S). The retention of DNB-amino acids on OA-2500(S),
which has a naphthyl group, was greater than OA-2000(S). The authors explained
the different patterns of the chiral resolution as being caused by the interactions of
different magnitudes on these CSPs.

In addition to the above-discussed chromatographic parameters, other factors are
also important for controlling the chiral resolution on these phases. These include
injection amount, particle size of silica gel, spacer between the chiral selector and
the silica gel, and the dimension of the column. Recently, Baeyens et al. [26]
carried out the chiral resolution of pirprofen on Whelk-O1 columns of diameters
of 2.1 and 4.6 mm. The authors reported the best resolution on the column having
4.6 mm as the internal diameter (Fig. 9).

FIGURE 9 A comparison of the chiral resolution of pirprofen on Whelk-O1 CSP of (a)
2.1 and (b) 4.6 mm internal diameters. (From Ref. 26.)

Pirkle type CSPs contain a chiral moiety having phenyl ring and, therefore, the
formation of a p p charge-transfer diastereoisomeric complex of the enantiomers
(with the phenyl group) with CSP is supposed to be essential. In view of this, the
p-acidic CSPs are suitable for the chiral resolution of p-donor solutes and vice
versa. However, the newly developed CSPs containing both p-acidic and p-basic
groups are suitable for the chiral resolution of both types of solute (i.e., p-donor
and p-acceptor analytes).
Different studies were carried out to predict the chiral recognition mechan-
isms on these CSPs. The most important methodologies include the use of
chromatography [9,72,109,145,146], X-ray [142], NMR [9,20,147,148], mole-
cular modeling [9,25,142], and computer-aided chemistry [9,149–151]. Initially,
Pirkle et al. [72,109] obtained the chiral resolution of a series of homologous
compounds on different CSPs. The authors advocated two antinomic mechanisms
involving either hydrogen-bondings or the dipole stacking phenomenon. In
another study, Pirkle and Däppen [7], starting from the reciprocality concept,
established the presence of hydrogen-bondings and dipole stacking mechanisms.
Wainer and Alembic [39] observed the reverse order of elution of some amides by
changing the dipole group and the authors reported the existence of hydrogen-
bondings and dipole stacking processes. Vinkovic et al. [145] studied the chiral
resolution of 2-arylpropionic acid enantiomers on different CSPs. The authors
reported that hydrogen-bondings and p p interaction forces are responsible for
the chiral resolution. Even though chromatographic studies provide adequate
evidence for the chiral recognition mechanisms, they are also limited because

they give an overall view of the mechanisms; hence, more models were developed
with the help of X-ray, nuclear magnetic resonance (NMR), and molecular
modeling studies.
Altomare et al. [142] carried out the X-ray and circular dichroism
measurements of 3-phenyl-4-(1-adamantyl)-5-X -phenyl-D2 -1,2,4-oxadiazolines
on N ,N 0 -(3,5-dinitrobenzoyl)-1(R),2(R)-diaminocyclohexane CSP. The authors
claimed the chiral recognition is the result of p-basicity and hydrophobicity of
the analytes. Pirkle and Pochapsky [147] studied the chiral binding of 3,5-
dinitrobenzoyl leucine propylamide on (S)-methyl(N )-(2-naphthyl)alaninate CSP
by NMR. The chiral recognition model of this study is shown in Figure 10, which
shows the presence of hydrogen-bondings and p p interactions. Similarly, Fuku-
shima et al. [20] postulated the presence of p p interactions and hydrogen-
bondings in the diastereoisomeric complexes of the enantiomers and CSP. In
addition to these studies, computation aided chemistry and molecular modeling
calculations were carried out and applied to the chromatographic experiments.
The combination of these calculations and the results obtained from the experi-
mental methodologies (X-ray, NMR, chromatography) indicated that p p inter-
actions, hydrogen-bondings, steric effects and dipole–dipole forces are
responsible for the chiral resolution on Pirkle-type CSPs.
FIGURE 10 Chiral recognition model showing three simultaneous bondings between (S)-
methyl-N-(2-naphthyl)alaninato and (S)-N-(3,5-dinitrobenzoyl)leucine n-propylamine.
(From Ref. 9.)

Briefly, Pirkle-type CSPs contain a chiral moiety which provides the chiral
environment to the enantiomers. Therefore, the enantiomers interact with this
chiral moiety with different fittings (due to different spatial configuration of the
enantiomers). In this way, the two enantiomers form the diastereoisomeric
complexes having different binding energies. The different binding energies of
the diastereoisomeric complexes are the result of the various interactions, as
mentioned earlier, of different magnitude. Therefore, the two enantiomers eluted
at different retention times with the flow of the mobile phase and hence the chiral
resolution occurred. A general graphical representation of the chiral resolution of
naproxen enantiomers on (S,S)-Whelk-O1 CSP is shown in Figure 11, which
represents the above-mentioned concept.
FIGURE 11 Graphical representation of the chiral recognition mechanisms of naproxen

enantiomers on (S,S)-Whelk-O1 CSP.

Pirkle type CSPs have been used in sub-FC and SFC models of chromatography
since 1985. Mourier et al. [95,152] reported the chiral resolution of phosphine
oxides on DNBPG CSP with carbon dioxide mixed with various modifiers.
Macaudiere et al. [38,153,154] compared the chiral resolution of amides and
phosphine oxides using SFC and high-performance liquid chromatography
(HPLC). Later, several reports were published on the chiral resolution of a
variety of racemic compounds using sub-FC and SFC techniques [155–158].
Blum et al. [159] reported the chiral resolution of warfarin, trans-stilbene oxide,
benzoin, verapamil, ketoprofen, abscissic acid, N -mesitylsulfonyl-D-alanine, and
phenylmethyl sulfoxide on the Whelk-O1 column at analytical and preparative
scales. Furthermore, the authors separated 200 mg of warfarin enantiomers within
10 min on the analytical Whelk-O1 column (preparative separations). Terfloth et
al. [160] resolved the enantiomers of warfarin, flubiprofen, and benzoin on
Whelk-O1 CSP using sub-FC and SFC models of chromatography. The enantio-
separations of b-blockers was achieved on the ChyRoSine-A CSP with a
modified carbon dioxide eluent, but the same compound could not be resolved
by HPLC [161]. According to one of the reviews published by Terfloth [162], the
enantiomers of propranolol were resolved at the preparative scale on ChyRoSine
A CSP using carbon dioxide as the mobile phase in SFC. The chromatograms of
the chiral resolution of ibuprofen and ketoprofen on Whelk-O1 column are
shown in Figure 12. The applications of the chiral resolution on Pirkle-type CSPs
using SFC are summarized in Table 5.
The effects of the subcritical and supercritical chromatographic parameters
on the chiral resolution of racemic compounds on these phases were also
investigated. Macaudiere et al. [38,153,154] compared the chiral resolution of
amides and phosphine on SFC and HPLC. The authors reported greater values of
resolution factors with fivefold smaller values of retention times in SFC in
comparison to HPLC. The comparative results for their studies are shown in
Figure 13. Furthermore, they also reported the effect of various parameters such
as composition of the mobile phase, use of organic modifiers, and temperature on
chiral resolution using SFC. According to them, the use of a small amount of
water in the mobile phase resulted in an improved chiral resolution (Fig. 13).
They concluded that the effects of these parameters on the chiral resolution by
SFC were comparable with HPLC. Blum et al. [159] compared the chiral
resolution of some drugs on SFC and HPLC and the authors advocated the
superiority of SFC in terms of speed, efficiency, and method development
procedures. Stringham [163] presented a model which predicted the relationship
between the chiral sub-FC and the resolution times. The author reported that the
increased column efficiency of sub-FC at typical flow rates rescued separations

FIGURE 12 Chromatograms of the chiral resolution of (a) ibuprofen and (b) ketoprofen
on Whelk-O1 CSP using SFC. (From Ref. 158.)
that failed in HPLC. The effect of the temperature [155,156] on the chiral
resolution of some drugs was evaluated. Generally, it was observed that the
enantioselectivities decreased at higher temperature. Blackwell et al. [158]
presented an empirical relationship which related properties of the mobile
phase modifiers to the chiral selectivities for a number of analytes. Furthermore,
Stringham and Blackwell [164] studied the effect of the temperature on the chiral
resolution of benzoins and Z-phenylalaninol and related compounds using SFC
model of liquid chromatography. The authors reported a decrease in chiral
resolution by increasing the temperature. The effect of the temperature on the
chiral resolution of benzoins and Z-phenylalaninol is shown in Figure 14. In other
studies, the same authors [165,166] achieved the chiral resolution of a set of

TABLE 5 Enantiomeric Resolution of Racemic Compounds on Pirkle-Type CSPs
Using Sub-FC and SFC
Phosphine oxides DNBPG 38, 95, 153, 154

Amidotetralin Whelk-O1 156
Amines Whelk-O1 162
Anticoagulants Whelk-O1 162
Aryloxypropionic acids Whelk-O1 162
Arylpropionic acids Whelk-O1 159, 160, 162
Chlorohydrin Whelk-O1 163
Dinitrobenzamide Whelk-O1 162
Epoxides Whelk-O1 162
Hydantoins Whelk-O1 162
b-Blockers ChyRoSine-A 161, 162
FIGURE 13 A comparison of the chiral resolution of 2-naphthyl amide derivatives of 2-

aminooctane enantiomers on 3,5-dinitrobenzoyl phenylglycine CSP by HPLC and SFC
using (u) hexane–2-propanol (95 : 5, v=v), (j) carbon dioxide–2-propanol (95 : 5, v=v),
and (d) carbon dioxide–2-propanol–water (95 : 4.8 : 0.2, v=v=v) as the mobile phases.
(From Ref. 9.)

FIGURE 14 Effect temperature on the chiral resolution of (a) benzoin and (b) Z-
phenylalaninol on Whelk-O1 CSP using SFC, 1=Tc and 1=Tc : CO2 are the critical
temperatures of the mobile phase and CO2, respectively, j and d are the ln k values of
the two enantiomers. (From Ref. 163.)

phenyl-substituted N -t-butoxycarbonyl phenylalanine analogs on the a-Bruke 2
column using various mobile phase additives. The acidic mobile phase additives
used were acetic acid, chloroacetic acid, dichloroacetic acid, trifluoroacetic acid,
methanesulfonic acid, and trifluoromethanesulfonic acid. It was reported that
trifluoromethanesulfonic acid resulted in good separation. The authors modeled
the selectivity factors and predicted the presence of hydrogen-bondings and p p
interactions between the enantiomers and CSP. Briefly, the chiral recognition
mechanisms on these CSPs using SFC are similar to that of HPLC chiral
separations.

In spite of the high speed and efficiency of capillary electrochromatography, the
Pirkle-type CSPs could not be used frequently for chiral resolution purposes.
Only a few reports are available on this issue. Cavender et al. [167] and Wolf et al.
[168] utilized Pirkle-type CSPs, in the form of packed capillary columns, for the
chiral resolution of N -[-(4-bromophenyl)]-2,2-dimethylpropionamide, 3,5-dinitro-
benzoyl amino acids, hydroxy benzoin, and cyclopropane derivatives. Peters et al.
[169] prepared several monolithic chiral stationary phases for reversed-phase
electrochromatography within the confines of untreated fused silica capillaries by
the direct copolymerization of the chiral monomer 2-hydroxyethyl methacrylate
(N -L-valine-3,5-dimethylanilide) carbamate with ethylene dimethacrylate, 2-
acrylamido-2-methyl-1-propanesulfonic acid, and butyl or glycidyl methacrylate
in the presence of a protogenic solvent. The authors also reported that the
hydrophilicity of the stationary phase, which may be enhanced further by the
hydrolysis of the epoxide functionalities of the glycidyl methacrylate moieties
within the monolith, was found to have a pronounced effect on the enantio-
separation. Using the most hydrophilic monolithic capillary column and opti-
mized elution conditions, the enantiomers of 3,5-dinitrobenzoyl leucine diallyla-
mide were resolved successfully.
Lienne et al. [170] resolved the enantiomers of albendazole sulfoxides on a
column derived from the (S)-N -(3,5-dinitrobenzoyl)tyrosine chiral selector. The
developed method was applied for the enantiomeric resolution of albendazole
sulfoxides in plasma samples. Witherow et al. [171] immersed a commercially
available thin-layer plate (thin-layer chromatography) into a solution of N -(3,5-
dinitrobenzoyl)-L-leucine solution. The developed plate was used for the chiral
resolution of 2,2,2-trifluoro-(9-anthryl)ethanol and 1,10 -binaphthol enantiomers.
5.8 CONCLUSION
Pirkle-type CSPs have achieved a good status in the field of the chiral resolution
by liquid chromatography. In these phases, the chiral moiety on the silica support

can be bonded selectively and, therefore, these CSPs can be prepared as per the
requirement of chiral resolution. There is no serious drawback associated with
these phases. However, a search of literature indicates that the chiral resolution on
these CSPs requires the prederivatization of some racemic compounds, which is,
of course, a tedious and time-consuming job. Moreover, the derivatization of
racemic compounds in natural samples (e.g., biological and environmental
samples) is not possible; therefore, the application of these phases for the
chiral resolution in natural samples is very limited. In addition, most of the
chiral resolution reports on these CSPs deal with the use of the normal mobile
phase mode which have, again, limited choice of optimization of the chiral
resolution. However, with the development of the new and more stable CSPs, the
reversed phase mode was used in some studies. In conclusion, it seems that these
CSPs are not fully developed and are underway for their development. We hope
that, in the future, these phases will achieve a good reputation, especially in
natural samples, for chiral resolution.
REFERENCES
1. Mikeš F, Boshart G, Gil-Av E, J Chromatogr 122: 205 (1976).
2. Pirkle WH, Sikkenga DL, J Chromatogr 123: 400 (1976).
3. Pirkle WH, House DW, J Org Chem 44: 1957 (1979).
4. Pirkle WH, House DW, Fin JM, J Chromatogr 192: 143 (1980).
5. Pirkle WH, Finn JM, J Org Chem 46: 2935 (1981).
6. Pirkle WH, Welch CJ, J Org Chem 49: 138 (1984).
7. Pirkle WH, Däppen R, J Chromatogr 404: 107 (1987).
8. Finn JM, Rational design of Pirkle type chiral stationary phases, in Chromato-
graphic Chiral Separations, Zief M, Crane LJ (Eds.), Chromatographic Science
Series Vol. 40, Marcel Dekker, New York (1988).
9. Macaudiere P, Lienne M, Tambute A, Caude M, Pirkle type and related chiral
stationary phases for enantiomeric resolution, in Chiral Separations by HPLC,
Krstulovic AM (Ed.), Ellis Horwood, New York (1989).
10. Aboul-Enein HY, Wainer IW (Eds.), The Impact of Stereochemistry on Drug
Development and Use, John Wiley & Sons, New York (1997).
York (1998).
12. Persson BA, Andersson S, J Chromatogr A 906: 195 (2001).
13. Pirkle WH, Fin JM, Schreiner JL, Hamper BC, J Am Chem Soc 103: 32,964
(1981).
14. Kip J, Van Haperen P, Karaak JC, J Chromatogr 356: 423 (1986).
15. Gargaro G, Gasparrini F, Misiti D, Palmieri G, La Torre F, Villani C, 16th
International Symposium on Chromatography, Paris (1986).
16. Hyun MH, Min CS, Cho YJ, Na MS, J Liq Chromatogr 18: 2527 (1995).
17. Uray G, Niederreiter KS, Maier NM, Spitaler MM, Chirality 11: 404 (1999).
18. Imai K, Fukushima T, Uzu S, Biomed Chromatogr 7: 177 (1993).

19. Imai K, Fukushima T, Biomed Chromatogr 7: 275 (1993).
20. Fukushima T, Kato M, Santa T, Imai K, Biomed Chromatogr 9: 10 (1995).
21. Kato M, Fukushima T, Shimba N, Shimada I, Kawakami Y, Imai K, Biomed
Chromatogr 15: 227 (2001).
22. Siddiqui MA, Jin H, Evans CA, Dimarco MP, Tse HLA, Mansour TS, Chirality 6:
156 (1994).
23. Caccamese S, Failla S, Finocchiaro P, Principato G, Chirality 10: 100 (1998).
24. Quaglia MG, Desideri N, Bossu E, Sgro R, Conti C, Chirality 11: 495 (1999).
25. Quaglia MG, Mai A, Artico SM, Ragno R, Massa S, Piano DD, Setzu G, Doratiotto
S, Cotichini V, Chirality 13: 75 (2001).
26. Baeyens WRG, Van der Weken G, Aboul-Enein HY, Reygaerts S, Smet E, Biomed
Chromatogr 14: 58 (2000).
27. Uray G, Kosjek B, Enantiomer 5: 329 (2000).
28. Kosjek B, Uray G, Chirality 13: 657 (2001).
29. Wainer IW, Doyle TD, J Chromatogr 259: 465 (1983).
30. Pirkle WH, Finn JM, Hamper BC, Schreiner J, Pribish JR, A useful and
conveniently accessible chiral stationary phase for liquid chromatographic separa-
tions of enantiomers, in Asymmetric Reactions and Process in Chemistry, Eliels EL,
Otsuka S (Eds.), ACS Symposium Series No. 185, American Chemical Society,
Washington DC, p. 245 (1982).
31. Wainer IW, Doyle TD, Donn KH, Powell JR, J Chromatogr 306: 405 (1984).
32. Zief M, Crane LJ, Horvath J, J Liq Chromatogr 7: 709 (1984).
33. Wainer IW, Doyle TD, Hamidzadeh Z, Aldridge M, J Chromatogr 261: 123 (1983).
34. Wainer IW, Doyle TD, Fry FS, Hamidzadeh Z, J Chromatogr 355: 149 (1986).
35. Wainer IW, Doyle TD, Hamidzadeh Z, Aldridge M, J Chromatogr 268: 107 (1983).
36. Doyle TD, Wainer IW, J High Resolut Chromatogr 7: 38 (1984).
37. Smith DF, Pirkle WH, Psychopharmacology 89: 392 (1986).
38. Macaudiere P, Tambute A, Caude M, Rosset R, Alembik MC, Wainer IW, J
Chromatogr 371: 177 (1986).
39. Wainer IW, Alembic MC, J Chromatogr 367: 59 (1986).
40. McErlane KM, Igwemezioe L, Kerr CR, J Chromatogr 415: 335 (1987).
41. Wainer IW, Doyle TD, Adams WM, J Pharm Sci 73: 1162 (1984).
42. Meyers AI, Bailey TR, J Org Chem 51: 872 (1986).
43. Wainer IW, Doyle TD, LC, HPLC Mag 2: 88 (1984).
44. Crowther JB, Covey TR, Dewey EA, Henion JD, Anal Chem 56: 2921 (1984).
45. Lee ED, Henion JD, Brunner CA, Wainer IW, Doyle TD, Gal J, Anal Chem 58:
1349 (1986).
46. Doyle TD, Adams WM, Fry FS, Wainer IW, J Liq Chromatogr 9: 455 (1986).
47. Pirkle WH, Hyun MH, J Chromatogr 322: 295 (1985).
48. Baker JK, Clark AM, Hufford CD, J Liq Chromatogr 9: 493 (1986).
49. Pirkle WH, Welch CJ, Mahler GS, Meyers AI, Fuentes LM, Boes M, J Org Chem
49: 2504 (1984).
50. Pirkle WH, Pochapsky TC, Mahler GS, Field RE, J Chromatogr 348: 89 (1985).
51. Pirkle WH, Pochapsky TC, J Org Chem 51: 102 (1986).
52. Kasai M, Froussios C, Ziffer H, J Org Chem 48: 459 (1983).

53. Pirkle WH, Finn JM, J Org Chem 47: 4037 (1982).
54. Perry JA, Rateike JD, Szczerba TJ, J Chromatogr 389: 57 (1987).
55. Perry JA, Rateike JD, Szczerba TJ, J Liq Chromatogr 9: 3297 (1986).
56. Pettit GR, Sing SB, Cragg GM, J Org Chem 50: 3404 (1985).
57. Yang SK, Weems HB, Anal Chem 56: 2658 (1984).
58. Weems HB, Yang SK, Anal Biochem 125: 156 (1982).
59. Weems HB, Fu PP, Yang SK, Carcinogenesis 7: 1221 (1986).
60. Yang SK, Mushtaq M, Fu PP, J Chromatogr 371: 195 (1986).
61. Weems HB, Mushtaq M, Fu PP, Yang SK, J Chromatogr 371: 211 (1986).
62. Fu PP, Yang SK, Biochem Biophys Res Commun 109: 927 (1982).
63. Mushtaq M, Weems HB, Yang SK, Biochem Biophys Res Commun 125: 539
(1984).
64. Yang SK, Li XC, J Chromatogr 291: 265 (1984).
65. Yang SK, Weems HB, Mushtaq M, Fu PP, J Chromatogr 316: 569 (1984).
66. Weems HB, Mushtaq M, Yang SK, Anal Chem 59: 2679 (1987).
67. Yang ZY, Barknan S, Brunner C, Weber JD, Doyle TD, Wainer IW, J Chromatogr
324: 444 (1985).
68. Pirkle WH, Schreiner JL, J Org Chem 46: 4988 (1981).
69. Pirkle WH, Finn J, Separation of enantiomers by liquid chromatographic methods,
in Asymmetric Synthesis, Volume 1, Analytical Methods, (Morrison JD (Ed.),
Academic Press, New York, p. 87 (1983).
70. Pirkle WH, Tsipouras A, J Chromatogr 291: 291 (1984).
71. Pirkle WH, Tsipouras A, Sowin TJ, J Chromatogr 319: 392 (1985).
72. Pirkle WH, Hyun MH, Tsipouras A, Hamper BC, Bank B, J Pharm Biomed Anal 2:
173 (1984).
73. Sioufi A, Colussi D, Marfil F, Dubois JP, J Chromatogr 414: 131 (1987).
74. Oi N, Matsumoto Y, Kitahara H, Miyazaki H, Bunseki Kagaku 35: 312 (1986).
75. Wainer IW, Doyle TD, J Chromatogr 284: 117 (1984).
76. McDaniel DM, Snider BG, J Chromatogr 404: 123 (1987).
77. Nicoll-Griffith DA, J Chromatogr 402: 179 (1987).
78. Demerson CA, Humber LG, Abraham NA, Schilling G, Martel RR, Pace-Asciak C,
J Med Chem 26: 1778 (1983).
79. Chapman RA, J Chromatogr 258: 175 (1983).
80. Papadopoulou-Mourkidou E, Chromatographia 20: 376 (1985).
81. Cayley GR, Simpson BW, J Chromatogr 356: 123 (1986).
82. Dernoncour R, Azerad R, J Chromatogr 410: 355 (1987).
83. Blessington B, Crabb N, O‘Sullivan J, J Chromatogr 396: 177 (1987).
84. Wainer IW, Doyle TD, Breder CD, J Liq Chromatogr 7: 731 (1984).
85. Mazzo DJ, Lindemann CJ, Brenner GS, Anal Chem 58: 636 (1986).
86. Lienne M, Caude M, Rosset R, Tambute A, J Chromatogr 448: 55 (1988).
87. Pirkle WH, Tsipouras A, Hyun MH, Hart DJ, Lee CS, J Chromatogr 358: 377
(1986).
88. Pirkle WH, Sowin TJ, J Chromatogr 387: 313 (1987).
89. Bonnaud B, Calmel F, Pastoiseau JF, N’Guyen NT, Cousse H, J Chromatogr 318:
398 (1985).

90. Brown TM, Grothusen JR, J Chromatogr 294: 390 (1984).
91. Oliveros L, Cazau M, J Chromatogr 409: 183 (1987).
92. Pescher P, Caude M, Rosset R, Tambute A, Oliveros L, Nouv J Chem 9: 621 (1985).
93. Pescher P, Caude M, Rosset R, Tambute A, J Chromatogr 371: 159 (1986).
94. Tambute A, Gareil P, Caude M, Rosset R, J Chromatogr 363: 81 (1986).
95. Mourier P, Eliot E, Caude M, Rosset R, Tambute A, Anal Chem, 57: 2819 (1985).
96. Shimizu T, Kobayashi M, Bull Chem Soc Jpn 59: 2654 (1986).
97. Shimizu T, Kobayashi M, J Org Chem 52: 3399 (1987).
98. Allenmark S, Nielson L, Pirkle WH, Acta Chem Scand B37: 325 (1983).
99. Pirkle WH, Däppen R, Reno DS, J Chromatogr 407: 211 (1987).
100. Abidi SL, J Liq Chromatogr 10: 1085 (1987).
102. Oi N, Nagase M, Inda Y, Doi T, J Chromatogr 259: 487 (1983).
103. Oi N, Kitahara H, J Chromatogr 265: 117 (1983).
104. Pirkle WH, Malher GS, Pochapsky TC, Hyun MH, J Chromatogr 388: 307 (1987).
105. Takagi T, Itabashi Y, J Chromatogr 366: 451 (1986).
106. Itabashi Y, Takagi T, J Chromatogr 402: 257 (1987).
107. Pirkle WH, Sowin TJ, J Chromatogr 396: 83 (1987).
108. Däppen R, Arm H, Meyer VR, J Chromatogr 373: 1 (1986).
109. Pirkle WH, Hyun MH, Bank B, J Chromatogr 316: 585 (1984).
110. Däppen R, Meyer VR, Arm H, J Chromatogr 361: 93 (1986).
112. Däppen R, Meyer VR, Arm H, J Chromatogr 295: 367 (1984).
113. Tambute A, Begos A, Lienne M, Caude M, Rosset R, J Chromatogr 396: 65 (1987).
114. Pettersson C, Gioeli C, J Chromatogr 398: 247 (1987).
116. Berndt H, Krüger G, J Chromatogr 348: 275 (1985).
117. Krüger G, Grötzinger J, Berndt H , J Chromatogr 397: 223 (1987).
118. Lloyd MJB, J Chromatogr 351: 219 (1986).
119. Griffith OW, Campbel EB, Pirkle WH, Tsipouras A, Hyun MH, J Chromatogr 362:
345 (1986).
120. Rosini C, Altemura P, Pini D, Bertucci C, Zullino G, Savadori P, J Chromatogr 348:
79 (1985).
121. Ikuno Y, Maoka T, Shimizu M, Komori T, Matsuno T, J Chromatogr 328: 387
(1985).
122. Aboul-Enein HY, Al-Duraibi IA, J Liq Chrom & Rel Technol 21: 1817 (1998).
123. Stationary HPLC Phases for Chiral Separations, IRIS Technologies, Lawrence, KS
(2001).
124. Clevland T, J Liq Chromatogr 18: 649 (1995).
125. The Innovative Direction in Chiral Separations, Phenomenex, Torrance, USA
(1992).
126. Kromasil Chiral Phases for HPLC, SFC and SMB, Eka Chemicals AB, Marietta,
GA (2000).
127. Pirkle-1J Chiral HPLC Column, Regis Technologies, Morton Grove, IL (1995).
128. Toyo’oka T, Jin D, Nagakawa K, Murofushi S, Biomed Chromatogr 13: 103 (1999).

129. Iwaki K, Yoshida S, Nimura N, Kinoshita T, J Chromatogr A 617: 279 (1993).
130. Magora A, Abu-Lafi S, Levin S, J Chromatogr 866: 183 (2000).
131. Welch CJ, Chem New Zealand 9 (1993).
132. Francotte E, Junker-Buchheit A,. J Chromatogr 576: 1 (1992).
133. Möller P, Sanchez D, Persson B, Andersson S, Allenmark S, 11th International
Symposium on Preparative and Industrial Chromatography (1994).
134. Jageland PT, Bryntesson LM, Möller P, Chromatographic Workshop (1995).
135. Chiral Columns for Enantiomeric Separations by HPLC, Sumika Chemical Analy-
sis Service, Osaka, Japan (1995).
136. Pirkle WH, Koscho ME, J Chromatogr A 840: 151 (1999).
137. Fell AF, Days AM, Analyst 116: 1343 (1991).
139. Macaudiere P, Lienne M, Caude M, Rosset P, Tambute A, J Chromatogr 467: 357
(1989).
140. Iwaki K, Yoshida S, Nimura N, Kinoshita T, J Chromatogr 404: 117 (1987).
141. Pirkle WH, Murray PG, J High Resolut Chromatogr 16: 285 (1993).
142. Altomare C, Cellamare S, Carotti A, Barrreca ML, Chimirri A, Monforte AM,
Gasparrini F, Villani C, Cirilli M, Mazza F, Chirality 8: 556 (1996).
143. Pirkle WH, Spence PL, J Chromatogr A 775: 81 (1997).
144. Pirkle WH and Welch CJ, J Liq Chromatogr 15: 1947 (1992).
145. Vinkovic V, Kontrec D, Sunjic V, Navarini L, Zanetti F, Azzolina O, Chirality 13:
581 (2001).
146. Hyun MH, Kang MH, Han SC, J Chromatogr 868: 31 (2000).
147. Pirkle WH, Pochapsky TC, J Am Chem Soc 109: 597 (1987).
148. Shah P, Hsu TB, Rogers LB, J Chromatogr 396: 31 (1987).
149. Lipkowitz KB, Demeter DA, Parish CA, Darden T, Anal Chem 59: 1731 (1987).
150. Norinder U, Sundholm EG, J Liq Chromatogr 10: 2825 (1987).
151. Suzuki T, Timofei S, Iuras BE, Uray G, Verdino P, Walter MF, J Chromatogr A 922:
13 (2001).
152. Mourier P, Sassiat P, Caude M, Rosset R, J Chromatogr 353: 61 (1986).
154. Macaudiere P, Caude M, Rosset R, Tambute A, Proceedings of the International
Symposium on Chiral Separations (1987).
155. Wolf C, Pirkle WH, J Chromatogr A 785: 173 (1997).
156. Selditz U, Copinga S, Grol CJ, Franke JP, De-Zeeuw RA, Wikstrom H, Gyllenhaal
O, Pharmazie 54: 183 (1999).
tions, in Chiral Separation Techniques: A Practical Approach, Subramanian G (Ed.),
Weinham, Germany, p. 299 (2001).
158. Blackwell JA, Stringham RW, Xiang D, Waltermire RE, J Chromatogr 852: 383
(1999).
159. Blum AM, Lynam KG, Nicolas EC, Chirality 6: 302 (1994).
160. Terfloth GJ, Pirkle WH, Lynam KG, Nicolas EC, J Chromatogr A 705: 185 (1995).
161. Bargmann-Leyder N, Thiebaut D, Vergne F, Begos A, Tambute A, Caude M,
Chromatographia 39: 673 (1994).

163. Stringham RW, Chirality 8: 249 (1996).
165. Blackwell JA, Chirality 11: 91 (1999).
166. Blackwell JA, Stringham RW, Chirality 11: 98 (1999).
167. Cavender DM, Wolf C, Spence PL, Pirkle WH, Derrico EM, Rozing GP, J
Chromatogr A 782: 175 (1997).
168. Wolf C, Spence PL, Pirkle WH, Cavender DM, Derrico EM, Electrophoresis 21:
917 (2000).
169. Peters EC, Lewandowski K, Petro M, Svec F, Frechet JM, J Anal Commun 35: 83
(1998).
170. Lienne M, Caude M, Rosset R, Tambute A, Delatour P, Chirality 1: 142 (1989).
171. Witherow L, Spurway TD, Raune RJ, Wilson ID, London K, J Chromatogr 553: 497
(1991).

6
Protein-Based Chiral Stationary
Phases
Proteins are natural polymers and are made of amino acids, which are chiral
molecules, with the exception of glycine, through amide bonds. However, some
glycoproteins also contain sugar moieties. The protein polymer remains in the
twisted form because of the different intramolecular bondings. These bonding are
responsible for different types of loop=groove present in the protein molecule.
This sort of twisted three-dimensional structure of protein makes it enantio-
selective in nature. Enantioselective interactions between small molecules and
proteins in biological systems are well known [1]. For the first time in 1954,
Karush [2] reported that the two enantiomers of N -aroylated phenylglycine gave
nonidentical scatchard plots when the concentration dependence of their binding
to human serum albumin (HSA) in a buffer solution was investigated. Later, in
1958, McMenamy and Oncley [3] also observed the enantioselective nature of
protein. They observed that L-tryptophan binds more strongly with serum
albumin than D-tryptophan in the isotopic labeling experiment. Müller and
Wollert [4,5] reported in gel filtration studies, that the hemisuccinate of the
drug oxazepam showed a highly enantioselective behavior to human serum
albumin. SðþÞ-enantiomer was found to bind 30 times stronger than the R-()-
enantiomer. Similarly, other studies were carried out and it was reported that
proteins are enantiospecific in nature (e.g., the binding difference of the two
antipodes of phenprocoumon, warfarin [6], ketoprofen [7], and oxazepam
derivatives [8] was reported on protein molecules).

Because of the enantioselective nature of proteins, Stewart and Doherty [9]
packed a column with bovine serum albumin (BSA)–succinoylaminoethyl–
agarose and resolved the enantiomers of DL-tryptophan; the technique is called
affinity chromatography (protein racemate complex formation). The same method
was used for the resolution of other drugs [10,11]. Later, BSA was bonded on
sepharose and some racemates were resolved using low-pressure liquid chroma-
tography [12–14]. These types of column resulted into a good chiral resolution of
certain racemates, but the column efficiency was poor and, therefore, further
development in protein-based CSPs was realized [12–14]. Attempts were made to
immobilize proteins on solid supports. The silica-gel-immobilzed proteins were
packed into the columns and were used successfully for the chiral resolution of a
variety of racemates by high-performance liquid chromatography (HPLC).
Although all of the protein molecules are complex in structure and enantio-
specific, they could not be used as successful chiral selectors because the
enantiomeric separation varies from one protein to another. Albumin proteins
used as chiral selectors in liquid chromatography are BSA, HSA, rat serum
albumin (RSA), and guinea pig serum albumin (GPSA); BSA and HSA were
found to be successful chiral selectors. However, other proteins molecules were
explored for their chiral resolution [i.e., glycoproteins such as a1 -acid glycopro-
tein (AGP), ovomucoid (OVM), ovotransferin, avidin, trypsin (CT), and certain
enzymes like chymotrypsin, riboflavin, lysozyme, pepsin, amyloglucosidase and
lactoglobulin]. Cellobiohydrase-I (CBH-I), a protein obtained from fungus, was
also used as chiral selector in HPLC [15]. Because of the importance of the
protein molecules in chiral resolution by liquid chromatography, attempts were
made to describe their structures, properties, applications, the effect of various
chromatographic factors, and their chiral recognition mechanisms. Furthermore,
the use of the protein molecules as chiral selectors in other modes of liquid
chromatography has also been addressed.

Although all proteins are complex in structure and chiral in nature, some of them
could achieve the status of a chiral selector in liquid chromatography. The
complex structures of proteins are the result of the different intramolecular
hydrogen-bonding, disulfide bridges, and other types of bonding. All of the
proteins used for chiral resolution in liquid chromatography are obtained from
animals except for cellobiohydrolase-I. The structures and properties of some of
the most commonly used proteins as chiral selectors are discussed herein.

6.1.1 Bovine Serum Albumin
Bovine serum albumin is a globular protein of molecular mass 66,210 consisting
of 581 amino acids in a single chain and 17 intramolecular disulfide bridges
connecting the 34 half-cysteines with the formation of nine double loops. The
protein is relatively acidic and soluble in water, with an iosoelectric point of 4.7.
At pH 7.0, the net charge is 18. The 17 disulfide bridges form 9 loops grouped
into 3 similar domains. It is cigar shaped with molecular dimension 141 42 Å.
BSA has the capacity to bind many of the organic compounds containing a
hydrophobic contribution of at least five to six methylene groups [16]. However,
BSA has the ability to bind many inorganic anions which are very hydrophobic in
nature [17]. Fatty acids anions are also known to be very tightly bound and to
exert a stabilizing effect. Therefore, BSA is stabilized with caprylic acid.
6.1.2 Human Serum Albumin

Human serum albumin is structurally related to BSA and shows similar properties
when used as a chiral selector in liquid chromatography. The protein contains a
single polypeptide chain containing 580 amino acids with a molecular mass of
69,000. The isoelectric point of this protein is 4.8. The 17 disulfide bridges give
rise to 9 loops grouped into 3 homologous domains, each containing 3 loops. The
slight difference between BSA and HSA lies in the third loop. The binding areas
of this protein are benzadiazapine–indole and azapropazone–warfarin sites.
6.1.3 a1 -Acid Glycoprotein

a1 -Acid glycoprotein or orosomucoid is a human plasma protein and present in
55–140 mg=mL of human plasma. It is a glycoprotein with 181 amino acids and
has a molecular mass of 41,000. It is acidic in nature, with an isoelectric point of
2.7. It is a stable protein with two disulfide bridges. It also contains 40 sialic acid
residues. The sialic acid residues bind with ammonium-type compounds at
neutral pH and are essential for the enantioselective process.
6.1.4 Ovomucoid
Ovomucoid protein is obtained from the white part of a chicken egg and it is an
acidic glycoprotein. It contains 186 amino acids with a molecular mass of 55,000.
The single chain of the protein forms three homologous domains and incorpo-
rates nine disulfide bridges. Four to five asparagine residues are glycosylated, and
sialic acid constitutes 0.5–1% of the total weight. The isoelectric point is 4.5. It is
capable of binding amines and acids.

6.1.5 Avidin
This is another protein obtained from chicken egg white and it is basic in nature,
having an isoelectric point between 9.5 and 10.0. The protein is composed of four
identical subunits, each having a molecular mass of 16,400. A glycosidic chain is
attached to asparagine 17 of each subunit, which also can bind 1 mol of biotin.
The advin biotin binding affinity is the strongest known and its pK is around 15,
which approaches the strength of a covalent bond. Avidin has good enantiose-
lective capacity particularly for anionic analytes (profen group) because of the net
positive charge on the protein at neutral pH.
6.1.6 Ovotransferrin
Ovotransferrin is also obtained from the white portion of a chicken egg and has
been used as a chiral selector in liquid chromatography. This protein is also called
conalbumin. It is a metal ion (iron, copper, manganese, and zinc) binding protein
of molecular mass 70,000–78,000 and with an isoelectric point of 6.1–6.6. This
protein is sensitive to acids and heat.
6.1.7 Chymotrypsin
This protein is extracted from pancreatic tissues. This protein occurs in a-form
and b-form, but the a-form is used as chiral selector in liquid chromatography.
The molecular mass is 25,000, with an isoelectric point of 8.1–8.6. It is inhibited
by metal ions. The protein is useful for chiral resolution of amino acids and
amino esters.
6.1.8 Cellobiohydrolase-I
Most of the protein used as chiral selectors in liquid chromatography are obtained
from animals, but cellobiohydrolase-I is the first plant protein. It is obtained from
Trichderma reesi fungus. Basically, it is one of the cellulose-degrading enzymes
(cellulases). It is an acid glycoprotein having an isoelectric point of 3.6. The
molecular weight of this protein is 60,000. This protein contains two parts (viz.
cellulose binding and glycosylated regions).

As discussed earlier, the proteins used as chiral selectors in affinity chromato-
graphy cannot be used under the high-pressure HPLC with a variety of mobile
phases; therefore, these proteins were immobilized with some solid support such
as hydroxyethylmethacrylate, polystyrene–divinylbenzene, polyethylene fibers,
and silica gel [14,15]. A variety of techniques have been used for the immobiliza-

tion of proteins on a solid support. Some of these make use of reactions causing
cross-linking of proteins, whereas others leave the protein in its monomeric state.
In the early stage, BSA was adsorbed onto a silica gel surface [18] and anion-
exchange resin [19] and was used for chiral resolution. However, the limited
choice of mobile phases makes this technique less attractive.
Later, proteins were bonded covalently to a spherical silica gel surface
(most commonly used solid in liquid chromatography). There are a number of
synthetic procedures available to achieve the goal. The protein can be linked to a
silica surface through amino or carboxylic groups, but the most common methods
involve binding through the amino group. The amino group is protected in many
ways and the most common reagent used is tert-butyloxycarbonyl azide; the
procedure is shown in Figure 1. Similarly, silica gel is also reacted to bind the
appropriate organic moiety (by silane reagent) to which the peptide or protein can
be attached. A commonly employed reagent for this purpose is 3-glycidoxypropyl
triethoxysilane and the reaction path is presented in Figure 1. The protected
FIGURE 1 The chemical pathway of protein immobilization on silica gel.

protein is allowed to react with modified silica gel in dichloromethane. If the
protein is large and insoluble in dichloromethane, then a more polar solvent
should be used. The protecting reagent is removed at the end of the reaction using
hydrochloric acid to free the amino group, as shown in Figure 1. The influence of
the cross-linking reagent on the enantioselectivity of the BSA column was studied
in Ref. 20. Glutaraldehyde, formaldehyde, and (N ,N -disuccinimidyl)carbonate
were used as bifunctional reagents for the immobilization of BSA. The chiral
stationary phases (CSPs) prepared this way showed different chromatographic
enantioselectivities [20]. When there are number of amino and carboxylic acid
groups available on the same protein, care must be taken not to allow these
groups to react with themselves because these types of phase have a limited
choice of mobile phases. In this way, the proteins can be bonded covalently to
silica gel and are packed in stainless-steel columns of different dimensions for use
in HPLC. Different companies have commercialized these columns by different
trade names. The commonly used chiral columns supplied by various companies
are given in Table 1.
TABLE 1 Various Protein-Based Commercial Chiral Columns
Trade names (protein names) Company
Chiral AGP (a1 -acid glycoprotein), Advance Separation Tech.,

Chiral HSA (HSA protein), Whippany, NJ, USA
Chiral CBH (cellobiohydrolase-I protein)
Chiral AGP (a1 -acid glycoprotein), Chrom Tech, Ltd., Cheshire,
Chiral CBH (cellobiohydrolase-I protein), UK
Chiral HSA (HSA protein)
Resolvosil BSA-7, Resolvosil BSA-7PX Macherey-Nagel, Duren, Germany
(BSA proteins)
Chiral AGP (a1 -acid glycoprotein), Regis Technologies,
Chiral CBH (cellobiohydrolase-I protein), Morton Grove, IL, USA
Chiral HSA (HSA protein)
AFpak ABA-894 (BSA protein) Showa Denko, Kanagawa, Japan
Keystone HSA (HSA protein), Thermo Hypersil, Bellefonte, PA,
Keystone BAS (BSA proteins) USA
TSKgel Enantio L1, TSKgel Enantio-OVM Tosoh, Tokyo, Japan
(ovamucoid protein)
EnantioPac (a1 -acid glycoprotein) LKB Pharmacia, Bromma, Sweden
Bioptic AV-1 (advin protein) GL Sciences, Tokyo, Japan
Ultron ES-BSA (BSA protein), Shinwa Chemical Industries,
Ultron ES-OVM Column (ovomucoid protein), Kyoto, Japan
Ultron ES-OGP Column (ovoglycoprotein),
Ultron ES-Pepsin (pepsin)

6.3 APPLICATIONS
In 1973, Stewart and Doherty [9] resolved enantiomers of tryptophan on a
column packed with BSA–succinoylaminoethyl–agarose in a discontinuous
elution procedure. The mobile phase used was 0.1 M borate buffer (pH 9.2).
The chromatograms of this classical research are shown in Figure 2. Several years
later, this technique was applied for the chiral resolution of warfarin enantiomers
[10]. In 1981, the enantiomers of tryptophan and warfarin racemates were
resolved on various serum albumin CSPs [11,21,22]. The same method was
used for the resolution of other drugs [12–14]. Allenmark et al. [23] studied the
resolution of a series of active racemic sulfoxides on a BSA column using 0.08 M
phosphate buffer (pH 5.8) as the eluting solvent.
The protein phases were the first to be developed and are still in use for the
chiral resolution of different racemates. Because both BSA and HSA are similar
in structure, they have similar enantiorecognition capabilities. Warfarin and
FIGURE 2 Enantiomeric resolution of DL-tryptophan on defated BSA–succinoyl-

aminoethyl–agrose column (0.925 cm) using borate buffer (0.1 M). (From Ref. 9.)

indole are the main sites for chiral recognition for racemates (Sec. 6.1.2). It has
been demonstrated that compounds belonging to benzodiazepines bind to the
indole site [24–26]. Basic and neutral racemates were resolved on these CSPs.
However, some acidic compounds were also separated [14]. Allenmark carried
out an extensive and remarkable work on the chiral resolution of various
racemates using BSA-based CSPs. The enantiomers of glutamic acid, warfarin,
N -benzoylamino acids [27,28], benzonals, N -acetyl tryptophan, N -benzoyl
phenylglycine [29], chlorthalidone (a diuretic and closely related to the
benzothiadiazine group), tryptophan derivatives [30], benzoin, N-2,4-dinitro-
phenyl-aspartic (DNP) acid [31,32], some sedative, diuretics, muscle-relaxant
drugs [33], N -acetyl tryptophan ethyl ester, N -(4-nitrobenzoyl) [34], enantiomers
of degradation of certain drugs [35], phthalimido-threonine, N -benzenesulfonyl
serine [36], anticonvulsant benzonals and a series of analogs [37], N -(2,4-
dinitrophenyl)- and dansyl amino acids [38], and other derivatized amino acids
[39] were resolved successfully on BSA-based CSPs. The mobile phases used for
these studies were phosphate buffers of different concentrations and pHs. The
organic modifiers used were 1-propanol, 2-propanol, octanoic acid, and hexanoic
acid. A mixture of three peptides was obtained by enzymatic cleavage of BSA
and were immobilized on silica gel. The developed CSPs were tested for the
chiral resolution of tryptophan derivatives, oxazepam, and ibuprofen drugs [40].
Lienne et al. [41] resolved cytotoxic a-methylene-g-butyrolactone enantiomers on
Resolvosil CSP (BSA) using phosphate buffer (7.5 mM, pH 6.9)–2-propanol
(97.5 : 1.5, v=v) as the mobile phase. The BSA fragments (FG75 and F2) were
isolated and bonded to silica gel. The enantioselectivity was investigated for
2-arylpropionic acid derivatives, benzadiazepines, warfarin, and benzoin race-
mates [42]. Recently, the enantioselectivity of BSA coated to zirconia was also
investigated [43]. To show the nature of chiral resolution on BSA-based CSP, the
chromatograms of chiral resolution of DNP- and dansyl glutamic acid are shown
in Figure 3.
The enantiomers of oxazepam hemisuccinate were resolved on HSA and
acylated HSA proteins [44]. The native enantioselectivities in the binding of HSA
toward 2-aryl propionic acid nonsteroidal anti-inflammatory drugs (fenoprofen,
benoxaprofen, indoprofen, naproxen, ketoprofen, flurbiprofen, ibuprofen, supro-
fen, and pirprofen) were investigated [45]. The chiral resolution was achieved
using phosphate buffer (50 mM, pH 6.9)–acetonitrile (85 : 15, v=v) as the mobile
phase. The capacity factors were modified using octanoic acid as the mobile
phase modifier. The chiral recognition of tryptophan enantiomers on the HSA
column was studied [46]. The equilibrium constants for the two enantiomers were
determined and were found to be different [46]. Derivatization of the free
cysteine34 in HSA anchored to silica was found to be enantioselective for the
enantiomers of warfarin and phenylbutazone [47]. A series of 12 carboxylic acid
racemates were resolved on the HSA column using potassium phosphate buffer
(0.1 M, pH 7.0)–1-propanol (98 : 2, v=v) as the mobile phase [48]. The chiral

FIGURE 3 Chromatograms of (a) DNP-glutamic acid, (b) dansyl glutamic acid, and (c)
ibuprofen on BSA (a, b) and HSA (c) CSPs using (a) phosphate buffer (50 mM)–1-
propanol (96 : 4, v=v, pH 7.7), (b) phosphate buffer (50 mM)–1-propanol (98 : 2, v=v, pH
7.9), and (c) phosphate buffer (50 mM, pH 6.9)–acetonitrile (85 : 15, v=v) containing 4 mM
octanoic acid. (From Refs. 38 and 45.)

discrimination of N -(dansyl)-amino acids was carried out on the HSA protein
column. Thermodynamic parameters for the transfer of enantiomers from the
mobile phase to the CSP were determined [49,50]. In another study, the effect of a
polymer sublayer on the chiral recognition ability of HSA was determined [51].
The chromatograms of the enantiomeric resolution of ibuprofen on HSA column
are given in Figure 3.
a1 -Acid glycoprotein was found to recognize basic compounds. However,
acidic and neutral compounds have also been resolved. The protein was used very
frequently for the chiral resolution of a wide variety of racemates. The most
commonly used mobile phases were buffered aqueous systems containing various
amounts of organic modifiers (1–10%). The most important racemates resolved
are verapamil, epibatidine, leukotriene D4 antagonist, vamicamide [52], amines,
amino alcohols, barbiturates, carboxylic acids and their derivatives, lactams,
lactones, hydantoins [12–14,53], idrapril [54], thalidomide [55], cholecystokinin
antagonist 4(3H)-quinazolone derivatives [56], and methadone [57]. Suckow et
al. [58] coupled the chiral AGP column with Supelcosil LC-15 (achiral column)
and used this combination for the chiral resolution of phenylmorpholinol
metabolites of bupropion in human plasm, as shown in Figure 4.
Ovomucoid (OVM) protein-based CSP was found suitable for the chiral
resolution of both nonprotolytes as well as acidic and basic protolytes. The CSP
was explored for the chiral resolution of the two categories of racemates.
Phosphate buffers with ethanol or acetonitrile were found to be suitable mobile
phases [12–14,62]. Lammerhofer and Lindner carried out the optical purity
determination of econazole and other imidazoles on OVM CSP using phosphate
buffer (0.01 M, pH 6.5)–acetonitrile (70 : 30, v=v) as the mobile phase [63]. CSPs
obtained from ovoglycoprotein and crude ovomucoid were compared for the
chiral recognition. The CSP obtained from crude ovomucoid showed better chiral
recognition ability than the CSP obtained from ovoglycoprotein for some racemic
compounds [64]. The enantioselectivity of ovoglycoproteins obtained from
chicken and Japanese quail egg whites were compared. The chicken egg protein
column was found suitable for the basic compound and the CSP obtained from
the quail egg protein showed good chiral recognition ability for acidic racemic
compounds [65]. The effect of immobilization of ovoglycoprotein on chiral
resolution was studied. The CSP prepared from the amino group of protein was
found suitable for basic racemates, whereas the CSP obtained by bonding the
carboxylic group of protein showed good chiral resolution characteristics for
acidic compounds [66]. In 1992, Mano et al. [67] introduced a CSP based on
ovotransferin (conalbumin) protein and has been used for the chiral resolution of
basic drugs having a pK value greater than 8.0. The enantioselectivity of this CSP
is pH-specific and a baseline resolution for azelastine was achieved using
phosphate buffer (50 mM, pH 5.0)–ethanol (80 : 20, v=v) [64] as the the mobile
phase. A new column-switching method for chiral analysis of 4-(4-chlorobenzoyl)-

FIGURE 4 Chromatograms of (a) oxazepam (I) and oxazepam hemisuccinate (II) on
Chiral AGP CSP, (b) 8-hydroxy-2-(di-N -propylamino)-tetraline hydrochloride on ovo-
mucoid CSP and (c) 4-(4-chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4yl)-1-(2H)-
phthalazinone on ovotransferin CSP using (a) phosphate buffer (0.01 M)–acetonitrile
(95 : 5, v=v), (b) phosphate buffer (11 mM)–acetonitrile (83 : 17, v=v) and (c) phosphate
buffer (1 mM)–methanol (90 : 10, v=v) as the mobile phases. (From Refs. 59–61.)

2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone in plasma was
developed by coupling the chiral column with a mass spectrometer [59]. The
chromatograms of the chiral resolution on ovomucoid and ovotransferin are given
in Figure 4. Recently, Monaco et al. [68] immobilized chicken liver fatty acid
binding proteins (FABPs) to silica gel and the developed stationary phase was
used to examine the enantioselectivity of some chiral drugs. The enantiomers of
basic and neutral drugs were poorly retained and not resolved by the developed
CSP. Contrarily, the resolution of some acidic racemates was achieved.
Avidin, having a positive charge at neutral pH, was used for the chiral
resolution of anionic analytes such as profens. An increase in the pH of the
mobile phase has resulted in a drastic decrease in retention of racemates [69]. It
has also been reported that avidin could not resolve the basic racemates even at
partial level because of its basic character [69]. It was also shown that biotin
completely eliminates the chiral recognition ability of this CSP, as observed from
the experiments carried out by Miwa et al. [69]. Oda and co-workers [70]
prepared avidin CSP and this was applied for the chiral resolution of ketoprofen
in plasma. The mobile phase used was 0.1 M sodium hydrogen carbonate buffer
[70]. In 1992, Oda et al. [71] carried out the chiral resolution of 1-benzyl-4-[(5,6-
dimethoxy-1-indanon)-2-yl] methyl piperidine–hydrochloride and its metabolites
in plasma on the avidin column. The authors reported that the hydrophobicity
(alkyl chain length) of a spacer affected the enantioselectivity significantly. Later,
Oda et al. [72] coupled avidin CSP with ovumucoid protein column and resolved
the enantiomers of many drugs in plasma. This research group compared the
chiral recognition capacities of avidin and ovomucoid proteins using flurbiprofen,
warfarin, and propranolol racemates [73]. Both CSPs were found to have
excellent stability and there was no significant decrease in retention or enantio-
selectivity even after the injection of 200 samples [73]. In another study, the same
authors [74] studied the chiral recognition ability of avidin acylated protein at
both amino and carboxylic groups separately. These CSPs were used for the
successful chiral resolution of profen drugs. The chiral recognition capacities of
these acylated avidin proteins were found to be different. Recently, the chiral
resolution of some anti-inflammatory drugs was described on avidin CSP by Smet
et al. [75]. The authors described the combination of the central composite design
results in a multicriteria decision-making approach in order to obtain a set of
optimal experimental conditions, leading to the most desirable compromise
between resolution and analysis time. The chromatograms of the chiral resolution
of piperofen on this CSP are presented in Figure 5.
Wainer et al. [77] presented a CSP based on a-chymotrypsin protein, and,
initially, the chiral resolution of certain amino acids and amino ester was achieved
on this protein CSP [14,77]. Later, this CSP was used for the chiral resolution of
dipeptides and profens [78,79]. Recently, Felix and Descorps [80,81] used
immobilized a-chymotrypsin for the chiral resolution of a variety of racemic
compounds. Cellobiohydrolase-I (CBH-I) immobilized to silica gel was found to

FIGURE 5 Chromatograms of (a) pirprofen on avidin CSP using phosphate buffer (0.1
M)–acetotirile (95 : 5, v=v) and (b) cathionine on Chiral CBH-I CSP using phosphate
buffer (10 mM)–ethanol (95 : 5, v=v, pH 6.0 containing 50 mM Na2 EDTA) as mobile
phases. (From Refs. 75 ad 76.)

be a highly interesting CSP for the chiral resolution of racemic drugs [82]. CBH-I
was immobilized on silica gel using different methods, but it was found that the
use of an epoxide silica gel gave the best chiral recognition. Trypsin-based CSP
was presented by Thelohan et al. [83] and the authors resolved the enantiomers of
O and N,O derivatives of amino acids. A successful chiral resolution of amino
alcohols and barbiturates was achieved on CBH-I protein using phosphate buffer
(pH 6.8) containing 2-propanol [84]. Allenmark and Andersson [85] achieved a
baseline chiral resolution of b-blockers on the CBH-I protein column. Aboul-
Enein and Serignese [76] described a direct isocratic HPLC method for the chiral
resolution of cathinone and its metabolites on CBH-I CSP under reversed-phase
conditions. The chromatograms of the chiral resolution of cathinone on CBH-I
CSP are given in Figure 5. Recently, Gotmer et al. [86] studied the influence of
solute hydrophobicity on the enantioselectivity of CBH-I CSP using racemic b-
blockers. The authors fit the adsorption data to the bi-Langmuir model. The
adsorption of the S-enantiomer was found exothermic at low pH, endothermic at
high pH and athermal at a narrow pH range depending on the b-blocker under
investigation. The order of increasing energy of the chiral interactions was the
same as that of hydrophobicity (i.e., propranolol > alprenolol > metoprolol).
Some applications of the protein-based CSPs are summarized in Table 2.
In addition to the use of the above-cited proteins as chiral selectors, other
proteins were also explored as suitable tools for chiral resolution in liquid
chromatography. Lysozyme was bonded to silica gel by Haginaka et al. [92].
The authors used this CSP for the chiral resolution of basic and neutral racemic
compounds, whereas no resolution of acidic compounds was reported. The same
authors [93] introduced a new pepsin-based CSP. The developed CSP was found
useful for the chiral resolution of basic and neutral racemic compounds, whereas
the chiral resolution of acidic compounds had not been reported. Furthermore, it
has also been noted that the pepsin column lost chiral recognition capacity using
an eluent of basic pH. In another study, Haginaka et al. [94] immobilized a pepsin
and ovamucoid protein mixture on porous aminopropyl silica gel. The enantio-
selectivity of this CSP was compared and it was found that this column was
superior to the pepsin-based column. On the other hand, the enantioselectivity of
this mixed-protein CSP was comparable to the CSP obtained from the ovomucoid
protein. In 1999, Karlsson et al. [95,96] immobilized amyloglucosidate on
aldehyde silica gel and the developed CSP was tested for the chiral resolution
of b-blockers. The authors observed a decrease in retention of some b-blockers
by increasing the buffer ionic strength without any loss of enantioselectivity.

It is well known that a small fraction of protein is involved in the chiral resolution
at the analytical scale and, therefore, the preparative-scale capabilities of protein

TABLE 2 Enantiomeric Resolution of Different Racemic Compounds Using Protein-
Based CSPs
Amino acids (aromatic) BSA 21

Glutamic acid, warfarin and N -benzoylamino acids BSA 27, 28
Benzonals, N -acetyl tryptophan, N -benzoyl BSA 29
phenylglycine
Chlorthalidone and tryptophan derivatives BSA 30
Benzoin and N -DNP-aspartic acid BSA 31, 32
Sedative, diuretics and muscle relaxant drugs BSA 33
N -Acetyl tryptophan ethyl ester and N -(4-nitrobenzoyl) BSA 34
Enantiomers of degradation of certain drugs BSA 35
Phthalimido-threonine and N -benzenesulfonyl serine BSA 36
Anticonvulsant benzonals and a series of analogs BSA 37
N -(2,4-Dinitrophenyl)- and dansyl amino acids BSA 38
Derivatized amino acids BSA 39
Tryptophan derivatives, oxazepam and ibuprofen drugs BSA 40
Cytotoxic a-methylene-g-butyrolactone BSA 41
2-Arylpropionic acid derivatives, benzadiazepines, BSA 42
warfarin and benzoin racemates
Carboxylic acids BSA 76
Sulfoxides and sulfoximines BSA 22,23
2-Aryl propionic acid non-steroidal anti-inflammatory HSA 45
drugs (fenoprofen, benoxaprofen, indoprofen,
naproxen, ketoprofen, flurbiprofen, ibuprofen,
suprofen and pirprofen)
Tryptophan enantiomers HSA 46
Carboxylic acid racemates HSA 48
Derivatized amino acids, profens and other organic HSA 53
acids
Verapamil, epibatidine, leukotriene D4 antagonist, and AGP 52
vamicamide
Amines, amino alcohols, barbiturates, carboxylic acids AGP 12–14, 53
and their derivatives, lactums, lactones, and
hydantoins
Idrapril AGP 54
Thalidomide AGP 55
Chlecystokinin antagonist 4(3H)-quinazolone AGP 56
derivatives
Methadone AGP 57
Amines, amino alcohols, barbiturates, AGP 87
benzodiazepinenones, benzothiadiazines, coumarin
derivatives, and dihydropyridines
(continued )

TABLE 2 Continued
Carboxylic acids and derivatives, hydantoins, and AGP 88

lactams
Vinca alkaloids and other drugs AGP 53
Econazole and other imidazoles OVM 60
Amines and amino alcohols OVM 89
Barbiturates OVM 90
Verapamil OVM 91
Profens, b-blockers, and other drugs OVM 59
b-Blockers, halofantrine, and other drugs OVM 60
Azelastine Ovotransferin 67
4-(4-Chlorobenzoyl)-2-(hexahydro-1-methyl-1H- Ovotransferin 59
azepin-4-yl)-1
Ketoprofen Avidin 70
1-Benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl] Avidin 71
methyl piperidine–hydrochloride and its
metabolites
Anti-inflammatory drugs Avidin 74
Amino acids and amino esters a-Chymotrypsin 14
Cathinone and its metabolites a-Chymotrypsin 79
Amino alcohols and barbiturates CBH-I 85
b-Blockers CBH-I 86
b-Blockers and other drugs CBH 53
columns are not very good. However, Erlandsson et al. [18] immobilized BSA, an
inexpensive and readily available protein, and packed a 500 22-mm column.
This column was used to resolve the enantiomers of tryptophan at the preparative
scale. Only 0.25 mg of tryptophan was resolved in a single run using this column.
The conditions for the preparative chiral separation on BSA column is described
by Jacobson et al. [97].

One of the advantages of protein-based CSPs is that chiral chromatography is
carried out under the reversed-phase mode; that is, aqueous mobile phases are
used frequently and, therefore, there is a great chance to optimize the chiral
resolution. The most important parameters to be optimized are the composition of

the mobile phase, the pH of the mobile phase, ionic strength, and temperature.
The optimization of these parameter are discussed herein.
6.4.1 Mobile Phase Compositions

Primarily, buffers of different concentrations and pHs are used for the chiral
resolution on these CSPs because these phases are stable under the reversed-
phase mode. The elution is carried out by the isocratic mode, with the exception
of a few reports for which gradient elution was used. The most commonly used
buffers are phosphate and borate. These buffers were used in the concentration
range 20–100 mM with a 2.5–8.0 pH range. However, with all silica-based CSPs,
the prolonged use of alkaline pH buffer (>8.5) is not suitable. Contrarily, at lower
pH, irreversible changes are possible in cross-linked protein phases and, hence,
the long-term of buffers of low pH for the best are not recommended. In view of
this, buffers in the 3–7 pH range are of choice. An ammonium acetate buffer of
pH 4.5 may be useful. For the mobile phase development, any buffer (50 mM,
pH 7) can be used and the optimization is carried out by changing the
concentration and pH. The use of organic solvents in the optimization of chiral
resolution on these CSPs has been reported successfully because the hydrophobic
interactions are effected by their use. The most commonly used organic solvents
are methanol, ethanol, 1-propanol, 2-propanol, acetonitrile, tetrahydrofuran
(THF), hexanoic acid, and octanoic acid. These organic modifiers were used in
the 1–10% range. Care must be taken when using these organic modifiers, as they
can denature the protein. However, the high concentrations of methanol and
acetonitrile have been used on some of the cross-linked protein CSPs. The
selection of these organic modifiers depends on the structure of racemic
compounds and the CSP used. In some cases, charged modifiers such as octanoic
acid and quaternary ammonium compounds have been used for the optimum
chiral resolution [87,98]. Allenmark et al. [32] studied the effect of 1-propanol
concentration on the chiral resolution of certain substituted amino acids on BSA
(Fig. 6a). It was found that 1–10% 1-propanol was suitable for the best chiral
resolution [32]. Furthermore, Andersson and Allenmark [29] have carried out a
study on the effect of octanoic acid and octyl amine as the organic modifiers on
the chiral resolution ibuprofen and ketoprofen. The results of these findings are
presented in Figure 6b, which indicates 1–2 mM as suitable concentrations of
these organic modifiers. A higher concentration of both modifiers resulted in poor
enantioselectivity. Oda et al. [99] studied the effect of THF concentration on the
chiral resolution of ketoprofen using ovomucoid CSP. These findings are shown
in Figure 6c, which indicates 4–8% as the best concentration of THF under the
reported chromatographic conditions. Furthermore, Oda et al. [73] studied the
chiral resolution of flurbiprofen, propranolol, and warfarin on avidin and
ovomucoid CSPs using methanol, ethanol, propanol, and acetonitrile organic

FIGURE 6 The effect of organic modifiers on the enantioresolution: (a) 1-propanol on
enantiomers of C6 H5 CONHCHRCO2 H where R is (m) CH2 OH, (j) CH3 and (d)
CH3 on BSA CSP; (b) octanoic acid (on ibuprofen) and octyl amine (on ketoprofen) on
BSA CSP; (c) THF (ketoprofen) on ovomucoid CSP with phosphate buffer as the main
component of the mobile phases in all the studies. (From Refs. 29, 32, and 99.)

SCHEME 1 The protocol for the development and optimization of mobile phases on
protein CSPs.
modifiers. Generally, the chiral recognition behavior of these modifiers on avidin

and ovomucoid CSPs was in the order methanol > ethanol > propanol >
acetonitrile. Similarly, various reports have been published on the optimization
of chiral resolution using different types of mobile phase and the concentrations
of organic modifiers [100 –103]. Briefly, the selection of mobile phases varies
from one solute to another and also depends on the structure of the protein CSP
used. A protocol for the development and optimization of mobile phases for the
chiral resolution on protein-based CSPs is presented in Scheme 1.

The influence of pH is more pronounced on charged analytes than the uncharged
ones. The decrease in retention of carboxylic acids by increasing pH is due to the
decreasing number of positive charges on the protein, leading to fewer charge
interactions with ionic analytes [14]. Similarly, retention factors of amines and
other basic racemates decrease with a decrease of pH due to the decreasing
number of negative charges on the protein for charge interactions with the
cationic analytes. Therefore, chiral resolution on protein-based CSPs can be
controlled by adjusting the pH of the eluent. The effect of pH on the chiral

resolution of different racemic compounds on protein-based CSPs was studied by
various workers. The effect of pH on the chiral resolution of certain amino acids
on the BSA-based CSP was carried out by Allenmark et al. [32] and is given in
Figure 7a. It is clear from this figure that pH values of 4–6 are suitable for the
chiral resolution under the reported chromatographic conditions. Fitos et al. [61]
studied the effect of pH on the chiral resolution of oxazepam on the Chiral AGP
CSP (Fig. 7b). It may be concluded from this Figure 7b that, again, values of pH
between 5 and 6 are suitable for the chiral resolution of the reported drugs (in the
presence of acetonitrile and isopropanol as organic modifiers separately). Simi-
larly, the best chiral resolution of N -benzenesulfonyl alanine was achieved on
BSA-based CSP using the mobile phase having pH values of 5–6 (Fig. 7c) [104].
Mano et al. [67] reported the best chiral resolution of azelastine on conalbumin
CSP at 5.5 pH. Furthermore, Mano et al. [105] studied the effect of pH on the
chiral resolution of profens, warfarin, and benzoin racemic compounds using
flavoprotein-conjugated silica gel CSP and the best results were obtained at pH
values of 4 – 4.8. Oda and co-workers [73] studied the chiral resloution of a
variety of racemic compounds on ovomucoid and avidin protein CSPs. It was
observed that higher pH values were suitable for chiral resolution with avidin
CSP, whereas good resolution was observed at lower pHs when ovomucoid CSP
was used. Recently, Munro and Walker [103] studied the effect of pH on the
chiral resolution of buprion enantiomers on the ovomucoid column. Finally, there
are several reports dealing with the optimization of chiral resolution by pH
control and it was found that pHs ranging from 3 to 6 are the best for chiral
resolution on most of the protein-based CSPs.
6.4.3 Ionic Strength of Mobile Phase

The chiral resolution on protein CSPs is affected greatly by the change of ionic
strength. A decrease of ionic strength results in an increase of charge interactions
between analytes and protein CSP and, accordingly, an increase in the retention of
enantiomers results. At high ionic strength, the hydrophobic interactions are often
favored and this may result to a more complex dependence, yielding a retention
minimum at a particular salt (buffer) concentration. Allenmark et al. [32] studied
the chiral resolution of certain amino acids over a range of buffer concentrations
and the results are given in Figure 8a, indicating the optimum resolution at 10–
50 mM concentration of the buffer. Furthermore, Allenmark et al. [28] also
studied the effect of ionic strength on the chiral resolution of N -benzoyl alanine
on the BSA-based CSP and the results of this are shown in Figure 8b, which
shows that a 50 mM buffer concentration is suitable for the purpose. In another
study, Allenmark and Andersson [33] studied the effect of increasing ionic
strength on some simple structurally rigid uncharged analytes (diuretics) at
constant pH. The authors reported that an increase in ionic strength resulted
into an increase of retention without any affect on enantioselectivity. Oda et al.

FIGURE 7 Effect of pH on enantioresolution of (a) enantiomers of C6 H5 CON
CHCHRCO2 H, where R is (m) CH2 OH, (j) CH3 and (d) CH3 on the BSA-
based CSP, (b) oxazepam on Chiral AGP CSP, and (c) N-benzenesulfonyl alanine on the
BSA-based CSP with phosphate buffer as the main component of the mobile phases in all
of the studies. (From Refs. 37, 61, 104.)

FIGURE 8 Effect of buffer (ionic) strength on enantioresolution of (a) enantiomers of
C6 H5 CONHCHRCO2 H, where R is (m) CH2 OH, (j) CH3 and (d) CH3 on the
BSA-based CSP, (b) N -benzoyl alanine on BSA-based CSP, and (c) ketoprofen on avidin
CSP with phosphate buffer as the main component of the mobile phases in all of the
studies. (From Refs. 28, 32, and 70.)

[70,99] studied the effect of ionic strength on the chiral resolution of ketoprofen,
as shown in Figure 8c. It is obvious from this figure that 10 mM phosphate buffer
is suitable for chiral resolution. In another study, the same authors [91] reported
the best resolution of verapamil enantiomers using 50 mM as the salt concentra-
tion on ovomucoid CSP. Mano et al. [67] studied the effect of ionic strength on
the enantiomeric resolution of azelastine on conalbumin CSP and the best results
were obtained using the 20 mM concentration of buffer. Mano et al. [105] studied
the effect of eluent concentration on the chiral resolution of profens, warfarin, and
benzoin and the authors reported 10–50 mM as the best concentration of the
buffers. A comparative chiral resolution study was carried out by Oda et al. [73]
using flurbiprofen, warfarin, propranolol, and benzyl benzoate racemates on
avidin and ovomucoid columns. The authors claimed that 50–100 mM concen-
trations of buffers were found suitable for good chiral resolution on both CSPs. In
the same study, the authors reported the effect of phosphate, citrate, acetate, and
borate anions on chiral resolution. Generally, the chiral resolution capacity was in
the order phosphate > citrate > acetate > borate for all racemates and on both
CSPs. Recently, Munro and Walker [103] optimized the chiral resolution of
bupropion enantiomers by controlling the ionic strength of the mobile phase.
Apart from these few reports discussed herein, much work was carried out by
scientists on the optimization of the chiral resolution on protein CSPs by
controlling the ionic concentration of the mobile phase. Therefore, the ionic
strength is the key parameter for controlling the chiral resolution on protein
phases.
6.4.4 Temperature
The effect of temperature on the chiral resolution of protein phases is very
crucial; however, few reports are available dealing with this. Gilpin and co-
workers [106] found that the retention of D-tryptophan on the BSA-based CSP
increased by decreasing the temperature, whereas for L-tryptophan, there was first
an increase in retention, followed by a slight decrease. The effect of temperature
on the retention factors is shown in Figure 9a. Similarly, Jönsson et al. [107]
observed that an increase in temperature resulted in a decrease in the retention of
R-propranolol, whereas the S-enantiomer became more retained, resulting in a
large value of the separation factor on CBH-I CSP. The chromatograms of
propranolol enantiomers at 10 C and 45 C are shown in Figure 9b. Similarly,
Fulde and Frahm [108] studied the effect of temperature on the chiral resolution
of sotalol on CBH-I CSP. A reversal order of elution was observed in the 17–
28 C range. A change in the enantiomeric resolution order of felodipine and
mosapride and its metabolites at 20–30 C on Chiral AGP CSP was also observed
by Karlsson and Aspegren [109]. Recently, Williams et al. [102] optimized the
chiral resolution of roxifiban enantiomers on the AGP column by controlling the

FIGURE 9 Effect of the temperature on the chiral resolution of (a) DL-tryptophan [(d) D-
enantiomers and (s) L-enantiomers] on the BSA-based CSP using phosphate buffer
(50 mM, pH 7.4) as the mobile phase and (b) propranolol at 10 C and 45 C on CBH-I CSP
using acetate buffer (pH 5.5) as the mobile phase. (From Refs. 106 and 107).
temperatures. Munro et al. [103] also reported the optimization of the

chiral resolution of bupropion enantiomers on ovomucoid CSP by temperature
variations.
6.4.5 Flow Rate

The optimization of chiral resolution on protein phases by flow rate is seldom
carried out. However, Kirkland et al. [60] optimized the chiral resolution of

FIGURE 10 Effect of flow rate on the chiral resolution of lorglumide on ovomucoid CSP
using phosphate buffer (13 mM)–acetonitrile (74 : 26, v=v, pH 6.3) as the mobile phase:
(s) resolution and (u) selectivity factors. (From Ref. 60.)
lorglumide on ovomucoid protein CSP. The results of flow rate variation are given
in Figure 10. The flow rate was varied from 0.2 to 1.2 mL=min and it was
observed that the 1.0-mL=min flow rate was suitable for the chiral resolution of
the reported drug. The authors reported that although plate numbers were
somewhat smaller than those for the well-packed achiral reversed-phase
column of the same dimension, the reduced plate number may be the result of
an increase in kinetic interactions by the thick immobilized protein layer on the
surface of CSP particles. Similar results were also reported for other drugs [110].

As in case of other CSPs, the chiral resolution is also effected on protein phases
by the structures of the racemic compounds. Allenmark and co-workers [23]
resolved several sulfoxides on the BSA-based CSP. These sulfoxides contain
different structures with various groups such as methyl, methoxy, and acetate. We
analyzed the results of this study and, generally, it was found that the separation
factor decreased by introducing larger groups in the sulfoxides. This behavior
may be the result of a steric effect the author did not consider in the discussion

FIGURE 11 The chemical structures of anticonvulsants. (From Ref. 37.)
part [23]. Another study carried out by Allenmark [27] on the chiral resolution of 2-
pyridinylmethyl-2-benzimidazolyl sulfoxides on the BSA-based CSP indicated the
reverse results (i.e., the separation factors increased by introducing bulky groups in
the sulfoxides). However, in the same study, no trend in the enantioselectivities of
benzodiazepine derivatives was observed. Furthermore, Allenmark and co-workers
[37] carried out a very interesting study of the chiral resolution of anticonvulsants
on the BSA-based CSP. The structures of the studied anticonvulsants are shown in
Figure 11 and the results are given in Table 3 which reflected a pronounced effect of
the substituents, specially the introduction of p-chloro substituents in Ib caused a
multiple increase in capacity factors. Also, a marked effect in elution behavior was
found on the substitution of the N -benzoyl group for a phenyl group (If ).
Furthermore, Allenmark et al. [20,33] studied the chiral resolution of different
racemates, having various substituents, on the BSA-based CSP and it was observed
that the chiral resolution was affected by the substitution. Fitos et al. [61] studied
the chiral recognition of benzodiazepines on Chiral AGP CSP. It was observed that,
generally, retention increased by introducing the bulky alkyl groups. Recently, Abe
and co-workers [111] described the chiral resolution of carbazole carbonyl amino
acids with the linear alkyl side chain (C1 C4 ) on the BSA-based CSP. From these
studies, it was concluded that the alkyl chains and groups of the racemates affect the
chiral resolution on protein phases.
6.4.7 Injection Amount

The loading capacities of protein CSP may be understood from a ¼ k2 =k1 and
k ¼ ks þ kn , where ks and kn correspond to selective and nonselective contribu-
tions, respectively. When the amount of the analyte on CSP increases, the relative

TABLE 3 Effect of Substituents on the Chiral Resolution of
Barbiturates (Fig. 11) on the BSA-Based CSP Using Phosphate
Buffer (50 mM, pH 5.8)–1-Propanol (94 : 6, v=v) as the Mobile
Phase
Barbiturates derivatives k1 k2 a
Ia 14.6 23.2 1.6

Ib 34.9 44.8 1.3
Ic 55.1 70.6 1.3
Id 122.5 137.1 1.1
Ie 27.2 32.5 1.2
If 7.8 8.9 1.1
Ig 29.3 36.4 1.2
Source: Ref. 37.
contribution from kn to the observed k values (k1 and k2 ) also increases. The
critical selective sites become saturated, resulting in a decrease in separation
factors because k ¼ as =am , where as and am are the amounts of analytes in
stationary and mobile phases, respectively. An increased analyte concentration
means a decrease in the observed k values, because the relative amounts present
in the stationary phase decrease due to the lower affinity of the nonselective sites.
Kirkland et al. [60] described the loading of 1.5–3.0 nmol=g packing, producing a
15% decrease in resolution (30% decrease in column plate number) on the
150.46-cm ovomucoid column. According to the authors, samples of micro-
grams per liter are typical for most of the analytical applications on the 150.46-
cm column of ovomucoid protein. Andersson et al. [40] prepared BSA-based and
BSA-fragment CSPs and the effect of loading amount of benzoin was carried out.
At low concentration no effect on chiral resolution was observed on both CSPs.
However, the chiral recognition capacity of the BSA-fragment CSP decreased at a
higher solute concentration. The asymmetry factors were calculated for both the
CSPs and are shown in Figure 12a. Furthermore, Andersson et al. [20] prepared
three BSA-based CSPs (i.e., BSA–GLA (glutaraldehyde cross-linked BSA),
BSA–FA (formaldehyde cross-linked BSA)), and BSA–DSC (N ,N 0 -disuccinimi-
dyl carbonate cross-linked BSA)). The authors studied the peak symmetry and
calculated plate heights for all of the CSPs. These findings are shown in Figures
12b (asymmetry factors) and 12c (plate number). This figure indicates that BSA–
DSC CSP has a larger column efficiency than the other two CSPs, whereas BSA–
FA CSP showed the highest column-load threshold. For a small amount of solute
injected (<10 nmol), there was no significant difference in the extent of
deterioration of the peak symmetry and plate height on the three different
CSPs for oxazepam enantiomers (Figs 12b and 12c). However, as the column

FIGURE 12 Effect of the loading amount on the enantioresolution of (a) benzoin on (j)
the BSA-based CSP and (d) the BSA-fragment CSP using phosphate buffer (50 mM, pH
7.6)–1-propanol (96 : 4, v=v) as the mobile phase, (b, c) oxazepam on (n, m) BSA–DSC,
(s, d) BSA–FA, and (u, j) BSA–GLA CSPs (for detail, see text) using phosphate buffer
(50 mM, pH 7.1)–2-propanol (93 : 7, v=v) as the mobile phase. The open symbols
represent the first eluted enantiomer. (From Refs. 20 and 40.)

load increased, the peak started to show tailing with poor resolution. Recently,
Munro et al. [103] studied the loading capacity of ovomucoid CSP for the chiral
resolution of bupropion enantiomers. In spite of the good chiral enantio-
selectivities of different protein CSPs, the loading capacities are very poor.
6.4.8 Structures of Proteins

The complex structure of proteins having different types of group, loop, and
bridge are responsible for the chiral resolution of racemic compounds. Therefore,
a small change in the protein molecule resulted into a drastic change in
enantioselectivity. A few reports are available which indicate that different
structures of proteins are responsible for different chiral resolution capacities.
Andersson et al. [20] prepared three types of BSA-based CSP [i.e. BSA–GLA,
BSA–FA and BSA–DSC (described in Sec. 6.4.7)]. These columns were used for
the chiral resolution of different racemic compounds and the enantioselectivities
were found different for all three CSPs. The chiral resolution data of oxazepam,
lorazepam, lormetazepam, and lopirazepam on these CSPs are given in Table 4.
This table indicates that BSA–FA is the best CSP because all four drugs resolved
on this CSP, whereas lormetazepam did not resolve on the other two CSPs.
Moreover, the resolution factors on these CSPs were in the order BSA–FA >
BSA–GLA > BSA–DSC. Oda et al. [71] compared the chiral resolution of 1-
benzyl-4-[(5,6-dimethoxy-1-indanon)2-yl] methylpiperidine hydrochloride on
avidin and avidin DSC (avidin disuccinimidyl carbonate cross-linked) CSPs.
The authors observed that the best chiral resolution was achieved on avidin-based
CSP (Fig. 13). Oda et al. [74] investigated the chiral resolution of some profens
and other drugs on avidin and modified avidin CSPs and the authors reported
different selectivities on the two columns. In another study, Oda et al. [73]
compared the chiral resolution of flurbiprofen, propranolol, and warfarin on
avidin and ovomucoid CSPs. The authors reported different results on these two
CSPs. Accordingly, different proteins have different enantioselectivities for a
TABLE 4 Different Enantioselectivities of BSA-Based CSPs
BSA–DSC BSA–FA BSA–GLA
Racemic drugs k1 a Rs k1 a Rs k1 a Rs
Oxazepam 4.38 5.78 5.69 5.87 5.16 9.10 5.70 3.53 7.16
Lorazepam 6.86 2.33 2.46 9.80 1.69 2.52 8.47 2.11 3.66
Lormetazepam 5.86 1.00 — 5.66 1.44 1.75 6.63 1.00 —
Lopirazepam 1.36 3.33 2.53 1.75 2.54 3.71 2.07 2.30 3.72
Source: Ref. 20.

FIGURE 13 Chromatograms of 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl] methyl-
piperidine hydrochloride enantiomers on (a) avidin–DCS and (b) avidin CSPs using
ammonium acetate (0.1 M, pH 5.0) with (a) 5% and (b) 1% acetonitrile as the mobile
phases. (From Ref. 71.)
particular racemic compound. Therefore, optimization of chiral resolution on

suitable protein-based CSPs may be achieved by selecting the protein phase
arbitrarily.

In addition to the above-discussed parameters, other factors such as dimension of
the column, particle size of the silica gel, and mobile phase additives may be
considered for the optimization of chiral resolution on these CSPs. Metal ions
often are important structural components in some proteins to organize confor-
mation [112]. Therefore, the effect of metal ions as mobile phase additives may
be useful. Oda et al. [74] used zinc ions as the mobile phase additive on avidin
CSP to improve the chiral resolution of ibuprofen, chlormezanone, and other
drugs. The results are summarized in Table 5, which indicates that the addition of
zinc ions in the mobile phase has resulted into an improved resolution of some

TABLE 5 Effect of Zinc Metal Ions on the Enantiomeric Resolution of Some Drugs
on Avidin CSP
PP1 CM1 TP2 CP2 IP2
ZnCl2 k1 a k1 a k1 a k1 a k1 a
0 mM 1.43 1.00 5.69 1.00 2.05 1.48 4.34 1.00 9.95 1.13
5 mM 2.51 1.00 5.16 1.17 1.14 1.61 2.20 1.15 10.90 1.00
Note: PP: 2-phenylpropionic acid; CM: chlormezanone; TP: trihexylphenidyl hydrochloride; CP:
cloperastine; IP: ibuprofen. 1: 50 mM Tris buffer (pH 7)–methanol (90 : 10, v=v) mobile phase; 2:
50 mM Tris buffer (pH 7)–methanol (70 : 30, v=v) mobile phase.
Source: Ref. 74.
drugs. However, the authors reported that the use of zinc ions damaged the
column and resulted in poor chiral recognition capacities. Recently, Haginaka and
Takehira [113] studied the effect of silica pore size on the chiral resolution of
ovoglycoprotein CSP. The authors reported the best chiral resolution on the CSP
having the 12-nm pore size of silica gel. Furthermore, they have also studied the
effect of the loading amount of ovoglycoprotein on silica gel and found that the
best results were obtained on the CSP containing 80 mg ovoglycoprotein per 1 g
silica gel of 12 nm pore size. Fitos et al. [114] studied the effect of ibuprofen
enantiomers on the stereoselective binding of 3-acyloxy-1,4-benzodiazepines to
human serum albumin (HAS) using native and Sepharose-immobilized proteins.
This study indicated the different binding natures of the two types of protein in
the presence of ibuprofen molecules. Thus, the above-cited parameters are also
responsible for the different chiral resolutions on these CSPs.

The proteins are complex in structure and enantiospecific in nature with different
functional groups, alkyl chains, bridges, and chiral loops. Therefore, the chiral
recognition by proteins is a complex process. Recently, Hage [115] and Haginaks
[15] reviewed the applications of protein phases in liquid chromatography with a
discussion of certain studies carried out on chiral mechanisms. Generally,
proteins have specific chiral sites for a pair of enantiomers with a few exceptions
where the two antipodes bind to different sites [14]. The most common
interactions involved in the chiral recognition on protein CSPs are nonpolar,
dipole, or coulombic interactions, hydrogen-bondings, and steric effects
[115,116]. Of course, the protein loops provide the chiral environment to the
enantiomers if the enantiomers bind at the same site. Generally, if the enantiomers

bind at different sites, the contribution of chiral loops may or may not be involved
in the chiral recognition process. Ultimately, the combination of the above-cited
forces resulted into enantiospecific binding of enantiomers and the chiral
resolution is achieved. Important structural features with interaction forces,
identified by a qualitative structure relationship, for the binding of basic drug
(pheniramine) to AGP protein, are shown in Figure 14 [117].
As discussed earlier, the two binding sites of HSA [i.e. warfarin (I) and
indole (II)] are responsible for the chiral resolution of a variety of racemates. In
addition, other binding sites on this protein have been identified [15]. Recently,
He and Carter [118] established the three-dimensional structure of HAS, which
showed that I and II are the binding sites and are located in hydrophobic cavities.
It has also been reported that the chemistry of binding site I is homologous to that
of II. Yang and Hage [46,119,120] indicated that D- and L-tryptophan bind to
single but distinct sites of HAS, whereas R- and S-enantiomers of ibuprofen and
warfarin had one common binding site. Peyrin et al. [121,122] described II as the
binding site for dansyl amino acids on HSA.
Kremer et al. [123] observed the hydrophobic pockets as the binding site on
AGP protein. However, more than one binding site was reported. Haupt et al.
[124] presented a retention model for the chiral resolution of uncharged solutes,
felodipine, on AGP and the model has assumed the presence of two different
stereoselective sites for different enantiomers. In another study, Waters et al. [125]
carried out certain thermodynamic experiments for the determination of the
mechanism of chiral resolution on AGP protein. The authors reported the two
FIGURE 14 Structural features of the binding of pheniramine molecule on AGP protein

with protonated aliphatic nitrogen guiding the drug toward the anionic region in the
binding site. Hydrophobic moieties provide anchoring to the drug in the lipophilic
region(s) of the site. (From Ref. 117.)

different binding sites for two enantiomers. Sometimes sialic acid residues are
supposed to take part in the chiral resolution of enantiomers [126–128]. In spite
of all these studies, the exact mechanism of chiral resolution on this protein is not
known because of the lack of full knowledge of the tertiary structure of the
protein.
In order to gain information on the chiral recognition mechanism on
ovomucoid and ovoglycoproteins, various studies were carried out on these
phases [64–66,127,129–132]. It has been observed that the three domains present
on the protein took part in chiral resolution individually or in different combina-
tions. It has also been concluded that sialic acid or sialic acid galactose groups
sometimes play a role in the chiral recognition process on the reported proteins.
Oda et al. [71] carried out certain studies on modified avidin protein and they
have reported that avidin has multiple chiral recognition sites. Recently, Felix and
Descorps [80] observed the enantioselectivity of a-chymotrypsin protein and the
authors reported that enantioresolution was related to structures of enantiomers,
hydrophobicity, and electrostatic interactions. These relationships determine the
recognition mechanisms and the position of each enantiomer in the enzymatically
active sites [133]. Cellobiohydrolase-I protein was found to have a binding site on
both portions (Sec. 6.1.8) [134]. Recently, the three-dimensional structure of
CBH-I was determined by X-ray studies [135,136]. It was found that the binding
site is about a 40-Å long tunnel. Similarly, specific sites, responsible for chiral
resolution on other proteins, were determined and discussed by Haginaka in his
review [15]. Earlier, it was known that the three-point attachment of the
enantiomers to the protein was sufficient for the chiral resolution, but, recently,
Mesecar and Koshland [137] argued the importance of the four-point attachment
model for the chiral discrimination on protein CSPs. In spite of various studies on
the chiral recognition mechanisms on protein CSPs, the exact mechanism is not
known because of the complex structure of proteins. In addition, the change in
protein conformation in different solvents and environment may be another
hindrance in the determination of chiral recognition mechanisms. However,
further extensive physical and analytical studies are required to ascertain the
chiral recognition mechanism.

Much work has been done on chiral resolution on protein phases using HPLC,
but only a few reports are available using the mode of liquid chromatography. In
1994, Ishihama et al. [138] utilized ovomucoid as a chiral pseudostationary phase
in electrokinetic chromatography. The compounds separated were tolperisone,
benzoin, eperisone, and chlorpheniramine. The chromatograms for the chiral
resolution of eperisone are shown in Figure 15. Later, in 1999, Haddadian et al.
[116] studied the enantioselectivities of two types of protein-based CSPs in

FIGURE 15 Chromatograms of eperisone enantiomers on ovomucoid CSP using phos-
phate buffer (10 mM, pH 5.0)–2-propanol (95 : 5, v=v) as the mobile phase in electro-
kinetic chromatography. (From Ref. 138.)
electrokinetic capillary chromatography. Two polymeric dipeptide chiral surfac-

tants (PDCSs), poly (sodium N -undecanoyl isoleucyl)-valinate (SUILV) with
three chiral centers and poly (sodium N -undecanoyl leucyl)-valinate (SULV),
with two chiral centers, have been evaluated and compared as chiral pseudo-
stationary phases. The enantioselectivity of these two CSPs was analyzed using
anionic, cationic, and neutral analytes. Furthermore, the authors reported that the
chiral resolution is controlled by the steric effect.
6.7 CONCLUSION
It is evident that proteins are successful chiral selectors in liquid chromatography
due to the flexibility of the separation systems. The use of wide range of mobile
phases makes them ideally suitable CSPs. In addition, the multiple binding
interaction sites are responsible for good chiral recognition capacities of protein
molecules. Various chromatographic parameters can be optimized easily to
control the chiral resolution on these phases. However, there are certain limita-
tions with these phases, as they are not suitable at the preparative scale. Also, the
low loading capacity, lack of column ruggedness, and limited understanding of
the chiral recognition mechanisms may be other drawbacks. Sometimes, after the
prolonged use of organic modifiers, certain columns are denatured; however,
these columns may be regenerated to some extent using a buffer of appropriate
pH and concentration. In spite of this, the future of protein CSPs is bright. Other
new protein fragments or mutant proteins, which may be more stable and

enantioselective (better CSPs) than the native proteins, should be prepared by
genetic engineering. Therefore, further research is required, especially on the
chiral discrimination mechanisms, so that scientists can modulate future experi-
ments in the exact and right directions.
REFERENCES
1. Lowe CR, Dean PGD, Affinity Chromatography, John Wiley & Sons, London
(1974).
2. Karush F, J Am Chem Soc 76: 5536 (1954).
3. McMenamy RH, Oncley JL, J Biol Chem 233: 1436 (1958).
4. Müller WE, Wollert U, Res Commun Chem Pathol Pharmacol 9: 413 (1974).
5. Müller WE, Wollert U, Mol Pharmacol 11: 52 (1975).
6. Brown NA, Jähnchen E, Muller WE, Wollert U, Mol Pharmacol 13: 70 (1977).
7. Rendic S, Alebic-Kolbah T, Kajfez F, Sunjic V, Farmaco Sci 35: 51 (1980).
8. Gratton G, Rendic S, Sunjic V, Kajfez F, Acta Pharm Jugoslav 29: 119 (1979).
9. Stewart KK, Doherty RF, Proc Natl Acad Sci USA 70: 2850 (1973).
10. Lagercrantz C, Larsson T, Karlsson H, Anal Biochem 99: 352 (1979).
11. Lagercrantz C, Larsson T, Denfros I, Comp Biochem Physiol 69C: 375 (1981).
12. Allenmark S, Protein based phases, in Chiral Separations by HPLC: Applications to
Pharmaceutical Compounds, Krstulovic AM (Ed.), Ellis Horwood, New York
(1989).
13. Allenmark S, Chromatographic Enantioseparations: Methods and Applications,
IInd (Ed.), Ellis Horwood, New York (1991).
14. Allenmark S, Separation of enantiomers by protein based chiral phases, in A
Practical Approach to Chiral Separations by Liquid Chromatography, Subramanian
G (Ed.), Wiley–VCH, Weinheim (1994).
15. Haginaka J, J Chromatogr A 906: 253 (2001).
16. McMenamy RH, Albumin binding sites, in Albumin Structure Function and Uses,
Rosenoer VM, Oratz M, Rothschild MA (Eds.), Pergamon Press, Oxford, p. 143
(1977).
17. Lewin S (Ed.), Displacement of Water and its Control of Biochemical Reactions,
Academic Press, New York (1974).
18. Erlandsson P, Hansson L, Isaksson R, J Chromatogr 370: 475 (1986).
19. Jacobson SC, Guiochon G, J Chromatogr 590: 119 (1992).
20. Andersson S, Thompson RA, Allenmark S, J Chromatogr 591: 65 (1992).
21. Allenmark S, Bomgren B, Boren H, J Chromatogr 237: 473 (1982).
22. Allenmark S, Bomgren B, J Chromatogr 252: 279 (1982).
23. Allenmark S, Bomgren B, Boren H, Lagerstrom PO, Anal Biochem 136: 293
(1984).
24. Sjöholm I, Ekman B, Kober A, Ljungstedt-Pahlman I, Mol Pharmacol 16: 767
(1979).
25. Kragh-Hansen U, Pharmacol Rev 33: 17 (1981).
26. Fehske KJ, Müller WE, Wollert U, Biochem Pharmacol 30: 687 (1981).
27. Allenmark S, J Liq Chromatogr 9: 425 (1986).

29. Andersson S, Allenmark S, J Liq Chromatogr 12: 345 (1989).
30. Allenmark S, LC–GC 3: 348 (1985).
31. Thompson RA, Andersson S, Allenmark S, J Chromatog 465: 263 (1989).
33. Allenmark S, Andersson S, Chirality 1: 154 (1989).
34. Allenmark S, Bomgren B, Andersson S, Prep Biochem 14: 139 (1984).
35. Allenmark S, Bomgren B, Boren H, Enzyme Microb Technol 8: 404 (1986).
36. Allenmark S, Bomgren B, J Liq Chromatogr 9: 667 (1986).
37. Allenmark S, Andersson S, Bojaraski J, Chromatogr 436: 479 (1988).
38. Allenmark S, Andersson S, J Chromatogr 351: 231 (1986).
39. Allenmark S, Andersson S, Chromatographia 31: 429 (1991).
40. Andersson S, Allenmark S, Erlandsson P, Nilsson S, J Chromatogr 498: 81
(1990).
41. Lienne M, Caude M, Rosset R, Tambutte A, J Chromatogr 448: 55 (1988).
42. Haginaka J, Kanagusi N, J Chromatogr A 769: 215 (1997).
43. Park JH, Ryu JK, Park JK, McNeff CV, Carr PW, Chromatographia 53: 405 (2001).
44. Noctor TAG, Wainer IW, Pharmacol Res 9: 480 (1992).
45. Noctor TAG, Felix G, Wainer IW, Chromatographia 31: 55 (1991).
46. Yang J, Hage DS, J Chromatogr A 766: 15 (1997).
47. Bertucci C, Wainer IW, Chirality 9: 335 (1997).
48. Andrisano V, Booth TD, Cavrini V, Wainer IW, Chirality 9: 178 (1997).
49. Peyrin E, Guillaume YC, Chromatographia 48: 431 (1998).
50. Peyrin E, Guillaume YC, Morin N, Guinchard C, J Chromatogr A 808: 113 (1998).
51. Millot MC, Loehman L, Hommel H, Chromatographia 50: 641 (1999).
York, p. 317 (1998).
53. User’s Guide: Separation of Chiral Drugs and Other Chiral Compounds on Chiral–
AGP, Chiral–CBH and Chiral–HSA, Chrom Tech, Hägersten, Sweden (1994).
54. Cirilli R, Di Bugno C, La Torre F, Chromatographia 49: 628 (1999).
55. Alvarez C, Sanchez-Brunete JA, Torrado-Santiago S, Cadorniga R, Torrado JJ,
Chromatographia 52: 455 (2000).
56. Gyimesi-Forras K, Szasz G, Gergely A, Szabo M, Kokosi J, J Chromatogr Sci 38:
430 (2000).
57. Ortelli D, Rudaz S, Chevalley AF, Mino A, Deglon JJ, Balant L, Veuthey JL, J
Chromatogr A 871: 163 (2000).
58. Suckow RF, Zhang MF, Cooper TB, Biomed Chromatogr 11: 174 (1997).
59. Mano N, Oda Y, Ohe H, Asakawa N, Yoshida Y, Sato T, J Pharm Biomed Anal 12:
557 (1994).
60. Kirkland KM, Neilson KL, McComb DA, DeStefano JJ, LC–GC 10: 322 (1992).
61. Fitos I, Visy J, Simonyi M, Hermansson J, J Chromatogr A 709: 265 (1995).
62. Ultron Technical Report for Ultron ES-OVM Column.
63. Lammerhofer M, Lindner W, Chirality 6: 261 (1994).
64. Haginaka J, Takehira H, J Chromatogr A 777: 241 (1997).
65. Haginaka J, Kagawa C, Matsunaga H, J Chromatogr A 858: 155 (1999).
66. Haginaka J, Okazaki Y, Matsunaga H, J Chromatogr A 840: 171 (1999).

67. Mano N, Oda Y, Miwa T, Asakawa N, Toshiba Y, Sato T, J Chromatogr 603: 105
(1992).
68. Monaco HL, Perduca M, Caccialanza, Wainer IW, J Chromatogr A 751: 117 (2001).
69. Miwa T, Miyakawa T, Miyake Y, J Chromatogr 457: 227 (1988).
70. Oda Y, Asakawa N, Abe S, Yoshida Y, Sato T, J Chromatogr 572: 133 (1991).
71. Oda Y, Ohe H, Asakawa N, Yoshida Y, Sato T, Nakagawa T, J Liq Chromatogr 15:
2997 (1992).
72. Oda Y, Asakawa N, Yoshida Y, Sato T, J Pharm Sci 1227 (1992).
73. Oda Y, Mano N, Asakawa N, Yoshida Y, Sato T, Nakagawa T, Anal Sci 9: 221
(1993).
74. Oda Y, Mano N, Asakawa N, Yoshida Y, Sato T, J Liq Chromatogr 17: 3393 (1994).
75. Smet E, Staelens L, Heyden YV, Baeyens WRG, Aboul-Enein HY, Van der Weken
G, Garcia-Campana A, Chirality 13: 556 (2001).
76. Aboul-Enein HY, Serinese V, Biomed Chromatogr 11: 47 (1997).
77. Wainer IW, Jadaud P, Schombaum GR, Kadodkhar SV, Henry MP, Chromatographia
25: 903 (1988).
78. Marle I, Karlsson A, Pettersson C, J Chromatogr 604: 185 (1992).
79. Jadaud P, Wainer IW, J Chromatogr 476: 165 (1989).
80. Felix G, Descorps V, Chromatographia 49: 595 (1999).
81. Felix G, Descorps V, Chromatographia 49: 606 (1999).
82. Erlandsson P, Marle I, Hansson L, Isaksson R, Pettersson C, Pettersson G, J Am
Chem Soc 112: 4573 (1990).
83. Theolohan S, Jadaud P, Wainer IW, Chromatographia 28: 551 (1989).
84. Marle I, Erlandsson P, Hansson L, Isaksson R, Pettersson C, Pettersson G, J
Chromatogr 586: 233 (1991).
85. Allenmark S, Andersson S, Chirality 4: 24 (1992).
86. Gotmar G, Fornstedt T, Andersson M, Guiochon G, J Chromatogr 905: 3 (2001).
87. Hermasson J, Trends Anal Chem 8: 251 (1989).
88. Hermansson J, Eriksson M, J Liq Chromatogr 9: 621 (1986).
89. Miwa T, Kuroda H, Sakashita S, Asakawa N, Myake Y, J Chromatogr 511: 89
(1990).
90. Haginaka J, Seyama C, Yasuda H, Fujima H, Wada H, J Chromatogr 592: 301
(1992).
91. Oda Y, Asakawa N, Kajima T, Yoshida Y, Sato T, J Chromatogr 541: 411 (1991).
92. Haginaka J, Murashima T, Seyama C, J Chromatogr A 666: 203 (1994).
93. Haginaka J, Miyano Y, Saizen C, Seyama C, Murashima T, J Chromatogr A 708:
161 (1995).
94. Haginaka J, Miyano Y, Anal Sci 12: 727 (1996).
95. Nystrom A, Strandberg A, Aspergren A, Behr S, Karlsson A, Chromatographia 50:
209 (1999).
96. Strandberg A, Nystrom A, Behr S, Karlsson A, Chromatographia 50: 215 (1999).
97. Jacobson S, Felinger A, Guiochon G, Biotechnol Bioeng 40: 1210 (1992).
98. Hermansson J, J Chromatogr A 666: 181 (1994).
99. Oda Y, Asakawa N, Yoshida Y, Sato T, J Pharm Biomed Anal 10: 81 (1992).
100. Makamba H, Andrisano V, Gotti R, Carvini V, Felix G, J Chromatogr A 818: 43
(1998).

101. Cirilli R, Torre FL, J Chromatogr A 818: 53 (1998).
102. Williams RC, Myawa JH, Boucher RJ, Brockson RW, J Chromatogr A 844: 171
(1999).
103. Munro JS, Walker TA, J Chromatogr A 913: 275 (2001).
104. Bomgren B, Allenmark S, J Liq Chromatogr 9: 667 (1986).
105. Mano N, Oda Y, Asakawa N, Yoshida Y, Sato T, J Chromatogr 623: 221 (1992).
106. Gilpin R, Ehtesham SE, Gregory RB, Anal Chem 63: 2825 (1991).
107. Jönsson S, Schon A, Issakson R, Pettersson C, Pettersson G, Chirality 4: 505
(1992).
108. Fulde K, Frahm AW, J Chromatogr A 858: 33 (1999).
109. Karlsson A, Aspegren A, Chromatographia 47: 189 (1998).
110. Kirkland KM, Neilson KL, McComb DA, J Chromatogr 545: 43 (1991).
111. Abe Y, Shoji T, Matsubara M, Yoshida M, Sugata S, Iwata K, Suzuki H, Chirality
12: 565 (2000).
112. Berg JM, J Biol Chem 265: 6513 (1990).
113. Haginaka J, Takehira H, J Chromatogr A 773: 85 (1997).
114. Fitos I, Visy J, Simonyi M, Hermansson J, Chirality 11: 115 (1999).
115. Hage DS, J Chromatogr A 906: 459 (2001).
116. Haddadian F, Billiot EJ, Shami SA, Warner IM, J Chromatogr A 858: 219 (1999).
117. Kaliszan R, Nasal A, Turowski M, Biomed Chromatogr 9: 211 (1995).
118. He MX, Carter DC, Nature 358: 209 (1992).
119. Yang Y, Hage DS, J Chromatogr A 645: 241 (1993).
120. Yang Y, Hage DS, J Chromatogr A 725: 27 (1996).
121. Peyrin E, Guillaume YC, Guinchard C, J Chromatogr Sci 36: 97 (1998).
122. Peyrin E, Guillaume YC, Guinchard C, Anal Chem 69: 4253 (1998).
123. Kremer JMH, Wilting J, Janssen LHM, Pharmacology 40: 1 (1988).
124. Haupt D, Pettersson C, Westulund D, Chirality 7: 23 (1995).
125. Water MS, Sidler DR, Simon AJ, Middaugh CR, Thompson R, August LJ, Bicker
G, Perpall HJ, Grinberg N, Chirality 11: 224 (1999).
126. Shiono H, Shibukawa A, Kuroda Y, Nakagawa T, Chirality 9: 291 (1997).
127. Kuroda Y, Shibukawa A, Nakagawa T, Anal Biochem 268: 9 (1999).
128. Haginaka J, Matsunaga H, Enantiomer 5: 37 (2001).
129. Pinkerton TC, Howe WJ, Urlich EL, Comiskey JP, Haginaka J, Murashima T,
Walkenhorst WF, Westler WM, Markley JL, Anal Chem 67: 2354 (1995).
130. Haginaka J, Seyama C, Murashima T, J Chromatogr A 704: 279 (1995).
131. Haginaka J, Matsunaga H, Chirality 11: 426 (1999).
132. Haginaka J, Matsunaga H, Anal Commun 36: 39 (1999).
133. Norin M, Hult K, Biocatalysis 7: 131 (1993).
134. Marle I, Jonsson S, Isaksson R, Pettersson C, Pettersson G, J Chromatogr 648: 333
(1993).
135. Divne C, Stahlberg J, Reinikainen T, Ruohonen L, Pettersson G, Knowles J, Teeri T,
Jones TA, Science 265: 524 (1994).
136. Divne C, Stahlberg J, Teeri T, Jones TA, J Mol Biol 275: 309 (1998).
137. Mesecar AD, Koshland DE Jr, Nature 403: 614 (2000).
138. Ishihama Y, Oda Y, Asakawa N, Yoshida Y, Sato T, J Chromatogr A 666: 193
(1994).

7
Ligand Exchange^Based Chiral
Stationary Phases
In chiral ligand-exchange chromatography (CLEC), the separation occurs as a

result of the exchange of the ligands and enantiomers on a metal ion. The ligand
exchange involves the breaking and formation of coordinate bonds among the
metal ions of the complex, ligands, and enantiomers. Therefore, ligand-exchange
chromatography is useful for the chiral resolution of molecules containing
electron-donating atoms such as oxygen, nitrogen, and sulfur. These types of
molecule include amino acids and their derivatives, amines, hydroxy acids, and
peptides, among other drugs. Some molecules containing p-electron-donating
double bonds can form complexes with the metal ion and, therefore, can be
separated by ligand exchange chromatography. In 1961, Helfferich [1] reported
the ligand-exchange process by replacing two molecules of ammonia by a
diamine molecule in a copper ammonia complex. It was found that coordination
of the chiral selector and enantiomers occurred at the same metal ion and, hence,
provided the best conditions for the chiral recognition of enantiomers. Sometimes
the fast kinetics of ligand-exchange reactions in the metal ion coordination sphere
makes this technique suitable for the chiral resolution of kinetically labile
complexes. CLEC developed by Davankov [2,3] in 1969 was the first liquid-
chromatographic technique successfully applied for the complete separation of
enantiomers of amino acids. Subsequently, Davankov et al. [4–8] carried out
extensive work on the chiral resolution of other racemic compounds using CLEC,
which resulted in several publications. The scope of CLEC was also extended to

the complexes formed by polydentate ligands and to outer-sphere complexation
[3]. Chiral resolution using CLEC has also been reviewed by several authors [9–
14]. Copper(II) was used as the ligand metal ion in most of the applications of
CLEC. However, other metal ions such as nickel and zinc were also tested
[15,16]. In spite of the development of more effective chiral selectors (Chaps. 2–
6), CLEC still remains the best technique of choice from a theoretical point of
view. Many theoretical concepts developed in CLEC are of general interest for
the explanation and prediction of chiral recognition in all chiral chromatographic
systems. Moreover, the simple and inexpensive nature of CLEC makes it a
suitable and useful technique. This chapter describes chiral resolution by ligand-
exchange chromatography.

The main component of CLEC is the chiral selector (ligand). The different types
of chiral molecule containing electron-donating atoms, such as nitrogen, oxygen,
and sulfur, are considered the best ligands, as they can coordinate with metal ions.
The most commonly used amino acids and their derivatives for the preparation of
CSPs are proline, hydroxyproline, histidine, phenylalanine, aspartic acid, gluta-
mic acid, methionine, thereonine, leucine, and valine [17–20]. However, cyclic
amino acids, such as proline, hydroxyproline, allohydroxyproline, azetidene and
some carboxylic acids, also proved to be suitable chiral ligands. The chiral ligand
itself, or complexed with a metal ion, is bonded to a solid support. With regard to
the use of metal ions, Davankov [12] tested copper(II), nickel(II), and zinc(II)
metal ions; however, the best resolution was reported for the copper(II) ion. It has
also been reported that tetra coordinate copper(II) ions produced the highest
enantioselectivity effects when combined with bifunctional solute molecules and
bidentate chiral matrix fixed ligands, whereas nickel(II) ion, having a coordina-
tion number of 6, was preferable in combination with tridentate ligands. These
ligands provide the suitable chiral environment for the enantiomers because of
their stereo-specific nature. Other functional groups, such as alkyl or phenyl
groups, also take part in the interactions with the enantiomers. The presence of
metal ions is essential, as it provides the site for the exchange process between the
ligands and enantiomers. The chemical structures of some important chiral
ligands used in CLEC are shown in Figure 1.

Cross-linked polystyrene resins incorporating chiral amino acids were utilized as
the chiral stationary phases (CSPs) in CLEC [6,21]. Davankov et al. [12] reported
the use of a resin incorporating L-proline in a polystyrene-type matrix. The resin
was prepared by reacting L-proline with the chlormethylated styrene–divinyl-

FIGURE 1 Chemical structures of ligand exchangers.
benzene copolymer [12]. A more general procedure involves the use of methyl
esters or amides of amino acids and p-chloromethylated styrene-co-polymers
[12]. Several other groups have synthesized chiral CSPs, starting from the
conventional styrene–divinylbenzene copolymers containing amino acids [22–
26]. A French research group later grafted the porous hydrophobic beads of cross-
linked polyacrylamide and used it as the solid support for the chiral ligands
[22,23]. The other hydrophobic polymeric support used were Separon H1000
[26] and TSK 2000 PW [27]. In spite of high enantioselectivity and exchange
capacities, these CSPs suffer from high-pressure resistance and slow mass
transfer as compared to other rigid solid supports such as silica gel. The swelling
of these resins in the aqueous mobile phase is a major problem. Therefore, later,
silica gel was used as the solid support for the preparation of ligand-exchange-
based CSPs.

Initially, the chiral selectors were allowed to adsorb on the surface of silica
gel and were packed into the columns [21,28–31]. Miyazawa et al. [32] deposited
N ,S-dioctyl-D-penicillamine onto the surface of RP-18 silica gel. The same chiral
selector and (R,R)-tartaric acid mono(R)-1-(a-naphthyl)-ethylamide were applied
by Oi et al. [33] for the modification of the Sumipax ODS column. Slivka et al.
[34] synthesized N -alkylphenoxyglycinols and loaded them onto silica gel C18 .
Kurganov et al. [35] prepared a CSP by loading Cu(II)[N -octadecyl-(S)-proline]2
on the surface of Superspher-100 RP-18 silica gel. The coating of chiral ligands
was achieved on both bare and chemically modified bonded silica gels. These
types of CSP were prepared with low-molecular-mass ligands or complexes.
Alternatively, the coated types of CSP were prepared by simply shaking the chiral
ligand with silica gel at different time intervals [12]. Of course, these CSPs were
used for the chiral separation of various racemates, but, again, they have certain
drawbacks. These drawbacks include the limitations of the choice of mobile
phases, especially with organic modifiers. Sometimes these CSPs deteriorated at a
high column pressure. Therefore, more promising methods of the covalent
binding of chiral ligands to the surface of silica gel, yielding highly stable and
selective CSPs, were developed.
In 1979, three different groups [36–38] reported the preparation of
covalently bonded chiral ligand-exchange CSPs and tested for the chiral resolu-
tion of amino acids. Gübitz et al. [39,40] prepared two CSPs containing L-proline
covalently bonded to silica gel. These are popular CSPs in CLEC due to their
excellent chiral recognition capabilities. A similar chiral stationary phase contain-
ing S-proline was prepared by Yang et al. [41]. The chiral selector was connected
to silica gel through a single S-triazine spacer. Recently, Hyun et al. [42] prepared
a CSP by covalently bonding (S)-N ,N -carboxymethyl undecyl leucinol mono-
sodium salt onto silica gel. About 40 different chiral ligand exchangers were
developed and used for chiral resolution by CLEC. The structure of some of the
important ligand-exchange CSPs are given Figure 2. There are many ways to
prepare covalently bonded ligand-exchange CSPs [12,18–20,43–46]. As an
example, one method for the preparation of chiral CSP is presented in Figure 3
[15].
Figure 3 describes the preparation of N -o-undecenoyl-L-valine CSP
bonded to silica gel. The carboxylic acid group of L-valine was protected by
the reaction with isobutylene using the method of Roeske [47]. The formed tert-
butyl ester of L-valine was precipitated from diethyl ether as the oxalate by the
dropwise addition of a solution of 10% oxalic acid in absolute ethanol. The
precipitate is dried and the oxalate group is removed by the reaction of sodium
hydroxide. The tert-butyl ester of L-valine was treated with undecenoic acid in
tetrahydrofuran (THF), which resulted in N -o-undecenoyl-L-valine methyl ester.
In another step, 10 mM of monochlorosilane was dissolved in 20 mL of dry
pyridine and was allowed to react with N -o-undecenoyl-L-valine methyl ester.

FIGURE 2 Chemical structures of ligand-exchange CSPs.

FIGURE 3 Chemical pathway for covalent bonding of ligand exchanges with silica gel.
The obtained product was allowed to react with silica gel. The tertiary butyl
protecting group was removed by the reaction of trifluoroacetic acid. The
obtained product was washed thoroughly with 90% methanol followed by
100% methanol and dried at 60 C. The material was packed in appropriate
stainless-steel columns. The ligand-exchange-based CSPs commercialized by
different companies are given in Table 1.

TABLE 1 Various Ligand Exchange–Based Commercial CSPs
Commercialized CSP Companies
Chirosolve JPS Chemie, Switzerland

Chiralpak WH, Chiralpak WM, Separations Kasunigaseki-Chrome,
Chiralpak WE, and Chiralpak MA Tokoyo, Japan
Chiralpak WH and Chiralpak WM Daicel Chemical Industries, Tokyo, Japan
Nucleosil Chiral-1 Macherey-Nagel, Duren, Germany
Phenylglycine and leucine types Regis Technologies, Austin, TX, USA
Chirex types Phenomene, Torrance, CA, USA
Orpak CRX-853 Showa Denko, Kanagawa, Japan
7.3 APPLICATIONS
It is well known that the chiral resolution of these CSPs occurred as a result of the
exchange of ligands and enantiomers on the same metal ion. Therefore, these
CSPs are suitable only for those racemates which can coordinate with the metal
ion. Therefore, racemates like amino acids, amines, and hydroxy acids have been
resolved successfully by the ligand-exchange process. As mentioned earlier,
either the individual chiral ligand or one complexed with a metal ion is bonded
onto silica gel support. Therefore, in the case of the first type of CSP, the metal
ion is used in the mobile phase; no metal ion is required in the mobile phase in
the latter case.

Davankov et al. [3,11,12] have carried out extensive and remarkable work on the
chiral resolution using these CSPs. The chiral ligand-exchange resins based on
macronet isoporous styrene copolymers containing L-hydroxyproline were used
for the chiral resolution of amino acids. Because of the high resolving power of
the resin, short (2 cm) columns were developed and used. L-Hydroxyproline-
based resins were used for the chiral resolution of mandelic acid, b-phenyl-b-
alanine, 2-aminopropanol-1, 1 N -benzyl-propane-diamine, and ephedrine [48,49].
Grafted L-phenylalanine has been used successfully for the chiral resolution of
amino acids with values of a separation factor of more than 1.25 [50]. The
chromatograms of the resolved amino acids on macronet isoporous polystyrene-
type resin containing N 1 -benzyl-(R)-diaminopropane-1,2 are shown in Figure 4a.
The coated ligand-exchange CSPs have been used with the mobile phases
that did not cause bleeding effects. Otherwise, the CSP may lose its chiral ligand
after a few runs [12]. It is very interesting to note that the values of separation
factors were very high on the coated CSPs. The values of the separation factors
for proline and valine amino acids were reported at 16.4 and 6.9, respectively

FIGURE 4 Chromatograms of the resolved amino acids and dipeptides on (a) leucine (1),
serine (2), alanine (3), and lysine (4) on a glass microbore column with a macronet
isoporous polystyrene-type resin containing groups of N 1 -benzyl-(R)-diaminopropane-1,2
chiral selector using 0.25 M sodium acetate containg 1.5 M copper acetate; (b) alanine (1),
proline (2), abrine (3), isovaline (4), and tyrosine (5) on Zorbax C8 coated with C10 -L-
histidine using 104 M aqueous copper acetate as the mobile phase; and (c) gly-ther (1)
and gly-leu (2) on hydroxy proline-bonded CSP using aqueous 105 M copper(II) ions as
the mobile phase. (From Refs. 12, 17, and 40.)

[12]. N -(2-Hydroxy-decyl)-L-hydroxyproline was used to determine the enantio-
meric purity of D-penicillamine [51]. Zorbex ODS C8 and LiChrosorb RP-18
columns were coated by N -decyl-L-histidine and charged with copper(II) ions.
The developed CSPs were used for the chiral resolution of amino acids using
aqueous copper acetate (0.0001 M) as the mobile phase [17]. Yuki et al. [52]
developed a novel chiral phase consisting of (1R,2S)- and diastereoisomeric
(1S,2S)-2-carboxymethylamino-1,2-diphenylethanol separately. These phases
were used successfully for the chiral resolution of amino acids and their
derivatives and hydroxy acids. Takeuchi et al. [53] coupled the Chiralpak WH
column with a hydrophobic column (Hypersil ODS-3) in a series and achieved
the chiral resolution of seven pairs of dansyl amino acids. The chromatograms of
the chiral resolution of amino acids on a Zorbax C18 column coated with L-
histidine are shown in Figure 4b.
Foucault et al. [46] bonded L-proline to 3-aminopropylsilated silica gel and
the developed CSP was used for the chiral resolution of amino acids. Gübitz et al.
[20] reported the successful separation of amino acids on silica gel covalently
bonded with L-proline. Moreover, the authors reported the chiral separation of a
mixture of four to five amino acids in less than 1 hr. The authors reported the high
retention of L-enantiomers of all of the amino acids used in this study. The same
authors [54,55] reported the resolution of biologically important molecules like
thyroid hormones and 3,4-dihydroxyphenylalanine (DOPA). Furthermore, Gübitz
[56] achieved the chiral separation of dipeptides on L-hydroxyproline-bonded
CSP. Sinibaldi et al. [57,58] bonded the copper(II) complex of trans-cyclo-
hexanediamine-1,2 to glycidoxypropyl silica gel and the developed CSPs were
used for the chiral resolution of several amino acids and mandelic acid. In 1983,
Watanabe [59] used L-histidine-based CSP for the chiral resolution of amino
acids under acidic conditions using a phosphate buffer. A good resolution of
dansyl amino acids was achieved on diamide-type phases prepared from L-proline
[44]. The chiral separation of chlorquine and other amine derivatives were carried
out on anion exchangers modified with heparin using a phosphate buffer with
acetonitrile [60]. Recently, penicillamine bonded to silica gel was used as the
chiral ligand for the chiral resolution of lactic acid in wine [61] and cyclic b-
substituted a-amino acids [62]. Vidyasankar et al. [63] synthesized chiral ligands
by molecular imprinting techniques and the developed CSPs were used for the
chiral resolution of amino acids. Bulk polymers were prepared by allowing the
functional polymer, Cu(II)-N -(4-vinylbenxzyl)iminodiacetic acid, to form
complexes with the template amino acids in solution, followed by cross-linking
with ethylene glycol dimethacrylate. The imprinted polymer was grafted onto
derivatized silica gel. To show the nature of the chiral resolution on these phases,
the chromatograms of the chiral resolution of dipeptides on the chemically
bonded CSP (derivatized L-proline) are shown in Figure 4c. The most important
racemic compounds resolved on CLEC are given in Table 2.

TABLE 2 Enantiomeric Resolution of Racemic Compounds on Ligand Exchange–
Based CSPs
Racemic compound CSPs Refs.
Amino acids L-Proline, L-hydroxyproline 18, 21, 40, 42,

N -Octyl-(S)-phenylalaninamide, 53, 64, 65, 67
N -dodecyl-(S)-phenylalaninamide,
N -Octyl-(S)-norleucinamide
(1R,2S)- and diastereoisomeric (1S,2S)-2- 52
carboxymethylamino-1,2-diphenylethanol
[Cu(II) 3-(L-propyl)propyl]þ , [Cu(II) 19
3-(L-hydroxypropyl)]þ
L-Histidine 17, 59
L-Tryptophan 30
Dansyl amino N -o-(Dimethylsiloxyl)undecanoyl-L-valine 15
acids L-phenylalaninamide, L-alaninamide, 72
L-prolinamide
Dipeptides L-Proline, L-hydroxyproline 40
N -Benzyloxycarbonyl L-Valine 66
of amino acids
Penicillamine (2S,4R,20 RS)-4-hydroxy-1-(20 -hydroxydodecyl) 51
proline
Amino alcohols L-Proline 71
Hydroxy acids L-Hydroxyroline 69
(1R,2S)- and diastereoisomeric 52
(1S,2S)-2-carboxymethylamino-1,2-
diphenylethanol
L-Penicillamine 62
L-phenylalaninamide, L-alaninamide, 72
L-prolinamide
Thyroid hormones L-Phenyalanine 55
Lactate Shodex Orpack RX-453 68
Imidazole anti- Chiralpak WH 70
fungal agents

As a result of certain drawbacks attached to coated silica gel CSPs, they could not
be used for preparative separations. However, the literature provides some reports
on the preparative chiral separations on the bonded CSPs. The bonded CSPs are
suitable for use at a preparative scale but the yield is very poor due to poor
loading capacities. Davankov et al. [73] packed a column with 300 g of the L-
hydroxyproline-type resin and used the chiral separation at a preparative scale.

The authors reported the chiral separation of proline and thereonine amino acid
up to 20 and 6 g, respectively, in a single run. Micropreparative resolution of
lecucine was presented. The resolution was discussed with respect to the degree
of sorbent saturation with copper(II), elution rate, eluent concentration, tempera-
ture, and column loading condition [16]. Weinstein [74] reported the micro-
preparative separation of alkylated amino acids on a Chiral ProCu column. In
another article, a preparative chiral resolution of 3-methylene-7-benzylidene-
bicyclo[3.3.1]nonane was achieved on 7.5% silver(I)–d-camphor–10-sulfonate
CSP [75]. Later, Shieh et al. [71] used L-proline-loaded silica gel for the chiral
resolution of (R,S)-phenylethanolamine as the Schiff base of 2-hydroxy-4-
methoxyacetophenone. Gris et al. [76] presented the preparative separations of
amino acids on Chirosolve L-proline and Chirosolve L-pipecolic acid CSPs.

Ligand-exchange chromatography has been used for the chiral resolution of
racemic compounds containing electron-donating atoms; therefore, their applica-
tions are confined. Mostly buffers, sometimes containing organic modifiers, were
used as mobile phases. Therefore, the optimization was carried out by controlling
the composition of the mobile phase. However, pH, effects of temperature,
concentration of metal ions, and flow rate were also varied. The optimization
of these parameters are discussed in detail.

There are two strategies for the development and use of mobile phases on these
CSPs. An aqueous mobile phase containing a suitable concentration of metal ions
is used with the CSP having only a chiral ligand. In the case of the CSP
containing a metal ion complex as the chiral ligand, the mobile phase is used
without the metal ions. In most of the applications, aqueous solutions of metal
ions or buffers were used as the mobile phases. The most commonly used buffers
are ammonium acetate and phosphate. However, the use of a phosphate buffer is
avoided if the metal ion is being used as a mobile phase additive to avoid the
complex formation between the metal ion and the phosphate which may block the
column. A review of literature indicates that these buffers (20–50 mM) were used
frequently for successful chiral resolution, but in some instances, organic
modifiers were also used to improve the resolution. Generally, acetonitrile was
used as the organic modifier [15]. However, some reports deal with the use of
methanol, ethanol, and THF [17,19,65,71]. The concentrations of these modifiers
used vary from 10% to 30%. However, some reports indicated the use of these
organic modifiers up to 75% [65,71]. There are only a few reports which

indicated the use of these CSPs under normal phase modes. Perry et al. [77] used
isopropanol–hexane (10 : 90, v=v) for the chiral resolution of trifluoro-1-(9-
anthryl)-ethanol. Recently, Aboul-Enein and Ali [70] used hexane–2-propanol–
diethylamine (400 : 99 : 1, v=v=v) as the mobile phase for the chiral resolution of
the antifungal agents econazole, miconazole, and sulconazole on a Chiralpak WH
column.
Generally, the chiral resolution of highly retained solutes is optimized using
organic modifiers. The organic modifiers reduce the hydrophobic interactions
resulting into improved resolution. Roumeliotis et al. [19,65] studied the effect of
methanol, acetonitrile, and THF organic modifiers on the chiral resolution of
amino acids and they reported methanol as the best solvent. Furthermore, the
concentration of methanol was optimized and 50% was found to be a suitable
concentration. These findings are shown in Tables 3 and 4. Kurganov et al. [21]
carried out an extensive study on the variation of methanol and acetonitrile
concentrations on the chiral resolution of amino acids. The authors reported 5–
20% as the best concentrations of these modifiers. Similarly, Takeuchi et al. [53]
TABLE 3 Effect of Different Organic Solvents on the Chiral Resolution of Amino

Acids on [Cu(II)–L-Hydroxypropyl)]methyl–Silica Gel
Methanol Acetonitrile THF
Amino acid k1 a k1 a k1 a
Aspartic acid 2.64 0.95 3.40 0.99 1.52 0.95

Glutamic acid 2.04 1.14 2.92 1.12 1.25 1.17
Histidine 4.42 0.46 5.86 0.59 2.65 0.54
Alanine 2.10 1.11 2.68 1.10 1.47 1.09
Asparagine 4.03 0.84 4.87 0.92 2.37 0.87
Serine 3.00 0.88 3.59 0.93 1.83 0.95
Proline 2.33 1.68 2.61 1.63 1.74 1.61
Threonine 3.41 1.03 4.00 1.11 2.08 1.12
Valine 2.49 1.01 3.01 1.02 1.71 1.03
Lysine 4.90 0.85 — — 2.50 0.91
Tyrosine 3.13 0.78 3.12 0.85 2.04 0.85
Methionine 2.66 1.13 2.90 1.19 1.67 1.21
Arginine 4.42 1.05 — — 2.60 1.08
Isoleucine 2.20 0.97 2.85 0.90 1.52 0.98
Leucine 2.56 0.90 2.92 0.90 1.75 0.89
Phenylalanine 3.04 0.87 2.87 0.94 1.96 0.95
Tryptophan 5.27 0.66 4.28 0.71 3.05 0.78
Source: Ref. 65.

TABLE 4 Effect of Methanol Concentration on the Chiral Resolution of Amino
Acids on Cu(II)–L-Hydroxypropyl)methyl–Silica Gel
Percentage of methanol
10 30 50 100
Amino acid k1 a k1 a k1 a k1 a
Aspartic acid 1.00 1.00 1.13 1.00 2.64 0.95 0.44 1.00
Glutamic acid 0.88 1.09 0.74 1.14 2.04 1.14 0.39 1.08
Histidine 3.42 0.54 3.58 0.48 4.42 0.46 1.62 0.67
Alanine 1.18 1.07 0.79 1.10 2.10 1.11 0.47 1.08
Asparagine 1.94 0.93 1.74 0.93 4.03 0.84 0.81 0.96
Serine 1.52 0.93 1.17 0.95 3.00 0.88 0.57 0.96
Proline 1.46 1.42 0.97 1.26 2.33 1.68 0.79 1.14
Threonine 1.91 1.03 1.53 1.10 3.41 1.03 0.79 1.07
Valine 1.66 1.00 1.04 1.01 2.49 1.01 0.80 1.00
Lysine 2.59 0.91 1.47 0.90 4.90 0.85 0.99 0.93
Tyrosine 1.88 0.77 1.30 0.81 3.13 0.78 0.75 0.82
Methionine 1.87 1.09 1.18 1.18 2.66 1.13 0.91 1.07
Arginine 2.97 1.02 1.54 1.02 4.48 1.03 1.21 1.00
Isoleucine 1.66 0.98 1.12 0.96 2.20 0.97 0.88 0.96
Leucine 1.89 0.92 1.41 0.90 2.56 0.90 0.97 0.92
Phenylalanine 2.30 0.86 1.41 0.89 3.04 0.87 1.10 0.93
Tryptophan 3.77 0.64 2.42 0.65 5.27 0.66 1.58 0.70
Source: Ref. 65.
studied the effect of acetonitrile on the chiral resolution of amino acids on a

Chiralpak WH column. The authors reported the best resolution at 5–30%
acetonitrile concentrations. The results of this research is shown in Figure 5.
Davankov et al. [17] used ethanol for the optimization of the chiral separation of
amino acids and the authors reported the improved resolution at a higher
concentration of ethanol. The maximum value of the separation factor was
1.81 using 100% ethanol. Okubo et al. [68] optimized the chiral resolution of
lactate by varying the concentration of methanol on an Orpac CRX-453 B
column. The authors reported 1.68, 1.77, and 1.60 as the values of separation
factors without methanol and with 10% and 20% methanol, respectively.
Schlauch et al. [62] observed the reversal order of elution of some amino acids
when using different concentrations of acetonitrile. The protocol for the devel-
opment and optimization of mobile phase is given in Scheme 1.

FIGURE 5 Effect of the concentration of acetonitrile on (a) the retention (k) and the (b)
separation (a) factors for the chiral resolution of (s) dansyl asparagine and (u) dansyl
valine on a Chiralpak WH column using 0.25 M ammonium acetate as the major
component of the mobile phase. (From Ref. 53.)

SCHEME 1 Protocol for the development and optimization of mobile phases on ligand-
exchange-based CSPs. *Note: Use phosphate buffer only with CSPs containing ligand
metal complex as the chiral selector.

The pH of the mobile phase was recognized as one of the most important
controlling factors of chiral resolution on ligand-exchange chiral phases [78]. The
retention of all the racemates increased as the pH increased. The selectivity of
separation was only affected moderately by pH changes, whereas the efficiency of
the column showed a different trend depending on the relative retentions of
racemates. Buffers having a pH from 3 to 5 were used. However, Gübitz and
Juffmann [55] achieved the chiral resolution of thyroid enantiomers at pH 8.5. In
another study, Gübitz and Jellenz [18] reported the maximum chiral resolution of
certain amino acids at a pH higher than 8.0. Watanabe et al. [30] studied the effect
of pH (4–5.5) on the chiral resolution of asparagine, thereonine, and histidine.
The effect of pH on the chiral resolution of these amino acids is shown in Figure
6a, which indicates 5.5 as the best pH. Roumeliotis et al. [65] carried out an
extensive study on the chiral resolution of amino acids with respect to pH
variation. The pH varied from 4.5 to 6.0 and the best results were obtained at pH
4.5. Furthermore, Roumeliotis et al. [19] optimized the chiral resolution of amino
acids on different CSPs using the mobile phase of different pHs and the best

FIGURE 6 Effect of the pH on the chiral resolution of amino acids (a) (s) asparagine,
() valine, and (u) histidine and (b) aspartic acid (1), glutamic acid (2), histidine (3),
alanine (4), serine (5), proline (6), thereonine (7), valine (8), lysine (9), tyrosine (10),
leucine (11), phenylalanine (12), and tryptophan (13) with L- (—) and D-enantiomers (- - -).
(From Refs. 21 and 30.)

chiral resolution was reported at pH 4.75. Similarly, Kurganov et al. [21] varied
the pH from 4.6 to 5.0 and observed the best resolution of amino acids at pH 5.0.
The results of their findings are presented in Figure 6b. Schlauch et al. [62]
resolved four pairs of amino acids in a single run by optimizing the pH
conditions.
7.4.3 Ionic Strength of the Mobile Phase

The concentration of buffer is also a very important aspect in the optimization of
the chiral resolution on these CSPs. It has been reported that an increase in buffer
concentration caused a decrease in the retention and selectivity for all amino acids
except for the basic amino acids. Therefore, the separation of basic amino acids is
possible only with the most concentrated buffers. The buffers of concentrations in
the 25–50-mM range were used for the chiral resolutions with some exceptions.
In spite of this, few reports are available for the optimization of the chiral
resolution by varying the ionic strength of the mobile phase. The effect of ionic
strength of phosphate buffer on the chiral resolution of serine was carried out by
Gübitz and Jellen [18] and the best resolution was achieved at 0.01 M concentra-
tion (Fig. 7). In another study, the concentration of ammonium acetate (0.001–
0.01 M) was varied to optimize the chiral resolution of amino acids [19]. The
effect of the concentration of ammonium acetate on the chiral resolution of amino
FIGURE 7 Effect of the ionic strength of the buffer on the chiral resolution of (d):
D-serine and (d) L-serine. (From Ref. 18.)

TABLE 5 Effect of the Concentrations of Ammonium Acetate on the Chiral
Resolution of Amino Acids
Concentration of ammonium acetate
0.001 M 0.01 M 0.1 M
Amino acid k1 a k1 a k1 a
Aspartic acid 2.19 0.97 0.58 1.00 0.20 1.00

Glutamic acid 2.51 1.16 0.49 1.14 0.06 1.00
Histidine 8.62 1.00 3.13 0.81 1.08 0.73
Alanine 4.37 1.05 0.83 1.09 0.11 1.27
Asparagine 4.27 0.97 1.08 1.00 0.32 1.00
Glutamine 4.29 0.98 0.84 0.58 0.17 0.35
Serine 4.21 0.98 1.06 0.83 0.23 1.04
Proline 5.39 1.27 1.06 1.78 0.16 1.75
Threonine 4.65 0.97 1.28 0.92 0.33 0.88
Valine 5.54 1.08 1.69 1.10 0.24 1.29
Lysine 14.4 1.13 2.95 1.04 0.31 1.00
Tyrosine 5.62 0.95 2.26 0.89 0.49 0.92
Methionine 5.70 1.04 1.94 1.05 0.38 1.08
Arginine 18.46 1.01 3.79 1.06 0.60 1.00
Isoleucine 5.34 6.11 1.76 1.20 0.29 1.32
Leucine 5.61 1.06 1.77 1.10 0.31 1.16
Phenylalanine 6.50 1.00 2.43 1.07 0.55 1.09
Tryptophan 10.67 0.97 5.12 0.96 1.30 0.98
Source: Ref. 19.
acids is given in Table 5, which indicates a decrease in the values of separation

factors at a high concentration of ammonium acetate. Davankov et al. [17] studied
the chiral resolution of some amino acids with and without ammonium chloride
in the mobile phase. The authors reported a rapid decrease of chiral resolution by
the addition of ammonium chloride in the mobile phase. It may have been the
result of the combined effect of the increased ionic strength, partial protonation of
both fixed and mobile amino acids ligands (due to a decrease in pH by adding
ammonium chloride), and increased concentration of ligand (ammonia) compet-
ing for coordination with copper(II). Jin and He [79] observed the long retention
of amino acids using chloride ions in the mobile phase.
7.4.4 Concentration of the Metal Ions

The retention and selectivity of enantiomeric resolution was also investigated
with respect to metal ion concentrations on these CSPs. The chiral resolution on

the CSPs containing only chiral ligands was carried out using metal ions in the
mobile phase. It has been reported that different concentrations of metal ions were
used for the chiral resolution of different racemic compounds under varied
chromatographic conditions. The literature reveals few reports on the variation
of metal ion concentrations. Watanabe et al. [30] studied the effect of the
concentration of copper(II) ions on the chiral resolution of glutamine, thereonine,
and asparagine and the best resolution was achieved at 0.0005 M concentration
(Fig. 8a). The authors suggested avoiding the use of copper metal ions at higher
concentrations, as the copper(II) ions absorb ultraviolet (UV) radiation, increas-
FIGURE 8 Effect of the concentration of copper(II) metal ion on the chiral resolution of
(a) (s) glutamine, () threonine, and (u) asparagine; and (b) phenylalanine. (From Ref.
30.)

TABLE 6 Effect of the Concentrations of Copper Sulfate on
the Chiral Resolution of Lactate Enantiomers
Retention times (min)

Copper sulfate
(mM) L-Lactate D-Lactate a Rs
0.50 14.07 16.56 1.23 1.66

1.00 13.79 16.19 1.23 1.68
1.25 13.60 15.96 1.23 1.63
1.50 13.27 15.56 1.23 1.56
2.00 12.60 14.79 1.23 1.51
Source: Ref. 68.
ing the limit of detection. Davankov et al. [17] also carried out the chiral
resolution of amino acids by varying the concentrations of copper acetate
(0:5 104 to 2 104 M). It has been observed that an increase in the
concentration of copper(II) ions produced a decrease in the values of retention
factors; hence, 0:05 104 M was found as the suitable concentration. The effect
of the copper(II) ions concentration on the retention of phenylalanine was also
carried out, and higher values of retention factors were observed at 0.25 mM
concentration [67]. This effect of copper(II) ions concentration on the retention of
phenylalanine is shown in Figure 8b. Recently, Okubo et al. [68] varied the
concentration of copper sulfate from 0.5 to 2.00 mM for the separation of lactate
enantiomers. The values of the retention and separation factors are given in Table
6, which indicate the higher separation at 1 mM concentration.
7.4.5 Temperature
Temperature is also a very important parameter for controlling the chiral
resolution of these CSPs. It has been observed that an increase in temperature
has resulted in a decrease in the retention of all racemates, excluding basic amino
acids [78]. The selectivity of resolution has been reduced by an increase in
temperature. However, the column efficiency increased with a rise in temperature.
The decrease in the retention times of the racemates at a high temperature
indicated the exothermic nature of the ligand-exchange process. The effect of
temperature (0–60 C) on the chiral resolution of arginine was presented by
Gübitz and Jellen [18] and is shown in Figure 9a. This figure indicates no
resolution at 0–20 C, partial resolution at 20–50 C, and complete resolution at
50 C or higher. The effect of temperature on the chiral resolution of arginine was
also carried out by Watanabe et al. [30] (Fig. 9b) at 10–60 C. In another study
[17], an increase in the temperature (i.e., 18–45 C) resulted in the decrease of

FIGURE 9 Effect of the temperature on the chiral resolution of (a) arginine and (b)
asparagines. (From Refs. 18 and 30.).
retention of amino acids, which improved the chiral resolution. Roumeliotis et al.
[19] observed a decrease in the retention of amino acids at higher temperature.
The authors explained the decrease in the retention as the result of the weakness
in the complexation and hydrophobic interactions at higher temperature. In
another study [65], the same authors reported the reversal order of the elution
of amino acids by varying the temperature. Jin and He [79] reported a decrease in
the retention of amino acids at higher temperature. The authors explained the
decrease in retention as the result of distortion of polymer conformation in the

ligand-exchange process. Okubo et al. [68] also observed a decrease in the
retention of lactate enantiomers at higher temperature, with little effect on
enantioselectivity. Therefore, temperature may be used to control the enantio-
separation on ligand-exchange CSPs.
7.4.6 Flow Rate of the Mobile Phase

In ligand-exchange high-performance liquid chromatography (HPLC), the effi-
ciency of the chiral resolution may be controlled by adjusting the flow rate of the
mobile phase. However, it has been reported that the chiral resolution at low flow
rates did not follow the well-known Van Deemter’s plot, which may be due to the
slow ligand-exchange kinetics. There are very few studies dealing with the
optimization of chiral resolution on these CSPs by adjusting the flow rates.
However, Jin and He [79] studied the effect of flow rates (7.2–34.0 mL=hr) on the
chiral resolution of amino acids. The authors reported an increase in the values of
separation and resolution factors at low flow rates. However, on the other hand,
the authors also reported the fast resolution of some amino acids at high flow
rates. Aboul-Enein and Ali [70] reported a better resolution of econazole,
miconazole, and sulconazole at a 0.5-mL=min flow rate. The authors rationalized
the better resolution at the 0.5-mL=min flow rate as being the result of the greater
residence time of enantiomers on the chiral stationary phase, which was sufficient
for the ligand-exchange process to take place under the reported chromatographic
conditions.

As in the case of other CSPs, the chiral resolution on these CSPs is also affected
by a change in the structures of the racemic compounds. The different selectiv-
ities of amino acids on these CSPs may be considerd as the best example. The
effect of structures of the racemates on the chiral resolution may be understood
from the work carried out by Shieh et al. [71]. The authors studied the chiral
resolution of amino acids as their Schiff ’s bases. These racemates differ slightly in
their structure and the substituent, such as alkyl groups, hence showed different
values of enantioselectivities. The values of retention and separation factors
decreased by introducing bulky groups in the racemates. Aboul-Enein and Ali
[70] observed the lower values of retention factors of miconazole in comparison
to econazole and sulconazole. The authors explained this sort of behavior on the
basis of the steric effect exerted by the extra chlorine atom in miconazole
molecule.

7.4.8 Structures of Ligand Exchangers
The chiral separations on these CSPs are based on the kinetics of ligand
exchangers and the enantiomers. The exchange kinetics vary from one chiral
selector to another. Therefore, the structures of the chiral selectors are very
important from the selectivity point of view. Accordingly, the same racemate may
behave in different ways on the different CSPs. This effect may be observed from
the work carried out by Roumeliotis et al. [65] in which [Cu(L-hydroxypropyl)-
methyl] silica and [Cu(L-hydroxypropyl)n -octyl] silica gels were used as the
chiral selectors for the enantiomeric resolution of amino acids (Table 7). The
different values of retention and separation factors is presented in Table 7. Similar
behavior for the chiral resolution of amino acids on different CSPs is shown in the
research work of the same authors [19]. A very interesting study was carried out
by Gübitz and Jellenz [18] using L- and D-enantiomers of proline as the chiral
selectors separately for the chiral resolution amino acids. The two CSPs showed
different chiral selectivities for certain amino acids. It has also been observed that
L-proline is a better chiral ligand than D-proline. This could be because of the
steric effects, as the two enantiomers differ only in their configurations. These
TABLE 7 Effect of the Structures of CSPs on the Chiral Resolution of Amino Acids
[Cu(L-Hydroxy- [Cu(L-Hydroxy-
propyl)methyl]þ silica propyl)n -octyl]þ silica
Amino acid k1 a k1 a
Aspartic acid 0.13 1.08 2.01 1.06

Glutamic acid 0.10 2.50 1.57 1.00
Histidine 1.70 0.75 2.22 0.86
Alanine 0.48 1.21 0.40 1.45
Asparagine 0.52 1.54 0.89 0.92
Serine 0.65 1.00 0.82 0.90
Proline 0.63 1.43 1.07 1.93
Threonine 0.73 1.37 1.14 1.02
Valine 0.80 1.12 2.81 0.96
Lysine 1.42 1.04 0.07 0.29
Tyrosine 1.37 0.69 12.25 0.79
Methionine 1.23 1.14 4.05 1.13
Arginine 2.05 0.87 0.31 1.26
Isoleucine 1.23 1.00 5.86 1.01
Leucine 1.30 0.79 4.80 1.07
Phenylalanine 1.32 1.00 17.60 0.88
Source: Ref. 65.

TABLE 8 Effect of the Structures of L-Proline
and D-Proline as Chiral Ligands on the Chiral
Resolution of Amino Acids
L-Proline D-Proline
Amino acid a a
Tryptophan 3.50 0.36

Phenylalanine 2.90 0.40
Tyrosine 3.10 0.38
Valine 1.50 0.66
Proline 0.60 2.30
Histidine 1.80 0.53
Thereonine 1.60 0.60
Source: Ref. 18.
results are presented in Table 8. In 1996, Galaverna et al. [67] carried out the
chiral resolution of amino acids on three different CSPs: N 2 -octyl-(S)-phenyl-
alaninamide, N 2 -octadecyl-(S)-phenylalaninamide, and N 2 -octyl-(S)-norleucina-
mide. These three CSPs differ only in their functional groups and, therefore,
showed different chiral recognitions. In 1997, Vidyasankar et al. [63] observed
that adsorbents prepared from amino acids with larger aromatic side chains
exhibited the highest selectivities for amino acids. Briefly, the different chiral
resolution on different CSPs is due to the different physical, stereochemical
properties of the CSPs.

In addition to the above-discussed parameters, other factors are also important for
controlling the chiral resolution of these CSPs. These parameters include particle
size of the silica gel, amount of chiral selector on the solid support, and the
injection volume. Roumeliotis et al. [19,65] used the silica support of different
particle sizes and the authors reported that the best resolution was obtained on the
silica gel of smaller particle size. It has also been reported that the packing of the
chiral selectors affected the chiral resolution, which may be the result of the
slowness of the ligand-exchange kinetics [5,27,64,80]. Boue et al. [64] studied
the effect of the amount of sample loading on the chiral resolution of valine and
the authors observed a shift from 3.0 to 3.5 in retention factor when the injected
sample decreased from 1 to 0.15 mg. Jin and He [79] studied the chiral resolution
of histidine using different loading amounts. They reported a decrease in the

FIGURE 10 Effect of the injection amount on the chiral resolution of histidine. (From
Ref. 79.)
retention at a higher concentration of histidine, which resulted in the improved

separation of the enantiomers. The variation of the retention factors with
respect to loading amounts is shown in Figure 10. The chiral resolution may
be optimized by introducing a suitable spacer between the solid support and the
chiral ligands.

The chiral resolution of these CSPs occur due to the exchange of the chiral
ligands and the enantiomers of specific metal ions through coordinate bonds. The
two enantiomers have different exchange capacities because of the stereospecific
nature of the ligand-exchange process; hence, chiral resolution takes place.
Davankov et al. [2,8,9] suggested a theoretical model for the mechanisms of
the chiral resolution on these CSPs. In this model, the enantiomers were
coordinated to the Cu(II) ions in different ways depending on their interactions
with the ligands bonded to the stationary phase acting as chiral selectors. The
authors explained that the chiral resolution is the result of different bondings

FIGURE 11 Graphical representation of the chiral recognition mechanism of (a) phenylalanine and (b) antifungal agents on the chiral
ligand-exchange CSPs. (From Refs. 18 and 70.)

along with the steric effects. In this way, the diastereoisomeric complexes are
formed by the two enantiomers. These diastereoisomeric complexes are stabilized
at different magnitudes by dipole–dipole interactions, hydrogen-bondings, van
der Waal forces, and steric effects. The diastereoisomeric complexes of phenyl-
alanine enantiomers and Cu(II)–L-proline are shown in Figure 11a. It is clear
from this figure that the diastereoisomeric complex having the D-enantiomer is
less stable, due to the presence of steric forecs, and hence eluted first followed by
L-enantiomer.
To make the concept much clearer, an example of the work carried out by
Aboul-Enein and Ali [70] is presented herein. The authors reported the chiral
resolution of econazole, miconazole, and sulconazole (antifungal agents) on the
Chiralpak WH column. The expected structures of the diastereoisomeric
complexes of these antifungal agents with the CSP are shown in Figure 11b.
All three antifungal agents contain electron-donating atoms such as nitrogen,
oxygen, and sulfur (Fig. 11b). The Chiralpak WH CSP is a L-proline–Cu(II)
complex attached to silica gel. The copper is a transition metal ion and contains
empty d-orbitals, which are essential for coordinate bonding. Therefore, nitrogen,
oxygen, and sulfur atoms of the antifungal agents are coordinated with a copper
atom and hence the ternary complexes of L-proline–Cu(II)-enantiomers are
formed. The enantiomeric resolution of these antifungal agents may be explained
on the basis of the ligand-exchange mechanism through coordination bondings.
Other interactions, such as hydrogen-bondings, dipole-induced dipole inter-
actions, steric effect, and van der Waal forces, also participate in the chiral
recognition phenomenon. Therefore, (þ)- and ()-enantiomers of the reported
antifungal agents formed diastereoisomeric complexes of different stabilities with
WH CSP in a stereo-specific way, which resulted in the complete resolution of the
enantiomers.
Figure 11b shows that for (þ)-isomers of antifungal agents, the substituents
on the chiral carbon of antifungal agents are located far from the pyrrolidine
group of L-proline, whereas the substituent on the chiral carbon of ()-
enantiomers are located near the pyrrolidine group of L-proline. Therefore, the
L-proline–Cu(II)–()-enantiomer complexes feel some steric force, whereas the
L-proline–Cu(II)–(þ)-enantiomer complexes do not face any steric effect and,
hence, the L-proline–Cu(II)–()-enantiomer complexes are less stable than L-
proline–Cu(II)–(þ)-enantiomer complexes. Because of this steric effect, the ()-
enantiomers of all three antifungal agents eluted first, followed by the (þ)-
enantiomers. It is also very interesting to observe that the coordination power of
nitrogen, oxygen, and sulfur is in the order S > N > O. Therefore, it may be
concluded that the stability of the L-proline–Cu(II)-enantiomer complex of
sulcanazole is greater than the complexes of the enantiomers of econazole and
miconazole. This explains the good resolution of the enantiomers as compared to
the resolution of econazole and miconazole enantiomers.

Other than HPLC, ligand-exchange chromatography has been used for chiral
resolution using capillary electrochromatography and thin-layer chromatography.
In 1998, Lämmerhofer and Lindner [81] prepared an anion-type chiral stationary
phase by the reaction of tert-butyl carbamoyl quinine and the CSP was packed
into fused silica capillaries of 25-cm lengths with diameters of 75 and 100 mm,
respectively. These developed capillaries were tested for the chiral resolution of
N-derivatized amino acids. The authors reported two to three times higher
efficiency of chiral resolution in comparison to the efficiencies obtained from
HPLC methods. Two years later, Tobler et al. [82] used the same CSP in
nonaqueous capillary electrochromatography for the chiral resolution of deriva-
tized amino acids and profens. Solvent composition of acetonitrile–methanol
(80 : 20, v=v) and enhanced electrolyte concentrations up to 600 mM acetic acid
at a constant acid–base (triethylamine and acetic acid) ratio of 100 : 1 with high
applied voltage of 25 kV proved to be optimum separation conditions. Further,
Lämmerhofer et al. [83] studied the different types of silica particle (porous and
nonporous) for the chiral resolution of N-derivatized amino acids using capillary
electrochromatography. The authors used the same chiral selector (i.e., tert-butyl
carbamoyl quinine) for these studies. They optimized the separation by varying
pH, the types of buffer with different concentrations, the types of organic
modifier with different concentrations, voltage, and temperature. The authors
described the reproducibility of the results by presenting 2% as the relative
standard deviation.
The chiral ligand-exchange methods are also applicable for the chiral
resolution by thin-layer chromatography (TLC). In 1984, two independent
groups, Günther et al. [84,85] and Weinstein [86], presented the chiral resolution
by ligand-exchange TLC. The procedures of both the groups were similar except
for the use of the chiral selectors. Günther et al. [84,85] used (2S,4R, 20 RS)-N -(20 -
hydroxy-dodecyl)-4-hydroxyproline as the chiral selector for the enantiomeric
resolution of amino acids. Weinstein [86] impregnated thin layers with the
optically active copper complex of N ,N -di-n-propyl-L-valine and the plates
were used for the chiral resolution of amino acids using sodium acetate
(0.3%)–acetonitrile (60 : 40, v=v) as the mobile phase. Further, Grinberg and
Weinstein [87] presented a two-dimensional TLC method for the chiral resolution
of dansyl amino acids. In another study, Grinberg [88] studied the effect of
temperature on the chiral resolution of amino acids. Later, Marchelli et al. [89]
studied the diaminodiamide copper(II) complex as the chiral selector for the
enantiomeric resolution of dansyl amino acids. Under license from Degussa [90],
Chiralplate was introduced as the chiral TLC plate, ready to use and based on
ligand-exchange chromatography, was developed and commercialized in 1985 by
Macherey-Nagel (Düren, Germany) [91]. Again in 1988, by license from

TABLE 9 Enantiomeric Resolution of Racemic Compounds Using Ligand-Exchange
TLC
Racemic compound CSP Ref.
Amino acids (2S,4R, 20 RS)-N -(20 -hydroxy-dodecyl)- 95

4-hydroxyproline,
N -(2-hydroxy-decyl)-L-hydroxyproline 96
Chiralplate 13, 100
Cu(II)–proline complex 99
(2S,4R,20 RS)-4-hydroxy-1-(20 - 101, 102
hydroxydodecyl)-L-proline
(Chiralplate)
Cu(II)–histidine complex 103
Derivatives of amino (2S,4R,20 RS)-4-hydroxy-1- 97
acids (2-hydroxydodecyl) proline
Chiralplate 13
Dipetides (2S,4R,20 RS)-N-(20 -hydroxy- 95
dodecyl)-4-hydroxyproline
Chiralplate 13
a-Hydroxy acids (2S,4R,20 RS)-N-(20 -hydroxy- 95
dodecyl)-4-hydroxyproline
Chiralplate 13
Mandelic acid Chiralplate 98
and derivatives
Thyroxine Chiralplate 104
Degussa, Merck Company (Darmstadt, Germany) developed and commercialized

HPTLC plates. These plates are very successful for the chiral resolution of amino
acids and related compounds. Luebben et al. [92] synthesized model chiral
selectors and tested for the chiral resolution of different racemic compounds.
Recently, the chiral resolution by TLC, including the use of ligand exchangers as
chiral selectors, has been reviewed [93,94]. The chiral resolution of amino acids
and other racemates using chiral ligand-exchange TLC is presented in Table 9.
7.7 CONCLUSION
With the development of the chiral ligand exchange chromatography by Davan-
kov, this technique has been used frequently for the chiral resolution of racemic
compounds containing electron-donating atoms. It is useful for providing the
basic information on the chiral resolution and, hence, is still in use. In spite of
this, there are some limitations with this chiral resolution technique. The most

unpleasant limitation of this technique is its narrow range of applications.
Davankov [8] concluded that the stability of the diastereoisomeric complexes
formed in CLEC is higher than the stability of the diastereoisomeric complexes
formed by many other chiral selectors in other equilibria. Therefore, the relatively
high stabilities of the diastereoisomeric complexes may result in slow ligand
exchange and reduce the plate count of CLEC columns, which result in poor
chiral recognition. Also, the metal ions in the mobile phase absorb UV radiation,
resulting into the increase of the limit of detection. In addition to these factors,
sometimes the recognition capabilities of the columns containing Cu(II)-
complexes as the chiral selectors is reduced, and, hence, regeneration of these
columns is required. Therefore, the use of this technique, currently, in chiral
resolution is very limited because of these drawbacks and the development of the
new CSPs.
REFERENCES
1. Helfferich FG, Nature 189: 1001 (1961).
2. Rogozhin SV, Davankov VA, German Patent 1932190 (1969).
3. Davankov VA, Navratil JD, Walton HF. Ligand Exchange Chromatography, CRC
Press, Boca Raton, FL (1988).
4. Davankov VA, Rogozhin SV, Piesliakas II, Vysokomolek Soed 14B: 276 (1972).
5. Davankov VA, Semechkin AV, J Chromatogr 141: 313 (1977).
6. Dvankov VA, Adv Chromatogr 18: 139 (1980).
7. Davankov VA, Kurganov A, Bochkov AS, Adv Chromatogr 22: 71 (1983).
8. Davankov VA, J Chromatogr 666: 55 (1994).
9. Rogozhin SV, Davankov VA, Chem Lett 490 (1971).
10. Davankov VA, Kurganov A, Bochkov AS, Resolution of racemates by high
performance liquid chromatography, in Advances in Chromatography, Giddings
JC, Grushka E, Cazes J, Brown PR (Eds.), Vol. 22, p. 71 (1983).
11. Davankov VA, Introduction to chromatographic resolution of enantiomers, in Chiral
Separations by HPLC, Krstulovic A (Ed.), Ellis Horwood, Chichester, p. 175
(1989).
12. Davankov VA, Ligand exchange phases, in Chiral Separations by HPLC, Krstulovic
A (Ed.), Ellis Horwood, Chichester, p. 447 (1989).
13. Günther K, Enantiomer separations, in Handbook of Thin Layer Chromatography,
Sherma J, Fried B (Eds.), Marcel Dekker, New York, p. 541 (1991).
14. Kurganov A, J Chromatogr A 906: 51 (2001).
15. Feibush B, Cohen MJ, Karger BL, J Chromatogr 282: 3 (1983).
16. Zolotarev YA, Myasoedov NF, Penkina VI, Petrenik OR, Davankov VA, J
Chromatogr 207: 63 (1981).
17. Davankov VA, Bochkov AS, Belov YP, J Chromatogr 218: 547 (1981).
18. Gübitz G, Jellenz W, J Chromatogr 203: 377 (1981).
19. Roumeliotis P, Unger KK, Kurganov AA, Davankov VA, J Chromatogr 255: 51
(1983).

20. Gübitz G, Jellenz W, Santi W, J Liq Chromatogr 4: 701 (1987).
21. Kurganov AA, Tevlin AB, Davankov VA, J Chromatogr 261: 223 (1983).
22. Petit MA, Jozefonvicz J, J Appl Polym Sci 21: 2589 (1977).
23. Jozefonvicz J, Petit MA, Szubarga A, J Chromatogr 147: 177 (1978).
24. Spassky N, Reix M, Quette J, Quette M, Sepulchre M, Blanchard J, Comp Rend
287: 589 (1978).
25. Tsuchida E, Nishikawa H, Terada E, Eur Polym J 12: 611 (1976).
26. Snyder RV, Angelichi RJ, Meck RB, J Am Chem Soc 94: 2660 (1972).
27. Lefebvre B, Audebert R, Quivoron C, Israel J Chem 15: 69 (1977).
28. Lefebvre B, Audebert R, Quivoron C, J Liq Chromatogr 1: 761 (1978).
29. Yamskov IA, Berezin BB, Davankov VA, Zolotarev YA, Dostovalon IN, Myasoedov
NF, J Chromatogr 217: 539 (1981).
30. Watanabe N, Ohzeki H, Niki E, J Chromatogr 216: 406 (1981).
31. Davankov VA, Bochkov AS, Kurganov AA, Roumeliotis P, Unger KK, Chromato-
graphia 13: 677 (1980).
32. Miyazawa T, Minowa H, Jamagawa K, Yamada T, Anal Lett 30: 867 (1997).
33. Oi N, Kitahara H, Akoi F, J Chromatogr A 707: 380 (1995).
34. Slivka M, Slebioda M, Kolodziejczyk A, Chem Anal (Warsaw) 42: 895 (1998).
35. Kurganov A, Davankov VA, Unger K, Eisenbeiss F, Kinkel J, J Chromatogr A: 99
(1994).
36. Gübitz G, Jellenz W, Lofler G, Santi W, J High Resolut Chromatogr 2: 145 (1979).
37. Bochkov AS, Zolotarev YA, Belov YP, Davankov VA, Second Danube Symposium
on Progress in Chromatography, Paper B 3.23 (1979).
38. Sugdan K, Hunter C, Lloyd-Jones G, J Chromatogr 192: 228 (1980).
39. Gübitz G, Mihellyess S, Kobinger G, Wutt A, J Chromatogr A 666: 91 (1994).
40. Gübitz G, Vollman B, Cannazza G, Schmid MG, J Liq Chromatogr Relat Technol
19: 2933 (1996).
41. Yang M, Hsieh M, Lin J, Taiwan Kexue 50: 17 (1997).
42. Hyun MH, Han SC, Lee CW, Lee YK, J Chromatogr A 950: 55 (2002).
43. Lindner W, Naturwiss 67: 345 (1980).
44. Engelhardt H, Kromidas S, Naturwiss 67: 353 (1980).
45. Davankov VA, Kurganov AA, Chromatographia 17: 686 (1983).
46. Foucault A, Caude M, Oliveros L, J Chromatogr 185: 345 (1979).
47. Roeske R, J Org Chem 28: 1251 (1963).
48. Davankov VA, Rogozhin SV, Piesliakas II, Semechkin AV, Sachkova TP, Doklady
Akad Nauk SSR 201: 854 (1971).
49. Roumeliotis P, Unger KK, Kurganov AA, Davankov VA, Angew Chem Int Ed Eng
21: 930 (1982).
50. Zolotarev YA, Myasoedov NF, Penkina VI, Dostovalov IN, Petrenik OV, Davankov
VA, J Chromatogr 207: 231 (1981).
51. Busker E, Günther K, Martens J, J Chromatogr 350: 179 (1985).
52. Yuki Y, Saigo K, Kimoto H, Tachibana K, Hasegawa M, J Chromatogr 400: 65
(1987).
53. Takeuchi T, Asai H, Ishii D, J Chromatogr 407: 151 (1987).
54. Gübitz G, Juffmann F, Jellenz W, Chromatographia 16: 103 (1982).

55. Gübitz G, Juffmann F, J Chromatogr 404: 391 (1987).
56. Gübitz G, J Liq Chromatogr 9: 519 (1986).
57. Sinibaldi M, Carunchio V, Corradini C, Girelli AM, Chromatographia 18: 459
(1984).
58. Corradini C, Federici F, Sinibaldi M, Messina A, Chromatographia 23: 118 (1987).
59. Watanabe N, J Chromatogr 260: 75 (1983).
60. Ito SN, Takeuchi T, Miwa T, J Chromatogr A 864: 25 (1999).
61. Buglass AJ, Lee SH, J Chromatogr Sci 38: 207 (2000).
62. Schlauch M, Volk FJ, Fondekar KP, Wede J, Frahm AW, J Chromatogr A 897: 145
(2000).
63. Vidyasankar S, Ru M, Arnold FH, J Chromatogr A 775: 51 (1997).
64. Boue EJ, Audebert R, Quivoran C, J Chromatogr 204: 185 (1981).
65. Roumeliotis P, Kurganov AA, Davankov VA, J Chromatogr 266: 439 (1983).
66. Bruckner H, Bosch I, J Chromatogr 395: 569 (1987).
67. Galaverna G, Corradini R, Dossena A, Marchelli R, Dallavalle F, Chirality 8: 189
(1996).
68. Okubo S, Mashige F, Omori M, Hashimoto Y, Nakahara K, Kanazawa H,
Matsushima Y, Biomed Chromatogr 14: 474 (2000).
69. Chilmonczyk Z, Ksycinska H, Cybulski J, Rydzewski M, Les A, Chirality 10: 821
(1998).
70. Aboul-Enein HY, Ali, Chromatographia 54: 200 (2001).
71. Shieh CH, Karger BL, Gelber LR, Feibush B, J Chromatogr 406: 343 (1987).
72. Chen Z, Uchiyama K, Hobo T, J Chromatogr A 942: 83 (2002).
73. Davankov VA, Zolotarev YA, Kurganov AA, J Liq Chromatogr 2: 1191 (1979).
74. Weinstein S, Tetrahedron Lett 25: 985 (1984).
75. Krasutskii PA, Rodionov VN, Tichonov VP, Yurchenko AG, Teoret Exper Khim 20:
58 (1984).
76. Gris GJ, Soerensen C, Su H, Porret J, Chromatographia 28: 337 (1989).
77. Perry JA, Rateike JD, Szczerba TJ, J Chromatogr 389: 57 (1987).
78. Remelli M, Fornasari P, Dandi F, Pulidori F, Chromatographia 37: 23 (1993).
79. Jin R, He B, J Liq Chromatogr 12: 501 (1989).
80. Cooke NHC, Viavattene RL, Esksteen R, Wong WS, Davies G, Karger BL, J
Chromatogr 149: 391 (1978).
81. Lämmerhofer M, Lindner W, J Chromatogr 829: 115 (1998).
82. Tobler E, Lämmerhofer M, Lindner W, J Chromatogr 875: 341 (2000).
83. Lämmerhofer M, Tobler E, Lindner W, J Chromatogr 887: 421 (2000).
84. Günther K, Martens J, Schickedanz M, Angew Chem 96: 514 (1984).
85. Günther K, Martens J, Schickedanz M, Angew Chem Int Ed Engl 23: 506 (1984).
87. Grinberg N, Weinstein S, J Chromatogr 303: 251 (1984).
88. Grinberg N, J Chromatogr 333: 69 (1985).
89. Marchelli R, Virgili R, Armani E, Dossena A, J Chromatogr 355: 354 (1986).
90. Günther K, Martens J, Schickedanz M, EP-PS Patent 143147 (to Degussa AG,
Hanau, Germany) (1985).

91. Günther K, Rausch R, Proceedings of Third International Symposium on Instru-
mental HPTLC (1985); Bad Dürkheim, Germany, p. 469 (1985).
92. Leubben S, Martens J, Hasse D, Phol S, Saak W, Tetrahedron Lett 31: 7127 (1990).
531 (1999).
95. Günther K, J Chromatogr 448: 11 (1988).
96. Günther K, Schickedanz M, Martens J, Naturwiss 72: 149 (1985).
97. Gont LK, Neuendorf SK, J Chromatogr 391: 343 (1987).
98. Mack M, Hauck H, Herbert H, J Planar Chromatogr 1: 304 (1988).
99. Bhushan R, Reddy GP, Joshi S, J Planar Chromatogr 7: 126 (1994).
100. Brinkman UATh, Kamminga DK, J Chromatogr 330: 375 (1985).
101. Günther K, Schickedanz M, Drauz K, Martens J, Fresenius J Anal Chem 325: 297
(1986).
102. Günther K, Martens J, Schickedanz M, Fresenius J Anal Chem 322: 513 (1985).
103. Remelli M, Pizza R, Pulidori F, Chromatographia 32: 278 (1991).
104. Aboul-Enein HY, Serignese V, Biomed Chromatogr 8: 317 (1994).

8
Crown Ether^Based Chiral
Stationary Phases
Crown ethers are synthetic macrocyclic polyethers with the appearance of a

crown. The appearance of their molecular structures and ability to crown
selectively with the cations give them their names ‘‘crown ethers.’’ Pedersen
[1,2] synthesized these polyethers in 1967. The ether oxygens, which are electron
donors, remain in the inner wall of the crown cavity and are surrounded by
methylene groups in a collar fashion. The IUPAC nomenclature of these ethers is
complex and, hence, trivials names are common and in use [2]. For example,
2,3,11,12-dibenzo-1,4,7,10,13,16 hexaoxa-cyclo-octadeca-2,11-diene is called
dibenzo-18-crown-6 ether, where dibenzo, 18, and 6 indicate the substituent
groups, total number of atoms in the ring, and the number of the oxygen atoms,
respectively. If oxygen atoms of the ether are replaced by nitrogen or sulfur
atoms, the crown ether is called as aza or thia crown ether, respectively. The
chirality in the crown ether is developed by introducing the chiral moieties and,
hence, the developed crown ether is called as chiral crown ether (CCE). The most
important chiral groups used for this purpose are binaphthyl [3–6], biphenanthryl
[7–9], helicene derivatives [10], tartaric acid derivatives [11], carbohydrate
moiety [12], chiral carbon atom with a bulky group directly incorporated in a
crown ring [13,14], aromatic bicyclo derivatives [3.3.1] nonane derivatives
[15,16] hexahydrochrysese or tetrahydroindenoinden [17], and 9,90-spiro-bifluor-
ene groups [18]. The capability of the crowning selectively of these CCEs and
their stereospecific configurations make them suitable chiral selectors in liquid

chromatography. Sousa et al. [19] reported the optical resolution of racemic
amino compounds on chiral crown ethers using liquid chromatography. In 1974,
Blasius et al. [20] reported the use of some chargeless crown ethers in liquid
chromatography. This chapter discusses crown ethers as chiral stationary phases;
however, their use as mobile phase additives will be covered in Chapter 10.

The main skeleton of the chiral crown ether molecule is the cyclic structure
containing oxygen and methylene groups alternatively. Other derivatives of crown
ethers, containing alkyl or phenyl or other groups (as cited earlier) attached to
methylene groups, have been reported. The structures of some of the important
chiral crown ethers are given in Figure 1. Most of the crown ethers form
complexes with metal ions (cations). However, some crown ethers were reported
to form complexes with organic compounds, especially compounds having
primary amino groups. The stability of the complex formed between guest
(molecule containing primary amino group) and host (crown ether) depends on
the molecular structure around the primary amino group of the guest molecule. A
decrease in the stability of the guest–host complex was reported by the reduction
FIGURE 1 Chemical structures of the chiral crown ethers.

in the number of hydrogen bonds available for guest–host interactions and an
increase in the steric hindrance, because of the increase in bulky substituent
groups attached to the amino group [21–23].

Various reports are available on the synthesis of CCEs [3–6,19,24–32]. Cram et
al. [3–6,19,29–32] carried out a systematic and extensive study on the synthesis
of CCEs. They synthesized a series of CCEs containing 1,10 -binaphthyl moiety
such as CE-1 to CE-6 (Cram’s crown ethers). There are well-known methods for
the preparation of chiral crown ethers and the topic is beyond the scope of this
chapter. However, recently, CCEs containing pyridine, acridine, and phenazine
heterocyclic units were synthesized from tetraethylene glycols containing suitable
substituents at the stereogenic centers, and diols with the same groups at the
stereogenic centers. The diols containing side chains with terminal double bonds
were also used for the synthesis of CCEs. Furthermore, in a new method, 1,9-
dichlorophenazine was allowed to react with enantiomerically pure dimethyl-
substituted tetraethylene glycol and diisobutyl-substituted diols containing side
chains with a terminal double bond [25–28]. Although there are many CCEs
available 18-crown-6 and its derivatives are still commonly used in liquid
chromatography (Fig. 1).
The CSPs based on chiral crown ethers were prepared by immobilizing
them on some suitable solid supports. Blasius et al. [33–35] synthesized a variety
of achiral crown ethers based on ion exchangers by condensation, substitution,
and polymerization reactions and were used in achiral liquid chromatography.
Later, crown ethers were adsorbed on silica gel and were used to separate cations
and anions [36–39]. Shinbo et al. [40] adsorbed hydrophobic CCE on silica gel
and the developed CSP was used for the chiral resolution of amino acids. Kimura
et al. [41–43] immobilized poly- and bis-CCEs on silica gel. Later, Iwachido et al.
[44] allowed benzo-15-crown-5, benzo-18-crown-6 and benzo-21-crown-7 CCEs
to react on silica gel. Of course, these types of CCE-based phases were used in
liquid chromatography, but the column efficiency was very poor due to the
limited choice of mobile phases. Therefore, an improvement in immobilization
was realized and new methods of immobilization were developed. In this
direction, CCEs were immobilized to silica gel by covalent bonds.
Machida et al. presented a method for the immobilization of CCE on silica
gel in 1998 [45]. They reported the covalent binding of (þ)-(18-crown-6)-
tetracarboxylic acid to 3-aminopropylsilanized silica gel and the prepared CSP
was tested to separate enantiomers of amino acids, amino alcohols and other
drugs (containing primary amino group). In 1998, the same CSP was prepared by
Hyun et al. [46]. The developed CSP was used extensively for the chiral
resolution of a variety of racemic compounds having a primary amino group

[46–51]. The (þ)-(18-crown-6)-2,3,11,12-tetracarboxylic acid and (þ)-(18-
crown-6)-dinaphthyl CCEs were immobilized to 3-aminopropyl and (3-amino-
propyl)-ethoxy silica gels separately and respectively. The immobilization was
carried out in two steps. The chiral (18-crown-6)-2,3,11,12-tetracarboxylic acid
was converted into dianhydride by treating with acetyl chloride via a known
FIGURE 2 Chemical pathway for covalent bonding of the chiral crown ether with silica
gel.

TABLE 1 Various CCE-Based Commercial CSPs
Commercialized CSP Company
Crownpak CR Chiral Technologies Inc., Exton, PA, USA

Crownpak CR Separations Kasunigaseki-Chrome, Tokyo, Japan
Crownpak CR Daicel Chemical Industries, Tokyo, Japan
Opticrown RCA USmac Corporation, Winnetka, Glenview, USA
Chiralhyun-CR-1 K-MAC (Korea Materials & Analysis Corp.), South Korea
Chirosil CH RCA Rstech, Corporation, Daedeok, Daejon, South Korea
procedure (step I) [11]. In step II, dianhydride of CCE was treated in dry
methylene chloride at 0 C under an argon atmosphere for 2 days with 3-
aminopropyl silica gel containing triethylamine, which was dried in advance by
azeotropic removal of water in refluxing benzene. The product was washed with
methanol, water, 1 N HCl, water, methanol, dichloromethane, and hexane, in that
order, and dried under high vacuum. The slurry of this product was prepared in
methanol and then packed into stainless-steel columns of the desired dimensions.
The protocol of this procedure is shown in Figure 2. The CCEs were commer-
cialized and are available in stainless-steel columns with specific dimensions. The
various commercial CSPs supplied by different companies are summarized in
Table 1.
8.3 APPLICATIONS
The chiral crown ethers have a good tendency to complex with compounds
having primary amino groups. Therefore, all of the chiral separations on these
CSPs belong to racemic compounds containing primary amino groups. Mostly
racemic compounds containing a primary amino group attached to a chiral center
have been resolved. However, some reports indicate chiral resolution for
compounds of which the primary amino group is not located at the chiral
center. Recently, Steffeck et al. [52] reported the chiral resolution of secondary
amines. The structures of some of the resolved racemic compounds on CCE-
based CSPs are shown in Figure 3. In spite of the availability of different types of
CCE, 18-crown-6 and its derivatives were used for the successful chiral resolution
in liquid chromatography. Cram et al. [4–6,19] achieved the chiral resolution of
certain amino acids and amino esters on CCE-based CSPs and the technique is
called guest–host complexation chromatography. The CCEs were adsorbed on
silica gel and the developed CSPs were used in normal and reversed-phase
modes. In 1987, Shinbo et al. [40] coated 18-crown-6 crown ether on ODS silica
gel and the CSP was tested for the chiral resolution of amino acids and amines

FIGURE 3 Structures of some racemic compounds having primary amino groups.

FIGURE 3 Continued.
under the reversed-phase mode using acidic mobile phases. Accordingly, in the
late 1980s and early 1990s, adsorbed CSPs were developed by different groups
and used for chiral resolution in liquid chromatography [53–63]. The typical
chromatograms of this work are shown in Figure 4.
In 1998, Machida et al. [45] and Hyun et al. [46] developed a new CCE-
based CSP (covalently bonded to silica gel; see Sect. 8.2). This CSP was used
successfully for the chiral resolution of certain racemic compounds using a
variety of mobile phases. The most important applications of this CSP are for the
resolution of amino acids, amino esters, amino alcohols, amines, amides,
quinolone antibacterials, and other drugs having primary amino groups [46–
51,64,65]. The typical chromatograms of the chiral resolution of amino acids on
(þ)-(18-crown-6)-2,3,11,12-tetracarboxylic acid CSP are shown in Figure 4. The
enantiomeric resolution of the racemic compound on CCE-based CSPs are listed
in Table 2. There is no report available on the chiral separations at the preparative
scale using these CSPs.

FIGURE 4 Chromatograms of the chiral resolution of (a) D-arginine (1), L-arginine (2),
D-methionine (3), L-methionine (4), D-tryptophan (5), and L-tryptophan (6) on a LiChro-
sorb RP-18 column coated with 49 mg chiral 18-crown-6 ether using 10 mM perchloric
acid as the mobile phase and (b) L-alanine (1), D-alanine (2), L-valine (3), D-valine (4),
L-methionine (5), D-methionine (6), L-leucine (7), and D-leucine (8) on (þ)-(18-crown-6)-
2,3,11,12 tetracarboxylic acid crown ether using 10 mM perchloric acid as the mobile
phase. (From Refs. 40 and 50.)

The applications of the CCE-based CSPs are very limited, as these are used only
for the chiral resolution of the compounds having primary amino groups.
Aqueous mobile phases containing organic modifiers and acids have been used
on these CSPs and, therefore, composition of the mobile phase is the key
parameter for the optimization of chiral resolution. However, in some reports,
the effects of temperature, pH, and flow rate were also studied. The optimization
of these parameters are discussed herein in detail.

TABLE 2 Enantiomeric Resolution of Racemic Compounds on CCE-Based CSPs
Amino acids (þ)-(18-Crown-6)-2,3,11,12-tetracarboxylic acid 45, 47, 51, 52

Binaphthyl-(þ)-(18-crown-6)-2,3,11,12-tetracarboxylic acid 4–6
18-Crown-6 40
Crownpak CR 59
Diphenyl-substituted 1,10 -binaphthol 67
Crownpak CR 48, 69, 70
Amino alcohols (þ)-(18-Crown-6-)-2,3,11,12-tetracarboxylic acid 45, 48
Amino esters Binaphthyl-18-crown-6 4–6
Crownpak CR 59
Amines Binaphthyl-18-crown-6 4–6
Binaphthyl-18-crown-6 40
(þ)-(18-Crown-6)-2,3,11,12-tetracarboxylic acid 48
Crownpak CR 55
Crownpak CR 72, 74
18-Crown-6 40
Amides Crownpak CR 68
Amino carbonyls (þ)-(18-Crown-6)-2,3,11,12-tetracarboxylic acid 48
Quinolones (þ)-(18-Crown-6)-2,3,11,12-tetracarboxylic acid 46
Fluoroquinolones (þ)-(18-Crown-6)-2,3,11,12-tetracarboxylic acid 49
Dipeptides Crownpak CR 57
Miscellaneous racemic compounds (þ)-(18-Crown-6)-2,3,11,12-tetracarboxylic acid 50, 66, 70
with primary amino groups
Crownpak CA 56, 70, 71, 73

In all of the applications, aqueous and acidic mobile phases are used. The most
commonly used mobile phases are aqueous perchloric acid, aqueous methanol
containing sulfuric or perchloric acids separately. The compounds with higher
hydrophobicity in general have the longer retention times on CCE-based CSPs
and, therefore, organic modifiers are used to optimize the resolution [58].
Optimization of the resolution is carried out by adjusting the amounts of
methanol, sulfuric acid, and perchloric acid separately. Generally, the separation
increased with an increase in methanol and decrease in acid concentrations. The
other organic modifiers used were ethanol, acetonitrile, tetrahydrofuran (THF),
and trifluoroacetic acid, but methanol was found to be the best one [47–49]. Hyun
et al. [47–49] studied the effect of methanol concentration on the chiral resolution
of amino acids, amino alcohols, amines, and fluoroquinolones. It has been
observed that the retention increased with an increase of methanol concentration
but there was little effect on the separation of amino acids. However, a marked
effect on the resolution of fluoroquinolones has been observed as the resolution
increased by an increase in methanol contents [49]. It is very interesting to note
that the retention of some compounds decreased whereas separation increased
with an increase of methanol concentration [48]. Therefore, the effect of
methanol concentration varies from one analyte to another. Recently, Hyun
et al. [51] studied the effect of methanol and triethylamine concentrations on
the chiral resolution of certain racemates containing a primary amino group. The
authors reported an increase in the retention times with increasing amounts of
these two organic modifiers. The effect of methanol, ethanol, and acetonitrile
concentrations is presented in Table 3 [47].
The effect of the concentration of sulfuric acid was also studied in detail
and the best concentrations were found in the range of 10–20 mM [47–49]. As an
example, the effect of acids (sulfuric acid, perchloric acid, and trifluoroacetic
acid) on the chiral resolution of leucine and phenylglycine are given in Table 3
[47]. This table shows that the best mobile phases were 80% methanol containing
10 mM sulfuric acid and 100% methanol having 10 mM sulfuric acid for the
chiral resolution of leucine and phenylglycine separately and respectively.
Recently, Aboul-Enein et al. [75] also studied the effect of the concentrations
of sulfuric acid on the chiral resolution of thyroxine and tocainide racemates. It
has been observed that the separation decreased by increasing the amount of
sulfuric acid. However, there was no chiral resolution for tocainide at higher
concentrations of sulfuric acids, which may be the result of the higher polarity of
the mobile phase (Table 4). Furthermore, the authors have achieved the chiral
resolution of these drugs without using sulfuric acid. Therefore, 80% methanol
containing 10 mM sulfuric may be a suitable starting mobile phase. Optimization
can be carried out on the basis of the results obtained. A simplified protocol for

TABLE 3 Effect of Organic Modifiers and Sulfuric Acid on the Chiral Resolution of
Leucine and Phenylglycine
Leucine Phenylglycine
Mobile phase k1 a Rs k1 a Rs
20% CH3 OH þ H2 SO4 (10 mM) 0.32 1.34 1.46 1.02 1.96 3.16
40% CH3 OH þ H2 SO4 (10 mM) 0.44 1.39 1.32 1.43 2.09 4.89
80% CH3 OH þ H2 SO4 (10 mM) 0.73 1.32 1.42 2.07 2.25 6.46
100% CH3 OH þ H2 SO4 (10 mM) 0.99 1.21 0.72 3.48 2.49 9.60
80% CH3 OH þ H2 SO4 (1 mM) 0.66 1.45 1.71 3.23 2.23 4.54
80% CH3 OH þ H2 SO4 (5 mM) 0.68 1.40 1.63 2.16 2.26 5.74
80% CH3 OH þ H2 SO4 (20 mM) 0.80 1.28 1.36 2.09 2.25 7.02
20% EtOHþH2 SO4 (10 mM) 0.32 1.00 0.00 0.85 1.94 3.42
40% EtOHþH2 SO4 (10 mM) 0.49 1.00 0.00 1.33 2.07 4.65
80% EtOHþH2 SO4 (10 mM) 1.94 1.09 0.32 4.84 2.04 6.58
20% CH3 CN þ H2 SO4 (10 mM) 0.19 1.00 0.00 0.49 1.92 2.48
40% CH3 CN þ H2 SO4 (10 mM) 0.21 1.00 0.00 0.45 2.14 3.04
80% CH3 CN þ H2 SO4 (10 mM) 0.46 1.06 0.40 1.63 2.09 8.93
80% CH3 OH þ HClO4 (10 mM) 0.52 1.33 1.25 1.49 2.19 5.10
80% CH3 OH þ CF3 Ac (10 mM) 0.35 1.00 0.00 1.02 2.24 3.96
Source: Ref. 47.
the development and optimization of the mobile phases on CCE-based CSPs is

presented in Scheme 1.

In addition to the mobile phase composition, the effect of other parameters such
as temperature, flow rate, pH, and structure of the analytes were also studied, but
only a few reports were available in the literature. In 1995, Lin and Maddox [66]
studied the effect of temperature on the chiral resolution of amino acids and
esters. The temperature was varied from 5 C to 25 C and it was reported that the
resolution improved at low temperature. Hyun et al. [48–50,67] carried out the
effect of temperature on the chiral resolution of amino alcohols, amines,
fluoroquinolones, and other drugs. Again, lowering of temperature resulted in
better resolution. The effect of temperature on the chiral resolution of phenyl-
alanine, phenylglycine, and 2-hydroxy-2-(4-hydroxy-phenyl)-ethyl amine is
shown in Table 5 [50], which indicates an increase in retention factors at lower
temperature, but the best separation occurred at 20 C. These experiments
indicated the exothermic nature of chiral resolution on CCE-based CSPs. Lin
and Maddox [66] also studied the effect of flow rate on the chiral resolution of

TABLE 4 Effect of the Concentrations of Sulfuric Acids on
the Chiral Resolution of Thyroxine and Tocainide
H2 SO4 (mM) k1 ðÞ k2 ðþÞ a Rs
Thyroxine
0 4.50 14.00 3.11 2.60
5 2.50 6.30 2.51 2.33
10 1.56 3.77 2.41 2.06
20 1.32 2.88 2.18 2.00
30 1.10 2.23 2.10 1.56
40 0.94 1.97 2.08 1.00
50 0.94 1.97 2.08 1.00
Tocainide
0 2.18 2.74 1.26 1.30
5 0.44 0.53 1.20 0.20
10 0.32 0.41 1.18 0.15
20 0.29 0.35 1.16 0.12
30 0.24 0.30 1.13 0.10
40 nr
50 nr
Note: nr ¼ not resolved.

Source: Ref. 75.
SCHEME 1 Protocol for the development and optimization of mobile phases on CCE-
based CSPs.

TABLE 5 Effect of Temperature on the Chiral Resolution of Phenylalanine,
Phenylglycine, and 2-Hydroxy-2-(4-hydroxy-phenyl)-ethyl Amine
Temp. Phenylalanine Phenylglycine 2-Hydroxy-2-(4-

hydroxy-phenyl)-ethyl
amine
( C) k1 a Rs k1 a Rs k1 a Rs
10 3.54 2.63 2.40 1.66 4.79 3.03 3.89 1.86 1.23

20 2.71 2.55 2.50 1.40 4.32 3.98 2.67 1.67 1.08
25 2.24 2.51 2.37 1.05 4.04 3.24 2.06 1.62 0.97
30 1.78 2.48 2.32 0.91 3.84 3.07 1.66 1.57 0.87
amino acids and esters. They varied the flow rate from 0.3 to 0.7 mL=min and
observed a small effect on the chiral resolution, with the best resolution at
0.3 mL=min (Fig. 5). Because all of the mobile phases are acidic in nature, the
effect of pH on the chiral resolution is not significant. However, Kersten [59]
studied the effect of pH on the chiral resolution of amino acids and their esters
and found the pH 1.0 is the optimum. Lin and Maddox [66] carried out the chiral
resolution of amino acids and their esters at 1.0, 1.3, and 1.6 and reported the best
resolution at pH 1.0 (Fig. 5).
Because the steric effect contributes to the complex formation between
guest and host, the chiral resolution on these CSPs is affected by the structures of
the analytes. Amino acids, amino alcohols, and derivatives of amines are the best
classes for studying the effect of analyte structures on the chiral resolution. The
effect of analyte structures on the chiral resolution may be obtained from the work
of Hyun et al. [47,48]. The authors studied the chiral resolution of amino
alcohols, amides, amino esters, and amino carbonyls. The effects of the
substituents on the chiral resolution of some racemic compounds are shown in
Table 6. A perusal of this table indicates the dominant effect of steric interactions
on chiral resolution. Furthermore, an improved resolution of the racemic
compounds, having phenyl moieties as the substituents, may be observed from
this Table 6. It may be the result of the presence of p–p interactions between the
CCE and racemates. Generally, the resolution decreases with the addition of
bulky groups, which may be caused by the steric effects. In addition, some anions
have been used as the mobile phase additives for the improvement of the chiral
resolution of amino acids [76]. Recently, Machida et al. [69] reported the use of
some mobile phase additives for the improvement of chiral resolution. They
observed an improvement in the chiral resolution of some hydrophobic amino
compound using cyclodextrins and cations as mobile phase additives.

FIGURE 5 Effect of (a) flow rate and (b) pH on the chiral resolution of 2-(2-amino-1,3-
thiazol-4-yl)-methylglycine [I] and 2-(2-amino-1,3-thiazol-4-yl)-methylglycine methyl
ester [II] on a Crownpak CR column using aqueous perchloric acid as the mobile

Only racemic compounds having primary amino groups can be resolved on these
CSPs. Moreover, Hyun et al. reported no resolution for proline in which primary
amino group is not free [47]. This means that primary amino group is essential for
the chiral resolution and it plays an essential role in the chiral resolution and in
the formation of the guest–host complex. Pedersen [1] calculated the values of
distribution constants and free energies of the enantiomers of some amino acids
on a variety of CCEs. The author reported the different values of these parameters
for the two enantiomers. Furthermore, Cram et al. [3–6] determined the stability
of guest–host complex formation and postulated the importance of hydrogen, p–p
interaction, and steric forces in the guest–host complex formation. Pocsfalvi et al.
[24] described the guest–host complex formation of the enantiomers of two
ammonium cations on CCE and observed different stabilities of the complexes

TABLE 6 Effect of Substituents on the Chiral Resolution of Some
Racemic Compounds
RCH(NH2 )COY
R Y k1 k2 a Rs
CH3 NYHðCH2 Þ3 CH3 1.60 2.25 1.41 2.34

NHCðCH3 Þ3 1.39 1.98 1.42 2.32
NðCH2 CH3 Þ2 2.13 2.13 1.00 0.00
CHðCH3 Þ2 NHðCH2 Þ3 CH3 0.28 0.45 1.64 1.32
NHCðCH3 Þ3 0.25 0.39 1.59 1.11
NðCH2 CH3 Þ2 0.21 0.21 1.00 0.00
C6 H5 NHðCH2 Þ3 CH3 1.55 3.82 2.46 7.27
NHCðCH3 Þ3 1.28 3.42 2.67 6.32
NðCH2 CH3 Þ2 1.40 4.40 3.15 9.77
CH2 C6 H5 NHðCH2 Þ3 CH3 1.94 4.74 2.45 6.99
NHCðCH3 Þ3 2.06 4.68 2.28 7.36
NðCH2 CH3 Þ2 1.88 1.88 1.00 0.00
Source: Ref. 47.
formed between the two enantiomers and CCE. The authors also described
hydrogen, p–p, and steric interactions as the forces responsible for the complex
formation. Recently, Machida et al. [77] studied the guest–host complex forma-
tion by x-ray analysis. They reported the presence of the above-cited forces
between the chiral selectors and the analytes. It has also been indicated that the
presence of carboxylic groups on analytes enhanced hydrogen-bondings, which
resulted in an improved chiral resolution [76]. The best chiral resolution has been
observed when the functional and alkyl groups were located at the chiral center of
the analyte. Therefore, CCEs involve a simple chiral recognition mechanism. The
two enantiomers fit stereogenically at different extents into the chiral cavity of
CCE which are stabilized by the various interactions (as cited earlier) at different
magnitudes; hence, the chiral resolution occurs.
The primary amino group of the analyte ionizes in the presence of acid and
forms ammonium ion (NH3 þ ). The ammonium ions form strong hydrogen-
bondings with the oxygen atoms of CCE. Therefore, the presence of an acid in
the mobile phase is essential to achieve the chiral resolution on these CSPs.
However, recently, Aboul-Enein et al. [75] observed very interesting results for
the chiral resolution of thyroxine and tocainide racemates on the (þ)-(18-crown-
6)-2,3,11,12-tetracarboxylic acid CCE. The authors reported the chiral resolution
of these molecules without using an acid in the mobile phase. Moreover, they

FIGURE 6 Graphical representation of the guest–host diastereoisomeric complex forma-
tion (a) in the presence of acid in the mobile phase and (b) in the absence of acid in the
mobile phase. (c) Three-dimensional structures of the guest–host complexes formed
between R- and S-enantiomers of a-phenylethylamine and chiral 18-crown-6 ether CSP.
have also achieved the chiral resolution of thyroxine using triethylamine (a base)
as an organic modifier. Therefore, the acid is not essential for the chiral resolution
of all of the racemates containing primary amino groups. It may be concluded that
the acid is not required for the chiral resolution of the molecules that have a high
hydrogen-bonding capacity through the primary amino group, whereas it is
required for those molecules having a low ability of hydrogen-bonding. There-
fore, the acid is used to convert primary amino group into ammonium ion because
the latter (NH3 þ ) has a stronger hydrogen ability than the former (NH2 ).
Therefore, the concept of essentiality of the addition of an acid in the mobile
phase is not always required. However, the presence of primary amino group is an
essential feature for the chiral resolution on CCE-based CSPs. To make this
concept clear, the structure of the guest–host complex is shown in Figure 6.

CCE-based CSPs have limited application in the chiral resolution of racemic
compounds using HPLC. There is only one report on the use of these CSPs in

capillary electrochromatography [78]. Koide and Ueno [78] synthesized 2-allyl
esters of (þ)-tetraallyl-18-crown-6 carboxylate and (þ)-18-crown-6 tetracar-
boxylic acid CCEs. These esters were allowed to bind to a negatively charged
polyacrylamide gel and this treated gel was packed into the capillaries. The
developed CSPs were called monolithic chiral stationary phases. These CSPs
were used for the chiral resolution of some amino compounds using a 200 mM
triethanolamine–300 mM boric acid buffer as the mobile phase.
8.7 CONCLUSION
CCE-based CSPs are used only for the chiral resolution of racemic compounds
containing primary amino groups. Therefore, these CSPs are suitable for the
chiral resolution of amino acids, amino alcohols, amino esters, amino carbonyls,
amines, amides, and other compounds having primary amino groups. The
experimental cost of these CSPs is slightly low due to the inexpensive nature
of a mobile phase having water as the major component. However, there are some
serious limitations of these CSPs because their applications are very limited to a
particular class of compounds (i.e., racemates) having primary amino groups. In
addition, no report has been published on the chiral resolution at a preparative
scale. Additionally, the recovery of the resolved enantiomers requires special
attention to the complex procedure of extraction because of the presence of an
acid in the mobile phase. In view of these points, it may be concluded that these
CSPs cannot be used for other classes of racemic compounds (compounds not
having primary groups). For these reasons, these CSPs are not in their full swing
and hence require more development. More substituted CCEs should be prepared
and tested for the chiral resolution of a wider range of racemic compounds. We
think that the development of these CSPs is underway and, in the future, CCE-
based CSPs could be used for the chiral resolution of a wide variety of racemates,
including preparative separation.
REFERENCES
1. Pedersen CJ, J Am Chem Soc 89: 2495 (1967).
2. Pedersen CJ, J Am Chem Soc 89: 7017 (1967).
3. Kyba EP, Timko JM, Kaplan JL, de Jong F, Gokel GW, Cram DJ, J Am Chem Soc
100: 4555 (1978).
4. Peacock SC, Domeier LA, Gaeta FCA, Helgeson RC, Timko JM, Cram DJ, J Am
Chem Soc 100: 8190 (1978).
5. Peacock SC, Walba DM, Gaeta FCA, Helgeson RC, Timko JM, Cram DJ, J Am
Chem Soc 102: 2043 (1980).
6. Linggenfelter DS, Helgeson RC, Cram DJ, J Org Chem 46: 393 (1981).
7. Yamamoto K, Yumioka H, Okamoto Y, Chikamatsu H, Chem Commun 168 (1987).

8. Yamamoto K, Kitsuki T, Okamoto Y, Bull Chem Soc Jpn 59: 1269 (1986).
9. Yamamoto K, Noda K, Okamoto Y, Chem Commun 1065 (1985).
10. Nakazaki M, Yamamoto K, Ikeda T, Kitsuki T, Okamoto Y, Chem Commun 787
(1983).
11. Behr JP, Girodeau JM, Hayward RC, Lehn IM, Sauvage JP, Helv Chim Acta 63:
2096 (1980).
12. Gehin D, Cesare PD, Gross B, J Org Chem 51: 1906 (1986).
13. Davidson RB, Bradshaw JS, Jones BA, Dalley NK, Christensen JJ, Izatt RM, Morin
FG, Grant DM, J Org Chem 49: 353 (1984).
14. Chadwick JD, Cliffe IA, Sutherland IO, Newton RF, J Chem Soc Perkin Trans I
1707 (1984).
15. Naemura K, Fukunaga R, Chem Lett 1651 (1985).
16. Naemura K, Fukunaga R, Yamanaka M, Chem Commun 1560 (1985).
17. Naemura K, Komatsu M, Adachi K, Chikamatsu H, Chem Commun 1675
(1986).
18. Thoma AP, Viviani-Nauer A, Schellenberg KH, Bedekovic D, Pretsch E, Prelog V,
Simon W, Helv Chim Acta 62: 2303 (1979).
19. Sousa LR, Hoffman DH, Kaplan L, Cram DJ, J Am Chem Soc 96: 7100 (1974).
20. Blasius E, Adrian W, Jansen KP, Klaute G, J Chromatogr 96: 89 (1974).
21. Izatt RM, Lamb JD, Izatt NE, Rossiter BE, Christensen JJ, Haymore BL, J Am
Chem Soc 101: 6273 (1979).
22. Dietrich B, Lehn JM, Sanvage JP, Tetrahedron Lett 2885 (1969).
23. Wada F, Wada Y, Kikukawa K, Matsuda T, Bull Chem Soc Jpn 54: 458 (1981).
24. Pocsfalvi G, Liptak M, Huszthy P, Bradshaw JS, Izatt RM, Vekey K, Anal Chem 68:
792 (1996).
25. Gérczei T, Böcskei Z, Miklós Keserû G, Samu E, Huszthy P, Tetrahedron: Asymm
10: 1995 (1999).
26. Samu E, Huszthy P, Somogyi L, Hollósi M, Tetrahedron: Asymm 10: 2775
(1999).
27. Samu E, Huszthy P, Horváth G, Szöllõy A, Neszmélyi A, Tetrahedron: Asymm 10:
3615 (1999).
28. Huszthy P, Samu E, Vermes B, Mezey-Vándor G, Nógrádi M, Bradshaw JS, Izatt
RM, Tetrahedron 55: 1491 (1999).
29. Sogah GDY, Cram DJ, J Am Chem Soc 97: 1259 (1975).
31. Sousa LR, Sogah GDY, Hoffman DH, Cram DJ, J Am Chem Soc 100: 4569
(1975).
33. Blasius E, Heo GS, Smid J, Yagi K, Talanta 27: 107 (1980).
34. Blasius E, Papadoya IN, Smid J, Yagi K, Talanta 27: 127 (1980).
35. Blasius E, Akelah M, Nakajima M, J Chromatogr 201: 147 (1980).
36. Igawa M, Saito K, Tsukamoto J, Tanaka M, Anal Chem 53: 1942 (1981).
37. Igawa M, Saito K, Tanaka M, Yamabe T, Bunseki Kagaku 32: E137 (1983).
38. Kimura K, Hayata E, Shono T, Chem Commun 271 (1984).
39. Kimura K, Harino H, Hayata E, Shono T, Anal Chem 58: 2233 (1986).

40. Shinbo T, Yamaguchi T, Nishimura K, Sugiura M, J Chromatogr 405: 145
(1987).
41. Kimura K, Nakajima M, Shono T, Anal Lett 13: 741 (1980).
42. Nakajima M, Kimura K, Shono T, Anal Chem 55: 463 (1983).
43. Nakajima M, Kimura K, Shono T, Bull Chem Soc Jpn 56: 3052 (1983).
44. Iwachido T, Naito H, Samukawa F, Ishimaru K, Toei K, Bull Chem Soc Jpn 59:
1475 (1986).
45. Machida Y, Nishi H, Nakamura K, Nakai H, Sato T, J Chromatogr A 805: 85
(1998).
46. Hyun MH, Jin JS, Lee W, Bull Korean Chem Soc 9: 819 (1998).
47. Hyun MH, Jin JS, Lee W, J Chromatogr A 822: 155 (1998).
48. Hyun MH, Jin JS, Koo HJ, Lee W, J Chromatogr A 837: 75 (1999).
49. Hyun MH, Han SC, Jin JS, Lee W, Chromatographia 52: 473 (2000).
50. Hyun MH, Koo HJ, Jin JS, Lee W, J Liq Chromatogr Relat Technol 23: 2669
(2000).
51. Jin JS, Stalcup AM, Hyun MH, J Chromatogr A 933: 83 (2001).
52. Steffeck RJ, Zelechonok Y, Gahm KH, J Chromatogr A 947: 301 (2002).
53. Udvarhelyi PM, Watkins JC, Chirality 2: 200 (1990).
54. Motellier S, Wainer IW, J Chromatogr 516: 365 (1990).
55. Hilton M, Armstrong DW, J Liq Chromatogr 14: 9 (1991).
56. Aboul-Enein HY, Bakr SA, Islam R, Rothchild R, J Liq Chromatogr 14: 3475
(1991).
57. Hilton M, Armstrong DW, J Liq Chromatogr 14: 3673 (1991).
58. Shinbo T, Yamaguchi T, Yanagishita H, Kitamoto D, Sakaik K, Sugiura M, J
Chromatogr 625: 101 (1992).
59. Kersten BS, J Liq Chromatogr 17: 33 (1994).
60. Okamoto M, Takahashi KI, Doi T, J Chromatogr 675: 244 (1994).
61. Yamaguchi T, Kagaku 42: 255 (1989).
62. Walbroehl Y, Wanger J, J Chromatogr A 680: 253 (1994).
63. Walbroehl Y, Wanger J, J Chromatogr A 685: 321 (1994).
64. Török G, Peter A, Fulop F, Chromatographia 48: 20 (1998).
65. Machida Y, Nishi H, Nakamura K, Chromatographia 49: 621 (1999).
66. Lin S, Maddox NJ, J Liq Chromatogr 18: 1947 (1995).
67. Hyun MH, Han SC, Lipshutz BH, Shin JS, Welch CJ, J Chromatogr A 910: 359
(2001).
68. Peter A, Olajos E, Casimir R, Tourwe D, Broxterman QB, Kaptein B, Armstrong
DW, J Chromatogr A 871: 105 (2000).
69. Machida Y, Nishi H, Nakamura K, J Chromatogr A 830: 311 (1999).
70. Peter A, Torok G, Toth G, Den Nest WV, Laus G, Tourwe D, J Chromatogr A 797:
165 (1998).
73. Breda M, Sarati S, Basileo G, Dostert P, Chirality 9: 133 (1997).
74. Van Dort ME, Chirality 11: 684: (1999).
75. Aboul-Enein HY, Ali I, Hyun MH, Cho YJ, Jin JS, J Biochem Biophys Methods
54: 407 (2002).

76. Shibukawa A, Nagakawa T, The use of chiral crown ethers in liquid chromato-
graphy, in Chiral Separations by HPLC, Krstulovic AM (Ed.), Ellis Horwood, New
York, p. 477 (1989).
77. Machida Y, Nishi H, Nakamura K, Chirality 11: 173 (1999).
78. Koide T, Ueno K, J Chromatogr A 909: 305 (2001).

9
Miscellaneous Types of Chiral
Stationary Phase
The most popular and commonly used chiral stationary phases (CSPs) are
polysaccharides, cyclodextrins, macrocyclic glycopeptide antibiotics, Pirkle
types, proteins, ligand exchangers, and crown ether based. The art of the chiral
resolution on these CSPs has been discussed in detail in Chapters 2–8,
respectively. Apart from these CSPs, the chiral resolutions of some racemic
compounds have also been reported on other CSPs containing different chiral
molecules and polymers. These other types of CSP are based on the use of chiral
molecules such as alkaloids, amides, amines, acids, and synthetic polymers.
These CSPs have proved to be very useful for the chiral resolutions due to some
specific requirements. Moreover, the chiral resolution can be predicted on the
CSPs obtained by the molecular imprinted techniques. The chiral resolution on
these miscellaneous CSPs using liquid chromatography is discussed in this
chapter.
9.1 ALKALOID-BASED CSPs

Most of the alkaloids are chiral molecules having many chiral centers. Therefore,
these molecules have been used to prepare effective and successful CSPs.
Cinchona alkaloids (i.e., quinine, quinidine, epiquinine, epiquinindine, cincho-
nine, and cinchonidine), which differ in their absolute configuration and alkyl
side chains, have been used as the starting materials for the preparation of CSPs

[1–4]. Among these, the CSPs based on quinine, quinidine, and their derivatives
have proven to be most effective for chiral resolution. In addition, CSPs based on
alkaloids having bulky carbamate residues like tert-butyl or 1-adamantyl groups
have shown higher enantioselectivities in almost all cases. Contrarily, the CSPs
with aromatic carbamate residues such as 2,6-diisopropylphenyl, trityl, and 3,5-
dinitrophenyl groups are complementary in their enantioselective profile, exhibit-
ing higher enantioselectivities. tert-Butylcarbamoylated quinine linked to
mercaptopropylsilica was used for the chiral resolution of N-3,5-dinitrobenzoy-
lated leucine and phenylalanine with a values of 15.87 and 10.78, respectively,
using a buffer as the mobile phase [5]. The authors also observed the decrease in
the chiral resolution of leucine and phenylalanine by replacing the N-3,5-
dinitrobenzoyl group by the 2,4-dinitrophenyl ring. The reversible enantiomer-
ization of axially chiral 2-dodecycloxy-6-nitrophenyl-2-carboxylic acid was
studied on O-(tert-butylcarbamoyl) quinine as a chiral selector by stopped-flow
high-performance liquid chromatography (sfHPLC) [6].
Franco et al. [7] synthesized nine new quinine carbamate dimers and
immobilized them on silica gel. The role of the presence of a second quinine
subunit on the CSPs, as well as the influence of the structure and length of the
spacer, on the overall chiral recognition of a set of N-derivatized amino acids and
other acidic drugs was also investigated. The bulkiness of the intermediate spacer
tuned the chiral recognition abilities of these CSPs, with the 1,3-adamantyl-
derived CSP, which led to the best separations. Shorter spacers reduced the chiral
discrimination abilities of the dimeric selectors, with the n-hexylene bridge being
the most favorable distance to allow a nearly independent interaction of the two
quinine subunits with the racemic analytes. The comparison of five monomeric
CSPs showed that the dimeric ones usually retain the chiral analytes more
strongly, although the enantioseparation is not improved. Nevertheless, the
exceptional resolution abilities of dimeric CSPs with a trans-1,2-diaminocyclo-
hexylene-bridge for the separation of 2,4-dinitrophenyl (DNP) derivatives of
amino acids and certain acidic drugs of therapeutical interest (e.g., profens)
seemed to be superior in comparison to other CSPs [7]. The structures of some of
the cinchona alkaloid-based CSPs are shown in Figure 1 and the chiral resolution
of some amino acids derivatives on these CSPs is given in Table 1 [8].
The effect of mobile phase composition, including pH and organic
modifiers, was carried out on the chiral resolution of leucine derivatives on the
tert-butyl carbamoylated quinine-based CSP [2]. The results of these findings are
given in Table 2. This table shows that the best resolution was obtained at pH 5,
2 mM concentration of buffer, 60% methanol, and 80% acetonitrile concentra-
tions, separately. In another study, the same authors [4] studied the influence of
the mobile phase, pH, and temperature on the chiral resolution of leucine
derivatives. The effect of temperature on the chiral resolution of leucine
derivatives is shown in Figure 2. It is clear from this figure that the chiral

FIGURE 1 Structures of some CSPs based on cinchona alkaloids. (From Ref. 8.)
resolution decreases with increasing temperature. As a typical example, the chiral

resolutions of 3,5-dinitrobenzyloxycarbonyl (DNZ)–leucine, DNZ–glutamic acid,
and DNZ–phenylalanine are shown in Figure 3.
The ergot alkaloids were used to prepare different types of CSP and good
resolutions were obtained for acidic compounds in buffered aqueous media
[9–11]. The enantiomers of 2-aryloxypropionic acid, chrysanthemic acid, and
analogs and profens were also resolved on CSPs based on ergot alkaloids. The
most commonly used CSP, based on ergot alkaloid is 1-allyl terguride [12–14].
The tertiary amine of the methylergoline moiety represents the fixed charge of
this CSP. The urea group adjacent in the b-position to the primary ionic
interaction site is able to form hydrogen bonds. An interesting feature of the
terguride CSP is its self-recognition ability; that is, the terguride CSP can be used

TABLE 1 Chiral Resolution of Amino Acid Derivatives on Cinchona Alkaloid–Based
CSPs
Amino acid Derivative CSP k a
Leucine DNB I 11.74 15.88

Leucine DNB II 8.0 12.46
Leucine DNB III 11.38 1.16
Leucine DNB IV 9.41 1.15
Leucine DNB V 7.43 3.49
Leucine DNB VI 2.76 1.41
Leucine DNB V 13.75 1.74
Leucine DNB I 15.41 1.39
3-(4-Pyridyl)alanine Bz I 5.11 1.94
3-(2-Thienyl)alanine Ac I 4.65 1.41
tert-Leucine For I 2.67 1.25
Arginine FMOC I 1.14 1.68
Proline DNZ I 7.52 1.21
3-Amino-3-phenyl-propionic acid DNZ I 8.73 1.83
2-Methyltaurine DNZ I 5.00 1.92
Glutamic acid DNZ I 34.73 1.36
Citrulline DNZ I 3.89 1.49
Cysteic acid DNZ I 34.45 1.14
a-Aminopropyl phosphonic acid DNZ I 35.43 1.14
3-Aminobutyric acid PNZ I 4.06 1.32
Valine NVOC I 6.95 3.25
Serine Z I 3.61 1.21
3-Amino-3-phenyl-propionic acid Z VII 5.44 1.23
3-Aminobutyric acid Z VII 2.37 1.21
Tyrosine BOC VII 3.09 1.44
Tryptophan DNS V 34.88 2.97
Abbreviations: DNP: 2,4-dinitrophenyl; Bz: benzoyl; Ac: acetyl; For: formyl; FMOC: 9-fluorenyl-
methoxycarbonyl; DNZ: 3,5-dinitrobenzyloxycarbonyl; PNZ: 4-nitrobenzyloxycarbonyl; NVOC: 6-
nitroveratryloxycarbonyl; Z: benzyloxycarbonyl; BOC: tert-butoxycarbonyl; DNS: dansyl. CSPs:
I–VII, see Fig. 1.
Source: Ref. 8.
to separate the enantiomers of terguride [12]. The semipreparative separation of

fenoprofen on the terguride-based CSP has been described [11]. Blaschke et al.
[15] reported the analytical and preparative chiral resolutions of zopiclone
enantiomers on polymethacrylol-1R,2S-norephedrine CSP using 0.01 M phos-
phate buffer (pH 5.5) with 1.2% 2-propanol. The effect of pH and concentrations
of buffer and acetonitrile was studied on the chiral resolution of some profens on
the terguride-based CSP [11]. The results of these findings are given in Figures 4a

TABLE 2 Effect of Mobile Phase Composition (pH and Organic Modifiers) on the
Chiral Resolution of Leucine Derivatives
Leucine derivative k a Rs k a Rs k a Rs
Effect of pH pH 6 pH 5 pH 4
DNB–leucine 0.39 7.31 5.38 0.39 9.71 8.86 0.25 5.5 4.23
DNP–leucine 0.59 1.22 0.50 0.95 1.35 1.27 0.71 1.23 0.50
DNZ–leucine 0.36 2.13 1.24 0.38 2.07 1.39 0.16 1.54 0.50
Effect of buffer conc. 20 mM 10 mM 2 mM
DNB–leucine 0.43 4.12 9.26 0.44 9.75 9.23 0.81 10.2 12.30
DNP–leucine 0.83 1.12 1.04 0.84 1.32 1.03 0.57 1.27 1.37
DNZ–leucine 0.43 0.90 1.57 0.46 2.12 1.83 0.86 2.20 3.60
Effect of methanol conc. 80% 60% 40%
DNB–leucine 0.78 10.21 12.23 1.59 8.31 12.43 4.05 6.24 11.8
DNP–leucine 1.46 1.28 1.48 3.58 1.25 2.05 13.38 1.21 2.11
DNZ–leucine 0.81 2.22 3.59 1.95 2.00 4.55 6.31 1.76 5.19
Effect of acetonitrile conc. 80% 60% 40%
DNB–leucine 0.95 6.55 12.66 0.94 5.60 9.97 1.48 5.48 11.42
DNP–leucine 1.98 1.20 1.36 1.57 1.25 0.50 3.05 1.16 1.21
DNZ–leucine 0.77 1.84 2.51 0.97 1.78 2.62 1.81 1.77 3.63
Abbreviations: DNB: dinitrobenzoyl; DNP: 2,4-dinitrophenyl; DNZ: 3,5-dinitrobenzyloxycarbonyl.

CSP: tert-butyl carbamoylated quinine based; buffer: ammonium acetate.
Source: Ref. 2.
(pH), 4b (buffer conc.), and 4c (acetonitrile conc.), respectively. It is clear from

these figures that the enantioselectivity increased by decreasing pH and concen-
trations of buffer and acetonitrile, respectively. Flieger et al. [12] studied the effect
of pH and the concentration of methanol on the chiral resolution of terguride on
the 1-(3-aminopropyl) derivative of (þ)-(5R,8S,10R)-terguride-based CSP. The
effect of pH and the concentration of methanol on the chiral resolution of
terguride on 1-(3-aminopropyl) derivative of (þ)-(5R,8S,10R)-terguride-based
CSP is shown in Figure 5, which shows that the lower concentration of methanol
favored the enantioselectivity. The chromatograms of the chiral resolution of
fenoprofen, naproxen, ketoprofen, and flobuprofen on terguride-based CSP are
shown in Figure 6. The structures of some of the ergot alkaloids based CSPs are
shown in Figure 7.

FIGURE 2 Effect of temperature on the chiral resolution of dansyl valine amino acids on
CSP I (see Fig. 1) using methanol–0.1 M ammonium acetate (80 : 20, v=v). (From Ref. 8.)
9.2 AMIDE- AND AMINE-BASED CSPs

Many of the chiral molecules containing amide groups were bonded to a solid
support for the preparation of CSPs [16–19]. The racemic compounds resolved
on these CSPs include a-hydroxycarbonyls, b-hydroxycarbonyls, amino acids,
amino alcohols, amine, and derivatized and underivatized diols. The preliminary
chiral diamide phase [(N-formyl-L-valyl)aminopropyl)silica gel] has sufficient
separability for racemic N-acylated a-amino acid esters but not in other types
of enantiomer [16]. Most of the eluents used with these CSPs are of normal
phase mode, including n-hexane, 2-propanol, chlorinated organic solvents, and
acetonitrile.
Allenmark et al. [20] prepared a CSP consisting of N,N-diallyl-(R,R)-
tartaric acid diamide as chiral monomer. These monomers were cross-linked with
multifunctional hydrolisanes, yielding a network polymer which was used for the
chiral resolution of amino alcohols, profens, b-blockers, benzodiazepinones, and
benzothiadiazines. A highly sensitive high-performance liquid-chromatographic
(HPLC) method was developed for the separation of enantiomeric 1,2-diacyl-sn-
glycerols (S configuration), 2,3-diacyl-sn-glycerols (R configuration), and regio-

FIGURE 3 Chromatograms of the chiral resolution of (I) DNZ–leucine, (II) DNZ–
glutamine, and (III) DNZ-phenylalanine on tert-butyl carbamoylated quinine CSP using (a)
ammonium acetate (1 mM, pH 5.45) and (b) acetonitrile containing 1% ammonium acetate
with gradient elution (DNZ: 3,5-dinitrobenzyloxycarbonyl). (From Ref. 2.)
isomeric 1,3-diacyl-sn-glycerols. For this purpose, the diacylglycerols were

converted to 2-anthrylurethanes and subjected to chiral phase HPLC with
fluorescence detection. Satisfactory resolution of the enantiomers and regio-
isomers was achieved on a (R)-1-(1-naphthyl)ethylamine polymeric phase, using
a mixture of n-hexane–dichloromethane–ethanol (150 : 10 : 1, v=v=v) as the
mobile phase [21].

FIGURE 4 Effect of (a) pH, (b) concentration of buffer, and (c) concentration of
acetonitrile on the chiral resolution of some profens on terguride-based CSP. (From Ref.
11.)

FIGURE 5 Effect of methanol concentration on the chiral resolution of ergot alkaloid on
terguride-based CSP using 0.05 M ammonium acetate as the mobile phase at pH 7.2 (m),
6.1 (u), and 4.6 (d). (From Ref. 12.)
Abou-Basha and Aboul-Enein [22] presented an isocratic and simple

HPLC method for the direct resolution of the clenbuterol enantiomers. The
method involved the use of a urea-type CSP made of (S)-indoline-2-carboxylic
acid and (R)-1-(naphthyl) ethylamine known as the Chirex 3022 column. The
separation factor (a) obtained was 1.27 and the resolution factor (Rs ) was 4.2
when using a mobile phase composed of hexane–1,2-dichloroethane–ethanol
(80 : 10 : 10, v=v=v). The (þ)-enantiomer eluted first with a capacity factor (k) of
2.67 followed by a ()-enantiomer with a k of 3.38. Biesel et al. [23] resolved
1-benzylcyclohexane-1,2-diamine hydrochloride on a Chirex D-penicillamine
column. Gasparrini et al. [24] synthesized a series of the chiral selectors based
on trans-1,2-diaminocyclohexane. The developed CSPs were used for the chiral
resolution of arylacetic acids, alcohols, sulfoxides, selenoxides, phosphinates,
tertiary phosphine oxides, and benzodiazepines. In another study, the same
authors [25] described the chiral resolution of b-aminoesters enantiomers on
synthetic CSPs based on a p-acidic derivatives of trans-1,2-diaminocyclohexane

FIGURE 6 Chromatograms of the chiral resolution of (a) fenoprofen, (b) flobufen, (c)
naproxen, and (d) ketoprofen on 1-allyl terguride-based CSP using 20 mM potassium
acetate (pH 3.6)–acetonitrile (50 : 50, v=v). (From Ref. 11.)
310

FIGURE 7 Structures of some ergot alkaloids used for the preparation of CSPs. (From
Ref. 12.)
as the chiral selector. The application of different columns containing the

stationary phase with opposite configuration and in the racemic form for the
determination of enantiomeric excess in chemically impure samples is described.
The structures of some amide-based CSPs are given in Figure 8.
9.3 ACID-BASED CSPs

Cholic acid and 3-phenylcarbamoyl cholic acid allyl esters were grafted to
hydride-activated silica gel and the developed CSPs were used for the chiral
resolution of derivatized amino acids, amines, alcohols, hydantoins, and 2,20 -

FIGURE 8 Structures of some amide-based CSPs.
dihydroxy-binaphthyl [26,27]. Deoxycholic acid derivatives were linked to silica

gel by the conversion of acid to the allylamide, followed by the introduction of
two identical or two different arylcarbamate groups [28]. These CSPs were
utilized for the chiral resolution of amines, amino acids derivatives, acids, and
3-hydroxy benzodiazepin-2-ones. The enantiomer separation of C60 fullerene
derivatives on the CSP of (R)-()-2-(2,4,5,7-tetranitro-9-fluorenylidene-

aminooxy) propionic acid (TAPA) was achieved. A C60 fullerene tris- and
hexakis-adducts with achiral addends and an inherent chiral addition pattern
were separated on a microbore column containing R-()-TAPA bonded to silica
gel as the CSP. The stationary phase exhibited an intermediate polarity, and
separations were performed using the normal and reversed-phase modes. With
hexakis-adduct, near-baseline separation was achieved. The tris-adduct showed a
strong interaction with the CSP expressed by a high retention factor but inferior
enantiomer separation [29]. The synthesis of (þ)- and ()-hexahelicen-7-yl
acetic acid-bonded phases, using two bonding reagents, was conducted. The
relationship between the structure of a series of dinitrobenzoyl (DNB) derivatives
of chiral aryl alcohols and their enantioselectivity on the (þ)-hexahelicen-7-yl
acetic acid bonded phase was described. The DNB derivatives were selected to
reflect a range of alkyl side-chain lengths, spacer chain lengths between the chiral
center and the aromatic group, and the aromatic group size. The chiral resolution
increased with increasing length of the alkyl chain at the chiral center and
decreased on increasing the distance between the aromatic groups at the chiral
center. It was also reported that the enantiomer elution order reversed when
changing from the (þ)-hexahelicene phase to the ()-hexahelicene phase [30].
9.4 SYNTHETIC POLYMER^BASED CSPs

The synthesis of optically active polymers is an important area in macromolecular
science, as they have a wide variety of potential applications, including the
preparation of CSPs [31–37]. Many of the optically active polymers with or
without binding to silica gel were used as CSPs and commercialized [38]. These
synthetic polymers are classified into three groups according to the methods of
polymerization: (1) addition polymers, including vinyl, aldehyde, isocyanide, and
acetylene polymers, (2) condensation polymers consisting of polyamides and
polyurethanes, and (3) cross-linked gels (template polymerization). The art of the
chiral resolution on these polymer-based CSPs is described herein.
9.4.1 Addition Polymers

Various addition polymers were synthesized and used for the chiral resolution
purposes, but helical polymethacrylates and polymethacrylamides are more
effective and useful for chiral resolution. However, the chiral resolution on
other polymers is also discussed.
9.4.1.1 Helical Polymethacrylates

The helical polymethacrylates show a chiral recognition capability for different
racemic compounds, including macromolecules [39–41]. Among the various

FIGURE 9 Structures of (a) poly(triphenylmethyl methacrylate) [poly(TrMA)] and (b)
diphenyl-2-pyridyl methacrylate [poly(D2pyMA)] chiral selectors used for the preparation
of CSPs. (From Ref. 37.)
polymers, poly(triphenylmethyl methacrylate) [(poly(TrMA)] and diphenyl-2-

pyridyl methacrylate [(D2PyMA)] (Fig. 9) exhibit a high resolving power
toward various racemates.
Poly(triphenylmethyl methacrylate). The resolution of Tröger’s base,

hexahelicene, and cyclophanes were successfully resolved on the CSP based
on poly(TrMA) [37]. A significant improvement in the chiral resolution of
poly(TrMA) was achieved by coating onto macroporous silica gel [40]. This
coated CSP was very successful for the chiral resolution of a wide variety of
racemic compounds [32–46]. The structures of some of the racemic compounds
resolved on this CSP are given in Figures 10 and 11. The main characteristic
feature of this CSP is that it can resolve the racemic compounds, even those
lacking any functional groups. Moreover, the racemic compounds, difficult to
resolve on other CSPs, can be resolved on this CSP easily. The best mobile phase
for this CSP is the use of polar eluents having methanol and water mixtures,
which suggests that resolution takes place through hydrophobic interactions
between nonpolar groups of the solute and side groups of poly(TrMA) CSP.
It has also been observed that the concentration ratio of poly(TrMA) to
silica plays an important role for the chiral resolution. Generally, a high ratio of
poly(TrMA) to silica gel was found suitable for the chiral resolution of different
racemic compounds [39]. This observation may be explained on the basis of the
aggregation state of poly(TrMA) chains. At a higher concentration of the
polymer, the helical chains aggregate in an ordered form, which may create
new chiral spaces between closely packed polymer chains whose shapes may be
different from those of the space around isolated helical chains, and, hence,
greater chiral recognition is observed at a high concentration of poly(TrMA) onto
the silica gel. This coated CSP suffers from the drawback that it could not be used

FIGURE 10 Structures of some simple racemic compounds resolved on poly(TrMA)
CSP. (From Ref. 37.)

FIGURE 11 Structures of some complex racemic compounds resolved on poly(TrMA)
CSP. (From Ref. 37.)

FIGURE 12 Chromatograms of the chiral resolution of the perchlorotriphenylmethyl
radical on a Chiralpak OT (þ) column using methanol as the eluent. (From Ref. 46.)
with the eluent containing some organic solvents like chloroform and tetra-
hydrofuran. Therefore, Okamoto et al. [47] prepared a chemically bonded
poly(TrMA) CSP. The chemical binding of poly(TrMA) with silica gel was
achieved by (1) the reaction of poly(TrMA) and 3-trimethoxysilylpropyl metha-
crylate with silica gel or (2) the reaction of poly(TrMA) having a PhNH–
CH2 CH2 –N–(Ph) terminal group with silica gel pretreated with (3-aminopro-
pyl)-triethoxysilane and toulene-2,4-diyldiisocyanate. The chiral recognition
capacities of both CSPs were comparable. The CSP obtained by this polymer
was commercialized under the name Chiralpak OT (þ) by Daicel Chemical
Industries (Tokyo, Japan). The chiral resolution of the perchlorotriphenylmethyl
radical on Chiralpak OT (þ) CSP is shown in Figure 12 [46].
Diphenyl-2-pyridyl methacrylate. Diphenyl-2-pyridyl methacrylate

(D2PyMA) was more stable than the poly(triphenylmethyl methacrylate) polymer
[poly(TrMA)] and the chiral recognition of D2PyMA was comparable to the
chiral resolution of the poly(TrMA) polymer [47]. The chiral resolution of several
racemic compounds, including calixarene derivatives and Tröger’s base and
analogs has been achieved on the D2PyMA CSP [48]. In most of the cases,
chiral resolution was carried out using methanol, which indicates that hydro-
phobic interactions are controlling the chiral resolution on this CSP.

FIGURE 13 Structure of (a) polymethacrylate having binaphthol moiety and (b) simple
polymethacrylate CSPs. (From Ref. 37.)
In addition to these two CSPs, their derivatives were also synthesized and
tested for chiral resolution. The most important derivatives are poly(m-Cl-TrMA),
poly(m-F-TrMA), poly(m-Cl3 -TrMA), poly(m-Me3 -TrMA), poly(PB2PyPMA),
poly(D3PyMA), and poly(MPyDMA). All of these derivatives show slightly
lower chiral recognition capability than poly(TrMA) and D2PyMA CSPs,
whereas no chiral recognition was shown by poly(m-Me3 -TrMA) CSP [49–52].
An optically active nonhelical polymethacrylate having binaphthol moiety in the
side chain (Fig. 13a) was synthesized and showed chiral recognition capacities for
3,5-dinitrophenylcarbamates derivatives of 1,2-diols, 1,3-diols, and 1-phenyl-
alkanols [53]. Similarly, an optically active polymethacrylate (Fig. 13b) showed
chiral resolution capacities for some drugs [15]. The CSP obtained from
D2PyMA was commercialized by Daicel Chemical Industries (Tokyo, Japan)
under the name of Chiralpak OP (þ).
9.4.1.2 Polyacrylamide and Polymethacrylamide

Blaschke et al. [54–56] synthesized polyacrylamide and polymethacrylamide
containing chiral side chains. In order to make CSPs, these polymers were
bonded to silica gel chemically [54–56]. The CSP obtained by N-acrylol-(S)-
phenylalanine ethyl ester was commercialized by Merck Chemical Company by
the trade name ChiraSpher. The racemic compounds resolved are those capable of
forming hydrogen-bondings (i.e., amides, imides, carboxylic acids, and alcohols).
It has been reported that nonpolar solvents like benzene and toluene individually
or their mixtures were the best mobile phases. In addition to these CSPs, other
amide CSPs were prepared and tested for the chiral resolution [57,58].

9.4.1.3 Other Addition Polymers
In addition to the above-mentioned polymers, other addition polymers such as
polyolefin, polystyrene, polyvinylethers, polychloral, polyisocyanides, polyace-
tylene, and polyethers were synthesized and evaluated as the precursors for the
preparation of CSPs. Some of them were coated or chemically bonded to silica
gel and tested for the chiral resolution of different racemic compounds.
Pino et al. [59] resolved the enantiomers of poly[(R)-4-methyl-1-hexene]
and poly[S-4-methyl-1-hexene] on crystalline and insoluble (þ)-poly[(S)-3-
methyl-1-pentene]. An optically active styrene derivative was prepared and
ground to powder. The powder was packed into a column and used as the CSP
for the chiral resolution of several amines and alcohols having aryl groups.
However, this CSP could not resolve aliphatic alcohols and amines [60]. Kakuchi
et al. [61] resolved the enantiomers of phenylglycine, valine, and methionine
on CSP containing cyclopolymerized chiral divinyl ether. Ute et al. [62] resolved
the enantiomers of trans-stilbene oxide on polychloral CSP. Yamagishi et al.
[63] resolved the enantiomers of menthol and binaphthol on CSP containing
poly(t-butyl isocyanide). An optically active polyphenylacetylene derivative was
coated onto silica gel and the developed CSP was tested for the chiral resolution
of trans-stilbene oxide and Tröger’s base [64]. In another study, Yashima et al.
[65] also developed new polyacetylene-based CSPs and used them to resolve the
enantiomers of trans-stilbene oxide, Tröger’s base, and spiropyrans derivatives.
Umeda et al. [66] chemically bonded polysaccharides like polyether to silica gel
and the developed CSP was used for the chiral resolution of amino acids.
9.4.2 Condensation Polymers

Several polyamides and polyurethanes have been synthesized by condensation
polymerization and used as the precursors for the preparation of different CSPs.
These CSPs showed different chiral recognition properties than those of addition
polymers. Allenmark and Andersson [67] prepared a CSP containing silica gel
supported by s-triazine derivatives of L-valine isopropyl esters (Fig. 14) and the
FIGURE 14 Structure of polyamide-based CSP (s-triazine derivative of L-valine isopro-

pyl ester) (condensation polymer). (From Ref. 37.)

developed CSP was found suitable for the chiral resolution of amino acid
derivatives. Hirayama et al. [68] resolved some amino acid derivatives on
poly(L-leucine) or poly(L-phenylalanine) chemically bonded to poly(methyl
acrylate) macropore beads. Poly(N-benzyl glutamine) chemically bonded to
polystyrene beads also resolved the enantiomers of mandelic acid and hydantoin
derivatives [69]. It has also been reported [70–74] that polyamides prepared from
chiral diamine or chiral dicarboxilic acids or esters can resolve some polar
racemic compounds having functional groups capable of hydrogen-bondings. The
chiral recognition capacities depended on the structures of the chiral units and the
groups binding the chiral units. For example, polyamides having methylene
groups of even number in the diamine units show higher recognition than those
with an odd number. Sinibaldi et al. [75] prepared monosized nonporous urea
formaldehyde resin and used it for the chiral resolution of phenylalanine using
potassium and copper(II) acetate buffer as the mobile phase. The chiral recogni-
tion capacities of polyurethanes and polyurea urethanes have also been evaluated
[76–78].
9.4.3 Cross-Linked Gels (Template Polymerization)

Generally, cross-linked polymers recognize chiral resolution through chiral
cavities. Some polymers were synthesized and used for chiral resolution purposes
[79–82]. The applications of these CSPs include the chiral resolution of amino
acids, b-blockers, and profens. Wulf et al. [83] observed that the chiral resolution
capacity of these gels is significantly affected by the kind and amount of cross-
linker agent.
9.5 MOLECULARLY IMPRINTED CSPs

Polysaccharides, proteins, and synthetic polymers are readily available polymers
for the preparation of CSPs. A problem with these as well as other common CSPs
is the limited predictability of elution orders and separability, making screening of
stationary phase libraries a necessary step in the method development. Polymers
imprinted with chiral templates promise to alleviate these drawbacks and offer a
new generation of tailor-made CSPs with predictable selectivities [84–86].
Molecularly imprinted polymers (MIPs) can be prepared by a number of
approaches that are different in the way the template is linked to the functional
monomer and, subsequently, to the polymeric binding sites. The approaches to
generate imprinted binding sites are shown in Figure 15. The first example of
molecular imprinting of organic network polymers was introduced by Wulf [80];
it was based on a covalent attachment strategy (i.e., covalent monomer template
and covalent polymer template). Most of the polymers used in the preparation of
CSPs through the molecularly imprinted technique are synthesized by free-radical

FIGURE 15 Different approaches to generate imprinted binding sites. (From Ref. 85.)

polymerization mechanisms involving monofunctional unsaturated monomers
and an excess of cross-linking di- or triunsaturated monomers which resulted
in porous organic network materials [87]. Most of the polymers prepared by this
technique are based on vinylic, acrylic, and methacrylic monomers, which have
already been discussed in Section 9.4. The most important applications of these
CSPs are the chiral resolution of amino acids, amino acid derivatives, amines,
carboxylic acids, peptides, b-blockers, profens, alkaloids, and other pharmaceu-
ticals [85].
Kempe and Mosbach [88] improved the performance of MIPs by coating
the surface of macroporous silica gel or by grafting the MIP onto polymer beads,
and the resulted CSPs showed a moderate improvement in enantioselectivity.
Generally, an increase in the temperature [89] and gradient elution [90] yielded a
highly improved performance of MIP CSPs. Lin et al. [91] prepared L-aromatic
amino acid-imprinted polymers using azobisnitrile as their photoinitiators or
thermal initiators at temperature ranging from 4 C to 60 C. The resulting
polymers were grounded and sieved to a 25-mm size and packed into the
column. The developed CSP was used to resolve the enantiomers of amino
acids. The authors also studied the effect of temperature on the chiral resolution
of amino acids using this CSP (Fig. 16) and it was observed that chiral resolution
improved at a high temperature. A typical example of the chiral resolution on a
FIGURE 16 Effect of temperature on the chiral resolution of DL-phenylalanine on CSP

prepared by imprinted L-phenylalanine molecule by capillary electrochromatography using
acetonitrile–acetic acid (95 : 5, v=v). Imprinted polymers were prepared at (u) 60 C,
(d) 40 C, and (s) 4 C. (From Ref. 91.)

FIGURE 17 Chromatograms of the chiral resolution of Z-tyrosine-OH on Z-(S)-tyrosine-
OH-imprinted poly(pentaerythritol triacrylate-co-methylmethacrylate) CSP using chloro-
form–acetic acid (66 : 4, v=v) as the mobile phase. (From Ref. 8.)
MIP is shown in Figure 17, representing the chromatograms of the chiral

resolution of Z-tyrosine-OH on a Z-(S)-tyrosine-OH-imprinted poly(pentaerythri-
tol triacrylate-co-methylmethacrylate) CSP.
9.6 MISCELLANEOUS CSP IN SFC

The above-discussed miscellaneous CSPs have also been used in supercritical
fluid chromatography (SFC) for chiral resolution. Macaudiere et al. [92] carried
out a comparison of the chiral resolution using HPLC and SFC on Chiralpak OT.
The chromatographic behavior of this CSP was found to be quite different in
HPLC and SFC. A CSP based on the adsorption of a chiral anthrylamine on
porous graphitic carbon successfully resolved the enantiomers of tropic acid
derivatives and anti-inflammatory agents in SFC [93]. Schleimer et al. [94]
immobilized Chirasil nickel(II) bis[3-(heptafluorobutanoyl)-(1R)-10-methylene-
camphorate to poly(dimethylsiloxane) and packed in the capillary. The developed
CSP was used for the chiral resolution of 1-phenylethanol and camphor
enantiomers. The retention and separation factors depended on the applied
pressure, the density of the mobile phase, temperature, and flow rate. The
structure of this CSP is shown in Figure 18 [94]. The effect of the tempera-
ture on the chiral resolution of 1-phenylethanol and camphor is presented in
Figure 19. The elution profiles of 1-phenylethanol and camphor at different
temperatures and pressures are shown in Figure 20 [94]. In addition, the effect of

FIGURE 18 Structure of the Chirasil–nickel CSP. (From Ref. 94.)
FIGURE 19 Effect of temperature on the chiral resolution of (a, c) 1-phenylethanol and

(b, d) camphor on capillary containing the Chiralsil–nickel CSP (SFC). (From Ref. 94.)

FIGURE 20 Elution profile of (a) 1-phenylethanol at different temperatures and (b)
camphor at different pressures on a capillary containing a Chiralsil–nickel CSP (SFC).
(From Ref. 94.)
flow rate on the chiral resolution of camphor is given in Figure 21. A perusal of
all of these figures indicates that the chiral resolution depends on the different
SFC parameters.
9.7 MISCELLANEOUS CSP IN CEC

Sinibaldi et al. [95] resolved the enantiomers of 2-arylpropionic acids (flobufens)
and dansyl amino acids using a coated capillary of polyterguride using capillary
electrochromatography (CEC). It was found that the analytes, in the range of the
buffer pH between 2.5 and 4.0, were driven by anodic electro-osmotic flow

FIGURE 21 Chromatograms of the chiral resolution of camphor at different flow rates on
the capillary containing the Chiralsil–nickel CSP (SFC): (a) u0 ¼ 0:314 cm=sec, (b)
u0 ¼ 1:335 cm=sec. (From Ref. 94.)
originated by the positively charged moieties of the ergolinic skeleton and, only
partially, by their anodic electrophoretic mobility. The S-enantiomer was better
retained than R-enantiomer. The retention of the solutes was affected by the
concentrations and composition of the eluents. The effect of pH (on the chiral
resolution of flobufen) and acetonitrile concentration (on the chiral resolution of
fenoprofen) is shown in Figure 22, which indicates high enantioselectivities at
higher pH values and acetonitrile concentration [95]. Mandl et al. [5] used
O-(tert-butylcarbamoyl) quinine as the chiral selector for the reversible enantio-
merization of axially chiral 2-dodecycloxy-6-nitrophenyl-2-carboxylic acid by
stopped-flow capillary electrochromatography (sfCEC). The authors compared
the chiral resolution of 2-dodecycloxy-6-nitrophenyl-2-carboxylic acid by
sfHPLC and sfCEC and reported the best resolution by sfCEC. Furthermore,
the authors also studied the effect of temperature on the chiral resolution of 2-
dodecycloxy-6-nitrophenyl-2-carboxylic acid. The effect of temperature is shown
in Figure 23, which indicates that the chiral resolution decreased with the increase
in temperature [6].
The helical chiral poly(diphenyl-2-pyridylmethylmethacrylate)-based CSP,
in the form of a capillary, was used for the chiral resolution in aqueous and
nonaqueous modes of CEC [96]. The contribution of the aminopropyl groups of
the silica gel and the pyridyl groups of the chiral selector to the anodic electro-
osmotic flow (EOF) generated in these capillaries was evaluated. Furthermore,
different nonaqueous BGEs (methanol, acetonitrile), the influence of the ammo-
nium acetate concentration, the apparent pH of the BGE, and the composition of
the aqueous–organic BGE were investigated with regard to the EOF and basic
chromatographic parameters. The effect of the contributions of pressure-driven
and electrokinetically driven flows and mass-transfer characteristics of the
stationary phase on the plate heights and enantioseparations was also evaluated.

FIGURE 22 Effect of (a) pH on the chiral resolution of flobufen and (b) concentration of
acetonitrile on the chiral resolution of fenoprofen on polyterguride CSP using a phosphate
buffer (20 mM). (From Ref. 95.)

FIGURE 23 Chromatograms of the chiral resolution of 20 -dodecycloxy-6-nitrobiphenyl
carboxylic acid on O-(tert-butylcarbomyl) quinine-based CSP at different temperatures
using acetonitrile–methanol (80 : 20, v=v), containing 400 mM acetic acid and 4 mM
triethylamine, as the mobile phase. (From Ref. 6.)
Peters et al. [97] developed several monolithic chiral selectors based on 2-

hydroxyethyl methacrylate (N-L-valine-3,5-dimethylanilide) carbamate with ethy-
lene dimethacrylate, 2-acrylamido-2-methyl-1-propanesulfonic acid, and butyl or
glycidyl methacrylate and these chiral selectors were packed in capillaries. The
developed CSPs were used for the chiral resolution of N(3,5-dinitrobenzoyl)
leucine diallylamide enantiomers.
The CSPs prepared by the molecular imprint technique have also been used
for chiral resolution by CEC [98–100]. Lin et al. [91] synthesized L-aromatic
amino acid-imprinted polymers using azobisnitriles with either photoinitiators or
thermal initiators at temperatures ranging from 4 C to 60 C. Methacrylic acid
(MAA) was used as the functional monomer and ethylene glycol dimethacrylate
(EDMA) was used as the cross-linker. The resulting polymers were ground and
sieved to a particle size less than 10 mm, filled into the capillary columns, and
used for enantiomeric separations of some amino acids at different temperatures.
The relationships of separation factor and column temperatures were demon-
strated to be linear between the logarithm of the separation factors and the inverse
of the absolute temperature (Fig. 24). The authors also compared the obtained
chiral resolution with the chiral resolution achieved by HPLC and reported the
best resolution on CEC. The chromatograms of the chiral resolution of DL-

FIGURE 24 Effect of temperature on the chiral resolution of (a) DL-phenylalanine, (b)
DL-phenylglycine, (c) DL-tyrosine, and (d) DL-3-(3,4-dihydroxyphenyl) alanine on CSP
obtained by an imprinted L-phenylalanine molecule by CEC using acetonitrile–water–
acetic acid (80 : 10 : 10, v=v=v). Imprinted polymers were prepared at (u) 60 C, (e) 40 C,
and (s) 4 C. (From Ref. 91.)
phenylalanine at different temperatures are shown in Figure 25. The chiral

resolution of some amino acids on imprinted molecules is given in Table 3.
The chiral resolution on different types of CSP using CEC is summarized in
Table 4.

FIGURE 25 Chromatograms of the chiral resolution of DL-phenylalanine (at different
temperatures) on CSP obtained by an imprinted L-phenylalanine molecule by CEC using
acetonitrile–water–acetic acid (80 : 10 : 10, v=v=v). (From Ref. 91.)
TABLE 3 Chiral Resolution of Some Amino Acids on Molecularly Imprinted CSPs
Amino acid Imprinted molecule a Rs
DL-Phe L-Phe 1.15 1.74

DL-Phe L-Phe-AN 1.13 1.60
DL-Try L-Try 1.05 0.94
DL-DNS-Leu DNS-L-Leu 1.05 1.04
Note: DNS ¼ dansyl.

Source: Ref. 9.

TABLE 4 Chiral Resolution of Some Racemic Compounds on Different CSPs Using
CEC
Flubufen, dansyl-DL-amino acids Polyterguride 95

N-Derivatized amino acids Cinchona types 101, 102
Bendroflumethiazide Polyacrylamides 103
Benzoin, methylbenzoin, ethylbenzoin, Polymethacrylate 104, 96
isopropylbenzoin, benzoin oxime,
cyclobutyldianilide carbamate,
1,10 -binaphthyl-2,20 -diol, trans-
stilbene oxide, and Trögers’s base
DL-Clomipramine Lactone 105
3,5-Dinitrobenzoyl-DL-alanine a-Naphthylethylamine 105
DL-Phenylalanine, dansyl-DL-leucine L-Phenylalanine, Dansyl-Leucine 106
RS-Propranolol, RS-metoprolol R-Propranolol 107
RS-2-Phenylpropionic acid S(þ)-2-Phenylpropionic acid 108
9.8 MISCELLANEOUS CSP IN TLC

The miscellaneous types of CSP were also used for the chiral resolution of
racemic compounds by thin-layer chromatography (TLC). The CSPs for TLC are
prepared by impregnating the thin layers by a suitable chiral selector. The various
approaches of thin-layer impregnation include the mixing of the chiral selector
with the adsorbent and preparation of thin layers, immersion of a thin-layer plain
plate ascending or descending into the solution of chiral selector, exposing the
thin layer to the vapors of the chiral reagent, spraying of the chiral reagent
solution onto thin layer, and, sometimes, by the reaction of the inert material of
the thin layer with the chiral reagent. Aboul-Enein et al. [109] and Bhushan and
Martens [110] reviewed the chiral resolution on TLC and discussed the use of a
variety of chiral selectors as impregnating reagents for the thin layers. Further-
more, they [109,110] described the use of these impregnating thin layers for the
chiral resolution of some racemic compounds. A brief survey of the impregnating
reagent and their application toward the chiral resolution of different racemic
compounds are given in Table 5.
A combination of TLC and molecular imprinting technique was reported by
Mosbasch in 1994 [122]. One approach of the technique involves noncovalent
prearrangement of functional monomers in the presence of a print molecule prior
to polymerization. After the removal of the print molecules from the resulting
macroporous polymer matrix, the resulting polymer contains recognition sites
which, because of the shape and the arrangement of the functional groups, have

TABLE 5 Chiral Resolution of Some Racemic Compounds on Different CSPs Using
TLC
Amino acids ()-Brucine 111

(1R,3R,5R)-2-Azabicyclo-[3,3,0]-octane-3-carboxylic acid 112
Copper(II)-impregnated chitin and chitosan layers 113
Phenylthiohydantoin (þ)-Tartaric acids, (þ)-ascorbic acid 114
amino acids
Dansyl amino acids (1R,3R,5R)-2-Azabicyclo-[3,3,0]-octane-3-carboxylic acid 115
Poly-L-phenylalanineamide 116
N,N-Di-n-propyl-L-alanine with copper(II) acetate 117
Atropine and L-Aspartic acid 118
colchicine
DL-Penicillamine Copper(II) acetate 119
Lactic acid Copper(II) acetate 120
2-Arylpropionic ()-Brucine 121
acid
affinity for the print molecules. For example, the chiral resolution of
DL-phenylalanine anilide on an imprinted chiral selector was reported by Kriz
et al. [123]. The CSP was prepared by the molecularly imprinted technique L-
phenylalanine anilide and impregnated onto thin-layer plates. Various concentra-
tions of acetic acid in acetonitrile was used as the mobile phase.

As discussed earlier, the miscellaneous types of CSP contain different types of
structure containing various groups and atoms. There are only a few reports
dealing with the determination of chiral recognitions mechanisms on these CSPs.
However, Allenmark et al. [20] attempted to explain the chiral recognition
mechanisms of the separation of amino alcohols, profens, b-blockers, benzodia-
zepinones, and benzothiadiazines on CSP based on N,N-diallyl-(R,R)-tartaric acid
diamide. The authors reported the formation of various types of interaction such
as hydrogen-bonding, dipole–dipole stacking, and charge-transfer complexes
between the CSP and the racemic compounds. In another study, Franco et al.
[7] synthesized nine new quinine carbamate dimers and immobilized them onto
silica gel. The chiral recognition mechanisms were ascertained on these phases
using Fourier transform infrared and x-ray analysis and it was observed that
hydrogen-bonding and p–p interactions are responsible for the chiral resolution.
Therefore, the chiral recognitions on these CSPs depend on the structures of

CSPs and racemic compounds. The chiral resolutions are controlled by different
types of force and interaction such as hydrogen-bondings, p–p interactions,
formation of charge-transfer and inclusion complexes, dipole interactions, and
steric forces. Weak forces such as van der Waals and coordination bondings also
play a crucial role in the chiral resolution on these miscellaneous types of CSP.
The presence of a chiral moiety on the CSP is essential, as it provides the chiral
environment to the racemic compounds. The racemic compounds fit on the chiral
moiety in a different fashion and are stabilized, with different values of binding
energies, through the above-cited forces. As a result of the flow of the mobile
phase, the two enantiomers elute at different retention times and, hence, the chiral
resolution occurs.
9.10 CONCLUSION
In spite of the development of more successful and reliable CSPs (Chaps. 2–8),
these miscellaneous types of CSP have their role in the field of the chiral
resolution also. The importance of these CSPs lies in the fact that they are readily
available, inexpensive, and economic. Moreover, these CSPs can be used for
some specific chiral resolution purpose. For example, the CSP based on the
poly(triphenylmethyl methacrylate) polymer can be used for the chiral resolution
of the racemic compounds which do not have any functional group. The CSPs
based on the synthetic polymers are, generally, inert and, therefore, can be used
with a variety of mobile phases. The development of CSPs based on the
molecularly imprinted technique has resulted in various successful chiral resolu-
tions. The importance and application of these imprinted CSPs lies in the fact that
the chiral resolution can be predicted on these CSPs and, hence, the experimental
conditions can be designed easily without greater efforts. Because of the ease of
preparation and the inexpensive nature of these CSPs, they may be useful and
effective CSPs for chiral resolution. Briefly, the future of these types of CSP,
especially synthetic polymers and polymers prepared by the molecularly
imprinted technique, is very bright and will increase in importance in the near
future.
REFERENCES
1. Lämmerhofer M, Lindner W, J Chromatogr A 741: 33 (1996).
2. Piette V, Lämmerhofer M, Bischoff K, Lindner W, Chirality 9: 157 (1997).
3. Maier NM, Nicoletti L, Lämmerhofer M, Lindner W, Chirality 11: 522 (1999).
4. Lämmerhofer M, Maier NM, Lindner W, Am Lab 30: 71 (1998).
5. Mandl A, Nicoletti L, Lämmerhofer M, Lindner W, J Chromatogr A 858: 1 (1999).
6. Tobler E, Lämmerhofer M, Mancini G, Lindner W, Chirality 13: 641 (2001).
7. Franco P, Lämmerhofer M, Klaus PM, Lindner W, J Chromatogr A 869: 111 (2000).

8. Lämmerhofer M, Lindner W, Recent developments in liquid chromatographic
enantioseparation, in Separation Methods in Drug Synthesis and Purification,
Valko K (Ed.), Elsevier, Amsterdam, Vol. 1, p. 337 (2000).
9. Messina A, Girelli AM, Flieger M, Sinibaldi M, Sedmera P, Cvak L, Anal Chem 68:
1191 (1996).
10. Dondi M, Flieger M, Olsovska J, Polcaro CM, Sinibaldi M, J Chromatogr A 859:
133 (1999).
11. Olsovska J, Flieger M, Bachachi F, Messina A, Sinibaldi M, Chirality 11: 291
(1999).
12. Flieger M, Sinibaldi M, Cvak L, Castellani L, Chirality 6: 549 (1994).
13. Sinibaldi M, Flieger M, Cvak L, Messina A, Pichini A, J Chromatogr A 666: 471
(1994).
14. Padiglioni P, Polcaro CM, Marchese S, Sinibaldi M, Flieger M, J Chromatogr A
756: 119 (1996).
15. Blaschke G, Mempel G, Müller WE, Chirality 5: 419 (1993).
16. Dobashi A, Oka K, Hara S, J Am Chem Soc 102: 7122 (1980).
17. Dobashi Y, Hara S, J Org Chem 52: 2490 (1987).
18. Dobashi A, Dobashi Y, Kinoshita K, Hara S, Anal Chem 60: 1987 (1988).
19. Brain K, Rao KRN, Lloyd MJB, Novel chiral stationary phases, in Chiral
Separations by HPLC, Krstulovic AM (Ed.), Ellis Horwood, Chichester
(1989).
20. Allenmark SG, Andersson S, Möller P, Sanchez D, Chirality 7: 248 (1995).
21. Okabe H, Itabashi Y, Ota T, Kuksis A, J Chromatogr A 829: 81 (1998).
22. Abou-Basha LI, Aboul-Enein HY, Biomed Chromatogr 10: 69 (1999).
23. Bisel P, Schlauch M, Weckert E, Sin KS, Frahm AW, Chirality 13: 89 (2001).
24. Gasparrini F, Misiti D, Villani C, Chirality 4: 447 (1992).
25. Gasparrini F, D’Acquarica I, Villani C, Cimarelli C, Palmieri G, Biomed Chroma-
togr 11: 317 (1997).
26. Vaton-Chanvrier L, Peulon V, Combert JC, Chromatographia 46: 613 (1997).
27. Vaton-Chanvrier L, Combert Y, Combert JC, Chromatographia 54: 31 (2001).
28. Iuliano A, Salvadori P, Felix G, Tetrahedron: Asymm 10: 3353 (1999).
29. Gross B, Schurig V, Lamparth I, Hirsch A, J Chromatogr A 791: 65 (1997).
30. Alamo AD, Sally S, Tiritan ME, Matlin S, Chirality 11: 416 (1999).
31. Akelah A, Sherrington DC, Chem Rev 81: 557 (1981).
32. Farina M, Topics Spectrochem 17: 1 (1987).
33. Okamoto Y, Yashima E, Prog Polym Sci 15: 263 (1990).
34. Okamoto Y, Nakano T, Chem Rev 94: 349 (1994).
35. Yashima E, Maeda K, Okamoto Y, Nature 399: 449 (1999).
36. Allenmark SG, Chromatographic Enantioseparations. Methods and Applications,
Ellis Horwood, Chichester (1988).
37. Nakano T, J Chromatogr A 906: 205 (2001).
38. Okamoto Y, CHEMTECH 177 (1987).
39. Okamoto Y, Hatada K, J Liq Chromatogr 9: 369 (1986).
40. Okamoto Y, Honda S, Okamoto I, Yuki H, Murata S, Noyori R, Takaya H, J Am
Chem Soc 103: 6971 (1981).

41. Schmid R, Antoulas S, Rüttimann A, Schmidt M, Vecchi M, Helv Chim Acta 73:
1276 (1990).
42. Sedo J, Ventosa N, Ruiz-Molina D, Mas M, Molins E, Rovira C, Veciana J, Angew
Chem Int Ed Engl 37: 330 (1998).
43. van Es JJGS, Biemans HAM, Meijer WE, Tetrahedron: Asymm 8: 1825 (1997).
44. Harada N, Saito A, Koumura N, Roe DC, Jager WF, Zijlstra RWJ, de Lange BL,
J Am Chem Soc 119: 7249 (1997).
45. Reetz MT, Merk C, Naberfeld G, Rudolph J, Grebenow N, Goddard R, Tetrahedron
Lett 38: 5273 (1997).
46. Irurre J, Santamari J, Gonzalez-Rego MC, Chirality 7: 154 (1995).
47. Okamoto Y, Mohri H, Nakamura M, Hatada K, J Chem Soc Jpn 435 (1987).
48. Araki A, Inada K, Shinkai S, Angew Chem Int Ed Engl 35: 72 (1996).
49. Okamoto Y, Yashima E, Ishikura M, Hatada K, Polym J 19: 1183 (1987).
50. Nakano T, Taniguchi K, Okamoto Y, Polym J 29: 540 (1989).
51. Ren C, Chen C, Xi F, Nakano T, Okamoto Y, J Polym Sci 31: 2721 (1993).
52. Mohri H, Okamoto Y, Hatada K, Polym J 21: 719 (1989).
53. Tamai Y, Qian P, Matsunaga K, Miyano S, Bull Chem Soc Jpn 65: 817 (1992).
54. Blaschke G, Angew Chem Int Ed Engl 19: 13 (1980).
55. Blaschke G, Bröeker W, Frankel W, Angew Chem Int Ed Engl 25: 830 (1986).
56. Blaschke G, J Liq Chromatogr 9: 341 (1986).
57. Hasegawa S, Sakuri Y, 52nd National Meeting of the Chemical Society of Japan,
Abstract 2J36 (1986).
58. Yoshizako K, Hosoya K, Kimata K, Araki T, Tanaka N, J Polym Sci 35: 2747
(1997).
59. Pino P, Ciardelli F, Lorenzi GP, Natta G, J Am Chem Soc 82: 1487 (1962).
60. Kunieda N, Chakihara H, Kinoshita M, Chem Lett 317 (1990).
61. Kakuchi T, Takaoka T, Yokota K, Polym J 22: 199 (1990).
62. Ute K, Hirose K, Hatada K, Vogl O, Polym Prepr Jpn 41: 41 (1992).
63. Yamagishi A, Tanaka I, Taguchi M, Takahashi M, Chem Commun 1113 (1994).
64. Yashima E, Huang S, Okamoto Y, Chem Commun 1811 (1994).
65. Yashima E, Matsushima T, Nimura T, Okamoto Y, Korea Polym J 4: 139 (1996).
66. Umeda S, Satoh T, Satoh K, Yokota K, Kakuchi T, J Polym Sci 36: 901 (1998).
67. Allenmark SG, Andersson S, J Chromatogr A 666: 167 (1994).
68. Hirayama C, Ihara H, Tanaka K, J Chromatogr 450: 271 (1988).
69. Doi Y, Kiniwa H, Nishikaji T, Ogata N, J Chromatogr 396: 395 (1987).
70. Okamoto Y, Nagamura Y, Fukumoto T, Hatada K, Polym J 23: 1197 (1991).
71. Saigo K, Prog Polym Sci 17: 35 (1992).
72. Saigo K, Nakamura N, Adegawa Y, Noguchi S, Hasegawa M, Chem Lett 337
(1988).
73. Saigo K, Shiwaku T, Hayashi K, Fujioka K, Sukegawa M, Chen Y, Yonezawa N,
Hasegawa M, Hashimoto T, Macromolecules 23: 2830 (1990).
74. Tamai Y, Matsuzaka Y, Oi S, Miyano S, Bull Chem Soc Jpn 64: 2260 (1991).
75. Sinibaldi M, Castellani L, Federici F, Messina A, Girelli AM, Lentini A, Tesarova E,
J Liq Chromatogr 18: 3187 (1995).
76. Kobayashi T, Kakimoto M, Imai Y, Polym J 25: 969 (1993).

77. Chen Y, Lin JJ, J Polym Sci 30: 2699 (1992).
78. Chen Y, Tseng HH, J Polym Sci 31: 1719 (1988).
79. Wulf G, Angew Chem Int Ed Engl 28: 21 (1989).
80. Wulf G, Angew Chem Int Ed Engl 34: 1812 (1995).
81. Remcho VT, Tam ZJ, Anal Chem 72: 248A (1999).
82. Kriz D, Ramstrom O, Mosbach K, Anal Chem 69: 345A (1997).
83. Wulf G, Kemmer R, Vietmeier J, Poll HG, Nouv J Chim 6: 681 (1982).
84. Bartsch RA, Maeda M, (Eds.), Molecular and Ionic Recognition with Imprinted
Polymers, ACS Symposium Series No. 703, Oxford University Press, Washington
DC (1998).
85. Sellergren B, J Chromatogr A 906: 227 (2001).
86. O’Brien TP, Snow NH, Grinberg N, Crocker L, J Liq Chromatogr Relat Technol 22:
183 (1999).
87. Cowie JMG, Polymers—Chemistry and Physics of Modern Materials, Blackie,
Glasgow (1991).
88. Kempe M, Mosbach K, J Chromatogr A 694: 3 (1995).
89. Sellergren B, Shea KJ, J Chromatogr A 690: 29 (1995).
90. Kempe M, Anal Chem 68: 1948 (1996).
91. Lin JM, Nakagama T, Uchiyama K, Hobo T, Biomed Chromatogr 11: 298 (1997).
92. Macaudiere P, Caude M, Rosset R, Tambute A, J Chromatogr Sci 27: 583 (1989).
93. Wilkins SM, Taylor DR, Smith RJ, J Chromatogr A 697: 587 (1995).
94. Schleimer M, Fluck M, Schurig V, Anal Chem 66: 2893 (1994).
95. Sinibaldi M, Vinci M, Federici F, Flieger M, Biomed Chromatogr 11: 307 (1997).
96. Krause K, Chankvetadze B, Okamoto Y, Blaschke G, J Microcol Sep 12: 398
(2000).
97. Peters EC, Lewandowski K, Petro M, Svec F, Frechet MJ, Anal Commun 3: 83
(1998).
98. Lin JM, Nakagama T, Wu XZ, Uchiyama K, Hobo T, Fresenius J Anal Chem 357:
130 (1997).
99. Lin JM, Uchiyama K, Hobo T, Chromatographia 47: 625 (1998).
100. Shibukawa A, Bunseki 131 (1998).
102. Lämmerhofer M, Tobler E, Lindner W, J Chromatogr A 887: 421 (2000).
103. Krause K, Girod M, Chankvetadze B, Blaschke G, J Chromatogr A 837: 51 (1999).
104. Krause K, Chankvetadze B, Okamoto Y, Blaschke G, Electrophoresis 20: 2772
(1999).
105. Pesek JJ, Matyska MT, Menezes SJ Chromatogr A 853: 151 (1999).
106. Schweitz L, Andersson LI, Nilsson S, Anal Chem 69: 1179 (1997).
107. Schweitz L, Spegel P, Nilsson S, Analyst 125: 1899 (2000).
108. Brüggemann O, Freitag R, Whitcombe MJ, Vulfson EN, J Chromatogr A 781: 43
(1997).
531 (1999).
111. Bhushan R, Ali I, Chromatographia 23: 141 (1987).

112. Bhushan R, Martens J, Thiong’o GT, J Pharm Biomed Anal 21: 1143 (2000).
113. Malinowska I, Rozylo JK, Biomed Chromatogr 11: 272 (1997).
114. Bhushan R, Ali I, J Chromatogr 392: 460 (1987).
115. Bhushan R, Martens J, Walbaum S, Joshi S, Parshad V, Biomed Chromatogr 11:
286 (1997).
116. Sinibaldi M, Messina A, Girelli AM, Analyst 113: 1245 (1988).
118. Bhushan R, Ali I, Chromatographia 35: 679 (1993).
119. Bhushan R, Ali I, HPLC-93, 17th International Symposium of Liquid Chromato-
graphy (1993).
120. Cecchi L, Malaspina P, Anal Biochem 192: 219 (1991).
121. Bhushan R, Thiong’o GT, Biomed Chromatogr 13: 276 (1999)
122. Mosbach K, Trends Biochem Sci 19: 9 (1994).
123. Kriz D, Berggen C, Andersson LI, Mosbach K, Anal Chem 66: 2636 (1994).

10
Enantiomeric Separation by the
Chiral Mobile Phase Additives
There are two approaches for the direct chiral resolution by liquid chromato-
graphy: on chiral stationary phases, discussed in Chapters 2–9 and using the
chiral mobile phase additives (CMPAs). In the latter type of approach, the chiral
resolution is carried out by mixing a suitable chiral selector into the mobile phase.
The CMPAs, which vary greatly, offer the advantage of using less expensive
conventional achiral columns. As compared to the chiral columns, the achiral
conventional columns are more rugged, and more efficient and have higher
capacities. Generally, the chiral resolution using CMPAs is carried out on
reversed-phase columns and, therefore, a variety of mobile phases including
acids, bases, and organic solvents can be used without any problem. The chiral
selectors are often identical to those used for covalently bonded CSPs. The most
commonly used chiral selectors of the CMPAs are cyclodextrins, ligand exchan-
gers, proteins, macrocyclic antibiotics, and other miscellaneous types of chiral
molecule. The best CMPAs are those having good solubility in the mobile phase
and low ultraviolet (UV) absorbance. Moreover, the chiral selectors are selected
arbitrarily, which can form diastereoisomers with the racemic compounds to be
resolved. Briefly, in spite of the development of suitable and successful CSPs, few
reports on the chiral resolution by this mode of chromatography exist. In view of
this, the present chapter describes the art of chiral resolution using CMPAs in
various models of liquid chromatography.

10.1 CYCLODEXTRIN MOBILE PHASE ADDITIVES
Cyclodextrins (CDs) are cyclic and nonreducing oligosaccharides and obtained
from starch. The structures and properties of these molecules were discussed in
detail in Chapter 3. These molecules are soluble in aqueous mobile phases and,
hence, most of the chiral resolution was carried out under the reversed-phase
mode. Therefore, cyclodextrins were used frequently as CMPAs for the chiral
resolution of a wide variety of racemic compounds. The nontoxicity, nonvolatile,
poor UV absorbance, stability over a wide range of pHs, and inexpensive natures
of cyclodextrins make them superb CMPAs.
The first enantiomeric separation of mandelic acid using b-cyclodextrin as
CMPA was reported by Debowski et al. [1]. Since then, many enantiomers have
been resolved using cyclodextrins as CMPAs and a few review articles have been
published on this issue [2–6]. Gazdag et al. [7,8] used a-, b-, and g-cyclodextrins
for the chiral resolution of norgestrel, hydrocortisone acetate, triamcinolone
acetonide, prednislone, and hydrocortisone racemic compounds. The mobile
phase used was water–methanol with LiChrosorb RP-18, Nucleosil 5 C18 ,
Hypersil ODS, and Ultrasphere ODS columns. Rizzi and Plank [9] described
the chiral resolution of alanine, glutamine, threonine, valine, leucine, phenylala-
nine, ethylphenylhydantoin, hexabarbitals, oxazepam, and nomifensine using b-
cyclodextrin as the CMPA. Reepmeyer [10] reported the enantiomeric resolution
of thalidomide on Hypersil C18 , Altima C18 and Novapak C18 columns using
b-cyclodextrin as the CMPA. Ameyibor and Stewart [11] reported the chiral
resolution of some b-blockers and profens using b-cyclodextrin as the CMPA.
Similarly, b-cyclodextrin was used as the mobile phase additive for the chiral
resolution of a variety of racemic compounds [12–18]. The application of a-, b-,
and g-cyclodextrins as CMPAs for the chiral resolution of different compounds is
summarized in Table 1. To show the nature of the chiral resolution by this model
of chromatography, the chromatograms of the chiral resolution of thalidomide on
Prodigy C18 column using b-cyclodextrin as the mobile phase additive are shown
in Figure 1.
The chiral resolution using cyclodextrins as mobile phase additives is also
controlled by a number of chromatographic parameters as in case of CSPs. The
chiral resolution occurred by the formation of diastereoisomeric inclusion
complex formation and, hence, the composition of the mobile phase, pH,
concentration of cyclodextrins, and temperature are the most important control-
ling parameters.
The chiral resolution is optimized by adjusting the concentrations of buffers
and organic modifiers [7–11]. Ameyibor and Stewart [11] studied the chiral
resolution of some drugs using different ratios of 0.1% trifluoroacetic acid and
acetonitrile. The results of this finding are summarized in Table 2. It is clear from
this table that the 98 : 2 ratio of 0.1% trifluoroacetic acid and acetonitrile is the

TABLE 1 Chiral Resolution of Some Racemic Compounds Using Cyclodextrins as the
Mobile Phase Additives
Racemic compound Cyclodextrins Ref.
Aminomethyl benzodiaxane Carboxymethyl b-CD 19

derivative
Barbituric acid derivatives b-, DM-b-, TM-b-CDs 20, 21
Benzoin b-, TM-b-CDs 22–24
1,1-Binaphthyl-2-20 -diyl hydrogen b-, TM-b-CDs 25
phosphate
Brompheniramine b-CD 24
Budesonide b-, g-CDs 8, 26, 27
5-Butyl-1-methyl-5-phenylbarbituric TM-b-CD 23
acid
Camphene a-CD 28
Chlorpheniramine hydrogen Methylated b-CD 29
maleate chlorthalidone
Chlorthalidone b-CD 9, 30, 31
Cyclobarbital b-, DM-b-CDs 32
Dansyl amino acids b-, TM-b-, g-CDs 9, 25, 33–35
Ethotoin b-CD 36
Ephedrine CE-b-CD 19
Ethyl mandelate DM-b-, TM-b-, 22, 23, 32
AC-b-CDs
1-Ferrocenyl-ethanol b-, TM-b-CDs 25, 37
Flumecinol b-, g-CDs 7
Glutethimide b-, TM-b-CDs 22, 38
Glycyl-DL-phenylalanine b-CD 29
Heptobarbital b-, DM-b-CDs 32
Hexobarbital CE-b-, CM-b-, DM-b-, 9, 19, 22, 23, 36
TM-b-CDs
Hydantoins b-, DM-b-CDs 15, 21
5-(m-Hydroxy phenyl)-5- b-CD 36
phenylhydantoin
5-( p-Hydroxy phenyl)-5- b-CD 36, 39
phenylhydantoin
Isosalsoline b-CD 40
Laudanosoline b-CD 40
Lorazepam b-CD 41
Mandelic acid b-CD 1, 32
Mephenytoin b-, TM-b-CDs 38
Methyl mandelate b-, AC-b-, DM-b-, 22, 23, 32, 42
TM-b-CDs
Methylphenobarbital b-CD 22, 23, 36, 38
1-Methyl-5-phenyl-propylbarbital TM-b-CD 22
(continued )

TABLE 1 Continued.
Racemic compound Cyclodextrins Ref.
N-Methylsalsolinol b-CD 43
Morsuxamide b-, TM-b-CDs 38
Nomifensine b-CD 24
Norgesterl g-CD 7, 8, 26
Oxazepam b-CD 30, 41
a-Pinene a-CD 18, 28, 44
b-Pinene a-CD 28
Propranolol b-CD 29
Pseudoephedrine b-CD 45
Salsolinol b-CD 43
trans-Sobrerol b-CD 46
Terbutaline b-CD 30, 31
Tetrahydro-papaveroline b-CD 40
Thalidomide b-CD 10
Thiamylal b-CD 36
Trimeprazine b-CD 24, 47
b-Blocker and profens b-CD 11
Trimipramine b-CD 12
Doxazosin b-, CM-b-CDs 13
Chlorthalidone b-CD 14
Oxazolidone a-, b-, g-CDs 16
Naproxen Methyl-b-CD 17
Abbreviations: AC, peracetylated; CE, carboxyethyl; CM, carboxymethyl; DM, heptakis(2,6-di-O-

methyl); TM, heptakis(2,3,6-tri-O-methyl).
best combination for the chiral resolution of all drugs studied. Moreover, it can be
concluded from Table 2 that the resolution decreased by increasing the amount of
acetonitrile. The effect of organic modifiers on the chiral resolution was also
studied [7–11]. The most important modifiers used were methanol, ethanol, 2-
propanol, acetonitrile, and tetrahydrofuran. A very interesting study on the effect
of these organic modifiers was carried out by Gazdag et al. [7] and the results are
shown in Figure 2. It may be concluded from this figure that the resolution
increased by increasing the amount of these organic modifiers. The same authors
[8] also studied the effect of the ionic strength of sodium perchlorate on the chiral
resolution of norgestrel, budesonide, and flumecinol (Fig. 3). Figure 3 indicates
the small effect of the ionic strength on the chiral resolution.
The concentration of cyclodextrins is also very important for optimizing the
chiral resolution. Some reports have been published on this issue [7–14,45].
Mularz et al. [45] studied the effect of the concentration of b-cyclodextrin
on the chiral resolution of ephedrine and pseudoephedrine. The authors reported

FIGURE 1 Chromatograms of the chiral resolution of thalidomide on the Prodigy C18
column using phosphate buffer (10 mM, pH 4.0)–ethanol (95 : 5, v=v) as the mobile phase
containing b-cyclodextrin (20 mM) as the CMPA. (From Ref. 10.)
an increase in enantioselectivity by increasing the concentration of b-cyclodex-

trin. Similarly, Reepmeyer [10] studied the effect of the concentration of b-
cyclodextrin on the chiral resolution of thalidomide enantiomers and the author
reported an increase in chiral resolution by increasing the amount of cyclodextrin.
In one of the studies, Gazdag et al. [7] carried out the chiral resolution of
norgestrel, hydrocortisone, hydrocortisone acetate, triamcinolone acetonide, and
prednislone. The authors reported the decrease in the chiral resolution of these
drugs by increasing the concentration of cyclodextrin. The effect of the concen-
tration of the cyclodextrin is shown in Figures 4a and 4b.
The effect of pH on the chiral resolution in this type of chromatography is
also studied [8,13,14]. The different trends of pH on the chiral resolution were
observed. For example, the effect of pH on the chiral resolution of oxazosin [13]
and chlorthalidone [14] is shown in Figures 5a and 5b. It is clear from these
figures that the chiral resolution first increases and then decreases.

TABLE 2 Chiral Resolution of Some Drugs Using Different Ratios of 0.1%
Trifluoroacetic Acid (TFA) and Acetonitrile (ACN) Containing b-Cyclodextrin as the
CMPA on an Octadecylsilane Column
Mobile phase (v=v)
Racemic compound TFA ACN k Rs
Lorazepam 98 2 6.04 1.05

96 4 6.60 1.05
94 6 7.37 1.02
92 8 6.54 1.00
90 10 7.13 0.90
Temazepam 98 2 8.58 1.34
96 4 8.25 1.25
94 6 7.23 1.14
92 8 7.42 1.10
90 10 7.37 1.00
Oxazepam 98 2 3.79 1.97
96 4 4.66 1.90
94 6 4.19 1.74
92 8 4.60 1.74
90 10 4.11 1.65
Chlorthalidone 98 2 5.79 1.78
96 4 nr nr
94 6 nr nr
92 8 nr nr
90 10 nr nr
Note: nr ¼ not resolved.

Source: Ref. 11.
10.2 LIGAND-EXCHANGER MOBILE PHASE

ADDITIVES
The ligand exchangers were also used as mobile phase additives for the chiral
resolution in liquid chromatography [48,49]. For the first time, LePage et al. [50]
used L-2-alkyl-4-octyldiethylenetriamine with Zn(II) as the mobile phase additive
for the chiral resolution of dansyl amino acids on the octylsilyl (C8 )-bonded
phase. Furthermore, the same group [51] extended their work for the chiral
resolution of amino acids and amine using different chiral mobile phase additives
such as L-propyl-N-octylamine with Ni(II). Later, Gil-Av et al. [52,53] used
ligand exchangers [D- or L-proline-Cu(II) complex] as the CMPAs for the
enantiomeric separation of amino acids. Since then, the chiral resolution of a

FIGURE 2 Effect of the organic solvents on the enantioselectivity of norgestrel [(1) L-
and (2) D-enantiomers]: (s) methanol, (w) ethanol, (d) 2-propanol, (þ) acetonitrile, and
(n) tetrahydrofuran. (From Ref. 7.)
variety of racemic compounds was carried out using this approach [54–58]. The
application of ligand exchangers as the mobile phase additives for the chiral
resolution is summarized in Table 3. The typical chromatograms of the chiral
resolution of dansyl amino acids using the Cu(II) complex of (S,S)-N,N-2-
hydroxypropyl-phenylalaninamide as the mobile phase additive are shown in
Figure 6.
The effect of various chromatographic parameters, as in the case of
cyclodextrin mobile phase additives, on the chiral resolution of racemic
compounds using ligand exchangers as CMPAs has also been studied. Galaverna
et al. [55] studied the effect of the pH of the mobile phase and the concentration
of mobile phase additives (copper complexes of amino acid amides). These
findings are shown in Figure 7 (pHs) and Figure 8 (concentration of CMPAs). It
can be concluded from these figures that the chiral resolution is affected by
changing the pH and the concentration of the mobile phase additive. Similarly,
Galaverna et al. [57,58] studied the effect of pH, concentration of CMPA, ionic
strength of the mobile phase, and the eluent polarity on the chiral resolution of

FIGURE 3 Effect of sodium perchlorate on the chiral resolution of norgestrel [(I) D- and
(II) L-enantiomers] and budenoside [(III) R- and (IV) S-enantiomers] on Hypersil ODS
column using methanol–water (1 : 1, v=v) as the mobile phase containing g-cyclodextrin
(10 mM) as the CMPA. (From Ref. 8.)
amino acids. The authors reported different trends of the chiral resolution of
various amino acids. In a very interesting study, Marchelli and co-workers [56]
studied the effect of the structures of CMPA. The authors studied the effect of S,S
and R,S configurations of N,N-2-hydroxypropyl-phenylalaninamide (Table 4).
The authors reported the best separation with the S,S configuration as the CMPA.
10.3 PROTEIN MOBILE PHASE ADDITIVES

Proteins have also been used as CMPAs for chiral resolution by liquid chromato-
graphy. Bovine serum albumin (BSA) and a1 -acid glycoproteins (AGP) were
investigated as CMPAs. Allenmark et al. [87] used BSA protein as the CMPA for

FIGURE 4 Effect of the concentrations of cyclodextrins CMPAs (a) on the chiral
resolution of thalidomide on the Prodigy C18 column using phosphate buffer (10 mM,
pH 4.0)–ethanol (95 : 5, v=v) as the mobile phase (from Ref. 10) and (b) on the chiral
resolution of norgestrel on the LiChrosorb RP-18 column using water–methanol (3 : 4,
v=v) as the mobile phase (from Ref. 7).

FIGURE 5 Effect of the pH on the chiral resolution of (a) doxazosin on Nova-Pak C8
column using methanol–20 mM sodium dihydrogen phosphate (15.3 : 50, v=v) as the
mobile phase containing carboxymethyl b-cyclodextrin (15 mM) as the CMPA (from Ref.
13), (e) first and (u) second eluted enantiomers, and (b) of chlorthalidone on the
LiChrosphere C18 column using methanol–0.1 M sodium phosphate buffer (25 : 75, v=v) as
the mobile phase containing b-cyclodextrin (10 mM) as the CMPA and triethylamine
(10 mM) as the mobile phase modifier (from Ref. 14).

TABLE 3 Chiral Resolution of Some Racemic Compounds Using Ligand Exchangers
as the Mobile Phase Additives
Racemic compound Ligand exchangers Ref.
Amino acids Cu(II)–L- or D-proline 52, 53

Cu(II)–L-phenylalanine 59
Cu(II)–L-aspartyl-L-phenylalanine methyl ester 60
Cu(II)–L-aspartylcyclohexyl amide 61–63
Cu(II)–N-( p-toluenesulphonyl)-L-phenylalanine 64, 65
Cu(II)–N-( p-toluenesulphonyl)-D-phenylglycine 66, 67
Cu(II)–N,N-dialkyl-L-amino acids 68
Cu(II)-Di-n-propyl-L-alanine 69–71
Cu(II)–N,N,N,N-tetramethyl-(R)-propane1,2-diamine 72
Cu(II)-N-methyl-L-phenylalanine, N,N-dimethyl-L- 73
phenylalanine
Cu(II)–(R,R)-tartaric acid mono-n-octylamine 74
Cu(II)–amino acid amides 55
Cu(II)–terdentate ligands 57
Cu(II)–(S,S)-N,N-bis(phenylalanyl)-ethanediamine, 58
(S,S)-N,N-bis(methylphenylalanyl)-ethanediamine
Dansyl amino acids Zn(II), Cd(II), Ni(I), Cu(II), Hg(II) complexes of 51, 75
L-2-alkyl-4-n-octyldiethylene triamine
Ni(II)–L-propyl-n-octylamine, L-propyl-n- 75, 76
dodecylamide
Cu(II)–L-proline 77–79
Cu(II)–L-arginine 78
Cu(II)–L-histidine, L-histidine methyl ester 78, 80–82
Cu(II)–n-(R)- or N-(S)-2-hydroxypropyl(S)- 56
phenylalaninamide
Cu(II)–terdentate ligands 57
Hydroxy acids Cu(II)–L-phenylalanine 83, 84
Cu(II)–N-methyl-L-phenylalanine N,N-dimethyl-L- 73
phenylalanine
Cu(II)–(S)-phenylalaninamide 85
Cu(II)–L-proline 84
Amino alcohols Cu(II)–(R,R)-tartaric acid mono-n-octylamide 74
Cu(II)–9-(3,4-dihydroxybutyl)guanine 86
the chiral resolution of acidic drugs. Hermansson resolved the enantiomers of

disopyramide using AGP as the CMPA [88]. Hedeland et al. [89] used cellobio-
hydrolase I as CMPA for the chiral resolution of propranolol enantiomers. The
high absorbance of the proteins in the UV region makes them unpopular and,
therefore, the proteins could not be used frequently as the CMPAs.

FIGURE 6 Chromatograms of the chiral resolution of dansyl amino acids on the
Radialpak C18 column using water–acetonitrile (80 : 20, v=v) as the mobile phase contain-
ing the Cu(II) complex of (S,S)-2-hydroxypropyl-(S)-phenylalaninamide as the CMPA. I:
DNS–Glu; II: DNS–a-Nbu; III: DNS–Ser. (From Ref. 56.)
10.4 MACROCYCLIC GLYCOPEPTIDE ANTIBIOTIC

MOBILE PHASE ADDITIVES
Although the macrocyclic glycopeptide antibiotic CSPs are very effective for
the chiral resolution of many racemic compounds, their use as chiral mobile
phase additives is very limited. Only a few reports are available on this mode of
chiral resolution. It is interesting to note that these antibiotics absorb UV
radiation; therefore, the use of these antibiotics as the CMPAs is restricted.
However, Armstrong et al. used vancomycin as the CMPA for the chiral
resolution of amino acids by thin-layer chromatography, which will be discussed
in Section 10.7.
10.5 MISCELLANEOUS CHIRAL MOBILE PHASE

ADDITIVES
Other chiral molecules were also used as CMPAs. Lämmerhofer and Lindner [90]
resolved the enantiomers of N-derivatized amino acids (e.g., 3,5-dinitrobenzoyl,

FIGURE 7 Effect of pH on the chiral resolution of a-aminobutyric acid on the Spherisorb
ODS-2 column using water as the mobile phase containing (a) Cu(II)–L-proline (4 mM)
and (b) Cu(II)–L-methylphenyl alanine as CMPAs separately and respectively (from
Ref. 55).
3,5-dinitrobenzyloxycarbonyl, 2,4-dinitrophenyl, and 9-fluorenylmethoxycarbo-

nyl amino acids) on the Hypersil ODS-3 column in combination with a quinine
carbamate-type chiral ion-pair agent which was added to aqueous and non-
aqueous buffered mobile phases, respectively.

FIGURE 8 Effect of the concentration of (a) Cu(II)–L-methylphenyl alanine and (b)
Cu(II)–L-proline on the chiral resolution of a-aminobutyric acid on the Spherisorb ODS-2
column using water as the mobile phase (from Ref. 55).

TABLE 4 Effect of the Structure of S,S and R,S Configurations of N,N-2-
hydroxy-propyl-phenylalaninamide CMPA on the Chiral Resolution of Some Dansyl
Amino Acids
S,S Configuration R,S Configuration
Dansyl amino acid k a k a
Glutamine 1.28 1.62 0.29 2.41

Aspragine 2.21 1.48 0.32 2.38
Serine 7.28 1.41 1.65 2.10
Threonine 6.93 1.77 1.58 1.97
Valine 14.07 1.37 5.03 0.73
nor-Valaine 15.28 1.31 8.88 0.71
Leucine 20.10 1.82 11.97 0.84
nor-Leucine 25.93 1.41 16.38 0.66
Methionine 29.14 1.43 7.76 0.87
Phenylalanine 32.14 1.09 17.44 0.80
Source: Ref. 56.
10.6 CHIRAL MOBILE PHASE ADDITIVES IN SFC

AND CEC
In addition to high-performance liquid chromatography (HPLC), the chiral
resolution using CMPAs was also carried out by supercritical fluid chromato-
graphy (SFC) [91] and capillary electrochromatography (CEC) [92–98]. Salvador
et al. [91] used dimethylated b-cyclodextrin as the mobile phase additive on
porous graphite carbon as the solid phase for the chiral resolution of tofizopam,
warfarin, a benzoxazine derivative, lorazepam, flurbiprofen, temazepam,
chlorthalidone, and methyl phehydantoin by SFC. The authors also studied the
effect of the concentration of dimethylated b-cyclodextrin, the concentration of
the mobile phase, the nature of polar modifiers, outlet pressure, and the column
temperature on the chiral resolution.
Wang and Porter [92] resolved the enantiomers of oxazepam, lorazepam,
and temazepam using b-cyclodextrin as the CMPA by CEC. The authors varied
separation parameters such as voltage and mobile phase. Wei et al. [93] resolved
the enantiomers of phenylephrine and synephrine by varying the concentration of
b-cyclodextrin (CMPA), pH, electrolyte concentration, and temperature. Lelievre
et al. [99] separated the enantiomers of chlorthalidone using hydroxypropyl
b-cyclodextrin as the CMPA. Lämmerhofer and Lindner [90] resolved the
enantiomers of N-derivatized amino acids (e.g., 3,5-dinitrobenzoyl, 3,5-dinitro-
benzyloxycarbonyl, 2,4-dinitrophenyl, and 9-fluorenylmethoxycarbonyl amino

FIGURE 9 Electropherograms of the chiral resolution of (I) 1-cyanobenz[ f ]isoindole
(CBI)–selenomethionine and (II) CBI–selenoethionine enantiomers using a mixture of
boric acid (10 mM) and phosphate buffer (30 mM, pH 7) as the mobile phase containing b-
cyclodextrin (30 mM) and taurodeoxycholic acid (50 mM) as CMPAs with sodium dodecyl
sulfate (50 mM) as the mobile phase modifier (from Ref. 97).
acids) by enantioselective ion-pair formation and packed CEC using RP-18 silica
particles (Hypersil ODS-3 mm packed capillary column, 335 mm) using a quinine
carbamate-type chiral ion-pair agent which was added to aqueous and nonaqu-
eous buffered mobile phases respectively.
Ban et al. [94] used b-cyclodextrin as the CMPA for the chiral resolution of
racemorphan enantiomers by micellar electrokinetic chromatography (MEKC).
The authors investigated the effect of buffer pH, concentration of mobile phase
additives, and the detection wavelength. Similarly, Lucangioli et al. [95] resolved
the enantiomers of sertraline hydrochloride and related substances using b-
cyclodextrin as the CMPA by MEKC. Garcia-Ruiz et al. [96] used carboxy-
methylated and permethylated b-cyclodextrins as CMPAs for the chiral resolution
of polychlorinated biphenyls by electrokinetic chromatography (EKC). For a
reference, the chromatograms of the chiral resolution of seleno amino acid
derivatives by MEKC are shown in Figure 9.
10.7 CHIRAL MOBILE PHASE ADDITIVES IN TLC

The approach of CMPAs has also been used in thin-layer chromatography (TLC)
for the chiral resolution of a variety of racemic compounds [100–110]. Lepri et al.
[104,105] used BSA as a mobile phase additive for the chiral resolution of dansyl
amino acids and other drugs by TLC. Armstrong et al. [101,102] used unde-
rivatized and hydroxyethyl and hydroxypropyl b-cyclodextrins for the chiral
resolution of dansyl amino acids, alkaloids, and other compounds. Aboul-Enein

et al. [103] used b-cyclodextrin for the chiral resolution of aminoglutethimide,
acetylaminoglutethimide, and dansyl aminoglutethimide. Armstrong and Zhou
[106] used vancomycin as CMPA for the chiral resolution of dansyl amino acids,
6-aminoquinolyl-N-hydroxysuccinimidyl carbamate-derivatized amino acids, and
other racemic drugs on TLC under the reversed-phase mode. To stabilize the TLC
plates, sodium chloride was added into the mobile phase. Chemically bonded
diphenyl-F reversed-phase plates were used and obtained from Whatman Chemi-
cal Separation Division Inc. The mobile phase comprised different ratios of
acetonitrile, sodium chloride (0.6 M), and 1% triethyl ammonium acetate buffer
(pH 4.1).
The effect of various TLC parameters such as concentration of b-cyclodex-
trins, the pH of the mobile phase, and the concentration of organic modifiers were
also studied by different workers [100–103]. Armstrong et al. [101,102] observed
an increase in the enantioselectivity by increasing the amount of b-cyclodextrins
(Figs. 10a and 10b). Similar behavior of the chiral resolution of aminoglutethi-
mide, acetylaminoglutethimide, and dansyl aminoglutethimide enantiomers was
observed by increasing the concentration of b-cyclodextrins in mobile phase by
Aboul-Enein et al. [103] (Fig. 10c). Armstrong et al. [101] studied the effect of
the concentration of acetonitrile on the chiral resolution of dansyl serine amino
acid (Fig. 11a). Figure 11a indicates that no chiral resolution was observed at
lower and higher concentrations of acetonitrile. However, the best resolution
occurred using 20–40% acetonitrile. Aboul-Enein et al. [103] reported no marked
effect of the concentration of acetonitrile on the chiral resolution of aminoglu-
tethimide. However, the authors reported the best resolution of this compound
using 70% methanol as the organic modifier (Fig. 11b). In the same study, the
authors [103] also studied the effect of pH on the chiral resolution of aminoglu-
tethimide. The effect of pH on the chiral resolution of aminoglutethimide is
presented in Figure 12. It is interesting to observe from this figure that the higher
resolution occurred at pH 2.5 and 9.0, whereas the lower resolution was observed
at pH 7.0 and 12.0.

It is a well-known fact that the chiral environment is essential in liquid
chromatography for the chiral resolution. In this modality of chromatography,
the chiral situation is provided by the CMPAs. Basically, the chiral recognition
mechanisms on this type of liquid chromatography are similar to those on CSPs.
The differences between the chiral recognition mechanisms on these models (i.e.,
CMPAs and CSPs) lies in the fact that the diastereoisomeric complexes of the
racemic compounds are formed in the mobile phase (CMPAs), whereas these
complexes are formed on stationary phase in case of CSPs mode. These

FIGURE 10 Effect of the concentrations of cyclodextrins CMPAs in TLC (a) of b-
cyclodextrin on the chiral resolution of dansyl-DL-glutamic acid using acetonitrile–water
(30 : 70, v=v, saturated with urea) as the mobile phase, (s) D- and (d) L-enantiomers (from
Ref. 101), (b) of hydroxypropyl-b-cyclodextrin on the chiral resolution of dansyl-DL-
leucine (circles) and dansyl-DL-valine (triangles) using aqueous triethylamine as the
mobile phase (from Ref. 102), and (c) of hydroxy trimethylpropyl ammonium-b-cyclo-
dextrin on the chiral resolution of RS-aminoglutethimide using water and acetonitrile
mixture as the mobile phase (from Ref. 103).
diastereoisomeric complexes possess different physical and chemical properties

and, therefore, are separated on some solid support (achiral column). The
formation of diastereoisomeric complexes depends on the type and nature of
the CMPAs and analytes. In the case of cyclodextrins, inclusion complexes are

FIGURE 11 Effect of the concentrations of organic modifiers in TLC (a) of acetonitrile
on the chiral resolution of dansyl-DL-serine, (s) D- and (d) L-enantiomers (from Ref.
101), and (b) of methanol on the chiral resolution of RS-aminoglutethimide (from
Ref. 103).

FIGURE 12 Effect of pH on the chiral resolution of RS-aminoglutethimide by TLC using
water and acetonitrile mixture as the mobile phase containing hydroxy trimethylpropyl
ammonium-b-cyclodextrin as the CMPA (from Ref. 103).
formed, whereas in case of other CMPAs, simple chiral diastereoisomeric

complexes are formed. Again, as in case of CSPs, the diastereoisomeric
complexes formation is controlled by a number of interactions such as p–p
complexation, hydrogen-bondings, dipole–dipole interactions, ionic bindings,
and steric effects.
Lämmerhofer and Lindner [90] explained the chiral resolution of N-
derivatized amino acids by CEC. The authors explained the formation of the
transient diastereomeric ion-pairs between negatively charged analyte enantio-
mers and a positively charged chiral selector by multiple intermolecular interac-
tions which might be differentially adsorbed to the ODS stationary phase.
Furthermore, they claimed that the enantioseparation was achieved because of
different observed mobilities of the analyte enantiomers originating from different
ion-pair formation rates of the enantiomers and=or differential adsorption of the
diastereoisomeric ion-pairs to the ODS stationary phase [90].

10.9 CONCLUSION
It is interesting to note that the first report on the chiral resolution was published
using the chiral mobile phase additive approach. Later, the CSPs are developed
and, because of certain advantages, this approach is common nowadays. Of
course, the chiral resolution by this approach is inexpensive, as it involves the use
of inexpensive achiral columns and, therefore, it is considered an effective
method of the chiral resolution. The main advantage of this method lies in the
fact that a wide variety of mobile phases can be used and hence the chiral
resolution can be obtained easily. However, this approach is not attractive because
of some serious drawbacks and limitations. The serious weakness of this method
is the wastage of the costly chiral selectors. Sometimes the CMPAs, especially
proteins, absorb in the UV range, creating problems in detection. Moreover, the
resolved enantiomers are obtained in the form of diastereoisomeric complexes
and cannot be used directly for further pharmacological studies. Although this
approach is not attractive yet, it can be used as a mean of an inexpensive method
for chiral resolution.
REFERENCES
1. Debowski J, Sybilska D, Jurczak J, J Chromatogr 237: 303 (1982).
2. Sybilska D, Zukowski J, Cyclodextrin additives, in Chiral Separations by HPLC:
Applications to Pharmaceutical Compounds, Krstulovic AM (Ed.), Ellis Horwood,
New York (1989).
3. Camilleri P, Biomed Chromatogr 5: 128 (1991).
4. Husain N, Warner IM, Am Lab 80 (1993).
5. Han SM, Biomed Chromatogr 11: 259 (1997).
6. Jakubetz H, Juza M, Schurig V, GIT Labor Fachzeitschr 42: 479 (1998).
7. Gazdag M, Szepesi G, Huszar L, J Chromatogr 351: 128 (1986).
9. Rizzi AM, Plank C, J Chromatogr 557: 199 (1991).
10. Reepmeyer JC, Chirality 8: 11 (1996).
11. Ameyibor E, Stewart JT, J Liq Chromatogr 20: 855 (1997).
12. Ameyibor E, Stewart JT, J Liq Chromatogr 20: 3107 (1997).
13. Owens P, Fell AF, Coleman MW, Berridge JC, Chirality 9: 184 (1997).
14. Herraez-Hernandez R, Campins-Falco P, J Chromatogr B 740: 169 (2000).
15. Yao TW, Zeng S, Biomed Chromatogr 15: 141 (2001).
16. Lepri L, Boddi L, Del Bubba M, Cincinelli A, Biomed Chromatogr 15: 196 (2001).
17. Healy LO, Murrihy JP, Tan A, Cocker D, McEnery M, Glennon JD, J Chromatogr A
924: 459 (2001).
18. Bielejewska A, Duszczyk K, Sybilska D, J Chromatogr A 931: 81 (2001).
19. Szeman J, Ganzler K, J Chromatogr A 668: 509 (1994).
20. Zukowski J, Sybilska D, Bojarski J, Szejtli J, J Chromatogr 436: 381 (1988).
21. Zukowski J, Sybilska D, Bojarski J, J Chromatogr 364: 225 (1986).

22. Pawlowska M, J Liq Chromatogr 14: 2273 (1991).
23. Pawlowska M, Chirality 3: 136 (1991).
24. Cooper AD, Jefferies TM, Gaskell RM, Anal Proc 29: 258 (1992).
25. Hu R, Takeuchi T, Jin JY, Miwa T, Anal Chim Acta 259: 173 (1994).
27. Szepesi G, Gazdag M, J Pharm Biomed Anal 6: 623 (1988).
28. Zukowski J, Pawlowska M, J High Resolut Chromatogr 16: 505 (1993).
29. Clark BJ, Mama JE, J Pharm Biomed Anal 7: 1883 (1989).
30. Walhagen A, Edholm LE, Chromatographia 32: 215 (1991).
31. Wannman H, Walhagen A, Erlandsson P, J Chromatogr 603: 121 (1992).
32. Zukowski J, Nowakowski R, J Liq Chromatogr 12: 1545 (1989).
33. Shimada K, Hirakata K, J Liq Chromatogr 15: 1763 (1992).
34. Takeuchi T, Nagae N, J Chromatogr 595: 121 (1992).
35. Takeuchi T, Miwa T, Anal Chim Acta 292: 275 (1994).
36. Eto S, Noda H, Noda A, J Chromatogr 579: 253 (1992).
37. Takeuchi T, Miwa T, J Chromatogr A 666: 439 (1994).
38. Sybilska D, Bielejewska A, Nowakowski R, Duszczyk K, Jurczak J, J Chromatogr
625: 349 (1992).
39. Eto S, Noda H, Minemoto M, Noda A, Mizukami Y, Chem Pharm Bull 39: 2742
(1991).
40. Stammel W, Woesle B, Thomas H, Chirality 7: 10 (1995).
41. Fell AF, Noctor TAG, Mama JE, Clark BJ, J Chromatogr 434: 377 (1988).
42. Pawlowska M, Zukowski J, J High Resolut Chromatogr 14: 138 (1991).
43. Deng Y, Maruyama W, Yamamura H, Kawai M, Dostert P, Naoi M, Anal Chem 68:
2826 (1996).
44. Zukowski J, J High Resolut Chromatogr 14: 361 (1991).
45. Mularz EA, Cline-Love LJ, Petersheim M, Anal Chem 60: 2751 (1988).
46. Italia A, Schiavi M, Ventura P, J Chromatogr 503: 266 (1990).
47. Cooper AD, Jefferies TM, J Pharm Biomed Anal 8: 847 (1990).
48. Nimura N, Ternary complexation, in Chiral separations by HPLC: Applications to
Pharmaceutical Compounds, Krstulovic AM (Ed.), Ellis Horwood, New York,
p. 107 (1989).
49. Clark BJ, Separations of enantiomeric compounds by chiral selectors in the mobile
or solvent phase, in A Practical Approach to Chiral Separations by Liquid
Chromatography, Subramanian G (Ed.), VCH, Weinheim, p. 311 (1994).
50. LePage J, Lindner W, Davies G, Seitz D, Karger BL, J Chromatogr 185: 323 (1979).
51. LePage J, Lindner W, Davies G, Seitz D, Karger BL, Anal Chem 51: 433 (1979).
52. Hare PE, Gil-Av E, Science 104: 1226 (1979).
53. Gil-Av E, Tishbee A, Hare P, J Am Chem Soc 102: 5115 (1980).
54. Davankov VA, Kurganov AA, Ponomareva TM, J Chromatogr 452: 309 (1988).
55. Galaverna G, Corradini R, de Munari E, Dossena A, Marchelli R, J Chromatogr A
657: 43 (1993).
56. Marchelli R, Corradini R, Bertuzzi T, Galaverna G, Dossena A, Gasparrini F,
Galli B, Villani C, Misti D, Chirality 8: 452 (1996).
57. Galaverna G, Corradini R, Dossena A, Chiavaro E, Marchelli R, Dallavalle F,
Folesani G, J Chromatogr A 829: 101 (1998).

58. Galaverna G, Corradini R, Dallavalle F, Folesani G, Dossena A, Marchelli R,
J Chromatogr A 922: 151 (2001).
59. Oelrich E, Preusch H, Wilhelm E, J High Resolut Chromatogr 3: 269 (1980).
60. Gilon C, Lesham R, Tapuhi Y, J Am Chem Soc 101: 7612 (1979).
61. Gilon C, Lesham R, Greushka E, Anal Chem 52: 1206 (1980).
62. Gilon C, Lesham R, Greushka E, J Chromatogr 203: 365 (1981).
63. Greushka E, Lesham R, J Chromatogr 255: 41 (1983).
64. Nimura N, Suzuki T, Kasahara Y, Kinoshita T, Anal Chem 53: 1380 (1981).
65. Nimura N, Toyama A, Kinoshita T, J Chromatogr 234: 482 (1982).
66. Nimura N, Toyama A, Kasahara Y, Kinoshita T, J Chromatogr 239: 671 (1982).
67. Nimura N, Toyama A, Kinoshita T, J Chromatogr 316: 547 (1984).
68. Weinstein S, Angew Chem Suppl 96: 425 (1982).
69. Weinstein S, Engel M, Hare P, Anal Biochem 121: 370 (1982).
70. Weinstein S, Weiner S, J Chromatogr 303: 244 (1984).
71. Weinstein S, Grinberg N, J Chromatogr 318: 117 (1985).
72. Kurganov A, Davankov V, J Chromatogr 218: 559 (1981).
73. Wernicke R, J Chromatogr Sci 23: 39 (1985).
74. Lindner WF, Hirschbock I, J Liq Chromatogr 9: 551 (1986).
75. Lindner WF, LePage J, Davies G, Seitz D, Karger BL, J Chromatogr 185: 323
(1979).
76. Tapuchi Y, Miller N, Karger BL, J Chromatogr 205: 325 (1981).
77. Lam S, Chow F, J Liq Chromatogr 3: 1579 (1980).
78. Lam S, Chow F, Karmen A, J Chromatogr 199: 295 (1980).
79. Lam S, J Chromatogr 234: 483 (1982).
80. Lam S, Karmen A, J Chromatogr 239: 451 (1982).
81. Lam S, Karmen A, J Chromatogr 289: 339 (1984).
82. Lam S, J Chromatogr Sci 22: 416 (1984).
83. Klemisch W, von Hodenberg A, Vollmer K, J High Resolut Chromatogr 4: 535
(1981).
84. Horikawa R, Sakamoto H, Tanimura T, J Liq Chromatogr 9: 537 (1986).
85. Galaverna G, Panto F, Dossena A, Marchelli R, Bigi F, Chirality 7: 331 (1995).
86. Forsman U, J Chromatogr 303: 217 (1984).
87. Allenmark S, Bromgren B, Boren H, J Chromatogr 237: 473 (1982).
88. Hermansson J, J Chromatogr 316: 537 (1984).
89. Hedeland M, Isaksson P, Pettersson C, J Chromatogr A 807: 297 (1998).
91. Salvador A, Herbreteau B, Dreux M, Karlsson A, Gyllenhaal O, J Chromatogr A
929: 101 (2001).
92. Wang S, Porter MD, J Chromatogr A 828: 157 (1998).
93. Wei W, Luo G, Xiang R, Yan C, J Microcol Sep 11: 263 (1999).
94. Ban E, Choi S, Lee JA, Lho DS, Yoo YS, J Chromatogr A 853: 439 (1999).
95. Lucangioli SE, Hermida LG, Tripodi VP, Rodriguez VG, Lopez EE, Rouge PD,
Carducci CN, J Chromatogr A 871: 207 (2000).
96. Garcia-Ruiz C, Martin-Biosca Y, Crego AL, Marina ML, J Chromatogr A 910: 157
(2001).

97. Mendez SP, Gonzalez EB, Sanz-Medel A, Biomed Chromatogr 14: 8 (2000).
98. Fanali S, Catarcini P, Blaschke G, Chankvetadze B, Electrophoresis 22: 3131
(2001).
99. Lelievre F, Yan C, Zare RN, J Chromatogr A 723: 145 (1996).
100. Debowski J, Grassini-Strazza G, Sybilska D, J Chromatogr 349: 131 (1985).
101. Armstrong DW, He FY, Han SM, J Chromatogr 448: 345 (1988).
102. Armstrong DW, Faulkner JR, Han SM, J Chromatogr 452: 323 (1988).
103. Aboul-Enein HY, El-Awady M, Heard CM, J Liq Chromatogr Relat Technol 23:
2715 (2000).
104. Lepri L, Coas V, Desideri PG, Pettini L, J Planar Chromatogr Mod TLC 5: 175
(1992).
105. Lepri L, Coas V, Desideri PG, J Planar Chromatogr Mod TLC 5: 364 (1992).
106. Armstrong DW, Zhou Y, J Liq Chromatogr 17: 1695 (1994).
107. Huang MB, Li HK, Li GL, Yan CT, Wang LP, J Chromatogr 742: 289 (1996).
108. Tivert AM, Backman A, J Planar Chromatogr Mod TLC 2: 472 (1989).
109. Tivert AM, Backman A, J Planar Chromatogr Mod TLC 6: 216 (1993).
110. Duncan JD, Armstrong DW, J Planar Chromatogr Mod TLC 3: 656 (1990).


Chiral Separations by Liquid Chromatography Theory and Applications

Uploaded by

Copyright:

Available Formats

Chiral Separations by Liquid Chromatography Theory and Applications

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Chiral Separations by Liquid Chromatography Theory and Applications

Uploaded by

Copyright:

Available Formats

What is the book about?

What is the book about?

What information is provided on the copyright pages?

What information is provided on the copyright pages?

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

Trademark notice: Product or corporate names may be trademarks or registered trademarks

Library of Congress Cataloging-in-Publication Data

This book is printed on acid-free paper.

Distribution and Customer Service

Eastern Hemisphere Distribution

World Wide Web

Copyright # 2003 by Marcel Dekker, Inc. All Rights Reserved.

Current printing (last digit):

PRINTED IN THE UNITED STATES OF AMERICA

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

A Series of Textbooks and Reference Books

Editor: JACK CAZES

1. Dynamics of Chromatography: Principles and Theory, J. Calvin Giddings

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

ADDITIONAL VOLUMES IN PREPARATION

Handbook of Size Exclusion Chromatography and Related Techniques,

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

This book is dedicated to the memory of my father, Dr. Youssef Aboul-Enein,

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

The development of chiral resolution methods is considered an urgent need in

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

I would like to express my thanks to the administration of King Faisal Specialist

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

2 Polysaccharide-Based Chiral Stationary Phases

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

3 Cyclodextrin-Based Chiral Stationary Phases

4 Macrocyclic Glycopeptide Antibiotics–Based Chiral Stationary

5 Pirkle-Type and Related Chiral Stationary Phases

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

6 Protein-Based Chiral Stationary Phases

7 Ligand Exchange–Based Chiral Stationary Phases

8 Crown Ether–Based Chiral Stationary Phases

9 Miscellaneous Types of Chiral Stationary Phase

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

10 Enantiomeric Separation by the Chiral Mobile Phase Additives

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

1.1 CHIRALITY AND ITS OCCURRENCE

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

1.3 CHIRALITY IN MOLECULES

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

1.3.1 Nomenclature of Chiral Molecules

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

1.4 CHIRALITY AND ITS CONSEQUENCES IN

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

1.5 CHIRALITY AND DRUG DEVELOPMENT

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

Drugs (þ)-Enantiomer ()-Enantiomer

Barbiturates Excitation Sedation

priate information on chemistry as well as manufacturing and control data, such

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.

1.6 CHIRAL DRUGS AND THEIR ECONOMIC

Copyright 2003 by Marcel Dekker, Inc. All Rights Reserved.